WorldWideScience

Sample records for menstrual migraine clinical

  1. Menstrual migraine

    Directory of Open Access Journals (Sweden)

    Simić Svetlana

    2007-01-01

    Full Text Available Introduction. The prevalence of migraine in childhood and adolescence has not changed to a great extent, but it increases in adolescence, especially in female adolescents. Menstrual migraine – definition. There are two types of menstrual migraine: true menstrual migraine and menstrual related migraine. True menstrual migraine occurs predominantly around menstruation, whereas menstrual related migraine occurs during menstruation, but also at other times during the month. Causes. Exaggerated or abnormal neurotransmitter responses to normal cyclic changes in the ovarian hormones are probably the basic cause of menstrual migraines. The fall in estrogen levels during menstrual cycle is trigger for the menstrual migraine. Symptoms. Menstrual migraine has the same symptoms as other types of migraine, but the pain is stronger, IT lasts longer, AND IT IS more frequent than other types of migraines. Diagnosis. In order to make a diagnosis, women are asked to keep a headache diary for three months. If the migraine headache is severe and occurs regularly between two days before and three days after the start of menstrual bleeding, it is true menstrual migraine. Therapy. Menstrual migraines are more difficult to treat than other types of migraines. Treatment principles for menstrual migraine are the same as for migraines in general, with certain particularities. Conclusion. Hormonally associated migraine is a specific clinical entity. It is important to diagnose the type of migraine, considering the fact that a decline in estrogen level at the end of menstrual cycle triggers migraine, so it can be treated by low levels of estrogen. .

  2. Pure menstrual migraine with sensory aura: a case report.

    Science.gov (United States)

    Chen, Jiann-Jy; Hsu, Yung-Chu; Chen, Dem-Lion

    2012-07-01

    Hormonal changes related to the menstrual cycle have a great impact on migraines in women. Menstrual migraine attacks are almost invariably without aura. Categorizing migraines into menstrual or non-menstrual types is one way to stratify migraines without aura according to the appendix criteria of the International Classification of Headache Disorders. We report a peri-menopausal woman whose sensory aura exclusively heralded menstrual migraine. A 51-year-old woman had suffered from monthly episodic headaches since the age of 46. Before a headache, and within 1 h on the first day of her menstruation, she always experienced numbness in her entire left upper limb. After the sensory aura, migrainous headaches occurred with nausea and photophobia. In the postmenopausal period, she no longer had sensory aura, and her headache pattern changed and became less severe. Her physical and neurologic exams as well as electroencephalography, brain magnetic resonance imaging, and conventional angiography were all normal. She fulfilled the diagnosis of pure menstrual migraine with typical sensory aura. To our knowledge, this is the first formal case report of pure menstrual migraine with aura.

  3. Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine.

    Science.gov (United States)

    Shaik, Munvar Miya; Gan, Siew Hua

    2015-01-01

    Migraine is the most common form of headache disorder globally. The etiology of migraine is multifactorial, with genetic components and environmental interactions considered to be the main causal factors. Some researchers postulate that deficits in mitochondrial energy reserves can cause migraine or an increase in homocysteine levels can lead to migraine attacks; therefore, vitamins could play a vital role in migraine prevention. For instance, riboflavin influences mitochondrial dysfunction and prevents migraine. Genes such as flavoenzyme 5,10-methylenetetrahydrofolate reductase (MTHFR), especially the C677T variant, have been associated with elevated plasma levels of homocysteine and migraine with aura. Homocysteine catalyzation requires the presence of vitamins B6, B12, and folic acid, which can decrease the severity of migraine with aura, making these vitamins potentially useful prophylactic agents for treating migraine with aura. Menstrual migraine, on the other hand, is associated with increased prostaglandin (PG) levels in the endometrium, indicating a role for vitamin E, which is an anti-PG. Vitamin C can also be used as a scavenger of reactive oxygen species for treating neurogenic inflammation in migraine patients. This paper reviews possible therapies based on vitamin supplementation for migraine prophylaxis, focusing on migraine with aura and menstrual migraine.

  4. Vitamin Supplementation as Possible Prophylactic Treatment against Migraine with Aura and Menstrual Migraine

    Directory of Open Access Journals (Sweden)

    Munvar Miya Shaik

    2015-01-01

    Full Text Available Migraine is the most common form of headache disorder globally. The etiology of migraine is multifactorial, with genetic components and environmental interactions considered to be the main causal factors. Some researchers postulate that deficits in mitochondrial energy reserves can cause migraine or an increase in homocysteine levels can lead to migraine attacks; therefore, vitamins could play a vital role in migraine prevention. For instance, riboflavin influences mitochondrial dysfunction and prevents migraine. Genes such as flavoenzyme 5,10-methylenetetrahydrofolate reductase (MTHFR, especially the C677T variant, have been associated with elevated plasma levels of homocysteine and migraine with aura. Homocysteine catalyzation requires the presence of vitamins B6, B12, and folic acid, which can decrease the severity of migraine with aura, making these vitamins potentially useful prophylactic agents for treating migraine with aura. Menstrual migraine, on the other hand, is associated with increased prostaglandin (PG levels in the endometrium, indicating a role for vitamin E, which is an anti-PG. Vitamin C can also be used as a scavenger of reactive oxygen species for treating neurogenic inflammation in migraine patients. This paper reviews possible therapies based on vitamin supplementation for migraine prophylaxis, focusing on migraine with aura and menstrual migraine.

  5. Treatment of menstrual migraine: utility of control of related mood disturbances.

    Science.gov (United States)

    Negro, Andrea; Napoletano, Flavia; Lionetto, Luana; Marsibilio, Francesco; Sani, Gabriele; Girardi, Paolo; Martelletti, Paolo

    2014-05-01

    Menstrual migraine (MM) has a prevalence in the general population of approximately 7%, although it seems to be much higher within the population of females with migraine. Episodes of MM have been reported to be longer, more intense, more disabling, less responsive to acute therapy and more prone to recurrence than those of other types of migraine. MM is demonstrated to have a bi-directional link to affective illnesses such as premenstrual dysphoric disorder and depression. There is clinical and pathophysiological evidence suggesting that the relationship between MM and affective disorders could be linked to ovarian hormones. The aim of this review is to analyze treatment strategies in patients with co-existent MM and affective disorders.

  6. Investigation of polymorphisms in genes involved in estrogen metabolism in menstrual migraine.

    Science.gov (United States)

    Sutherland, Heidi G; Champion, Morgane; Plays, Amelie; Stuart, Shani; Haupt, Larisa M; Frith, Alison; MacGregor, E Anne; Griffiths, Lyn R

    2017-04-05

    Migraine is a common, disabling headache disorder, which is influenced by multiple genes and environmental triggers. After puberty, the prevalence of migraine in women is three times higher than in men and >50% of females suffering from migraine report a menstrual association, suggesting hormonal fluctuations can influence the risk of migraine attacks. It has been hypothesized that the drop in estrogen during menses is an important trigger for menstrual migraine. Catechol-O-methyltransferase (COMT) and Cytochrome P450 (CYP) enzymes are involved in estrogen synthesis and metabolism. Functional polymorphisms in these genes can influence estrogen levels and therefore may be associated with risk of menstrual migraine. In this study we investigated four single nucleotide polymorphisms in three genes involved in estrogen metabolism that have been reported to impact enzyme levels or function, in a specific menstrual migraine cohort. 268 menstrual migraine cases and 142 controls were genotyped for rs4680 in COMT (Val158Met), rs4646903 and rs1048943 in CYP1A1 (T3801C and Ile462Val) and rs700519 in CYP19A1 (Cys264Arg). Neither genotype nor allele frequencies for the COMT and CYP SNPs genotyped were found to be significantly different between menstrual migraineurs and controls by chi-square analysis (P>0.05). Therefore we did not find association of functional polymorphisms in the estrogen metabolism genes COMT, CYP1A1 or CYP19A1 with menstrual migraine. Further studies are required to assess whether menstrual migraine is genetically distinct from the common migraine subtypes and identify genes that influence risk.

  7. Menstrual-Cycle and Menstruation Disorders in Episodic vs Chronic Migraine: An Exploratory Study.

    Science.gov (United States)

    Spierings, Egilius L H; Padamsee, Aliya

    2015-07-01

    Migraine is a chronic condition of recurring moderate-to-severe headaches that affects an estimated 6% of men and 18% of women. The highest prevalence is in those 18-49 years of age, generally when women menstruate. It is divided into episodic and chronic migraine depending on the total number of headache days per month being 14 or less or 15 or more, respectively. Migraine has been associated with menorrhagia, dysmenorrhea, and endometriosis, the latter particularly in chronic migraine. We conducted a questionnaire survey of 96 women with migraine, 18-45 years old, to determine the occurrence of the menstrual-cycle disorders, oligomenorrhea, polymenorrhea, and irregular cycle, and the menstruation disorders, dysmenorrhea and menorrhagia, in episodic vs chronic migraine. The prevalence of menstrual-cycle disorders in general (41.2 vs 22.2%) and dysmenorrhea (51.0 vs 28.9%) was statistically significantly higher in the women with chronic migraine than in those with episodic migraine (P ≤ 0.05) (not corrected for multiple comparisons). Whether the migraine was menstruation sensitive, that is, the headaches consistently occurred or worsened with menstruation, did not impact the prevalence of menstrual disorders. We conclude that chronic migraine is possibly more often than episodic migraine associated with menstrual-cycle disorders in general and dysmenorrhea, without impact on menstruation sensitivity of the headaches. Wiley Periodicals, Inc.

  8. Clinical effect of flunarizine on menstrual migraine%盐酸氟桂利嗪胶囊治疗月经期偏头痛的临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    冷闻辉; 于明; 朱颖; 张晓林; 吴旭明

    2011-01-01

    目的 探讨盐酸氟桂利嗪胶囊治疗月经期偏头痛的临床疗效及最佳治疗方案.方法 将68例月经期偏头痛患者随机分为两组,A组为常规治疗组(每周服用盐酸氟桂利嗪胶囊5天,停用2天),B组为按生物节律周期治疗组(在月经来临前十天服用盐酸氟桂利嗪胶囊,连续服用20天).所有患者均于睡前服用5mg盐酸氟桂利嗪胶囊,并记录头痛日记和药物不良反应;根据头痛程度、发作频率、持续时间和伴随症状的变化情况,经量化记分,于用药1个月、3个月、6个月进行疗效判定,同时比较药物不良反应的发生率.结果 1个月和3个月两组间盐酸氟桂利嗪胶囊疗效无明显差异(P>0.05),但6个月时,B组患者头痛程度、发作频率、持续时间、伴随症状与A组相比,明显减轻/减少(P<0.001);两组间药物不良发应发生率无差异(P>0.05).结论 盐酸氟桂利嗪胶囊能够有效的防治月经期偏头痛;根据生物节律周期即女性雌激素分泌水平变化给予盐酸氟桂利嗪胶囊防治月经期偏头痛疗效更佳.%Objective To determine the clinical effect and therapeutic scheme of flunarizine on menstrual migraine. Methods Sixty-eight patients with menstrual migraine were randomly divided into two groups, routine treatment group and biological rhythm treatment group. The former were given flunarizine five times per week, the latter were continuously administrated twenty times ten days before the onset of menstruation. All of the patients were taken flunarizine 5mg before sleep and asked to record a headache diary and adverse drug reactions. According to degree, frequency, duration and associated symptoms of headache, clinical effects were determined at 1mon, 3mon and 6mon respectively. Meantime, adverse drug reactions between two groups were compared. Results There were no difference in clinical effect between two groups at 1 mon and 3mon ( P > 0.05 ). In the patient given biological

  9. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.

    Science.gov (United States)

    Savi, Lidia; Omboni, Stefano; Lisotto, Carlo; Zanchin, Giorgio; Ferrari, Michel D; Zava, Dario; Pinessi, Lorenzo

    2011-12-01

    The objectives of this study are to assess the efficacy and safety of frovatriptan, and rizatriptan in the subgroup of women with menstrually related migraine of a multicenter, randomized, double blind, cross-over study. Each patient received frovatriptan 2.5 mg or rizatriptan 10 mg in a randomized sequence: after treating 3 episodes of migraine in not more than 3 months with the first treatment, the patient had to switch to the other treatment. Menstrually related migraine was defined according to the criteria listed in the Appendix of the last IHS Classification of Headache disorders. 99 out of the 125 patients included in the intention-to-treat analysis of the main study were of a female gender: 93 had regular menstrual cycles and were, thus, included in this analysis. A total of 49 attacks classified as menstrually related migraine were treated with frovatriptan and 59 with rizatriptan. Rate of pain relief at 2 h was 58% for frovatriptan and 64% for rizatriptan (p = NS), while rate of pain free at 2 h was 31 and 34% (p = NS), respectively. At 24 h, 67 and 81% of frovatriptan-treated, and 61 and 74% of rizatriptan-treated patients were pain free and had pain relief, respectively (p = NS). Recurrence at 24 h was significantly (p rizatriptan). Frovatriptan was as effective as rizatriptan in the immediate treatment of menstrually related migraine attacks while showing a favorable sustained effect with a lower rate of migraine recurrence. These results need to be confirmed by randomized, double-blind, prospective, large clinical trials.

  10. Estrous Cycle Induces Peripheral Sensitization in Trigeminal Ganglion Neurons: An Animal Model of Menstrual Migraine.

    Science.gov (United States)

    Saleeon, Wachirapong; Jansri, Ukkrit; Srikiatkhachorn, Anan; Bongsebandhu-phubhakdi, Saknan

    2016-02-01

    Many women experience menstrual migraines that develop into recurrent migraine attacks during menstruation. In the human menstrual cycle, the estrogen level fluctuates according to changes in the follicular and luteal phases. The rat estrous cycle is used as an animal model to study the effects of estrogen fluctuation. To investigate whether the estrous cycle is involved in migraine development by comparing the neuronal excitability of trigeminal ganglion (TG) neurons in each stage of the estrous cycle. Female rats were divided into four experimental groups based on examinations of the cytologies of vaginal smears, and serum analyses of estrogen levels following each stage of the estrous cycle. The rats in each stage of the estrous cycle were anesthetized and their trigeminal ganglia were removed The collections of trigeminal ganglia were cultured for two to three hours, after which whole-cell patch clamp experiments were recorded to estimate the electrophysiological properties of the TG neurons. There were many vaginal epithelial cells and high estrogen levels in the proestrus and estrus stages of the estrous cycle. Electrophysiological studies revealed that the TG neurons in the proestrus and estrus stages exhibited significantly lower thresholds of stimulation, and significant increase in total spikes compared to the TG neurons that were collected in the diestrus stage. Our results revealed that high estrogen levels in the proestrus and estrus stages altered the thresholds, rheobases, and total spikes of the TG neurons. High estrogen levels in the estrous cycle induced an increase in neuronal excitability and the peripheral sensitization of TG neurons. These findings may provide an explanation for the correlation of estrogen fluctuations during the menstrual cycle with the pathogenesis of menstrual migraines.

  11. Clinical Records for Acupuncture Treatment of Migraine

    Institute of Scientific and Technical Information of China (English)

    陶莎

    2005-01-01

    @@ Migraine, characterized by periodic attacks that hampers the quality of the daily life, is an obstinate symptom complex commonly seen in the clinic. In contrast with the poor effects obtained in Western medicine, acupuncture is a safe and effective treatment for migraine. The following are the clinical records for acupuncture treatment of migraine in the recent 5 years.

  12. Vestibular migraine: clinical and epidemiological aspects

    Directory of Open Access Journals (Sweden)

    Ligia Oliveira Gonçalves Morganti

    Full Text Available ABSTRACT INTRODUCTION: Vestibular migraine (VM is one of the most often common diagnoses in neurotology, but only recently has been recognized as a disease. OBJECTIVE: To analyze the clinical and epidemiological profile of patients with VM. METHODS: This was a retrospective, observational, and descriptive study, with analysis of patients' records from an outpatient VM clinic. RESULTS: 94.1% of patients were females and 5.9% were males. The mean age was 46.1 years; 65.6% of patients had had headache for a longer period than dizziness. A correlation was detected between VM symptoms and the menstrual period. 61.53% of patients had auditory symptoms, with tinnitus the most common, although tonal audiometry was normal in 68.51%. Vectoelectronystagmography was normal in 67.34%, 10.20% had hyporeflexia, and 22.44% had vestibular hyperreflexia. Electrophysiological assessment showed no abnormalities in most patients. Fasting plasma glucose and glycemic curve were normal in most patients, while the insulin curve was abnormal in 75%. 82% of individuals with MV showed abnormalities on the metabolism of carbohydrates. CONCLUSION: VM affects predominantly middle-aged women, with migraine headache representing the first symptom, several years before vertigo. Physical, auditory, and vestibular evaluations are usually normal. The most frequent vestibular abnormality was hyperreflexia. Most individuals showed abnormality related to carbohydrate metabolism.

  13. Catamenial migraine: epidemiology, pathogenesis, diagnosis, clinical features

    Directory of Open Access Journals (Sweden)

    S A Gromova

    2010-01-01

    Full Text Available Based on a review of the literature, the authors consider the pathogenesis, diagnosis, epidemiology, and clinical features of catamenial migraine. The view that catamenial migraine attacks are severest receives more and more support. The criteria that may be used to predict a severer course of catamenial migraine attacks in a specific patient are to be further defined.

  14. Refractory migraine in a headache clinic population

    Directory of Open Access Journals (Sweden)

    Fernandez-Torron Roberto

    2011-08-01

    Full Text Available Abstract Background Many migraineurs who seek care in headache clinics are refractory to treatment, despite advances in headache therapies. Epidemiology is poorly characterized, because diagnostic criteria for refractory migraine were not available until recently. We aimed to determine the frequency of refractory migraine in patients attended in the Headache Unit in a tertiary care center, according to recently proposed criteria. Methods The study population consisted of a consecutive sample of 370 patients (60.8% females with a mean age of 43 years (range 14-86 evaluated for the first time in our headache unit over a one-year period (between October 2008 and October 2009. We recorded information on clinical features, previous treatments, Migraine Disability Assessment Score (MIDAS, and final diagnosis. Results Overall migraine and tension-type headache were found in 46.4% and 20.5% of patients, respectively. Refractory migraine was found in 5.1% of patients. In refractory migraineurs, the mean MIDAS score was 96, and 36.8% were medication-overusers. Conclusions Refractory migraine is a relatively common and very disabling condition between the patients attended in a headache unit. The proposed operational criteria may be useful in identifying those patients who require care in headache units, the selection of candidates for combinations of prophylactic drugs or invasive treatments such as neurostimulation, but also to facilitate clinical studies in this patient group.

  15. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.

    Science.gov (United States)

    Mannix, L K; Loder, E; Nett, R; Mueller, L; Rodgers, A; Hustad, C M; Ramsey, K E; Skobieranda, F

    2007-05-01

    These are the first prospective studies to use criteria for menstrual migraine proposed in the 2004 revision of the International Classification of Headache Disorders (ICHD-II) to examine the efficacy of rizatriptan for treatment of a menstrual attack. Two identical protocols (MM1 and MM2) were randomized, parallel, placebo-controlled, double-blind studies. Adult women with ICHD-II menstrual migraine were assigned to either rizatriptan 10-mg tablet or placebo in a 2 : 1 ratio. Patients treated a single menstrual migraine attack of moderate or severe pain intensity. The primary end-point was 2-h pain relief and the secondary end-point was 24-h sustained pain relief. A total of 707 patients (MM1 357, MM2 350) treated a menstrual migraine attack. The percentage of patients reporting 2-h pain relief was significantly greater for rizatriptan than for placebo (MM1 70% vs. 53%, MM2 73% vs. 50%), as was the percentage of patients reporting 24-h sustained pain relief (MM1 46% vs. 33%; MM2 46% vs. 33%). Rizatriptan 10 mg was effective for the treatment of ICHD-II menstrual migraine, as measured by 2-h pain relief and 24-h sustained pain relief.

  16. The association between candidate migraine susceptibility loci and severe migraine phenotype in a clinical sample

    DEFF Research Database (Denmark)

    Esserlind, Ann-Louise; Christensen, Anne Francke; Steinberg, Stacy

    2016-01-01

    INTRODUCTION: The objective of the study was to follow up and to test whether 12 previously identified migraine-associated single nucleotide polymorphisms were associated as risk factors and/or modifying factors for severe migraine traits in a Danish clinic-based population. METHODS: Semi...... polymorphisms showed nominal association with many lifetime attacks and prolonged migraine attacks. CONCLUSION: Our study supports previously reported findings on the association of several single nucleotide polymorphisms with migraine. It also suggests that the migraine susceptibility loci may be risk factors......-structured migraine interviews, blood sampling and genotyping were performed on 1806 unrelated migraineurs recruited from the Danish Headache Center. Genotyping was also performed on a control group of 6415 people with no history of migraine. Association analyses were carried out using logistic regression and odds...

  17. Migraine.

    Science.gov (United States)

    MacGregor, E Anne

    2017-04-04

    This issue provides a clinical overview of migraine, focusing on risk, prevention, diagnosis, treatment, follow-up, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance of additional science writers and physician writers.

  18. Menstrual questionnaires for clinical and research use.

    Science.gov (United States)

    Matteson, Kristen A

    2017-04-01

    Patient-reported outcome measures (PROMs) have the potential to be extremely valuable in the clinical care delivery for women who report heavy menstrual bleeding (HMB). Increasingly, studies on HMB have incorporated PROMs to evaluate the impact of bleeding on quality of life. These measures have included semiquantitative charts and pictograms, questionnaires to assess symptoms and impact on quality of life, and health-related quality of life questionnaires. Recent systematic reviews have highlighted inconsistency of outcome measurement across studies on HMB as a challenge limiting the interpretability of the body of literature and the ability to generate consensus on the relative effectiveness of treatment options. Consequently, research initiatives and international collaborations are working to harmonize outcome measurement. Harmonizing the use of questionnaires in research and clinical care has the potential to improve patient-centered care delivery for women with HMB and improve the generation of patient-focused evidence-based guidelines for the evaluation and treatment of HMB. Copyright © 2016. Published by Elsevier Ltd.

  19. Vestibular migraine: clinical and epidemiological aspects

    OpenAIRE

    Ligia Oliveira Gonçalves Morganti; Márcio Cavalcante Salmito; Juliana Antoniolli Duarte; Karina Cavalcanti Sumi; Juliana Caminha Simões; Fernando Freitas Ganança

    2016-01-01

    ABSTRACT INTRODUCTION: Vestibular migraine (VM) is one of the most often common diagnoses in neurotology, but only recently has been recognized as a disease. OBJECTIVE: To analyze the clinical and epidemiological profile of patients with VM. METHODS: This was a retrospective, observational, and descriptive study, with analysis of patients' records from an outpatient VM clinic. RESULTS: 94.1% of patients were females and 5.9% were males. The mean age was 46.1 years; 65.6% of patients h...

  20. Variability of clinical features in attacks of migraine with aura

    DEFF Research Database (Denmark)

    Hansen, Jakob M; Goadsby, Peter J; Charles, Andrew C

    2016-01-01

    BACKGROUND: There is significant variability in the clinical presentation of migraine, both among patients, and between attacks in an individual patient. We examined clinical features of migraine with aura in a large group of patients enrolled in a clinical trial, and compared retrospective...... migraine attack characteristics reported upon enrollment in the trial with those recorded prospectively in the trial. METHODS: Patients with migraine (n = 267) with typical visual aura in more than 30% of their attacks were enrolled from 16 centers for a clinical trial. Upon enrollment, patients provided...... a detailed retrospective description of the clinical features of their attacks of migraine. During the trial, clinical symptoms in migraine attacks starting with aura were recorded prospectively in 861 attacks. RESULTS: Retrospectively reported visual aura symptoms were variable and often overlapping...

  1. Comorbidity of epilepsy and migraines epidemiological and clinical aspects

    Directory of Open Access Journals (Sweden)

    Vujisic Slavica

    2012-03-01

    Full Text Available In patients with migraines, epilepsy occurs in 5.9% (1-17% of cases compared to a prevalence of 0.5-1% in the general population. Comorbidity of migraines and epilepsy can be explained by neuronal hyperexcitability, while cortical spreading depression is considered to be a pathophysiological mechanism that lies in the basis of the migraine aura. The study included 259 patients with epilepsy and 40 patients with both epilepsy and migraines. The aim of the investigation was to determine the prevalence of migraines, the existence of a temporal association between epileptic and migraine attacks, to determine the clinical characteristics of joint epileptic and migraine attacks, the existence of a significant connection between a certain type of epileptic seizure and type of headache, and finally to determine heredity for epilepsy and migraines in patients who have these conditions associated. Patients were diagnosed clinically, neurophysiologically and neuroradiologically. The research results show that the frequency of associated epilepsy and migraines occurred in 15.44%. The results of this investigation point to a significantly higher frequency of epilepsy and migraines in female patients (ratio 5 : 1, which is different from the data we found in existing studies. Temporally connected attacks of epilepsy and migraines were observed in 48% of patients. Preictal headaches appeared in 20% of patients, postictal in 28% of patients. There was no significant association between migraines and the particular type of epileptic attack. Heredity for migraines was present in 35% of patients with both epilepsy and migraines. This data is significantly lower than the data found in other studies.

  2. Clinical image: MRI during migraine with aura

    Energy Technology Data Exchange (ETDEWEB)

    McNeal, A.C. [Brooklyn VA Medical Center, NY (United States)

    1996-03-01

    Migraine refers to severe headaches that are usually unilateral, throbbing, and associated with nausea, vomiting, photophobia, and phonophobia. Migraine with aura (formerly called {open_quotes}classic migraine{close_quotes}) consists of the headache preceded or accompanied by neurological dysfunction. This dysfunction (aura) usually involves visual and sensory symptoms. The patient described herein experienced migraine with aura. MRI during and after the attack showed a reversible abnormality of the right posterior cerebral artery, with no parenchymal lesions. This appears to be the first report of abnormal MR vascular imaging during migraine with aura. 10 refs., 2 figs.

  3. Migraine accompagnee: Clinical and neutroradiological findings. Migraine Accompagnee: Klinische und neutroradiologische Befunde

    Energy Technology Data Exchange (ETDEWEB)

    Schaefer, E.M.

    1981-01-01

    This study analyses clinical data, EEC and X-ray findings of 102 stationary examined migraine patients, 62 of whom suffered from migraine accompagnee. Sex distribution, age at onset of disease, hereditary disease disposition and EEC findings largely correspond to the data given in literature. As it had been expected, the X-ray images of the skull and the cerebral angiographies performed in 46 patients suffering from migraine accompagnee did not show any pathological findings. The X-ray images were compared with those taken of patients without migraine anamnesis in order to detect non-pathologic variations. Neither differences in the intensity of vascular and diplovenous marking could be found in the native images of the skull nor any variations of the circle of Willis. The dependency of the posterior cerebral artery on the carotid circulation existing in 41% of the migraine accompagnee does not lead to any particular alteration of the accompanying symptoms and signs. The idea is discussed to divide the migraine syndrome into simple, focal and complicated migraine on the basis of a uniform pathogenesis.

  4. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.

    Science.gov (United States)

    Coffee, Andrea L; Sulak, Patricia J; Hill, Alexandria J; Hansen, Darci J; Kuehl, Thomas J; Clark, Jeffrey W

    2014-04-01

    Migraine headaches are a significant problem for American women with many of them suffering from headaches around the time of their menstrual cycle. Women taking oral contraceptives in the standard 21/7 cycle regimen often suffer from headaches around the time of the hormone free intervals (HFIs) as well. Extended oral contraceptive regimens have been shown to decrease the frequency, but not eliminate these headaches. This study is a double-blind, randomized, placebo-controlled pilot study of participants with menstrual-related migraines (MRMs) who were initiated on extended combined oral contraceptives and given frovatriptan prophylactically during HFIs. Participants having spontaneous menstrual cycles or taking daily combined oral contraceptives in a 21/7 regimen with MRMs were placed on a contraceptive containing levonorgestrel and ethinyl estradiol. Analyses compared headache scores during pre-study baseline cycles to those in a 168-day extended regimen with placebo versus frovatriptan treatments during HFIs. Daily headache scores decreased (p=0.034) from 1.29 ± 0.10 during pre-study cycles to 1.10 ± 0.14 during extended combined oral contraceptive use. Frovatriptan blocked the increase in headache score over the placebo during HFIs. However, following the withdrawal of frovatriptan, headache scores increased (p>0.01) despite resuming combined oral contraceptive use. Extended combined oral contraceptive regimen reduces MRM severity. Frovatriptan prevents headaches during HFIs, but is associated with new headache symptoms when withdrawn.

  5. Migraine

    Science.gov (United States)

    ... of the body Difficulty speaking Hearing noises or music Uncontrollable jerking or other movements Sometimes, a migraine ... to them. LTC may also be combined with cognitive behavioral therapy. More research is needed to better ...

  6. Review of zolmitriptan and its clinical applications in migraine.

    Science.gov (United States)

    Dowson, Andrew J; Charlesworth, Bruce

    2002-07-01

    Preclinical studies have shown that zolmitriptan is a selective serotonin 5-HT(1B/1D) receptor agonist (triptan). Randomised, placebo-controlled, double-blind trials in patients with migraine have shown that zolmitriptan has good efficacy measured using 2 h response and pain-free rates. Migraine-associated symptoms, including nausea, photophobia and phonophobia, are also improved with zolmitriptan. Oral zolmitriptan (2.5 and 5 mg) has an onset of action within 45 min and efficacy is sustained in most patients who respond at 2 h. The orally-disintegrating zolmitriptan tablet has the advantage that it may be taken immediately, without the need for additional fluids, any time a migraine headache occurs. Patients may benefit in terms of improved efficacy from the convenience of the disintegrating tablet, since there is evidence that taking triptan therapy as early as possible in an attack is advantageous. For similar reasons, as well as improved efficacy, a nasal spray formulation is in development. Zolmitriptan is effective in the treatment of migraine associated with menses and migraine with aura. There is no tachyphylaxis following repeated doses for multiple attacks of migraine over a prolonged period of time. Compared to placebo, the incidence of persistent migraine headache is reduced by zolmitriptan and recurrent migraine headache occurs less frequently. Zolmitriptan has also shown efficacy in the treatment of persistent and/or recurrent migraine headache. Comparative clinical studies have shown overall that zolmitriptan has similar or superior efficacy to sumatriptan in the treatment of migraine. Specifically, zolmitriptan 2.5 mg was significantly more effective than sumatriptan 25 or 50 mg according to a number of end points, including headache response at 2 h. Oral zolmitriptan is also effective in the acute treatment of cluster headache. Zolmitriptan is generally well tolerated, with most adverse events being mild-to-moderate, transient and resolving without

  7. Migraine

    Science.gov (United States)

    ... woman's menstrual cycle or with the use of birth control pills Changes in sleep patterns Drinking alcohol Exercise or ... other risk factors for stroke. These include: Taking birth control pills Eating unhealthy foods, which can cause high cholesterol ...

  8. Migraine and Hormones.

    Science.gov (United States)

    Pakalnis, Ann

    2016-02-01

    This article discusses the role that hormones play in adolescent girls and young women with headaches, which are very common in adolescent girls, in particular, migraine. In many cases, migraine onset may occur shortly around the time of menarche, prevalence of recurrent migraine in this population approaches 15%, and typically the symptoms continue through adulthood. Hormonal changes associated with puberty and the menstrual cycle may significantly influence migraine in young women. This article reviews the following topics: management of menstrually related headaches, changes in ovarian hormones and their relationship to migraine, and oral contraceptives and pregnancy effects on migraine.

  9. Migraine: etiology, risk, triggering, aggravating factors and clinical manifestations

    Directory of Open Access Journals (Sweden)

    Natalia Lindemann Carezzato

    2014-06-01

    Full Text Available This study aimed to identify the etiology and clinical manifestations of migraine. An integrative literature review was performed guided by the question: What is the evidence available in the literature about the etiology, signs and symptoms of migraine? The article search was conducted in the electronic databases PubMed and LILACS, considering publications in the period from 2006 to 2010. The selected articles were categorized and evaluated according to the level of evidence. One found 1,677 articles and 26 were selected for full reading. Most studies (84.6% consisted of a non-experimental design and were classified as evidence level IV. Although the clinical manifestations found in this study confirm the data available in the literature, it is noticed that migraine does not have well-established causes

  10. Early clinical experience with subcutaneous GR43175 in acute migraine

    DEFF Research Database (Denmark)

    Tfelt-Hansen, P; Brand, J; Dano, P

    1989-01-01

    In six European clinics 111 migraine patients were treated in a series of open dose-ranging studies with subcutaneous injections of 1 to 4 mg GR43175, a novel 5-HT 1-like receptor agonist. Response rates after 20-30 min were dose related and rose from 33% with 1 mg to 96% with 4 mg GR43175. Side ...

  11. Effect of Yoga on migraine: A comprehensive study using clinical profile and cardiac autonomic functions

    OpenAIRE

    Ravikiran Kisan; Sujan, M. U.; Meghana Adoor; Raghavendra Rao; Nalini, A.; Bindu M Kutty; B T Chindanda Murthy; Raju, T. R.; T N Sathyaprabha

    2014-01-01

    Context and Aims: Migraine is an episodic disabling headache requiring long-term management. Migraine management through Yoga therapy would reduce the medication cost with positive health benefits. Yoga has shown to improve the quality of life, reduce the episode of headache and medication. The aim of the present study was to evaluate the efficacy of Yoga as an adjuvant therapy in migraine patients by assessing clinical outcome and autonomic functions tests. Subjects and Methods: Migraine...

  12. Acute migraine | EU Clinical Trials Register [EU Clinical Trials Register

    Lifescience Database Archive (English)

    Full Text Available investigation E.1.1Medical condition(s) being investigated Acute migraine MedDRA Classification E.1.2 Medic...Classification code 10066635 E.1.2Term Acute migraine E.1.3Condition being studied is a rare disease No E.2

  13. Menorrhagia (Heavy Menstrual Bleeding)

    Science.gov (United States)

    Diseases and Conditions Menorrhagia (heavy menstrual bleeding) By Mayo Clinic Staff Menorrhagia is the medical term for menstrual periods with abnormally heavy or prolonged bleeding. Although heavy ...

  14. Vestibular Migraine: Clinical Challenges and Opportunities for Multidisciplinarity

    Directory of Open Access Journals (Sweden)

    Isabel Luzeiro

    2016-01-01

    Full Text Available Migraine and vertigo are two very prevalent conditions in general population. The coexistence of both in the same subject is a significant clinical challenge, since it is not always possible to understand whether they are causally related or associated by chance, requiring different diagnostic and therapeutic approaches. In this review we analyze and summarize the actual knowledge about vestibular migraine (VM, focusing on the new concepts proposed by the International Classification of Headache Disorders 3-beta and by the Bárány Society and also addressing the former concepts, which are still present in clinical practice. We conclude that clinical studies using a multidisciplinary approach are crucial in this field, since different specialists observe the same pathology with different eyes. Clinical presentation of VM is variable in what concerns vestibular symptoms temporal relation with migraine headache, as well as in their accompanying manifestations. Biomarkers, either genomics or functional, and molecular imaging techniques will be helpful to clarify many aspects of the complexity of this entity, helping to define to what extent can VM be considered a separate and independent clinical entity.

  15. Vestibular Migraine: Clinical Challenges and Opportunities for Multidisciplinarity

    Science.gov (United States)

    Luís, Leonel; Gonçalves, Freire; Pavão Martins, Isabel

    2016-01-01

    Migraine and vertigo are two very prevalent conditions in general population. The coexistence of both in the same subject is a significant clinical challenge, since it is not always possible to understand whether they are causally related or associated by chance, requiring different diagnostic and therapeutic approaches. In this review we analyze and summarize the actual knowledge about vestibular migraine (VM), focusing on the new concepts proposed by the International Classification of Headache Disorders 3-beta and by the Bárány Society and also addressing the former concepts, which are still present in clinical practice. We conclude that clinical studies using a multidisciplinary approach are crucial in this field, since different specialists observe the same pathology with different eyes. Clinical presentation of VM is variable in what concerns vestibular symptoms temporal relation with migraine headache, as well as in their accompanying manifestations. Biomarkers, either genomics or functional, and molecular imaging techniques will be helpful to clarify many aspects of the complexity of this entity, helping to define to what extent can VM be considered a separate and independent clinical entity. PMID:28082766

  16. Migrainous infarction

    DEFF Research Database (Denmark)

    Laurell, K; Artto, V; Bendtsen, L

    2011-01-01

    Migrainous infarction (MI), i.e. an ischemic stroke developing during an attack of migraine with aura is rare and the knowledge of its clinical characteristics is limited. Previous case series using the International Classification of Headache Disorders (ICHD) included......Migrainous infarction (MI), i.e. an ischemic stroke developing during an attack of migraine with aura is rare and the knowledge of its clinical characteristics is limited. Previous case series using the International Classification of Headache Disorders (ICHD) included...

  17. Reconsideration of the diagnosis and treatment of childhood migraine: A practical review of clinical experiences.

    Science.gov (United States)

    Saito, Yoshiaki; Yamanaka, Gaku; Shimomura, Hideki; Shiraishi, Kazuhiro; Nakazawa, Tomoyuki; Kato, Fumihide; Shimizu-Motohashi, Yuko; Sasaki, Masayuki; Maegaki, Yoshihiro

    2017-05-01

    To provide insight into the wide spectrum of migraine during childhood to establish practical and comprehensive treatment strategies. Although recent studies have confirmed the effect of anti-migraine agents in childhood headaches fulfilling the criteria of migraine without aura, there have been no studies regarding the efficacy of these drugs in childhood migraine without aura not filling the diagnostic criteria. In total, 154 patients with a clinical diagnosis of migraine, with onset of repetitive headaches at the age of ⩽15years, were retrospectively included from clinics in seven tertiary medical centers. Patients' diagnoses included migraine with aura (n=49), migraine without aura (n=65), clinical migraine without aura not fulfilling International Classification of Headache Disorders-3 beta criteria (suspected migraine without aura; n=38), and hemiplegic migraine (n=2). Abortive medicine was effective in 74 of 97 patients, and preventive medicine was effective in 61 of 84 patients. Drugs with high efficacy were acetaminophen and ibuprofen for abortive therapy and cyproheptadine, amitriptyline, and propranolol for preventive therapy. Psychosocial problems were less common, and abnormalities on electroencephalography were more common in the suspected migraine without aura group. Otherwise, clinical features and drug responsibility were comparable among the migraine with aura, migraine without aura, and suspected migraine without aura groups. Retrospectively, experts clinically diagnosed childhood migraine without aura when the headache met at least one of the three criteria B, C, and D in International Classification of Headache Disorders-3 beta in addition to A and E. Abortive and preventive medication including paroxetine (n=2) benefited 10 and 15 of the 33 patients with daily headache, respectively. Psychotherapy/counseling (n=4), treatment for orthostatic dysregulation (n=4), and elimination of stressors (n=3) markedly alleviated headache in this group

  18. Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update

    Directory of Open Access Journals (Sweden)

    Sergio Carmona

    2009-08-01

    Full Text Available Sergio Carmona1, Osvaldo Bruera1,21Department of Neuro-otology and Pain and Headache, Instituto de Neurociencias de Buenos Aires INEBA, Buenos Aires, Argentina; 2Department of Pain and Headache, Fundación Favaloro, Buenos Aires, ArgentinaAbstract: Migraine and migraine variants are common, chronic and incapacitating neurovascular disorders with a high impact on health resources. There is an extensive evidence base provided by double-blind, placebo-controlled trials showing that topiramate is a safe, effective and well tolerated drug in the management of migraine and its variants, being especially promising in the management of migraine-vertigo syndrome. Models both in the US and the UK have also shown that it offers a cost benefit when direct and indirect costs are evaluated, by reducing work loss, improving quality of life and reducing the use of increasingly scarce health resources.Keywords: migraine, migraine prophylaxis, topiramate, quality of life, basilar migraine, cluster headache, vestibular migraine

  19. Migraine in menopausal women: a systematic review

    Directory of Open Access Journals (Sweden)

    Ripa P

    2015-08-01

    Full Text Available Patrizia Ripa,1 Raffaele Ornello,1 Diana Degan,1 Cindy Tiseo,1 Janet Stewart,2 Francesca Pistoia,1 Antonio Carolei,1 Simona Sacco1 1Department of Applied Clinical Sciences and Biotechnology, Institute of Neurology, University of L’Aquila, L’Aquila, Italy; 2Psychology Division, School of Natural Sciences, University of Stirling, Scotland, UK Abstract: Evidence suggests that migraine activity is influenced by hormonal factors, and particularly by estrogen levels, but relatively few studies have investigated the prevalence and characteristics of migraine according to the menopausal status. Overall, population-based studies have shown an improvement of migraine after menopause, with a possible increase in perimenopause. On the contrary, the studies performed on patients referring to headache centers have shown no improvement or even worsening of migraine. Menopause etiology may play a role in migraine evolution during the menopausal period, with migraine improvement more likely occurring after spontaneous rather than after surgical menopause. Postmenopausal hormone replacement therapy has been found to be associated with migraine worsening in observational population-based studies. The effects of several therapeutic regimens on migraine has also been investigated, leading to nonconclusive results. To date, no specific preventive measures are recommended for menopausal women with migraine. There is a need for further research in order to clarify the relationship between migraine and hormonal changes in women, and to quantify the real burden of migraine after the menopause. Hormonal manipulation for the treatment of refractory postmenopausal migraine is still a matter of debate. Keywords: headache, female, menstrual cycle, sex hormones

  20. Research note. Clinical reports and analysis of patients with clinical manifestations of migraine-like headache and unruptured aneurysm.

    Science.gov (United States)

    Zhao, M

    2015-02-13

    A retrospective analysis of three cases of clinical manifestations of migraine-like headache, including clinical features, imaging findings, and follow-up results was done to explore the potential correlation between migraine and unruptured aneurysm. Clinical data and digital subtraction angiography (DSA) results were retrospectively analyzed. All three patients met the diagnostic criteria for migraine without aura stated in the second edition of the International Classification of Headache Disorders, established by the International Headache Society in 2004. The DSA results suggested that the aneurysms occurred in the anterior communicating artery (two cases) and in the internal carotid artery (one case); the migraine attacks disappeared after aneurysm embolization, with a follow-up time of 6, 10, and 16 months in the three cases, respectively. The pathogenesis of migraine is not fully understood; however, the potential correlation between migraine attack and unruptured saccular aneurysm needs attention, and the specific pathogenesis should be further investigated.

  1. Migraine with Aura

    Science.gov (United States)

    Migraine with aura Overview By Mayo Clinic Staff Migraine with aura (also called classic migraine) is a headache that strikes after or along with sensory disturbances called aura. These disturbances can include flashes of light, blind ...

  2. Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation.

    Science.gov (United States)

    Gori, Sara; Lucchesi, Cinzia; Baldacci, Filippo; Bonuccelli, Ubaldo

    2015-01-01

    It is well known that migraine attacks can preferentially occur during night sleep and/or upon awakening, however the possible implications of this timing on migraine clinical presentation remain unclear. The aim of this study was to assess the possible consequences of sleep-related migraine (defined as ≥ 75% of migraine attacks occurring during night sleep and/or upon awakening) on the migraine clinical picture (i.e. migraine-related disability, attack severity, use of symptomatic drugs), subjective sleep quality, excessive daytime sleepiness and fatigue. Two hundred consecutive migraine without aura patients were enrolled; patients with comorbid disorders or chronic medication use were excluded. 39% of the migraineurs included in the study received a diagnosis of sleep-related migraine. The mean frequency of migraine attacks (days per month) did not significantly differ between the patients with and those without sleep-related migraine, whereas migraine-related disability (pdrugs (psleep quality and excessive daytime sleepiness did not differ significantly between the two groups, whereas fatigue was significantly more present in the patients with sleep-related migraine (p=0.0001). These data seem to support the hypothesis that patients with sleep-related migraine represent a subset of individuals with a more severe and disabling clinical presentation of migraine and greater impairment of daily functioning, as suggested by the higher degree of fatigue. Migraineurs with night-time attacks Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation also showed a greater use of symptomatic drugs, possibly related to delayed use of symptomatic treatment. The identification of subtypes of patients with a higher disability risk profile could have crucial implications for individually tailored management of migraine patients.

  3. Optimizing prophylactic treatment of migraine: Subtypes and patient matching

    Directory of Open Access Journals (Sweden)

    Michel Dib

    2008-09-01

    Full Text Available Michel DibFédération du système nerveux central, Hôpital de la Salpêtrière, Assistance Publique- Hôpitaux de Paris, FranceAbstract: Advances in our understanding of the pathophysiology of migraine have resulted in important breakthroughs in treatment. For example, understanding of the role of serotonin in the cerebrovascular circulation has led to the development of triptans for the acute relief of migraine headaches, and the identification of cortical spreading depression as an early central event associated wih migraine has brought renewed interest in antiepileptic drugs for migraine prophylaxis. However, migraine still remains inadequately treated. Indeed, it is apparent that migraine is not a single disease but rather a syndrome that can manifest itself in a variety of pathological conditions. The consequences of this may be that treatment needs to be matched to particular patients. Clinical research needs to be devoted to identifying which sort of patients benefit best from which treatments, particularly in the field of prophylaxis. We propose four patterns of precipitating factors (adrenergic, serotoninergic, menstrual, and muscular which may be used to structure migraine prophylaxis. Finally, little is known about long-term outcome in treated migraine. It is possible that appropriate early prophylaxis may modify the long-term course of the disease and avoid late complications.Keywords: migraine, diagnosis, treatment, prophylaxis, subtypes

  4. Genetic and environmental determinants of menstrual characteristics

    Directory of Open Access Journals (Sweden)

    Shayesteh Jahanfar

    2012-01-01

    Full Text Available Background: The impact of women′s menstrual cycle on her quality of life, health, work, and community is substantial. Menstrual disturbance is linked with general ill conditions such as migraine, asthma, and endocrinopathies. The clinical significance of medical interventions to prevent these conditions becomes clear if the role of genetic or environment is clarified. Aims: To identify the genetic and environmental contribution on menstrual characteristics. Setting and Design: This was a cross-sectional study in 2 Asian countries. Materials and Methods: 2 cohorts of monozygotic and dizygotic twins born between (1945-1988, n = 122 and (1951-1993, n = 71 were taken. A standard questionnaire was designed inclusive of socio- demographic characteristics of subjects as well as menstrual history (duration, interval, amount, irregularity. Subjects were interviewed by phone. Statistical Analysis: Quantitative variables were analyzed using Falconars′ formula as well as maximum likelihood analysis. Structural modeling was then applied to twin correlations to provide estimates of the relative genetic and/or environmental factors contribution in determining the measured trait. Results: Menstrual characteristics were found to be under environmental influence where the best fitting model for menstrual interval and duration was common environment. CDF plotting confirmed the results for both variables. Proband-wise concordance analysis for amount of menstruation, amenorrhea, and irregular menstruation revealed no genetic influence. The best fitting model for menstrual irregularity was CE (C73%, E27%. The same model was defined for amenorrhea (C48%, E52%. Conclusions: Environmental factors are most likely responsible to determine the menstrual flow, its integrity, and regularity. These factors need to be studied further.

  5. The effect of menstrual cycle on periodontal health - a clinical and microbiological study.

    Science.gov (United States)

    Shourie, Varsha; Dwarakanath, Chini Doraswamy; Prashanth, Gujjar Vittalrao; Alampalli, Ramesh Vishwanathmurthy; Padmanabhan, Shyam; Bali, Shweta

    2012-01-01

    Fluctuations in female sex hormones result in changes in the gingival and periodontal tissues. The purpose of this study was to compare the periodontal status of premenopausal women at different time points during their menstrual cycle and to find the associated subgingival microbiota. One hundred premenopausal women participated in the study and were divided into two groups: group I consisted of 50 subjects with clinically healthy gingival, and group II consisted of 50 subjects with chronic gingivitis. Group II was further divided into group IIa and group IIb. Group IIa consisted of 25 subjects who did not receive any periodontal therapy during the study period. All the examinations were performed at three points during the menstrual cycle: ovulation (OV), pre-menstruation (PM) and menstruation (M). Plaque Index (PI), Gingival Index (GI), Papillary Bleeding Index (PBI), probing depth (PD), subgingival temperature (ST) recording, gingival crevicular fluid (GCF) collection, and estimation and microbiological examination using the benzoyl-DL-arginine-naphthylamide (BANA) test was carried out. For group IIb subjects, all the examinations were performed again during the next menstrual cycle, which followed 4 weeks after periodontal therapy. Women with clinically healthy gingiva exhibited negligible changes throughout the menstrual cycle, whereas women with gingivitis showed aggravated inflammation during ovulation and pre-menstruation as compared to menstruation. However, there was no alteration in subgingival microbiota. After treating gingivitis, the next menstrual cycle following 4 weeks after periodontal therapy was monitored, and no periodontal changes were detected. Ovarian hormones have a negligible effect on clinically healthy periodontium. However, these hormones may exaggerate pre-existing inflammation in gingival tissues, but the clinical significance of these changes remains uncertain.

  6. Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine

    DEFF Research Database (Denmark)

    Tfelt-Hansen, Peer

    2011-01-01

    In 3 randomized clinical trials (n = 1585) the calcitonin gene-related peptide antagonist telcagepant 300 mg orally had an incidence of adverse events similar to placebo when used in the acute treatment of migraine. Telcagepant, thus, has excellent tolerability in migraine. Only a quarter (26...... superior to telcagepant (26%) for pain free at 2 hours whereas rizatriptan 10 mg (25%) showed no difference from telcagepant 300 mg (19 %) for sustained pain free (2-24 hours). The introduction of calcitonin gene-related peptide receptor antagonism in the acute treatment of migraine is a major step forward...

  7. [Gluten migraine].

    Science.gov (United States)

    Kopishinskaya, S V; Gustov, A V

    2015-01-01

    to study the prevalence of migraine among patients with celiac disease (CD) and clinical features of «gluten migraine» syndrome and to assess the efficacy of gluten diet in its treatment. Authors examined 200 CD patients (main group) and 100 patients with reflux esophagitis and without CD (control group). All patients fulfilled the headache diary during three months before the diagnosis of migraine was made and six months during gluten diet. CD group had migraine syndrome four times more often than the control group (48.5%; psyndrome who were on the gluten diet and the reduction in the intensity and/or frequency of attacks was observed in 38% of patients. We revealed the clear association between migraine syndrome and CD and the high efficacy of gluten diet in the treatment of migraine symptoms.

  8. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.

    Science.gov (United States)

    Tfelt-Hansen, Peer C; Koehler, Peter J

    2011-05-01

    Pain research, and headache research in particular, during the 20th century, has generated an enormous volume of literature promulgating theories, questions, and temporary answers. This narrative review describes the most important events in the history of migraine research between 1910 and 2010. Based on the standard textbooks of headache: Wolff's Headache (1948 and 1963) and The Headaches (1993, 2000, and 2006) topics were selected for a historical review. Most notably these included: isolation and clinical introduction of ergotamine (1918); further establishment of vasodilation in migraine and the constrictive action of ergotamine (1938); identification of pain-sensitive structures in the head (1941); Lashley's description of spreading scotoma (1941); cortical spreading depression (CSD) of Leão (1944); serotonin and the introduction of methysergide (1959); spreading oligemia in migraine with aura (1981); oligemia in the wake of CSD in rats (1982); neurogenic inflammation theory of migraine (1987); a new headache classification (1988); the discovery of sumatriptan (1988); migraine and calcitonin gene-related peptide (1990); the brainstem "migraine generator" and PET studies (1995); migraine as a channelopathy, including research from the genetic perspective (1996); and finally, meningeal sensitization, central sensitization, and allodynia (1996). Pathophysiological ideas have evolved within a limited number of paradigms, notably the vascular, neurogenic, neurotransmitter, and genetic/molecular biological paradigm. The application of various new technologies played an important role within these paradigms, in particular neurosurgical techniques, EEG, methods to measure cerebral blood flow, PET imaging, clinical epidemiological, genetic, and molecular biological methods, the latter putting migraine (at least hemiplegic migraine) within a completely new classification of diseases.

  9. Menstrual Cycle

    Science.gov (United States)

    ... Luteal (after egg release) Changes During the Menstrual Cycle The menstrual cycle is regulated by the complex interaction of ... egg release) Luteal (after egg release) The menstrual cycle begins with menstrual bleeding (menstruation), which marks the first day of ...

  10. Effect of Yoga on migraine: A comprehensive study using clinical profile and cardiac autonomic functions

    Science.gov (United States)

    Kisan, Ravikiran; Sujan, MU; Adoor, Meghana; Rao, Raghavendra; Nalini, A; Kutty, Bindu M; Chindanda Murthy, BT; Raju, TR; Sathyaprabha, TN

    2014-01-01

    Context and Aims: Migraine is an episodic disabling headache requiring long-term management. Migraine management through Yoga therapy would reduce the medication cost with positive health benefits. Yoga has shown to improve the quality of life, reduce the episode of headache and medication. The aim of the present study was to evaluate the efficacy of Yoga as an adjuvant therapy in migraine patients by assessing clinical outcome and autonomic functions tests. Subjects and Methods: Migraine patients were randomly given either conventional care (n = 30) or Yoga with conventional care (n = 30). Yoga group received Yoga practice session for 5 days a week for 6 weeks along with conventional care. Clinical assessment (frequency, intensity of headache and headache impact) and autonomic function test were done at baseline and at the end of the intervention. Results: Yoga with conventional care and convention care groups showed significant improvement in clinical variables, but it was better with Yoga therapy. Improvement in the vagal tone along with reduced sympathetic activity was observed in patients with migraine receiving Yoga as adjuvant therapy. Conclusions: Intervention showed significant clinical improvement in both groups. Headache frequency and intensity were reduced more in Yoga with conventional care than the conventional care group alone. Furthermore, Yoga therapy enhanced the vagal tone and decreased the sympathetic drive, hence improving the cardiac autonomic balance. Thus, Yoga therapy can be effectively incorporated as an adjuvant therapy in migraine patients. PMID:25035622

  11. Effect of Yoga on migraine: A comprehensive study using clinical profile and cardiac autonomic functions.

    Science.gov (United States)

    Kisan, Ravikiran; Sujan, Mu; Adoor, Meghana; Rao, Raghavendra; Nalini, A; Kutty, Bindu M; Chindanda Murthy, Bt; Raju, Tr; Sathyaprabha, Tn

    2014-07-01

    Migraine is an episodic disabling headache requiring long-term management. Migraine management through Yoga therapy would reduce the medication cost with positive health benefits. Yoga has shown to improve the quality of life, reduce the episode of headache and medication. The aim of the present study was to evaluate the efficacy of Yoga as an adjuvant therapy in migraine patients by assessing clinical outcome and autonomic functions tests. Migraine patients were randomly given either conventional care (n = 30) or Yoga with conventional care (n = 30). Yoga group received Yoga practice session for 5 days a week for 6 weeks along with conventional care. Clinical assessment (frequency, intensity of headache and headache impact) and autonomic function test were done at baseline and at the end of the intervention. Yoga with conventional care and convention care groups showed significant improvement in clinical variables, but it was better with Yoga therapy. Improvement in the vagal tone along with reduced sympathetic activity was observed in patients with migraine receiving Yoga as adjuvant therapy. Intervention showed significant clinical improvement in both groups. Headache frequency and intensity were reduced more in Yoga with conventional care than the conventional care group alone. Furthermore, Yoga therapy enhanced the vagal tone and decreased the sympathetic drive, hence improving the cardiac autonomic balance. Thus, Yoga therapy can be effectively incorporated as an adjuvant therapy in migraine patients.

  12. Evaluation of menstrual cycle-related changes in 85 clinical laboratory analytes.

    Science.gov (United States)

    Masuda, Shiori; Ichihara, Kiyoshi; Yamanishi, Hachiro; Hirano, Yutaka; Tanaka, Yuji; Kamisako, Toshinori

    2016-05-01

    The menstrual cycle-related changes in clinical laboratory values were analysed by use of data obtained in the Asian multicentre study aimed at derivation of common reference intervals for 85 major clinical laboratory tests. Among 1876 healthy female volunteers, 893 had regular menstruation. They were classified into five groups according to dates between sample collection and the start of the last menstrual cycle: early follicular phase (1-6 days), late follicular phase (7-12 days), ovulatory phase (13-16 days), early luteal phase (17-22 days), and late luteal phase (23-31 days). Multiple linear regression analysis was performed to evaluate the menstrual cycle-related changes in test results. The magnitude was expressed as a standard deviation ratio of between-phase standard deviation to between-individual standard deviation based on nested ANOVA. Aside from obvious changes for four sex hormones (oestradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone), we observed statistically significant menstrual cycle-related changes in the following tests (standard deviation ratio >0.15): Na, Cl, creatine kinase, C-reactive protein, serum amyloid A, carbohydrate antigen 125, and parathyroid hormone were higher during the early follicular phase, while insulin, total cholesterol, and white blood cell were higher during the luteal phase. Significant associations of those test items with the four sex hormones were revealed. The menstrual cycle-related changes in laboratory test results were revealed in some commonly tested items other than sex hormones. The findings are of interest in understanding female physiology in relation to hormonal changes, but the magnitude of changes is rather small and not very relevant in interpreting test results. © The Author(s) 2016.

  13. Vestibular migraine in children and adolescents: clinical findings and laboratory tests

    Directory of Open Access Journals (Sweden)

    Thyra eLanghagen

    2015-01-01

    Full Text Available Introduction: Vestibular migraine (VM is the most common cause of episodic vertigo in children. We summarize the clinical findings and of laboratory test results in a cohort of children and adolescents with VM. We discuss the limitations of current classification criteria for dizzy children. Methods: A retrospective chart analysis was performed on 118 children with suspected VM at a tertiary care center. Patients with complaints related to migraine and who presented with vertigo/dizziness were grouped in the following categories: (1 definite vestibular migraine (dVM; (2 probable vestibular migraine (pVM; (3 suspected vestibular migraine (sVM; (4 benign paroxysmal vertigo (BPV; and (5 migraine with/without aura (oM according to the International Classification of Headache Disorders, 3rd edition (beta version. Results: The mean age of all patients was 12±3 years (range 3-18 years, 70 females. 36 patients (30% fulfilled criteria for dVM, 33 (28% for pVM, 34 (29% for sVM, 7 (6% for BPV, and 8 (7% for oM. Somatoform vertigo co-occurred in 27% patients. Episodic syndromes were reported in 8%; the family history of migraine was positive in 65%. Mild central ocular motor signs were found in 24% (most frequently horizontal saccadic pursuit. Laboratory tests showed that about 20% had pathological function of the horizontal vestibulo-ocular reflex, and almost 50% had abnormal postural sway patterns. Conclusion: Patients with definite, probable, and suspected VM do not differ in the frequency of ocular motor, vestibular, or postural abnormalities. VM is the best explanation for their symptoms. It is essential to establish diagnostic criteria in clinical studies. In clinical practice, however, the most reasonable diagnosis should be made in order to begin treatment. Such a procedure also minimizes the fear of the parents and children, reduces the need to interrupt leisure time and school activities, and prevents the development of somatoform vertigo.

  14. Effects of pyridoxine supplementation on severity, frequency and duration of migraine attacks in migraine patients with aura: A double-blind randomized clinical trial study in Iran.

    Directory of Open Access Journals (Sweden)

    Omid Sadeghi

    2015-06-01

    Full Text Available Migraine is a chronic disease that affects nearly 6% of men and 18% of women worldwide. There are various drugs, which can successfully decrease migraine symptoms and frequency of migraine attacks, but these drugs usually are expensive. Hence, this study aimed to assess the effects of pyridoxine supplementation on severity, frequency and duration of migraine attacks as well as headache diary results (HDR.This double-blind randomized clinical trial study was conducted on 66 patients with migraine with aura (MA in Khorshid and Emam Mosa Sadr clinics of Isfahan University of Medical Sciences, Iran, in 2013. Patients were randomly allocated to receive either pyridoxine supplements (80 mg pyridoxine per day or placebo. Severity, frequency and duration of migraine attacks and HDR were measured at baseline and at the end of the study.Mean age of patients was 34.24 ± 9.44 years old. Pyridoxine supplementation led to a significant decrease in headache severity (-2.20 ± 1.70 compared with -1 ± 1.50; P = 0.007, attacks duration (-8.30 ± 12.60 compared with -1.70 ± 9.60; P = 0.030 and HDR (-89.70 ± 134.60 compared with -6.10 ± 155.50; P = 0.040 compared with placebo, but was not effective on the frequency of migraine attacks (-2.30 ± 4 compared with -1.20 ± 7.80; P = 0.510.Pyridoxine supplementation in patients with MA was effective on headache severity, attacks duration and HDR, but did not affect the frequency of migraine attacks.

  15. Craniosacral therapy for migraine: Protocol development for an exploratory controlled clinical trial

    Directory of Open Access Journals (Sweden)

    Coeytaux Remy R

    2008-06-01

    Full Text Available Abstract Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral therapy (CST is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evidence of safety and efficacy. In this paper, we describe an ongoing feasibility study to assess the safety and efficacy of CST in the treatment of migraine, using a rigorous and innovative randomized controlled study design involving low-strength static magnets (LSSM as an attention control intervention. Methods The trial is designed to test the hypothesis that, compared to those receiving usual care plus a treatment with low-strength static magnets (attention-control complementary therapy, subjects receiving usual medical care plus CST will demonstrate significant improvement in: quality-of-life as measured by the Headache Impact Test (HIT-6; reduced frequency of migraine; and a perception of clinical benefit. Criteria for inclusion are either gender, age > 11, English or Spanish speaking, meeting the International Classification of Headache Disorders (ICHD criteria for migraine with or without aura, a headache frequency of 5 to 15 per month over at least two years. After an 8 week baseline phase, eligible subjects are randomized to either CST or an attention control intervention, low strength static magnets (LSSM. To evaluate possible therapist bias, videotaped encounters are analyzed to assess for any systematic group differences in interactions with subjects. Results 169 individuals have been screened for eligibility, of which 109 were eligible for the study. Five did not qualify during the baseline phase because of inadequate headache frequency. Nineteen

  16. Efficacy of Cinnarizine and Sodium Valproate in migraine prophylaxis: a clinical trial

    Directory of Open Access Journals (Sweden)

    M. Togha

    2006-07-01

    Full Text Available Background: Calcium-antagonists (CA are heterogeneous group of drugs with different efficacy in migraine prophylaxis. Several studies have firmly demonstrated flunarizine (FLU, and verapamil as the proven calcium-antagonists for migraine prophylaxis. Cinnarizine (CIN, is another CA with less complications and less antihistaminic action. There is very few studies to show the effect of this drug on migraine. The current study evaluates the efficacy and safety of cinnarizine on migraine in comparison to sodium valproate, an acceptable drug in migraine prophylaxis. Methods: The current study is a randomized double blind clinical trial on 133 participants with intractable migraine headache to evaluate the positive effect of cinnarizine in comparison to sodium valproate. The data was collected and analized by SPSS software. Results: The mean age of cases was 34.3±10 years in Cinnarizine group and 33.4±11 in Sodium Valproate users. The headache frequency decreased to about 50% and its severity to about 30% in both groups. Although the effect of Cinnarizine was started earlier than sodium valproate , there was no significant difference between two groups of cases in improvement of headache attacks. Statistically significant difference was noted in drug’s complication led to discontinuation of treatment, 5.2% in Cinnarizine users in respect to 14% in valproate group. Conclusion: The patients who received Cinnarizine, similar to the patients on sodium valprote showed significant improvement in headache attacks, frequency, duration and severity. Cinnarizine such as sodium valproate is an effective drug in migraine prophylaxis even in intractable headache, but with lesser severe complication.

  17. Scent of aura? Clinical features of olfactory hallucinations during a migraine attack (OHM).

    Science.gov (United States)

    Mainardi, Federico; Rapoport, Alan; Zanchin, Giorgio; Maggioni, Ferdinando

    2017-02-01

    Introduction Olfactory hallucination during a migraine attack (OHM) is a rare phenomenon. At present, it is not considered a manifestation of migraine aura. Material and methods The clinical features of OHM were collected in 11 patients. Results Of the 11 patients, 10 had migraine without aura and one migraine with aura associated with OHM. Mean age at onset of headache and at appearance of OHM were respectively 17.8 and 32.3 years. Migraine average frequency was 3.9 attacks/month, 19% of them being associated with OHM. The temporal pattern of OHM maintained the same characteristics in the different attacks. OHM onset was described as sudden ( n = 5), gradual ( n = 3), initially sudden and then gradual ( n = 2), or developing in a few seconds ( n = 1). In most of the cases ( n = 8) OHM lasted from 3 to 10 minutes; it persisted during the pain phase (2-24 hours) in only three patients. The type of the perceived smell was invariably constant in nine patients. Conclusion OHM features fulfilled the ICHD-III beta criteria for typical aura.

  18. Spreading depression and the clinical correlates of migraine.

    Science.gov (United States)

    Eikermann-Haerter, Katharina; Negro, Andrea; Ayata, Cenk

    2013-01-01

    Migraine is the most common neurologic condition. One-third of migraineurs experience transient neurologic symptoms, the so-called aura. There is strong evidence that spreading depression (SD) is the electrophysiologic substrate of migraine aura. SD is an intense pan-depolarization wave that slowly propagates in gray matter by way of contiguity and transiently disrupts neuronal function. When induced subcortically, striatal SD causes hemiparesis, hippocampal SD can trigger seizures and impact cognition, and bilateral thalamic SD can diminish consciousness. Recent data show that transgenic mice expressing familial hemiplegic migraine (FHM) type 1 mutations in voltage-gated Ca2+ channels (Cav2.1) develop mutation-specific aura-like signs after a cortical SD similar to patients with the respective mutation. These signs are associated with facilitated subcortical SD propagation. As in FHM, mice with the R192Q mutation develop pure hemiplegia associated with cortical SDs propagating into caudoputamen. S218L mice display additional signs such as seizures and coma when SD propagates into hippocampus and thalamus. In hyperexcitable FHM brains, SD may propagate between cortex and subcortical structures via permissive gray matter bridges, or originate de novo in subcortical structures, to explain unusual and severe aura signs and symptoms. Reciprocal spread and reverberating waves can explain protracted attacks.

  19. Effect of Yoga on migraine: A comprehensive study using clinical profile and cardiac autonomic functions

    Directory of Open Access Journals (Sweden)

    Ravikiran Kisan

    2014-01-01

    Conclusions: Intervention showed significant clinical improvement in both groups. Headache frequency and intensity were reduced more in Yoga with conventional care than the conventional care group alone. Furthermore, Yoga therapy enhanced the vagal tone and decreased the sympathetic drive, hence improving the cardiac autonomic balance. Thus, Yoga therapy can be effectively incorporated as an adjuvant therapy in migraine patients.

  20. Influence of hydrotherapy on clinical and cardiac autonomic function in migraine patients

    Directory of Open Access Journals (Sweden)

    M U Sujan

    2016-01-01

    Full Text Available Background: Migraine is associated with autonomic symptoms. The growing body of literature suggests that the dysfunctional autonomic nervous system might play a pivotal role in the pathogenesis of migraine. Thermal therapies have been hypothesized to modulate these changes and alleviate pain. However, data regarding the efficacy of hydrotherapy in migraine remain scant. We evaluated the effect of add on hydrotherapy procedure (a hot arm and foot bath with ice massage to head in migraine patients. Methods: Forty chronic migraine patients fulfilling the International Classification of Headache Disorders II criteria were recruited from the neurology outpatient clinic. Patients were randomized to receive either hydrotherapy plus conventional pharmacological care (n = 20 or conventional medication only (n = 20. Hydrotherapy group received treatment with hot arm and foot bath (103°F to 110°F and ice massage to head daily for 20 min for 45 days. Patients were assessed using headache impact test (HIT, visual analog scale for pain and cardiac autonomic function by heart rate variability (HRV before and after intervention period. Results: There was a significant decrease in HIT score, frequency, and intensity of headaches following treatment in both the groups. However, it was more evident in add on hydrotherapy group compared to pharmacological treatment alone group. There was also significant improvement in the HRV parameters. In particular, there was a significant decrease in heart rate (P = 0.017, increase in high frequency (HF (P = 0.014 and decrease in low frequency/HF ratio (P = 0.004 in add on hydrotherapy group. Conclusion: Our study shows that add on hydrotherapy enhanced the vagal tone in addition to reducing the frequency and intensity of headaches in migraine patients.

  1. Ischemic strokes and migraine

    Energy Technology Data Exchange (ETDEWEB)

    Bousser, M.G.; Baron, J.C.; Chiras, J.

    1985-11-01

    Lasting neurological deficits, though most infrequent, do occur in migrainous subjects and are well documented by clinical angiographic computed tomographic (CT scan) and even pathological studies. However the mechanism of cerebral ischemia in migraine remains widely unknown and the precise role of migraine in the pathogenesis of ischemic strokes is still debated. (orig./MG).

  2. Cerebral hemodynamics in migraine

    DEFF Research Database (Denmark)

    Hachinski, V C; Olesen, Jes; Norris, J W

    1977-01-01

    Clinical and angiographic findings in migraine are briefly reviewed in relation to cerebral hemodynamic changes shown by regional cerebral blood flow (rCBF) studies. Three cases of migraine studied by the intracarotid xenon 133 method during attacks are reported. In classic migraine, with typical...

  3. [Sporadic hemiplegic migraine].

    Science.gov (United States)

    Aytaç, Emrah; Pirinççioğlu, Faruk; İnan, Levent Ertuğrul

    2015-01-01

    Hemiplegic migraine, whose etiology is unclear, is a specific form of migraine with aura including hemiparesis. In this study, it was aimed to present the case of a 39-year-old women, suffering from sporadic hemiplegic migraine. The patient suffered recurrent severe headaches, and existing focal neurological symptoms, including alternant hemiparesis. On the basis of the history, thorough clinical observation and numerous accessory investigations, a diagnosis of sporadic hemiplegic migraine was established. Differential diagnoses of SHM were highlighted.

  4. Migrainous vertigo and basilar migraine(Analyze the clinical symptoms of 9 migraine patients with vertigo)%偏头痛性眩晕与基底型偏头痛(附9例临床分析)

    Institute of Scientific and Technical Information of China (English)

    马维娅; 单希征; 孙勍; 李娜; 戴静; 彭新

    2012-01-01

    Objective By analysing the results of clinical and laboratory examinations in 9 migraine patients with vertigo or dizziness, we aimed to recognize the relationship between migraine and vertigo, and to improve the diagnosis and treatments of the patients. Methods Nine migraine patients with vertigo/dizziness were selected from our hospital. Besides the detailed questionnaire on the medical history, clinical and laboratory examinations, including neurological examination, vestibule functioning, hearing tests and head CT/MR1, were adopted in each patient, so as to exclude the cases caused by central and vestibule related vertigo. Results Among the 9 migraine patients with vertigo /dizziness, there were 2 cases of hasilar migraine, 3 cases of migraine without aura, and 6 cases of migrainous vertigo (MV, in which 2 migraine patients changed to MV). In the 6 MV patients, vertigo or dizziness occurred several seconds to one hour prior to the headache in 3 cases, post headache in 1 case and simultaneously with headache in 1 case. There was one migraine case, whose headache never occurred together with vertigo, called migraine equivalent. Conclusions MV is a special type of migraine syndrome associated with vertigo or dizziness due to basilar migraine. The diagnosis needs to be distinguished clearly from Meniere' s disease, benign paroxysmal positional vertigo, posterior circulation ischemia (PCI), etc.%目的 分析9例偏头痛伴眩晕/头晕患者的临床及实验室检查结果,探讨头痛与眩晕/头晕的关系,以利正确诊治.方法 作者医院收治的偏头痛伴眩晕/头晕患者9例,对所有患者均详细收集病史,并进行神经系统查体以及前庭功能、听力检查和头颅CT/MRI等实验室检查,以除外中枢性和耳源性眩晕.结果 9例偏头痛伴眩晕/头晕患者中,基底型偏头痛2例,无先兆偏头痛3例,偏头痛性眩晕( migrainous vertigo,MV)6例(其中2例为无先兆偏头痛发作数年后和50

  5. A feasible repetitive transcranial magnetic stimulation clinical protocol in migraine prevention

    Directory of Open Access Journals (Sweden)

    Shawn Zardouz

    2016-10-01

    Full Text Available Objective: This case series was conducted to determine the clinical feasibility of a repetitive transcranial magnetic stimulation protocol for the prevention of migraine (with and without aura. Methods: Five patients with migraines underwent five repetitive transcranial magnetic stimulation sessions separated in 1- to 2-week intervals for a period of 2 months at a single tertiary medical center. Repetitive transcranial magnetic stimulation was applied to the left motor cortex with 2000 pulses (20 trains with 1s inter-train interval delivered per session, at a frequency of 10 Hz and 80% resting motor threshold. Pre- and post-treatment numerical rating pain scales were collected, and percent reductions in intensity, frequency, and duration were generated. Results: An average decrease in 37.8%, 32.1%, and 31.2% were noted in the intensity, frequency, and duration of migraines post-repetitive transcranial magnetic stimulation, respectively. A mean decrease in 1.9±1.0 (numerical rating pain scale ± standard deviation; range: 0.4–2.8 in headache intensity scores was noted after the repetitive transcranial magnetic stimulation sessions. Conclusion: The tested repetitive transcranial magnetic stimulation protocol is a well-tolerated, safe, and effective method for migraine prevention.

  6. Migraine Variants And Beyond

    Directory of Open Access Journals (Sweden)

    Chakravarty A

    2002-01-01

    Full Text Available The Classic presenting features of both migraine with and without aura have been clearly defined. Occasionally however migrainous headaches are accompanied by abrupt appearance of focal and ominous neurological signs. Such attacks can be labelled as migraine variants and the diagnosis in reality is one made by exclusion of other CNS diseases. Some but not all such conditions are mentioned in the International Headache Society (IHS classification under the general heading of migraine with aura. Rarely, the focal neurological deficit may outlast the migraine attack by days and occasionally with appearance of structural brain lesions on neuroimaging. Such attacks have been labelled as complicated Migraine by the IHS. The present review deal with the clinical, radiologic and pathophysiologic aspects of both these conditions - migraine variants and complicated migraine.

  7. Cinnarizine versus Topiramate in Prophylaxis of Migraines among Children and Adolescents: A Randomized, Double-Blind Clinical Trial

    Directory of Open Access Journals (Sweden)

    Mahmoud Reza ASHRAFI

    2014-12-01

    Full Text Available How to Cite This Article: Ashrafi MR, Najafi Z, Shafiei M, Heidari K, Togha M. Cinnarizinev ersus Topiramate in Prophylaxis of Migraines among Children and Adolescents: A Randomized, Double-Blind Clinical Trial. Iran J Child Neurol. 2014 Autumn;8(4: 18-27. AbstractObjectiveMigraines, a common health problem in children and adolescents, still do not have an FDA approved preventive treatment for patients under the age of 18 years. This study compares and contrasts the efficacy and safety of cinnarizine and topiramate in preventing pediatric migraines.Materials & MethodsIn this randomized, double-blind clinical trial 44 migrainous (from 4–15 years of age were equally allocated to receive cinnarizine or topiramate. The primary efficacy measure was monthly migraine frequency. Secondary efficacy measures were monthly migraine intensity and ≥ 50% responder rate. Efficacy measures were recorded at the baseline and at 4, 8, and 12 weeks of treatment.ResultsDuring the double-blind phase of the study, monthly migraine frequency and intensity were significantly decreased in both the cinnarizine and topiramate groups when compared to the baseline. However, at the end of the study, the cinnarizine group exhibits a significant decrease from the baseline in the mean monthly migraine intensity when compared to the topiramate group (4.7 vs. 3, respectively; 95% CI = -0.8 to -3.2.ConclusionNo significant difference between cinnarizine and topiramate was found for the prevention of pediatric migraines. Both treatments were well tolerated.ReferencesHershey AD, Winner PK. Pediatric Migraine: Recognition and Treatment. J Am Osteopath Assoc. 2005;105:2S-8.Lewis DW, Yonker M, Winner P, Sowell M. The treatment of pediatric migraine. Pediatric Annals. 2005;34:448-460.Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309:765-769.Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An Epidemiologic Study of Headache among

  8. Clinical Observations on Acupuncture Treatment of 68 Migraine Patients

    Institute of Scientific and Technical Information of China (English)

    ZHOU Wen-xue

    2006-01-01

    Objective To investigate the curative effect of points Fengchi(GB 20), Tianzhu(BL 10) and Wangu(GB 12) on migraine. Methods: A treatment group of 68 patients received acupuncture of bilateral points Fengchi(GB 20), Tianzhu(BL 10) and Wangu(GB 12) and a control group of 40 patients took orally Nimodipine and Oryzanol. The curative effect was evaluated in both groups after two courses of treatment. Results: The total efficacy rate was 92.7% and 72.5% and the control rate was 45.6% and 22.5%, respectively, in the two groups.Conclusion: Acupuncture is significantly more effective than Western medicine in treating migraine.%目的:观察风池、天柱和完骨穴对偏头痛得治疗效果.方法:68例患者接受双侧风池、天柱和完骨穴针刺治疗为治疗组;40例患者口服西药尼莫地平和谷维素为对照组,两组均治疗2个疗程后观察疗效.结果:两组总有效率分别为92.7%和72.5%,控制率分别为45.6%和22.5%.结论:针刺治疗偏头痛的效果明显优于西药治疗.

  9. More clinical observations on migraine associated with monocular visual symptoms in an Indian population

    Directory of Open Access Journals (Sweden)

    Vishal Jogi

    2016-01-01

    Full Text Available Context: Retinal migraine (RM is considered as one of the rare causes of transient monocular visual loss (TMVL and has not been studied in Indian population. Objectives: The study aims to analyze the clinical and investigational profile of patients with RM. Materials and Methods: This is an observational prospective analysis of 12 cases of TMVL fulfilling the International Classification of Headache Disorders-2nd edition (ICHD-II criteria of RM examined in Neurology and Ophthalmology Outpatient Department (OPD of Postgraduate Institute of Medical Education and Research (PGIMER, Chandigarh from July 2011 to October 2012. Results: Most patients presented in 3 rd and 4 th decade with equal sex distribution. Seventy-five percent had antecedent migraine without aura (MoA and 25% had migraine with Aura (MA. Headache was ipsilateral to visual symptoms in 67% and bilateral in 33%. TMVL preceded headache onset in 58% and occurred during headache episode in 42%. Visual symptoms were predominantly negative except in one patient who had positive followed by negative symptoms. Duration of visual symptoms was variable ranging from 30 s to 45 min. None of the patient had permanent monocular vision loss. Three patients had episodes of TMVL without headache in addition to the symptom constellation defining RM. Most of the tests done to rule out alternative causes were normal. Magnetic resonance imaging (MRI brain showed nonspecific white matter changes in one patient. Visual-evoked potential (VEP showed prolonged P100 latencies in two cases. Patent foramen ovale was detected in one patient. Conclusions: RM is a definite subtype of migraine and should remain in the ICHD classification. It should be kept as one of the differential diagnosis of transient monocular vision loss. We propose existence of "acephalgic RM" which may respond to migraine prophylaxis.

  10. Menstrual Disorders

    Science.gov (United States)

    ... Issues Listen Español Text Size Email Print Share Menstrual Disorders in Teens Page Content Article Body Within ... test Measurement of gonadotropins, prolactin and androgens How Menstrual Disorders are treated with Drug Therapy: After exclusion ...

  11. Clinical Observation on Treatment of Migraine with Acupuncture

    Institute of Scientific and Technical Information of China (English)

    CHEN Ze-lin

    2006-01-01

    Objective: To study the effect of puncturing points Taiyang (Ex-HN 5), Jiaosun (TE 20), Qiuxu (GB 40) and Shenmai (BL 62) on migraine. Methods: The 120 cases in the treatment group were treated with routine acupuncture therapy, while the 40 cases in the control group were treated with Ergotamine and Caffeine Tablet, and then the therapeutic effect and recovery time of the two groups were compared. Results: The recovery rate of the treatment group was 90.0%, which is higher than 70.0% of the control group (P< 0.01). The total effective rate of the treatment group was 100%, which is better than 92.5% of the control group (P < 0.05),The therapeutic effect of the treatment group was significantly better than the control group and the treatment group needed shorter treatment period (P< 0.05). Conclusions: Acupuncture has higher recovery rate and total effective rate as well as shorter treatment period than oral ergotamine and caffeine tablets, which indicated that acupuncture is superior to the routinely-administered oral western tablets in treating migraine.%目的:研究针刺太阳、角孙、丘墟和申脉对偏头痛的影响.方法:观察组120例患者采用常规针刺疗法,对照组40例患者采用口服麦咖片法,并将两组的治疗效果和痊愈时间进行对比观察.结果:观察组痊愈率90.0%高于对照组痊愈率70.0%(P<0.05).观察组总有效率100%好于对照组总有效率92.5%(P<0.01).观察组疗效明显优于对照组.而且观察组患者的治疗时间短(P<0.05).结论:针刺疗法痊愈率、总有效率均高于麦角胺咖啡因片,且疗程短,提示本法疗效优于口服常规西药的方法.

  12. Epidemiologic and Clinical Characteristics of Migraine and Tension-Type Headaches among Hospitals Staffs of Shiraz (Iran

    Directory of Open Access Journals (Sweden)

    Ayatollahi Seyyed Mohammad Taghi

    2009-05-01

    Full Text Available Headache is a common symptom that constitutes a major health problem to all countries in the world. This study was conducted to estimate the prevalence of migraine and tension -type headaches(TTH, its associated occupational risk factors among Shiraz hospitals staffs, and to report on clinical characteristics of migraine and TTH with using the International Headache Society (IHS diagnosis criteria. A random sample of 1023 staffs constituting a 20% sample of the hospitals staff population was selected. Sampling method was categorical random sampling. Within each group sampling was carried out systematically. Data were collected by screening questionnaire followed by clinical interviews, general physical and neurological examination, and diagnostic criteria of IHS. Prevalence of migraine, TTH and coexisting migraine and TTH were estimated as 11.2% (115 cases, 19.5% (199 subjects and 3.2% (33 subjects respectively. In this study , clinical characteristics of headache including type, site, number , intensity ,concomitant symptom of headaches had been surveyed. TTH and migraine headaches were significantly associated with self reported abnormal sleep pattern and female gender (P < 0.001. Also TTH was negatively associated with total 24hr duration of sleep and history of involvement in second job significantly (P<0.026. The average of prevalence of migraine and TTH were lower than their counter parts in western countries but higher than previous studies conducted in other Asian countries. Clinical characteristics were almost parallel with IHS criteria, headache- related missed work rates were higher for subjects with migraine headache, and also TTH and migraine were separate disorders and were not as a part of a continuum of headache disorders. Headache disorders deserve more attention, especially concerning strategies leading to adequate primary prevention, diagnosis and treatment.

  13. Contact lenses, migraine, and allodynia

    Directory of Open Access Journals (Sweden)

    Ozgur Bulent Timucin

    2016-01-01

    Full Text Available Clinical trials and electrophysiologic studies demonstrated increased perceptual sensitivity in patients suffering from migraines. At least, one triggering factor is described in 85% of migraine patients. The aim of this report was to investigate the relationship between contact lens (CL usage and migraine attacks in two cases. Two patients who were diagnosed with migraine reported that the frequency of migraine attacks increased after they switched to using CL with different base curves (BCs. These two patients, who began using CL with different BCs experienced discomfort and dryness of the eye. The ocular complaints were followed by migraine attacks. CL intolerance was also developed during migraine attack in one of the cases. The frequency of migraine attacks decreased and allodynia relieved significantly when flatter BCs were selected. CL related stimulus could have triggered the migraine attack. CLs should be well fitted in migraine patients with allodynia.

  14. The stigma of migraine.

    Science.gov (United States)

    Young, William B; Park, Jung E; Tian, Iris X; Kempner, Joanna

    2013-01-01

    People who have a disease often experience stigma, a socially and culturally embedded process through which individuals experience stereotyping, devaluation, and discrimination. Stigma has great impact on quality of life, behavior, and life chances. We do not know whether or not migraine is stigmatizing. We studied 123 episodic migraine patients, 123 chronic migraine patients, and 62 epilepsy patients in a clinical setting to investigate the extent to which stigma attaches to migraine, using epilepsy as a comparison. We used the stigma scale for chronic illness, a 24-item questionnaire suitable for studying chronic neurologic diseases, and various disease impact measures. Patients with chronic migraine had higher scores (54.0±20.2) on the stigma scale for chronic illness than either episodic migraine (41.7±14.8) or epilepsy patients (44.6±16.3) (pStigma correlated most strongly with the mental component score of the short form of the medical outcomes health survey (SF-12), then with ability to work and migraine disability score for chronic and episodic migraine and the Liverpool impact on epilepsy scale for epilepsy. Analysis of covariance showed adjusted scores for the stigma scale for chronic illness were similar for chronic migraine (49.3; 95% confidence interval, 46.2 to 52.4) and epilepsy (46.5; 95% confidence interval, 41.6 to 51.6), and lower for episodic migraine (43.7; 95% confidence interval, 40.9 to 46.6). Ability to work was the strongest predictor of stigma as measured by the stigma scale for chronic illness. In our model, adjusted stigma was similar for chronic migraine and epilepsy, which were greater than for episodic migraine. Stigma correlated most strongly with inability to work, and was greater for chronic migraine than epilepsy or episodic migraine because chronic migraine patients had less ability to work.

  15. Craniosacral therapy for migraine: Protocol development for an exploratory controlled clinical trial

    OpenAIRE

    Coeytaux Remy R; Wilkinson Laurel; Curtis Peter; Faurot Keturah R; Mann John D; Suchindran Chirayath; Gaylord Susan A

    2008-01-01

    Abstract Background Migraine affects approximately 20% of the population. Conventional care for migraine is suboptimal; overuse of medications for the treatment of episodic migraines is a risk factor for developing chronic daily headache. The study of non-pharmaceutical approaches for prevention of migraine headaches is therefore warranted. Craniosacral therapy (CST) is a popular non-pharmacological approach to the treatment or prevention of migraine headaches for which there is limited evide...

  16. Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine

    Directory of Open Access Journals (Sweden)

    Freeman JA

    2013-11-01

    Full Text Available John A Freeman, Terrance L Trentman Department of Anesthesiology, Division of Pain Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA Abstract: Chronic migraine is a disabling disorder that is costly to individuals and society. Occipital nerve stimulation has been used to treat refractory cases of primary headache disorders including drug-resistant chronic cluster headaches and chronic migraine. The Food and Drug Administration (FDA off-labeled application of equipment used for peripheral nerve (occipital stimulation is borrowed from FDA-labeled spinal cord stimulation. Manufacturer-sponsored randomized trials include a feasibility study (ONSTIM-Medtronic and a safety and efficacy study (St Jude. A non-industry sponsored prospective, randomized crossover study by Serra and Marchiotretto suggests improved quality of life and a significant reduction in medication use. Though preliminary studies suggest occipital nerve stimulation is safe and efficacious in treating chronic migraine headache, complication rates, including lead migration, lead fracture, and surgical site infections remain high. Further studies are needed to demonstrate long-term outcomes, while improved surgical techniques and site-specific equipment are needed to minimize complications. Keywords: headache, occipital nerve stimulation, peripheral nerve stimulation, neuromodulation, electrical stimulation therapy

  17. Molecular factors in migraine

    Science.gov (United States)

    Kowalska, Marta; Prendecki, Michał; Kozubski, Wojciech; Lianeri, Margarita; Dorszewska, Jolanta

    2016-01-01

    Migraine is a common neurological disorder that affects 11% of adults worldwide. This disease most likely has a neurovascular origin. Migraine with aura (MA) and more common form - migraine without aura (MO) – are the two main clinical subtypes of disease. The exact pathomechanism of migraine is still unknown, but it is thought that both genetic and environmental factors are involved in this pathological process. The first genetic studies of migraine were focused on the rare subtype of MA: familial hemiplegic migraine (FHM). The genes analysed in familial and sporadic migraine are: MTHFR, KCNK18, HCRTR1, SLC6A4, STX1A, GRIA1 and GRIA3. It is possible that migraine is a multifactorial disease with polygenic influence. Recent studies have shown that the pathomechanisms of migraine involves both factors responsible for immune response and oxidative stress such as: cytokines, tyrosine metabolism, homocysteine; and factors associated with pain transmission and emotions e.g.: serotonin, hypocretin-1, calcitonin gene-related peptide, glutamate. The correlations between genetic variants of the HCRTR1 gene, the polymorphism 5-HTTLPR and hypocretin-1, and serotonin were observed. It is known that serotonin inhibits the activity of hypocretin neurons and may affect the appearance of the aura during migraine attack. The understanding of the molecular mechanisms of migraine, including genotype-phenotype correlations, may contribute to finding markers important for the diagnosis and treatment of this disease. PMID:27191890

  18. Acute migraine Migraña Aguda | EU Clinical Trials Register [EU Clinical Trials Register

    Lifescience Database Archive (English)

    Full Text Available Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg ODT for the Treatment of Acute...ical condition or disease under investigation E.1.1Medical condition(s) being investigated Acute migraineMig....2Level LLT E.1.2Classification code 10066635 E.1.2Term Acute migraine E.1.3Condi

  19. What efficacy measures are clinically relevant and should be used in Cochrane Reviews of acute migraine trials?

    DEFF Research Database (Denmark)

    Tfelt-Hansen, Peer

    2015-01-01

    : The following EMs were used: pain free at two hours (30%), headache relief at two hours (60%), sustained pain free for 24 hours (19%) and sustained headache relief for 24 hours (39%). These EMs were also used in four other Cochrane reviews of acute migraine treatment. Of these EMs sustained headache relief...... for 24 h is not judged clinically relevant. CONCLUSION: Pain free and sustained pain free are clinically relevant, but the responses are rather low, demonstrating that there is a need for improvement of acute drug treatment in migraine.......BACKGROUND: Cochrane Reviews are methodologically of high quality but the clinical relevance of analysed efficacy measures (EMs) should also be assessed. METHODS: The clinical relevance of EMs used in one systematic Cochrane review of oral zolmitriptan for migraine headache was evaluated. RESULTS...

  20. Clinical and laboratory characteristics of adolescents with platelet function disorders and heavy menstrual bleeding

    Directory of Open Access Journals (Sweden)

    Amesse Lawrence S

    2013-01-01

    Full Text Available Abstract Background Platelet function disorders (PFDs have emerged as an important etiology of heavy menstrual bleeding (HMB in adolescents. However, neither clinical nor laboratory data have been methodically analyzed in this population subset. The objective of this study was to evaluate these parameters in order to distinguish characteristics of the disorder that in turn will lead to earlier diagnosis and therapy initiation. Methods Retrospective review of medical records from postmenarcheal adolescents with documented PFDs referred to a hemophilia treatment center and university faculty practices for bleeding diatheses with their clinical and laboratory data evaluated. Results Of 63 teens with documented PFDs, HMB was the most common clinical manifestation of PFD (43; 68.3%. Of these, 37 (86% were diagnosed with PFD either at or after menarche with the diagnosis based on HMB symptoms alone. Only 6 (14% were diagnosed with a PFD prior to menarche, based on associated bleeding, i.e., epistaxis, ecchymosis, and all developed HMB after menstruation onset. Interestingly, 20 girls were diagnosed with a PFD prior to menarche and of these, only 6 (30% went on to develop HMB after pubertal transition, while the majority (14; 70% did not. The average age-at-PFD diagnosis was 14.5yrs, significantly differing from the 10.9yrs average age-at-PFD diagnosis in their counterparts that, after menarche, did not develop HMB (PP P Conclusions Adolescents with PFDs and HMB appear to be clinically distinct from their non-HMB counterparts. This group of girls is characterized by HMB the major bleeding symptom, significantly high incidences of blood group O and the δ-SPD with a PFD diagnosed well after menarche. High false negative standard platelet function study results indicate additional diagnostic strategies, particularly for δ-SPD, should be considered.

  1. 割治分抑穴治疗偏头痛的临床研究%Clinical Study on the Treatment of Migraine by Cutting and Treating Migraine

    Institute of Scientific and Technical Information of China (English)

    王月

    2015-01-01

    Objective To investigate the clinical effect of treatment of migraine by cutting the treatment of migraine.Methods90 patients with migraine were randomly assigned to two groups with 45 cases in each group. Cutting treatment group with once cutting treatment,the drug therapy group with Zhen naoning capsule of 4 weeks,then observed the VAS score of two groups.ResultsAfter treatment of 4 weeks,the VAS score of two groups were significantly different(P<0.05),the efficacy of the treatment group was better than that of the drug treatment group. Conclusion It is a effective method to improve the pain symptoms in patients with migraine.%目的:探讨割治分抑穴治疗偏头痛的临床疗效。方法将90例偏头痛患者随机分两组各45例。割治组仅进行一次割治治疗,药物治疗组给予镇脑宁胶囊口服4周。观察两组治疗前后头痛程度VAS评分及头痛症状积分。结果治疗4周后,两组偏头痛VAS评分比较差异具有统计学意义(P<0.05),割治组疗效优于药物治疗组。结论割治分抑穴在改善偏头痛患者疼痛症状方面是一种有效的方法。

  2. Clinical status of migraine%对偏头痛临床现状的一些思考

    Institute of Scientific and Technical Information of China (English)

    陈晨; 王晓平

    2013-01-01

    偏头痛被公认为一种家族高聚集性神经系统疾病.基础和临床、西医和中医的深入结合,进一步明确偏头痛的根本发病机制、探索临床的有效乃至根治偏头痛治疗手段是研究的最终目标.本文综述偏头痛的中国现代史,中国人群偏头痛的患病率及局部注射治疗难治性偏头痛进展.%Migraine is recognized as a familial aggregation nervous system disease.For now,the pathogenesis and clinical treatment of migraine still need to be investigated further.Combined with basic research and clinical study of western medicine and traditional Chinese medicine,to further clarify the pathogenesis of migraine and to explore the effective clinical treatment are the ultimate goal of study.This review describes the migraine prevalence in Chinese people and the local injection treatment for refractory migraine patients.

  3. Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

    Science.gov (United States)

    Escher, Claus M; Paracka, Lejla; Dressler, Dirk; Kollewe, Katja

    2017-02-01

    Chronic migraine (CM) is a severely disabling neurological condition characterized by episodes of pulsating unilateral or bilateral headache. The United States Food and Drug Administration (FDA) approved onabotulinumtoxinA (Botox(®)) for the prophylactic treatment of CM in 2010. It has been shown that onabotulinumtoxinA is effective in the reduction of headache frequency and severity in patients with CM. Treatment is well tolerated by the patients. This review reports on the history of botulinum neurotoxin (BoNT) in CM and presents the current clinical evidence for the use of onabotulinumtoxinA in the treatment of CM.

  4. Acupuncture Analgesia in Migraine

    Institute of Scientific and Technical Information of China (English)

    吴根诚

    2009-01-01

    There is no curative treatment for migraine, although there does exist various options for pharmacological treatment.Drug treatment withβ-adrenoceptor blockers,calcium antagonists,or other agents has been shown to reduce the frequency of migraine attacks;however,the success of treatment is usually modest.Acupuncture has been increasingly used as adjunctive treatment in primary headache syndromes and there is growing evidences from clinical trials that it might be beneficial in the treatment of migraine,w...

  5. [Genetics of migraine].

    Science.gov (United States)

    Ducros, A

    2013-05-01

    The aim of genetic studies in migraine is to identify key proteins in order to better understand the molecular mechanisms of this frequent but still incompletely understood condition. This review describes the current knowledge in the field of migraine genetics. Migraine genes have been, and still are, difficult to identify. The more common varieties of migraine are characterized by a high prevalence in the general population, and a high phenotypic variability. In the absence of any objective diagnosis marker, the status for genetic studies is established only clinically. The first breakthrough was permitted by the study of familial hemiplegic migraine, a variety of migraine with motor aura. This rare condition has a monogenic, autosomal dominant mode of inheritance, thus enabling genetic studies. The three first genes, identified from 1996 to 2005, all encode ion-channel transporters: a neuronal calcium channel (CACNA1A, FHM1), a glial sodium/potassium pump (ATP1A2, FHM2) and a neuronal sodium channel (SCN1A, FHM3). Study of cellular and animal models have shown that mutations in CACNA1A and ATP1A2 facilitated the initiation of cortical spreading depression waves, the mechanism underlying the migraine aura, and most likely increased neuronal excitability with an excess of glutamatergic neurotransmission. In 2012, PRRT2 has been identified as the fourth FHM gene, and encodes an axonal protein associated to the exocytosis complex. In the 1990s, family and twin studies showed that the more common varieties of migraine (migraine without aura and migraine with typical aura) were polygenic, with an overall heritability nearing 50 %. These genetic factors interact with environmental factors. The initial attempts to identify migraine genes by candidate gene approaches or by linkage studies were deceiving. Since 2010, three large genome-wide association studies (GWAS) have identified six genetic variants associated with migraine. Each variant has only a modest

  6. Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™: review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine

    Directory of Open Access Journals (Sweden)

    Vikelis M

    2012-09-01

    Full Text Available Michail Vikelis,1 Dimos D Mitsikostas,2 Alan M Rapoport31Glyfada Headache Center, Glyfada, Greece; 2Neurology Department, Athens Naval Hospital, Athens, Greece; 3The David Geffen School of Medicine at UCLA, Los Angeles, CA, USAAbstract: Migraine is a chronic, painful, and often disabling primary headache disorder, typically presenting with recurrent attacks that may be accompanied by a variety of neurological, gastrointestinal, and autonomic symptoms. Gastrointestinal symptoms in association with migraine including, nausea, vomiting, and gastroparesis, affect a large proportion of migraine sufferers. These symptoms may result in delays or inconsistencies in the absorption of oral treatments. Hence, the necessity for an innovative, non-invasive, parenteral delivery formulation for quick and effective treatment of migraine attacks is evident. Iontophoresis utilizes minimal amounts of electrical potential to support the fast transfer of ionized medication transdermally and into the general circulation. Two pharmacokinetic clinical trials have shown that iontophoretic delivery of sumatriptan through the skin produces quick and reproducible therapeutic plasma concentrations. A randomized, double-blind, multicenter, phase III study demonstrated superior efficacy versus placebo and excellent tolerability, with no triptan-related adverse events. The proportion of patients that were pain-free at 2 h post-treatment was 18% for the sumatriptan patch vs 9% for placebo (P = 0.0092; number needed to treat = 11.1. Upon approval from the Food and Drug Administration and other regulatory authorities, the iontophoretic transdermal delivery of sumatriptan will be a good choice for patients experiencing poor absorption of oral medication often associated with migraine and/or for those with intolerable triptan-related adverse events.Keywords: iontophoretic patch, migraine, migraine treatment, sumatriptan, transdermal patch

  7. Clinical effectiveness of osteopathic treatment in chronic migraine: 3-Armed randomized controlled trial.

    Science.gov (United States)

    Cerritelli, Francesco; Ginevri, Liana; Messi, Gabriella; Caprari, Emanuele; Di Vincenzo, Marcello; Renzetti, Cinzia; Cozzolino, Vincenzo; Barlafante, Gina; Foschi, Nicoletta; Provinciali, Leandro

    2015-04-01

    To assess the effectiveness of OMT on chronic migraineurs using HIT-6 questionnaire, drug consumption, days of migraine, pain intensity and functional disability. 3-Armed randomized controlled trial setting: all patients admitted in the Department of Neurology of Ancona's United Hospitals, Italy, with a diagnosis of migraine and without chronic illness, were considered eligible for the study. Patients were randomly divided into three groups: (1) OMT+medication therapy, (2) sham+medication therapy and (3) medication therapy only. Patients received 8 treatments in a study period of 6 months. Changing from baseline HIT-6 score. 105 subjects were included. At the end of the study, ANOVA showed that OMT significantly reduced HIT-6 score (mean change scores OMT-conventional care: -8.74; 95% confidence interval (CI) -12.96 to -4.52; pOMT-sham: -6.62; 95% CI -10.85 to -2.41; pOMT-sham: RR=0.22, 95% CI 0.11-0.40; OMT-control: RR=0.20, 95% CI 0.10-0.36), days of migraine (OMT-conventional care: M=-21.06; 95% CI -23.19 to -18.92; pOMT-sham: -17.43; 95% CI -19.57 to -15.29; pOMT-sham: RR=0.42, 95% CI 0.24-0.69; OMT-control: RR=0.31, 95% CI 0.19-0.49) and functional disability (pOMT may be considered a valid procedure for the management of migraineurs. The present trial was registered on www.ClinicalTrials.gov (identifier: NCT01851148). Copyright © 2015 Elsevier Ltd. All rights reserved.

  8. Painful menstrual periods

    Science.gov (United States)

    Menstruation - painful; Dysmenorrhea; Periods - painful; Cramps - menstrual; Menstrual cramps ... related activities for a few days during each menstrual cycle. Painful menstruation is the leading cause of ...

  9. The stigma of migraine.

    Directory of Open Access Journals (Sweden)

    William B Young

    Full Text Available BACKGROUND: People who have a disease often experience stigma, a socially and culturally embedded process through which individuals experience stereotyping, devaluation, and discrimination. Stigma has great impact on quality of life, behavior, and life chances. We do not know whether or not migraine is stigmatizing. METHODS: We studied 123 episodic migraine patients, 123 chronic migraine patients, and 62 epilepsy patients in a clinical setting to investigate the extent to which stigma attaches to migraine, using epilepsy as a comparison. We used the stigma scale for chronic illness, a 24-item questionnaire suitable for studying chronic neurologic diseases, and various disease impact measures. RESULTS: Patients with chronic migraine had higher scores (54.0±20.2 on the stigma scale for chronic illness than either episodic migraine (41.7±14.8 or epilepsy patients (44.6±16.3 (p<0.001. Subjects with migraine reported greater inability to work than epilepsy subjects. Stigma correlated most strongly with the mental component score of the short form of the medical outcomes health survey (SF-12, then with ability to work and migraine disability score for chronic and episodic migraine and the Liverpool impact on epilepsy scale for epilepsy. Analysis of covariance showed adjusted scores for the stigma scale for chronic illness were similar for chronic migraine (49.3; 95% confidence interval, 46.2 to 52.4 and epilepsy (46.5; 95% confidence interval, 41.6 to 51.6, and lower for episodic migraine (43.7; 95% confidence interval, 40.9 to 46.6. Ability to work was the strongest predictor of stigma as measured by the stigma scale for chronic illness. CONCLUSION: In our model, adjusted stigma was similar for chronic migraine and epilepsy, which were greater than for episodic migraine. Stigma correlated most strongly with inability to work, and was greater for chronic migraine than epilepsy or episodic migraine because chronic migraine patients had less ability

  10. Tongue diagnosis:relationship between sublingual tongue morphology in three tongue protrusion angles and menstrual clinical symptoms

    Institute of Scientific and Technical Information of China (English)

    Tim Hideaki Tanaka

    2015-01-01

    OBJECTIVE:The morphological and color characteristics of the tongue sublingual veins (SLVs) can manifest differently within the subjects, depending on the way their tongue is curled upward. This study was conducted in order to investigate the clinical relevancy of tongue SLV diagnosis in relation to menstrual clinical symptoms (pain, clots, heavy, and scanty), using three different inspection procedures (IP1, IP2, and IP3). METHODS: Three-hundred and seventy-seven female patients were asked to stick out their tongues in three speciifc ways which were intended to create different tongue protrusion angles. The SLV parameters for thickness (TK), length (LE), color (CL), shape (SP), and nodules (ND) were then evaluated. RESULTS: According to the results of the Waldχ2 test, IP1 provides the best model for pain (R2 = 0.155), IP3 for clots (R2 = 0.437), IP2 for heavy (R2 = 0.268), and scanty (R2 = 0.192). Abnormal SLV diagnostic parameters were most strongly associated with the clinical symptom of clots (R2= 0.492). CONCLUSION: While the study showed the relations between tongue SLV features and menstrual clinical symptoms, as wel it showed that IP2 was the best overal predictor for the symptomatic indexes used in this study, and using one particular SLV inspection procedure may not be sufifcient. The application of a particular inspection method alone may cause under- or over-estimation of SLV abnormalities.

  11. Clinical Pharmacology of Current and Future Drugs for the Acute Treatment of Migraine

    DEFF Research Database (Denmark)

    Tfelt-Hansen, Peer

    2012-01-01

    Migraine is a common disorder with a female prevalence of 17% and a male prevalence of 9%. Migraine is most often disabling and the patients need treatment of the attacks. The introduction of triptans has been a revolution for many migraine patients but only a minority of patients use...... with no more adverse events than placebo, but only one quarter of migraine patients have been pain-free after 2 hours in phase III studies. The development of current CGRP antagonists has been stopped....

  12. Clinical Observations on the Treatment of Migraine by Acupuncture plus Auricular Plaster Therapy

    Institute of Scientific and Technical Information of China (English)

    孙培华

    2007-01-01

    目的:探讨针刺配合耳压辨证治疗偏头痛的临床疗效.方法:将150例偏头痛患者随机分为观察组(n=90)和对照组(n=60).观察组患者采用针刺配合耳压辨证治疗,对照组患者采用口服西比灵治疗,并将两组的治疗效果进行对比观察.结果:观察组总有效率为94.4%,好于对照组(73.3%),观察组痊愈率为87.8%,高于对照组(55.0%).两组差异有非常显著意义(P<0.01).结论:观察组疗效明显优于对照组,运用针刺配合耳压辨证治疗偏头痛,能获得良好的临床疗效.%Objective: To investigate the clinical efficacy of acupuncture plus auricular plaster therapy for treating migraine. Methods: One hundred and fifty migraine patients were randomly allocated to an observation group (n=90) and a control group (n=60). The observation group were treated by acupuncture plus auricular plaster therapy based on syndrome differentiation and the control group, by oral administration of Flunarizine. The curative effects were compared between the two groups. Results: The total efficacy rate was 94.4% in the observation group and higher than in the control group (73.3%). The recovery rate was 87.8% in the observation group and higher than in the control group (55.0%). There were significant differences between the two groups (both P<0.01). The curative effect was significantly better in the observation group than in the control group. Conclusion: Clinically, acupuncture plus auricular plaster therapy based on syndrome differentiation has a good effect on migraine.

  13. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.

    Science.gov (United States)

    Sarchielli, P; Pini, L A; Zanchin, G; Alberti, A; Maggioni, F; Rossi, C; Floridi, A; Calabresi, P

    2006-03-01

    The present study was aimed at verifying the clinical characteristics of a typical attack in 20 migraine patients, 10 responders and 10 non-responders to rizatriptan, and at investigating any differences in the levels of neuropeptides of the trigeminovascular or parasympathetic systems [calcitonin gene-related peptide (CGRP), neurokinin A (NKA) and vasoactive intestinal peptide (VIP) measured by radioimmunoassay methods in external jugular blood] between responders and non-responders. In all responders to rizatriptan, pain was unilateral, severe, and pulsating, and in five of them at least one sign suggestive of parasympathetic system activation was recorded. Five patients who were non-responders to rizatriptan referred bilateral and non-pulsating pain, even though severe in most of them. CGRP and NKA levels measured before rizatriptan administration were significantly higher in responders than in non-responders (P rizatriptan responders, detectable VIP levels were found at baseline. One hour after rizatriptan administration, a decrease in CGRP and NKA levels was evident in the external jugular venous blood of rizatriptan responders, and this corresponded to a significant pain relief and alleviation of accompanying symptoms. VIP levels were also significantly reduced at the same time in the five patients with autonomic signs. After rizatriptan administration, CGRP and NKA levels in non-responder patients showed less significant variations at all time points after rizatriptan administration compared with rizatriptan responders. The present study, although carried out on a limited number of patients, supports recent clinical evidence of increased trigeminal activation associated with a better triptan response in migraine patients accompanied by parasympathetic activation in a subgroup of patients with autonomic signs. In contrast, the poor response seems to be correlated with a lesser degree of trigeminal activation, lower variations of trigeminal neuropeptides after

  14. Study on clinical classification of pediatric migraine%小儿偏头痛的临床分型研究

    Institute of Scientific and Technical Information of China (English)

    黄瑞凝; 伍志勇; 黄小星; 商建青; 陈宝田

    2013-01-01

    Objective To propose new clinical classification of pediatric migraine. Methods To demonstrate it in theory and clinic:(1)According to the experience of clinic practice and relative epidemiological investigations, indicate the in-completeness of ICHDII. (2)A retrospective investigation was made according to illness history in the 200 patients with pediat-ric migraine. (3)Track down the best evidence for the new clinical classification of pediatric migraine in the aspects of AM, CVS and BPVC. Results (1)The clinical manifestation in morbidity period of pediatric migraine can be concluded in 3 kinds: ①Pure characterized by abdominal migraine, cyclical vomiting and benign paroxysmal vertigo of childhood ( the child-hood periodic syndromes that are commonly precursors of migraine ). ②Pure characterized by typical migraine. ③With abdomi-nal migraine, cyclical vomiting and benign paroxysmal vertigo of childhood as the main symptoms, and with a headache and other accompanied symptoms. (2)The natural course of pediatric migraine can be concluded in 3 kinds: ①Pediatric migraine begins with the childhood periodic syndromes that are commonly precursors of migraine, then migraine with or without aura ap-pears after the childhood periodic syndromes have disappeared for some time. ②After the childhood periodic syndromes that are commonly precursors of migraine have lasted for some times ( Several days to a few years ), occasional headache appears, and then the childhood periodic syndromes gradually disappeared and typical migraine with or without aura appears. (3)Abdominal migraine, cyclical vomiting and benign paroxysmal vertigo of childhood can appear individually or at the same time. The dura-tion of the childhood periodic syndromes is different; it lasts for several days to a few years. Conclusion Pediatric migraines should be divided into three types: Complete Type, Incomplete Type and Adult Type.%目的 提出新的小儿偏头痛临床分型标准.方法 从理

  15. Comorbidity of Migraine

    Directory of Open Access Journals (Sweden)

    Shuu-Jiun Wang

    2010-08-01

    Full Text Available Migraine is a common neurological disorder and can cause severely disabling during attacks. The highest prevalence occurs between the ages of 25 and 55 years, potentially the most productive period of life. Migraine leads to a burden not only to the individual, but also to the family and society. Prior studies have found migraine occurs with some illness at a greater than coincidental rate than is seen in the general population. These occurrences are called “comorbidity”, which means that these disorders are interrelated with migraine. To delineate migraine comorbidity is important because it can help improve treatment strategies and understand the possible pathophysiology of migraine. The comorbid illnesses in patients with migraine include stroke, sub-clinical vascular brain lesions, coronary heart disease, hypertension, patent foramen ovale, psychiatric diseases (depression, anxiety, bipolar disorder, panic disorder, and suicide, restless legs syndrome, epilepsy, and asthma. In this paper, we review the existing epidemiological and hospital based studies and illustrate the connections between these illness and migraine.

  16. [Migraine and epilepsy].

    Science.gov (United States)

    Tsuji, Sadatoshi

    2014-01-01

    Migraine and epilepsy are both common episodic disorders that share many clinical features and underlying pathophysiological mechanisms. The comorbidity of these two conditions is well known. However, the temporal association between migraine and epilepsy is a controversial issue, since these two conditions may occur in numerous ways. Four types of association between headache and epileptic seizure are recognized: pre-ictal headache, headache as the expression of an epileptic manifestation, post-ictal headache, and inter-ictal headache. The classification of epilepsy by the International League Against Epilepsy did not refer to the epileptic headache. On the other hand, the International Classification of Headache Disorders, 3rd edition (ICHD-3) defines three entities: migraine aura-triggered seizure which sometimes referred to as migralepsy, hemicrania epileptica, and post-ictal headache. However, ICHD-3 mentions that there is a complex and bidirectional association between migraine and epilepsy. Most of the previous reports of migralepsy corresponded to occipital seizures that mimic migraine with aura. The term migralepsy has recently been criticized. Migraine and epilepsy share several pathophysiological mechanisms which involve neurotransmitters and iron channel dysfunctions. There is the hypothesis of a shared genetic susceptibility to migraine and epilepsy. Strong support of a shared genetic basis comes from familial hemiplegic migraine.

  17. Migraine Associated with Gastrointestinal Disorders: Review of the Literature and Clinical Implications

    NARCIS (Netherlands)

    Hemert, van S.; Breedveld, A.C.; Rovers, J.M.P.; Vermeiden, J.P.W.; Witteman, B.J.M.; Smits, M.; Roos, de N.M.

    2014-01-01

    Recent studies suggest that migraine may be associated with gastrointestinal (GI) disorders, including irritable bowel syndrome (IBS), inflammatory bowel syndrome, and celiac disease. Here, an overview of the associations between migraine and GI disorders is presented, as well as possible mechanisti

  18. Clinical and electroencephalographic abnormalities during the full duration of a sporadic hemiplegic migraine attack.

    Science.gov (United States)

    Chastan, Nathalie; Lebas, Axel; Legoff, Floriane; Parain, Dominique; Guyant-Marechal, Lucie

    2016-11-01

    Electroencephalographic (EEG) abnormalities have been reported during migraine attacks but their spatial and temporal distributions are not well known. We report the temporospatial dynamics of EEG during the full duration of a migraine attack with aura in a 19-year-old woman. She experienced episodes of hemiplegic migraine since the age of 2.5 years, with right hemibody paralysis preceded by visual symptoms. She reported severe pain of the right hemibody just before hemiplegia that was enventually suggestive of possible epileptic seizure, justifying diagnostic video-EEG monitoring. Sporadic hemiplegic migraine was diagnosed in the absence of family history. EEG was normal at the beginning of visual aura. After 15minutes, posterior slow waves appeared over the migrainous hemisphere, spreading progressively towards anterior regions: first the central region (5minutes after onset of contralateral hemiplegia), then the frontal region and over both hemispheres. A new de novo mutation was identified in the SCN1A gene.

  19. Migraine and Central Sensitization: Clinical Features, Main Comorbidities and Therapeutic Perspectives.

    Science.gov (United States)

    de Tommaso, Marina; Sciruicchio, Vittorio

    2016-01-01

    Migraine is a very common neurologic disorder, characterized by recurrent attacks of severe headache, autonomic nervous system dysfunction and in some patients by an aura. Migraine is a very common neurologic disorder of neuro-vascular origin, being amongst the 20 most disabling diseases. Migraine attacks are characterized by severe headache, associated to autonomic nervous system dysfunction and in some patients by aura. Pathophysiology and Role of Central Sensitization: Abnormal neuronal excitability may subtend altered processing of sensory stimuli, leading to cortical spreading depression and trigeminal activation. A dysfunction of pain modulation enhances central sensitization phenomena, contributing to acute allodynia and headache persistence. The peculiarity of migraine pain facilitates the use of analgesics, and causes an adjunctive invalidating tendency toward drug over-use. Comorbidity: Chronic migraine patients are frequently affected by diffuse pain, framed in fibromyalgia diagnosis. This comorbidity seems to be supported by common pathophysiological mechanisms. It may aggravate migraine invalidity being worth of consideration for therapeutic management. Migraine Management: Acute and preventive treatments need to be tailored to single cases. Main comorbidity and factors facilitating central sensitization should be taken into account. The management of migraine patients should include a link between headache centers and general practitioner, in order to provide for a better patient information and treatment just at the onset of the disease. Despite its high epidemiologic impact, migraine is frequently underestimated and destined to evolve into chronic form and drugs abuse. A more focused attention to factors facilitating central sensitization and invalidating comorbidities, should reduce the global burden of the disease. migraine, pathophysiology, central sensitization, fibromyalgia comorbidity, acute and preventive therapy, patients - centered approach.

  20. Menstrual Cramps

    Science.gov (United States)

    ... symptoms cause you to miss school or other activities and over-the-counter medicine and other comfort measures don’t help, you should make an appointment with your health care provider. Tags: cramps , period , period tracker Related Content Menstrual Periods Painful Periods (Dysmenorrhea) I’ ...

  1. Frequency of Macroprolactinemia in Hyperprolactinemic Women Presenting with Menstrual Irregularities, Galactorrhea, and/or Infertility: Etiology and Clinical Manifestations

    Directory of Open Access Journals (Sweden)

    Alfredo Leaños-Miranda

    2013-01-01

    Full Text Available Aim. To determine the frequency of macroprolactinemia, its etiology, and the clinical manifestations in patients with hyperprolactinemia presenting with menstrual irregularities, galactorrhea, and/or infertility who were attended by the gynecology-endocrinology service. Methods. In a cross-sectional study, 326 hyperprolactinemic women were tested for serum prolactin (PRL concentrations before and after chromatographic separation (gel filtration and affinity with protein G and extraction of free PRL with polyethylene glycol (PEG. Results. Sera from 57 patients (17.5% were found to have macroprolactinemia. The presence of macroprolactinemia was attributable to anti-PRL autoantibodies in 54 (94.7% patients. The median serum PRL levels were similar in patients with or without macroprolactinemia (42.0 versus 38.1 ng/mL. In contrast, patients with macroprolactinemia had lower serum-free PRL levels (median 9.2 versus 31.7 ng/mL, . Patients without macroprolactinemia had a higher frequency of galactorrhea and abnormal pituitary imagine findings (. Conclusions. We can conclude that macroprolactinemia should be considered as a benign variant, and it must be ruled out in women presenting with menstrual irregularities, galactorrhea, and/or infertility in order to investigate other causes different than hyperprolactinemia. Serum PRL precipitated with PEG is a convenient and simple procedure to screen for the presence of macroprolactinemia.

  2. Migraine and hypertension

    Directory of Open Access Journals (Sweden)

    G. R. Tabeeva

    2015-01-01

    Full Text Available Investigations of a relationship between migraine and hypertension are being continued. In spite of numerous studies, the association of some types of migraine (migraine with aura and migraine without aura with hypertension has not been fully elucidated. This issue is particularly relevant since these forms differ both clinically and pathophysiologically. Of even greater importance are the analysis and prediction of associations between migraine and cardiovascular diseases (ischemic stroke, myocardial infarction, coronary heart disease. The review deals with the clinical and pathophysiological features of the relationship between hypertension and migraine. There is evidence for the anatomic and functional correlation between the antinociceptive system and blood pressure (BP regulation control. It has been speculated that the increase in pain threshold is not the result of just hypertension as a disease, but it is caused by elevated BP-related hypalgesia. The efficacy of antihypertensive drugs is the fact that supports the association between hypertension and endothelial dysfunction. Identification of groups of patients having migraine and a high cardiovascular risk will allow timely early primary prevention and therapy. Introduction of a stratification approach at diagnostic stages may cause a reduction in cardiovascular morbidity and mortality rates.

  3. 中医内科治疗偏头痛的效果研究%Clinical research on treating migraine in TCM

    Institute of Scientific and Technical Information of China (English)

    代国泽

    2013-01-01

    偏头痛作为一种常见的临床疾病,在青少年人群中较为多发,本文结合目前偏头痛的治疗情况,从中医内科角度对偏头痛的治疗效果做出研究。%Migraine is a common clinical disease, it is multiple in the young people crowd. Combining with the current migraine treatment, this paper researches the migraine treatment, from TCM internal medicine therapy angle.

  4. Failure to Consider the Menstrual Cycle Phase May Cause Misinterpretation of Clinical and Research Findings of Cardiometabolic Biomarkers in Premenopausal Women

    Science.gov (United States)

    Schisterman, Enrique F.; Mumford, Sunni L.; Sjaarda, Lindsey A.

    2014-01-01

    Biomarker assessment plays a critical role in the study and prevention of disease. However, variation in biomarkers attributable to the menstrual cycle in premenopausal women may impair understanding the role of certain biomarkers in disease development and progression. Thus, in light of the recently increasing evidence of menstrual cycle variability in multiple cardiometabolic biomarkers, a reexamination of approaches for appropriately studying and diagnosing cardiovascular disease in premenopausal women is warranted. We reviewed studies (from 1934 through 2012) evaluating changes in cardiometabolic biomarkers across phases of the menstrual cycle, including markers of oxidative stress, lipids, insulin sensitivity, and systemic inflammation. Each was observed to vary significantly during the menstrual cycle. For example, nearly twice as many women had elevated cholesterol levels warranting therapy (≥200 mg/dL) during the follicular phase compared with the luteal phase (14.3% vs. 7.9%), with only 3% having consistently high levels during all phases of the cycle. Similarly, nearly twice as many women were classified as being at an elevated risk of cardiovascular disease (high sensitivity C-reactive protein >3 mg/L) during menses compared with other phases (12.3% vs. 7.4%). Menstrual cycle–associated variability in cardiometabolic biomarkers is an important source of variability that should be accounted for in both research and clinical settings. PMID:24042431

  5. 李颖教授治疗经行头痛临证经验%Pro. Li Ying’s experience for treating menstrual headache in clinic

    Institute of Scientific and Technical Information of China (English)

    郭晓杰; 李颖

    2015-01-01

    经行头痛是指经期或经行前后头痛,近年来发病率有逐年上升的趋势,其发病与生活压力息息相关,李颖教授认为本病与肝的关系最为密切,依据多年从医经验独创疏肝养血止痛方治疗此病证,临症加减医治多例,效果显著。%The menstrual headache was headache in menstrual period. In recent years, the incidence was increased; and there is a close relation between life stress and menstrual headache. Professor Li Ying believed that there was a close relationship between menstrual headache and liver. So the Shugan Yangxue Zhitong prescription was devised by Professor Li Ying based on her extensive experience for treating menstrual headache, and shows a significant effect in clinic.

  6. Migraine: is it related to hormonal disturbances or stress?

    Directory of Open Access Journals (Sweden)

    Parashar R

    2014-10-01

    Full Text Available Rachna Parashar,1 Payal Bhalla,2 Nirendra K Rai,3 Abhijit Pakhare,4 Rashmi Babbar5 1Department of Physiology, All India Institute of Medical Sciences, Bhopal, 2Department of Physiology, Vardhaman Mahavir Medical College, New Delhi, 3Department of Neurology, 4Department of Community and Family Medicine, All India Institute of Medical Sciences, Bhopal, 5Department of Physiology, Maulana Azad Medical College, New Delhi, India Background: Common neurological syndrome (migraine without aura is more common among women than men. Migraine is among the top 20 causes of disability. Menstruation is known to be a powerful trigger for migraine, and so is stress, but the presentation of headache is similar in both. Also, women are more vulnerable to stress as well as migraine, and this makes a complex relationship of menstruation, stress, and migraine. Objective: This study was done to understand the association of hormonal fluctuation in menstruation and stress with common migraine. Materials and methods: A cross-sectional comparative study was conducted in 40 young adult females, of whom 20 participants were cases of migraine without aura (18–35 years old, and the remaining 20 participants were age-matched controls. The study was done in Maulana Azad Medical College, New Delhi. Study participants were selected on the basis of International Headache Society (ICHD-IIA1.1 (2004 classification. Study participants with neurological disorders, chronic diseases, and disease suggestive of any hormonal disturbances were excluded. Clinically diagnosed migraine cases were asked to maintain a headache diary and to fill in the Depression Anxiety Stress Scales questionnaire. Biochemical assessment of hormonal status for thyroid-stimulating hormone, triiodothyronine, thyroxine, estrogen, follicle-stimulating hormone, luteinizing hormone, and prolactin was also done on the second day of their menstrual cycle. We used the Mann–Whitney U test to compare hormonal levels

  7. Clinical efficacy of rizatriptan for patients with migraine: efficacy of drug therapy for migraine accompanied by tension headache-like symptoms, focusing on neck stiffness.

    Science.gov (United States)

    Okuma, Hirohisa; Kitagawa, Yasuhisa; Takagi, Shigeharu

    2005-12-01

    According to an epidemiological study in Japan, there are as many as 22 million patients with tension headache and 8.4 million with migraine. Furthermore, patients suffering from both types of headache concurrently are estimated to account for more than 50% of headache patients. We studied the efficacy of drug therapy for migraine accompanied by tension headache-like symptoms, focusing principally on neck stiffness. We evaluated the efficacy of rizatriptan by comparison of findings before and after therapy in 34 migraine patients, consisting of 16 without neck stiffness (migraine without neck factor: WONF) and 18 with it (migraine with neck factor: WNF), who received treatment at our neurology/internal medicine department from 1 March 2004 to 31 May 2005. In the study, all the patients were asked to keep a record of their migraine status. The severity of migraine was classified by physicians according to the International Headache Society diagnostic criteria, based on which drug efficacy was evaluated. We selected rizatriptan for migraine treatment in our study based on Dr. Ferrari's report. In the efficacy study of rizatriptan, in the group of 34 migraine patients, the pain relief rate (79.4%) and pain-free rate (41.2%) at two hours after treatment were as high as those reported in the meta-analysis performed by Ferrari et al., indicating high efficacy of rizatriptan. In the efficacy comparison between the WONF and WNF groups, the painfree rates were 56.3% and 27.8%, and cumulative pain relief rates were 100% and 61.1%, respectively, with better results in the WONF group. A test result was also significantly better (p=0.0076) in the WONF group. Rizatriptan was proved effective in treating migraine patients accompanied by tension headache-like symptoms. Comparison of efficacy rates between patient groups with and without tension headache-like symptoms showed that the pain relief rate in the group without neck stiffness was higher.

  8. The sensitivity of length of pregnancy using clinical estimate of gestation versus last menstrual period: an example with particulate matter and preterm birth

    Science.gov (United States)

    Estimating gestational age is usually based on last menstrual period date (LMP) or clinical estimation (CGA); both approaches introduce error and potential bias. Differences in the two methods of gestational age assignment may lead to misclassification and differences in risk est...

  9. The sensitivity of length of pregnancy using clinical estimate of gestation versus last menstrual period: an example with particulate matter and preterm birth

    Science.gov (United States)

    Estimating gestational age is usually based on last menstrual period date (LMP) or clinical estimation (CGA); both approaches introduce error and potential bias. Differences in the two methods of gestational age assignment may lead to misclassification and differences in risk est...

  10. [Vestibular migraine].

    Science.gov (United States)

    Hansen, Lars Juul; Kirchmann, Malene; Friis, Morten

    2015-12-14

    Dizziness caused by migraine, vestibular migraine (VM), has been highly debated over the last three decades. The co-morbidity of migraine and dizziness is higher than a random concurrence. One third of the patients with migraine and dizziness have VM. Recently, The International Headache Society approved VM as a diagnostic entity and the diagnostic criteria for VM appear in the appendix for The International Classification of Headache Disorders. VM is common but often underdiagnosed. Treatment follows migraine management guidelines although evidence is sparse.

  11. Caffeine discontinuation improves acute migraine treatment: a prospective clinic-based study.

    Science.gov (United States)

    Lee, Mi Ji; Choi, Hyun Ah; Choi, Hanna; Chung, Chin-Sang

    2016-12-01

    Caffeine has both excitatory and vasoconstrictive effects on central nervous system. Caffeine use might be associated with development and chronification of migraine. We aimed to evaluate the effect of caffeine cessation on the acute treatment of migraine. We prospectively recruited migraine patients who consumed caffeine drinks daily and instructed them to discontinue their caffeine intake. Triptans were prescribed for acute treatment. Patients were followed up after at least two weeks after screening and evaluated the efficacy of acute treatment with the migraine assessment of current therapy (Migraine-ACT) questionnaire. Excellent efficacy was defined as Migraine-ACT score of 4. Chronic migraine, body mass index, allodynia, depression, anxiety, antiemetic use, and use of prophylactic medication were included in the multivariate analysis if the univariate p caffeine intake (abstinence group). The efficacy of acute treatment was assessed at median 34.5 days (interquartile range, 28-89) after the screening. Twenty-six patients (72.2 %) in the abstinence group and 29 (40.3 %) in the non-abstinence group reported an excellent efficacy (p = 0.002). The abstinence group also showed a trend toward greater reduction of headache impact test-6 (HIT-6) scores (p = 0.085). Caffeine abstinence was independently associated with an excellent efficacy of acute treatment (multivariate odds ratio, 3.2; 95 % confidence interval, 1.2-8.4; p = 0.018) after controlling for covariates. Caffeine abstinence is associated with better efficacy of acute migraine treatment. Our uncontrolled study results encourage a further confirmatory study on this issue.

  12. MANAGEMENT OF ARDHAVABHEDAKA VIS-À-VIS MIGRAINE: AN OBSERVATIONAL CLINICAL STUDY

    Directory of Open Access Journals (Sweden)

    Shree Vidya P

    2013-12-01

    Full Text Available Headache is the most common health problem experienced by mankind. In that, around 40% of individuals worldwide are suffering from migraine headache which results in severe disabling condition. W.H.O has ranked migraine as number 19 among all diseases worldwide causing disability. According to International Headache Society, Migraine constitutes 16% of the primary headache and affects approximately 10-20% of general population (About 15% of women and 6% of men are the sufferers of migraine. Migraine can be defined as benign, recurring syndrome of headache, nausea, vomiting and/or other symptoms of neurological dysfunction in varying admixtures. The symptom complex of which similates with Ardhavabhedaka is one among the 11 types of shiroroga. The treatment protocol of contemporary science are not acceptable due to their drawbacks and they also cause drug dependence, relapse of headache within hours etc. beside this, the text Charaka samhita mentions Nasya karma as the master key for all shirorogas. So, this study has been carried out with an objective to evaluate the combined efficacy of shatahvadi taila nasya karma with Tablet Nimbadi guggulu and Mashadi kashaya in the management of Ardhavabhedaka vis-à-vis Migraine. The study had been carried out in 30 patients under a single group for a period of 30 days with pre, mid and post test. Overall assessment showed statistically highly significant results with the p value 0.000.

  13. New developments in oral contraception: clinical utility of estradiol valerate/dienogest (Natazia® for contraception and for treatment of heavy menstrual bleeding: patient considerations

    Directory of Open Access Journals (Sweden)

    Nelson AL

    2012-12-01

    Full Text Available Anita L NelsonObstetrics and Gynecology, David Geffen School of Medicine at UCLA, Harbor UCLA Medical Center, Torrance, California, USAAbstract: Natazia® is a new oral contraceptive with estradiol valerate and dienogest in a unique multiphasic formulation that includes a shortened hormone-free interval. This new formulation has been approved for both contraception and also as a treatment for heavy menstrual bleeding in women who desire to use oral contraceptives as their method of birth control. It is marketed in the US as Natazia® and elsewhere as Qlaira®. This article will review the properties of each of the major new features of this pill: estradiol used in place of ethinyl estradiol, dienogest as the progestin, and the unique dosing pattern of this product. It will also summarize the results of the pivotal clinical trials of contraceptive effectiveness, bleeding patterns, safety and tolerability. The lessons learned from the clinical trials about the effectiveness of this formulation in the treatment of excessive menstrual bleeding will be summarized. Also, results of trials comparing this new pill to other popular formulations for "menstrually-related" symptoms and for potential female sexual dysfunction related to use of oral contraceptives will be presented. This review will suggest how all this information might be used to counsel women about how to use this pill most successfully.Keywords: oral contraceptives, estradiol valerate, dienogest, heavy menstrual bleeding, menorrhagia, dynamic dosing

  14. Migraine aura

    DEFF Research Database (Denmark)

    Charles, Andrew; Hansen, Jakob Møller

    2015-01-01

    PURPOSE OF REVIEW: The migraine aura is a dramatic spontaneous change in brain activity resulting in a variety of transient neurological symptoms. The purpose of this review is to address recent advances in the understanding of aura and its role in migraine. RECENT FINDINGS: The formal...... classification of migraine aura is becoming both broader and more detailed. Traditionally viewed as a primary event that triggers a migraine attack, studies regarding the timing of aura relative to other symptoms of migraine indicate that it may not in fact play a primary role in initiating an attack. Careful...... recording and analysis of visual aura symptoms provides new insight into the initiation and propagation of the underlying brain phenomenon, and the different regions of visual cortex that produce different visual perceptions. Migraine with aura may have different responses to acute and preventive therapies...

  15. Sporadic Hemiplegic Migraine: A Separate Entity

    Directory of Open Access Journals (Sweden)

    J Gordon Millichap

    2003-04-01

    Full Text Available The clinical characteristics of 105 patients with sporadic hemiplegic migraine (SHM were compared with those of patients with migraine with typical aura (MA and patients with familial hemiplegic migraine (FHM in a study at the Danish Headache Center, Glostrup Hospital, Gentofte Hospital, University of Copenhagen, and the John F Kennedy Institute, Denmark.

  16. Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service.

    Science.gov (United States)

    Karsan, N; Prabhakar, P; Goadsby, P J

    2016-12-01

    The premonitory stage of migraine attacks, when symptomatology outside of pain can manifest hours to days before the onset of the headache, is well recognised. Such symptoms have been reported in adults in a number of studies, and have value in predicting an impending headache. These symptoms have not been extensively studied in children. We aimed to characterise which, if any, of these symptoms are reported in children seen within a Specialist Headache Service. We reviewed clinic letters from the initial consultation of children and adolescents seen within the Specialist Headache Service at Great Ormond Street Hospital between 1999 and 2015 with migraine in whom we had prospectively assessed clinical phenotype data. We randomly selected 100 cases with at least one premonitory symptom recorded in the letter. For these patients, the age at headache onset, presence of family history of headache, headache diagnosis, presence of episodic syndromes which may be associated with headache, developmental milestones, gestation at birth, mode of delivery and presence of premonitory symptoms occurring before or during headache were recorded. Of the 100 patients selected, 65 % were female. The age range of the patients was 18 months to 15 years at the time of headache onset. The most common diagnosis was chronic migraine in 58 %, followed by episodic migraine (29 %), New Daily Persistent Headache with migrainous features (8 %) and hemiplegic migraine (5 %). A history of infantile colic was noted in 31 % and was the most common childhood episodic syndrome associated with migraine. The most common premonitory symptoms recorded were fatigue, mood change and neck stiffness. The commonest number of reported premonitory symptoms was two. Premonitory symptoms associated with migraine are reported in children as young as 18 months, with an overall clinical phenotype comparable to adults. Better documentation of this stage will aid parents and clinicians to better understand

  17. Clinical Trial of Subcutaneous Steroid Injection in Patients with Migraine Disorder.

    Science.gov (United States)

    Nikkhah, Karim; Ghandehari, Kavian; Jouybari, Ali Ghabeli; Mirzaei, Mohammad Mousavi; Ghandehari, Kosar

    2016-01-01

    Neurologic literature on therapeutic effect of subcutaneous corticosteroids in patients with migrainous chronic daily headache is scarce. The aim of this research is to assess the therapeutic effects of this management in such patients. Consecutive patients with migrainous chronic daily headache enrolled a prospective before-after therapeutic study during 2010-2013. Methylprednisolone 40 mg was divided into four subcutaneous injection doses. Two injections were administered in the right and left suboccipital area (exactly at retromastoid cervicocranial junction) and the other two injections in the lower medial frontal area (exactly at medial right and left eyebrows). A daily headache diary was filled out by the patients before and one month after the intervention. The severity of pain was classified based on a pain intensity instrument using numeric rating scale from 0-10 point scale. Paired t-test and Chi-square test were used for statistical analysis. 504 patients (378 females, 126 males) with migrainous chronic daily headache were enrolled in the study. Dramatic, significant, moderate, mild, or no improvements respectively constituted 28.6%, 33.3%, 23.8%, and 14.3% of the post treatment courses. Therapeutic effect of intervention on mean pain scores was significant; t=7.38, df=20, P=0.000. Two cases developed subcutaneous fat atrophy in frontal injection site and three cases experienced syncope during injection. Subcutaneous corticosteroids could be used as an adjunct therapy in patients with migrainous chronic daily headache.

  18. Migraine Pathogenesis

    Institute of Scientific and Technical Information of China (English)

    Nabih M. M.D. Ramadan

    2000-01-01

    @@Introduction Various theories of migraine pathogenesis have been developed over the years. To this date, none fully explains all the migraine phenomena. A complete description of each proposed theory is beyond the scope of this chapter. Nonetheless, a brief description of the arguments for and against the leading theories is noteworthy

  19. Clinical features, anger management and anxiety: a possible correlation in migraine children.

    Science.gov (United States)

    Tarantino, Samuela; De Ranieri, Cristiana; Dionisi, Cecilia; Citti, Monica; Capuano, Alessandro; Galli, Federica; Guidetti, Vincenzo; Vigevano, Federico; Gentile, Simonetta; Presaghi, Fabio; Valeriani, Massimiliano

    2013-01-01

    Psychological factors can increase severity and intensity of headaches. While great attention has been placed on the presence of anxiety and/or depression as a correlate to a high frequency of migraine attacks, very few studies have analyzed the management of frustration in children with headache. Aim of this study was to analyze the possible correlation between pediatric migraine severity (frequency and intensity of attacks) and the psychological profile, with particular attention to the anger management style. We studied 62 migraineurs (mean age 11.2 ± 2.1 years; 29 M and 33 F). Patients were divided into four groups according to the attack frequency (low, intermediate, high frequency, and chronic migraine). Pain intensity was rated on a 3-levels graduate scale (mild, moderate and severe pain). Psychological profile was assessed by Picture Frustration Study test for anger management and SAFA-A scale for anxiety. We found a relationship between IA/OD index (tendency to inhibit anger expression) and both attack frequency (r = 0.328, p = 0.041) and intensity (r = 0.413, p = 0.010). When we analyzed the relationship between anxiety and the headache features, a negative and significant correlation emerged between separation anxiety (SAFA-A Se) and the frequency of attacks (r = -0.409, p = 0.006). In our patients, the tendency to express and emphasize the presence of the frustrating obstacle (EA/OD index) showed a positive correlation with anxiety level (“Total anxiety” scale: r = 0.345; p = 0.033). Our results suggest that children suffering from severe migraine tend to inhibit their angry feelings. On the contrary, children with low migraine attack frequency express their anger and suffer from separation anxiety.

  20. 偏头痛临床特点回顾性分析%A retrospective study of clinical features of migraine

    Institute of Scientific and Technical Information of China (English)

    邱恩超; 于生元; 郭艳娥; 周志彬; 姜磊; 董钊

    2008-01-01

    目的 分析门诊偏头痛的临床特征,为偏头痛的正确诊治提供帮助.方法 回顾性分析309例偏头痛的临床特点,比较不同性别、类型之间的异同,以及总结偏头痛发生药物过量性头痛(MOH)的危险因素.结果 女性与男性之比约为3:1,76.1%的患者有诱因,最常见的头痛特点是中到重度疼痛(97.7%)、日常体力活动加剧头痛(75.1%)及伴有恶心(90.9%)或呕吐(70.6%);不同性别、类型之间临床特点不全相同;偏头痛发生MOH的危险因素是发病年龄大、发作频率高和频繁使用止痛药缓解头痛.结论 详细询问患者头痛特点、诱因、治疗史是正确诊治偏头痛的基础.%Objective To observe the clinical features of migraine based on out-patient clinic data and provide help for the diagnosis and treatment of migraine. Methods In a retrospective study of 309 patients with migraine, we investigated the clinical characteristics of migraine of both genders and different types, and the risk factors for MOH transformed from migraine. Results The female to male ratio was about 3:1,76.1% of the patients had triggering factors. The most common characteristics of headache were moderate to severe intensity of the pain (97.7%), aggravation by routine physical activity (75.1%), and association with nausea (90.9%) and/or vomiting (70.6%). There were significant differences in some clinical characteristics of migraine in females as compared with these in males and in patients with migraine without aura (MWOA) as compared with those with aura (MWA). The risk factors for MOH transformed from migraine were elder age of onset, high attack frequency and the analgesics frequently used (P < 0.05).Conclusion It is suggested that carefully collecting the characteristics of headache, triggering factors and therapeutic history is the foundation of correct diagnosis and effective treatment for migraine.

  1. Migraine and function of the immune system : a meta-analysis of clinical literature published between 1966 and 1999

    NARCIS (Netherlands)

    Kemper, RHA; Meijler, WJ; Korf, J; Ter Horst, GJ

    2001-01-01

    Mechanisms underlying migraine precipitation are largely unknown. A role of the immune system in migraine precipitation is a matter of debate because of the association of atopic disorders and migraine. Recently, it was demonstrated that migraineurs benefit from eradication of a Helicobacter pylori

  2. Epidemiology of migraine and headache in children and adolescents.

    Science.gov (United States)

    Wöber-Bingöl, Ciçek

    2013-06-01

    Migraine and headache are global disabling conditions causing considerable individual suffering and impaired quality of life in adults as well as in children and adolescents. Therefore, epidemiological studies are essential to assess the scope of the problem. This review covers epidemiological studies on migraine and headache in children and adolescents published in the past 25 years. A total of 64 cross-sectional studies have been identified, published in 32 different countries and including a total of 227,249 subjects. The estimated overall mean prevalence of headache was 54.4% (95% CI 43.1-65.8) and the overall mean prevalence of migraine was 9.1% (95% CI 7.1-11.1). There is a lack of population-based studies from low and low-middle income countries. In addition, there is very little information about the prevalence of probable migraine and chronic migraine and no information about menstrual migraine in the young.

  3. Apnoeic spells following general anaesthesia in a patient with familial hemiplegic migraine.

    Science.gov (United States)

    Willson, J; Kapur, S

    2007-09-01

    Hemiplegic migraine is an unusual variant of migraine, characterised by a temporary hemiparesis or hemiplegia associated with headache. We report a patient with hemiplegic migraine who developed atypical migraine with apnoeic spells, aphasia and hemiparesis following general anaesthesia. We review the clinical features of hemiplegic migraine and the considerations for its anaesthetic management.

  4. Migraine and neuropeptides.

    Science.gov (United States)

    Tajti, János; Szok, Délia; Majláth, Zsófia; Tuka, Bernadett; Csáti, Anett; Vécsei, László

    2015-08-01

    Migraine is a common disabling neurovascular primary headache disorder. The pathomechanism is not clear, but extensive preclinical and clinical studies are ongoing. The structural basis of the leading hypothesis is the trigeminovascular system, which includes the trigeminal ganglion, the meningeal vasculature, and the distinct nuclei of the brainstem, the thalamus and the somatosensory cortex. This review covers the effects of sensory (calcitonin gene-related peptide, pituitary adenylate cyclase-activating polypeptide and substance P), sympathetic (neuropeptide Y) and parasympathetic (vasoactive intestinal peptide) migraine-related neuropeptides and the functions of somatostatin, nociceptin and the orexins in the trigeminovascular system. These neuropeptides may take part in neurogenic inflammation (plasma protein extravasation and vasodilatation) of the intracranial vasculature and peripheral and central sensitization of the trigeminal system. The results of human clinical studies are discussed with regard to the alterations in these neuropeptides in the plasma, saliva and cerebrospinal fluid during or between migraine attacks, and the therapeutic possibilities involving migraine-related neuropeptides in the acute and prophylactic treatment of migraine headache are surveyed.

  5. The Effect of Orem's Self-Care Model on Quality of Life in Patients with Migraine: a Randomized Clinical Trial.

    Science.gov (United States)

    Mahmoudzadeh Zarandi, Fatemeh; Raiesifar, Afsaneh; Ebadi, Abbas

    2016-03-01

    Many aspects of the lives of migraineurs are commonly affected by the condition, including occupational affairs, social and family life, responsibilities and ultimately the quality of life. This study was designed to determine the effect of orem's self-care nursing model on quality of life in patients with a migraine. This study was carried out in Tehran, Iran. According to the pre-post design of the randomized clinical trial, 88 patients were selected. After obtaining approval from the ethics committee of the Baqiyatallah Medical Sciences University's Research Deputy; Patients who signed the informed consent aged 20-55 years and without any more disease or disability affecting the quality of life were selected and randomly assigned to a group. Data collection tools were a demographic questionnaire, general health survey short form (SF36), and Orem cognition form and self-care checklist. Self-care model were held as four 30-45 minutes training sessions based on self-care deficit needs for the experimental group. The quality of life scores was measured in two stages, before and three months after intervention then were compared in both groups. Data were analyzed with statistical software SPSS and use of descriptive analysis tests, Chi-square, Mann-Whitney u and Wilcoxon. The final analysis was performed on 43 experimental and 40 controls. No significant difference was detected in the two groups in terms of demographic variables (P>0.05). All dimensions of quality of life including physical functioning, physical role limitation, body pain, general health, vitality, social functioning and emotional role limitation and mental health in the experimental group showed a significant increase after intervention compared to the control group (Pcare nursing model improves function and overall quality of life and reduces the high cost of a migraine and migraine-related disability to individuals and society.

  6. [Migraine and irritable bowel syndrome].

    Science.gov (United States)

    Mulak, Agata; Paradowski, Leszek

    2005-01-01

    The association between migraine and functional gastrointestinal disorders has been confirmed by many clinical observations and epidemiological studies. In most patients during the attacks of migraine, apart from various neurological and vascular symptoms, gastrointestinal disturbances occur including nausea, vomiting, abdominal pain or diarrhea. Functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), are reported in migraine patients in periods between the attacks as well. On the other hand 23-53% of IBS patients have frequent headaches. Migraine and IBS often coexist with fibromyalgia and other chronic pain syndromes and functional disorders. Migraine and IBS affect approximately 10-20% of the general population, usually young adults. Both diseases are more prevalent in women, perhaps due to the role of estrogen in their pathogenesis. Looking for the common pathogenetic mechanisms of IBS and migraine the role of the brain-gut axis, neuroimmune and neuroendocrine interactions are being considered. The influence of stress on symptom occurrence and severity seems to be associated with hyperactivity of the hypothalamic-pituitary-adrenal axis. The enteric nervous system as a source of numerous neurotransmitters and visceral reflexes is a plausible common pathogenic link between IBS and migraine. In particular serotonin being the main neurotransmitter of the gastrointestinal tract plays a relevant role in the pathogenesis of IBS as well as migraine. Nowadays, agonists and antagonists of serotoninergic receptors are the most efficacious drugs for IBS and migraine therapy. Some side effects of triptans, 5-HT(1B/D) agonists, used in migraine treatment may be connected with the influence of triptans on the gastrointestinal functions. A better understanding of the relationship between migraine and IBS may result in more effective treatment of both diseases.

  7. Migraine in the era of precision medicine

    Science.gov (United States)

    Zhang, Lv-Ming; Yu, Sheng-Yuan

    2016-01-01

    Migraine is a common neurovascular disorder in the neurologic clinics whose mechanisms have been explored for several years. The aura has been considered to be attributed to cortical spreading depression (CSD) and dysfunction of the trigeminovascular system is the key factor that has been considered in the pathogenesis of migraine pain. Moreover, three genes (CACNA1A, ATP1A2, and SCN1A) have come from studies performed in individuals with familial hemiplegic migraine (FHM), a monogenic form of migraine with aura. Therapies targeting on the neuropeptids and genes may be helpful in the precision medicine of migraineurs. 5-hydroxytryptamine (5-HT) receptor agonists and calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated efficacy in the acute specific treatment of migraine attacks. Therefore, ongoing and future efforts to find new vulnerabilities of migraine, unravel the complexity of drug therapy, and perform biomarker-driven clinical trials are necessary to improve outcomes for patients with migraine. PMID:27127758

  8. Migraine-like episodic pain behavior in a dog: can dogs suffer from migraines?

    Science.gov (United States)

    Plessas, I N; Volk, H A; Kenny, P J

    2013-01-01

    Migraines and other primary headache disorders commonly affect people. There is evidence to suggest that migraines can occur in dogs. In this review, we present a dog with paroxysmal episodes that have a striking resemblance to human migraine, and we give an overview of migraine in people. The current classification, clinical signs, and diagnosis in people are discussed, as well as the anatomy of head pain, pathophysiology, pharmacology, and treatment options.

  9. Aromatherapy Massage on the Abdomen for Alleviating Menstrual Pain in High School Girls: A Preliminary Controlled Clinical Study

    Directory of Open Access Journals (Sweden)

    Myung-Haeng Hur

    2012-01-01

    Full Text Available This study investigated the alleviating effects of aromatherapy massage and acetaminophen on menstrual pain in Korean high school girls. Subjects were divided into two groups: the aromatherapy massage (treatment group (=32 and the acetaminophen (control group (=23. Aromatherapy massage was performed on subjects in the treatment group. The abdomen was massaged once using clary sage, marjoram, cinnamon, ginger, and geranium in a base of almond oil. The level of menstrual pain was assessed using a visual analogue scale at baseline and twenty-four hours afterward. The reduction of menstrual pain was significantly higher in the aromatherapy group than in the acetaminophen group. Using multiple regression, aromatherapy massage was found to be more highly associated with reduction in the level of menstrual pain than acetaminophen. These finding suggest that aromatherapy massage may be an effective treatment for menstrual pain in high school girls. However, it could not be verified whether the positive effects derived from the aromatherapy, the massage, or both. Further rigorous studies should be conducted using more objective measures.

  10. The Effect of Yoga Nidra on Psychological Problems of Woman with Menstrual Disorders: a Randomized Clinical Trial

    Directory of Open Access Journals (Sweden)

    Khushbu Rani

    2016-03-01

    Full Text Available Introduction: Menstrual disorders are common problems among women in the reproductive age group. Yuga interventions may decrease the physical and psychological problems related to menstrual disorders. The present study was aimed to assess the effect of Yoga Nidra on psychological problems in patients with menstrual disorders. Methods: A total number of 100 women recruited from the department of obstetrics and gynecology and were then randomly allocated into two groups: a intervention received yogic intervention and medication for 6 month, and b control group received no yogic intervention and they only received prescribed medication. Psychological General Well-Being Index (PGWBI and hormonal profile were assessed at the time of before and after six months on both groups. Results: The mean score of anxiety, depression, positive well-being, general health, and vitality scores, as well as hormonal levels, in posttest were significantly different in intervention group as compared with pretest. But there was no significant difference in control group. Conclusion: Yoga Nidra can be a successful therapy to overcome the psychiatric morbidity associated with menstrual irregularities. Therefore, Yogic relaxation training (Yoga Nidra could be prescribed as an adjunct to conventional drug therapy for menstrual dysfunction.

  11. Clinical Trial of Subcutaneous Steroid Injection in Patients with Migraine Disorder

    Directory of Open Access Journals (Sweden)

    Karim Nikkhah

    2016-02-01

    Full Text Available Background: Neurologic literature on therapeutic effect of subcutaneous corticosteroids in patients with migrainous chronic daily headache is scarce. The aim of this research is to assess the therapeutic effects of this management in such patients. Methods: Consecutive patients with migrainous chronic daily headache enrolled a prospective before-after therapeutic study during 2010-2013. Methylprednisolone 40 mg was divided into four subcutaneous injection doses. Two injections were administered in the right and left suboccipital area (exactly at retromastoid cervicocranial junction and the other two injections in the lower medial frontal area (exactly at medial right and left eyebrows. A daily headache diary was filled out by the patients before and one month after the intervention. The severity of pain was classified based on a pain intensity instrument using numeric rating scale from 0-10 point scale. Paired t-test and Chi-square test were used for statistical analysis. Results: 504 patients (378 females, 126 males with migrainous chronic daily headache were enrolled in the study. Dramatic, significant, moderate, mild, or no improvements respectively constituted 28.6%, 33.3%, 23.8%, and 14.3% of the post treatment courses. Therapeutic effect of intervention on mean pain scores was significant; t=7.38, df=20, P=0.000. Two cases developed subcutaneous fat atrophy in frontal injection site and three cases experienced syncope during injection. Conclusion: Subcutaneous corticosteroids could be used as an adjunct therapy in patients with migrainous chronic daily headache.

  12. Vestibular Function Tests for Vestibular Migraine: Clinical Implication of Video Head Impulse and Caloric Tests

    OpenAIRE

    Kang, Woo Seok; Lee, Sang Hun; Yang, Chan Joo; Ahn, Joong Ho; Chung, Jong Woo; Park, Hong Ju

    2016-01-01

    Vestibular migraine (VM) is one of the most common causes of episodic vertigo. We reviewed the results of multiple vestibular function tests in a cohort of VM patients who were diagnosed with VM according to the diagnostic criteria of the Barany Society and the International Headache Society and assessed the efficacy of each for predicting the prognosis in VM patients. A retrospective chart analysis was performed on 81 VM patients at a tertiary care center from June 2014 to July 2015. Patient...

  13. Vestibular function tests for vestibular migraine: clinical implication of video head impulse and caloric tests

    OpenAIRE

    Woo Seok Kang; Sang Hun Lee; Chan Joo Yang; Joong Ho Ahn; Jong Woo Chung; Hong Ju Park

    2016-01-01

    Vestibular migraine (VM) is one of the most common causes of episodic vertigo. We reviewed the results of multiple vestibular function tests in a cohort of VM patients who were diagnosed with VM according to the diagnostic criteria of the Barany Society and the International Headache Society and assessed the efficacy of each for predicting the prognosis in VM patients. A retrospective chart analysis was performed on 81 VM patients at a tertiary care center from June 2014 to July 2015. Patient...

  14. Vestibular migraine

    DEFF Research Database (Denmark)

    Lempert, Thomas; Olesen, Jes; Furman, Joseph

    2012-01-01

    This paper presents diagnostic criteria for vestibular migraine, jointly formulated by the Committee for Classification of Vestibular Disorders of the Bárány Society and the Migraine Classification Subcommittee of the International Headache Society (IHS). The classification includes vestibular mi....... Symptoms that qualify for a diagnosis of vestibular migraine include various types of vertigo as well as head motion-induced dizziness with nausea. Symptoms must be of moderate or severe intensity. Duration of acute episodes is limited to a window of between 5 minutes and 72 hours....

  15. Clinical features of unilateral headaches beyond migraine and cluster headache and their response to indomethacin.

    Science.gov (United States)

    Seidel, Stefan; Lieba-Samal, Doris; Vigl, Marion; Wöber, Christian

    2011-09-01

    The majority of previous studies on unilateral headaches beyond migraine and cluster headache have focussed on certain disorders such as paroxysmal hemicrania, SUNCT and primary stabbing headache. We assessed headache characteristics, importance of neuroimaging and response to indomethacin in an unselected series of uncommon unilateral headaches. We investigated all consecutive patients presented with unilateral headaches not fulfilling ICHD-II criteria of migraine and cluster headache. Patients underwent cranial magnetic resonance imaging or computed tomography as well as an indo-test, i.e. oral indomethacin 75 mg b.i.d. for 3 days. Among 63 patients we diagnosed primary stabbing headache in 12 patients, (probable) paroxysmal hemicrania in 6 and tension-type headache in 3 patients. One patient each had probable SUNCT, new daily persistent headache and nasociliary neuralgia. Eight patients had a secondary headache and 31 could not be classified according to ICDH-II. Imaging revealed lesions causally related to the headache in 8 patients. Indo-test achieved full remission of headache in 13 of 51 patients. At follow-up 11 ± 3 months after the first visit 29% of the patients were headache-free for ≥3 months. In conclusion, almost half of the patients presented with unilateral headaches beyond migraine and cluster headache cannot be classified according to ICHD-II. Among classifiable headaches primary stabbing headache was the most common. Imaging should be considered to rule out secondary headaches. The course is favourable in one third of the patients.

  16. Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies

    Science.gov (United States)

    Carreño, Oriel; Corominas, Roser; Serra, Selma Angèlica; Sintas, Cèlia; Fernández-Castillo, Noèlia; Vila-Pueyo, Marta; Toma, Claudio; Gené, Gemma G; Pons, Roser; Llaneza, Miguel; Sobrido, María-Jesús; Grinberg, Daniel; Valverde, Miguel Ángel; Fernández-Fernández, José Manuel; Macaya, Alfons; Cormand, Bru

    2013-01-01

    Hemiplegic migraine (HM) is a rare and severe subtype of autosomal dominant migraine, characterized by a complex aura including some degree of motor weakness. Mutations in four genes (CACNA1A, ATP1A2, SCN1A and PRRT2) have been detected in familial and in sporadic cases. This genetically and clinically heterogeneous disorder is often accompanied by permanent ataxia, epileptic seizures, mental retardation, and chronic progressive cerebellar atrophy. Here we report a mutation screening in the CACNA1A and ATP1A2 genes in 18 patients with HM. Furthermore, intragenic copy number variant (CNV) analysis was performed in CACNA1A using quantitative approaches. We identified four previously described missense CACNA1A mutations (p.Ser218Leu, p.Thr501Met, p.Arg583Gln, and p.Thr666Met) and two missense changes in the ATP1A2 gene, the previously described p.Ala606Thr and the novel variant p.Glu825Lys. No structural variants were found. This genetic screening allowed the identification of more than 30% of the disease alleles, all present in a heterozygous state. Functional consequences of the CACNA1A-p.Thr501Met mutation, previously described only in association with episodic ataxia, and ATP1A2-p.Glu825Lys, were investigated by means of electrophysiological studies, cell viability assays or Western blot analysis. Our data suggest that both these variants are disease-causing. PMID:24498617

  17. Cranial Autonomic Symptoms in Migraine

    Directory of Open Access Journals (Sweden)

    J Gordon Millichap

    2009-11-01

    Full Text Available Cranial autonomic symptoms (CAS in patients with migraine and cluster headaches (CH were characterized and compared in a prospective study of consecutive patients attending a headache clinic at Taipei Veterans General Hospital, Taiwan.

  18. Current Treatment Options in Vestibular Migraine

    Science.gov (United States)

    Obermann, Mark; Strupp, Michael

    2014-01-01

    Approximately 1% of the general population in western industrialized countries suffers from vestibular migraine. However, it remains widely unknown and often under diagnosed despite the recently published diagnostic criteria for vestibular migraine. Treatment trials that specialize on vestibular migraine are scarce and systematic randomized controlled clinical trials are now only emerging. This review summarizes the knowledge on the currently available treatment options that were tested specifically for vestibular migraine and gives an evidence-based, informed treatment recommendation with all its limitations. To date only two randomized controlled treatment trials provide limited evidence for the use of rizatriptan and zolmitriptan for the treatment of vestibular migraine attacks because of methodological shortcomings. There is an ongoing multicenter randomized placebo-controlled trial testing metoprolol 95 mg vs. placebo (PROVEMIG-trial). Therefore, the therapeutic recommendations for the prophylactic treatment of vestibular migraine are currently widely based on the guidelines of migraine with and without aura as well as expert opinion. PMID:25538676

  19. What Causes Menstrual Irregularities?

    Science.gov (United States)

    ... Publications What causes menstrual irregularities? Skip sharing on social media links Share this: Page Content Menstrual irregularities can be caused by a variety of conditions, including pregnancy, hormonal imbalances, infections, malignancies, diseases, trauma, and certain ...

  20. Menstruation and Menstrual Problems

    Science.gov (United States)

    ... and Menstrual Problems: Condition Information Skip sharing on social media links Share this: Page Content What is menstruation? What is the menstrual cycle? When happens when a pregnancy occurs? What is menstruation? Menstruation (pronounced men-stroo- ...

  1. Menstrual Cycle Problems

    Science.gov (United States)

    ... Read MoreDepression in Children and TeensRead MoreBMI Calculator Menstrual Cycle ProblemsFrom missed periods to painful periods, menstrual cycle problems are common, but usually not serious. Follow ...

  2. 补肾法治疗月经后期临床体会%Kidney Treatments for Menstrual Clinical Experience

    Institute of Scientific and Technical Information of China (English)

    于桂艳

    2011-01-01

    Menstruation is one of gynecological diseases later to kidney, TCM believes that the virtual failure related, the modem medical science thinks menstrual regulation is a complicated process, some endocrine hormone release and adjust the menstrual cycle, influence is normal or not. Mentor adopts the kidney treatments for menstruation, square with Guishen pill to add and subtract WenTong kidney Yang,treatment, efficacy and reliable led blood descending, reflect the menstrual disease treatment principle,focusing on the fundamental menstrual function, and with a balance of Yin and Yang, ezer in flat.%月经后期是妇科常见病之一,中医认为与肾的虚衰有关,现代医学认为月经调节是个复杂的过程,一些内分泌激素的释放与调节,影响月经周期的正常与否.导师采用补肾法治疗月经后期,方用"归肾丸"加减治疗,温通肾阳,引血下行,疗效可靠,体现了月经病的治疗原则,重在治本以调经,谨察阴阳,以平为期.

  3. Clinical spectrum in three families with familial hemiplegic migraine type 2 including a novel mutation in the ATP1A2 gene.

    Science.gov (United States)

    Roth, Christian; Freilinger, Tobias; Kirovski, Georgi; Dunkel, Juliane; Shah, Yogesh; Wilken, Bernd; Rautenstrauß, Bernd; Ferbert, Andreas

    2014-03-01

    Familial hemiplegic migraine (FHM) is a rare subtype of migraine with transient hemiplegic aura. We describe three unrelated families with familial hemiplegic migraine type II (FHM2). Retrospectively, information on 47 family members could be obtained, 15 by personal examination and 32 by indirect anamnesis from relatives. Genetic analyses were performed in 13 patients. One family had a novel missense mutation in the ATP1A2 gene (c.659C>T, p.Ser220Leu) that segregated with the phenotype in three generations. Two further unrelated families with different ethnic backgrounds (one from Germany and one from Russia) had a missense mutation that has not been described as yet in FHM, but occurred in only a single patient with sporadic hemiplegic migraine (c.2723G>A, p.Arg908Gln). Clinically the patients had severe attacks lasting up to several weeks as well as epileptic seizures. Three patients with a proven mutation in the ATP1A2 gene clinically presented without hemiparesis. Furthermore, there was a possible relation of FHM2 to mental retardation in another two patients. Clinical symptoms may last for several weeks in some patients. Patients with FHM2 may also present without hemiplegia. Therefore, the full family history has to be taken into account to establish the diagnosis of FHM.

  4. Prevalence of Migraine Headache in Epileptic Patients.

    Directory of Open Access Journals (Sweden)

    Sayena Jabbehdari

    2015-06-01

    Full Text Available Epilepsy is one of the most common neurological disorders which a physician might come across in his career life. On the other hand, migraine is common disorders in society chronic headache such as migraine in epileptic patients give ride to difficulties in seizure treatment due to altering the sleeping pattern and calmness disarrangement. Therefore, early diagnosis and suitable treatment in epileptic patients is definitely inevitable, and it will help in a more desirable patients' treatment. So we aimed to evaluate the prevalence of migraine in epileptic patients and relation between these two disorders. Number of 150 epileptic patients attended to neurology clinic of Shohadaye Tajrish Hospital and Iranian Epilepsy Association between June 2010 to May 2011 were fulfilled the questionnaire, and the data has been assessed by SPSS software. In this study, we used MS-Q (migraine screening -questionnaire designed for early diagnosis of migraine in the general population. From all patients filling the questionnaire, the prevalence of migraine (with or without aura was as follows: 23 persons had criteria compatible with migraine with aura; 26 patients had migraine without aura. Migraine was more common in these patients: persons with academic degrees, women, patients who were used 2 antiepileptic drugs, and patients with high BMI. In this study, we showed that migraine in epileptic patients is more prevalent than the general population. Thus, early diagnosis and efficient treatment of migraine headache in these patients is mandatory. More studies are needed for evaluation of this issue.

  5. Spreading depolarization may link migraine and stroke.

    Science.gov (United States)

    Eikermann-Haerter, Katharina

    2014-01-01

    Migraine increases the risk of stroke, particularly in young and otherwise healthy adults. Being the most frequent neurological condition, migraine prevalence is on a par with that of other common stroke risk factors, such as diabetes or hypertension. Several patterns of association have emerged: (1) migraine and stroke share a common association (eg, vasculopathies, patent foramen ovale, or pulmonary A-V malformations); (2) injury to the arterial wall such as acute arterial dissections can present as migraine aura attacks or stroke; (3) strokes rarely develop during a migraine attack, as described for "migrainous stroke." Increasing experimental evidence suggests that cerebral hyperexcitability and enhanced susceptibility to spreading depolarization, the electrophysiologic event underlying migraine, may serve as a mechanism underlying the migraine-stroke association. Mice carrying human vascular or neuronal migraine mutations exhibit an enhanced susceptibility to spreading depolarization while being particularly vulnerable to cerebral ischemia. The severe stroke phenotype in migraine mutant mice can be prevented by suppressing spreading depolarization. If confirmed in the clinical setting, inhibiting spreading depolarization might protect migraineurs at stroke risk as well as decrease attacks of migraine. © 2014 American Headache Society.

  6. Clinical Study on Effect of Xiaoyao Nose Drops (逍遥滴鼻液) in Stopping Episode of Migraine

    Institute of Scientific and Technical Information of China (English)

    HU Huai-qiang; ZHOU Yong-hong; WANG Xin-lu

    2006-01-01

    Objective: To observe the effect of Xiaoyao Nose Drops (逍遥滴鼻液, XYND) in stopping episode of migraine. Methods: Adopted was the randomized double-blinded placebo-controled method, with the 126 patients equally assigned to two groups, the treated group treated with XYND and the control group with placebo, and the therapeutic course was 30 days for all. The clinical total effective rate and effect in alleviating headache were observed. And hemorrheological parameters as well as the blood flow of the anterior cerebral artery (ACA), median cerebral artery (MCA) and posterior cerebral artery (PCA) were measured before and after treatment. Results: The clinical total effective rate and headache alleviating rate in the treated group were 93. 33% and 96. 67% respectively, while those in the control group were 18. 33% and 20.00% respectively, and comparison between the two groups showed significant difference (all P<0.01).The blood viscosity (high, middle and low shear), plasma viscosity and fibrinogen got lowered significantly in the treated group after treatment, showing significant difference in comparison either with those before treatment or with those in the control group after treatment (P<0.05 or P<0.01 ). The velocity of blood flow in all cerebral arteries lowered significantly, also showing significant difference in comparison either with those before treatment or with those in the control group after treatment (P<0.05 or P<0.01). Conclusion:XYND is effective in stopping the headache of patients with migraine, and worth applying in clinical practice.

  7. Emerging targets in migraine.

    Science.gov (United States)

    Hoffmann, Jan; Goadsby, Peter J

    2014-01-01

    Migraine is a common and highly disabling neurological disorder. Despite the complexity of its pathophysiology, substantial advances have been achieved over the past 20 years in its understanding, as well as the development of pharmacological treatment options. The development of serotonin 5-HT(1B/1D) receptor agonists ("triptans") substantially improved the acute treatment of migraine attacks. However, many migraineurs do not respond satisfactorily to triptans and cardiovascular co-morbidities limit their use in a significant number of patients. As migraine is increasingly considered to be a disorder of the brain, and preclinical and clinical data indicate that the observed vasodilation is merely an epiphenomenon, research has recently focused on the development of neurally acting compounds that lack vasoconstrictor properties. This review highlights the most important pharmacological targets for which compounds have been developed that are highly likely to enter or have already advanced into clinical trials for the acute and preventive treatment of migraine. In this context, preclinical and clinical data on compounds acting on calcitonin gene-related peptide or its receptor, the 5-HT(1F) receptor, nitric oxide synthase, and acid-sensing ion channel blockers are discussed.

  8. Review of frovatriptan in the treatment of migraine

    Directory of Open Access Journals (Sweden)

    Leslie Kelman

    2008-03-01

    Full Text Available Leslie KelmanHeadache Center of Atlanta, Atlanta, GA, USAAbstract: Triptans are recommended for the acute treatment of moderate to severe migraine or failure to respond to other acute migraine treatments. Seven triptans are available providing a wide range of choices. These triptans are more similar than dissimilar but patients do note differences in effectiveness and in tolerance. Also migraine situations may differ from attack to attack, providing the opportunity to exploit the uniqueness of a particular triptan. Frovatriptan has a uniquely long-half life, five times that of other triptans. This provides the opportunity to use frovatriptan in mini-prophylaxis such as in menstrual-related migraine and other situations, as well as use in long-lasting or recurrent migraine.Keywords: frovatriptan triptans, migaine, treatment

  9. [Familial and sporadic hemiplegic migraine].

    Science.gov (United States)

    Ducros, A

    2008-03-01

    Hemiplegic migraine (HM) is a rare variety of migraine with aura characterized by the presence of a motor weakness during the aura. Hemiplegic migraine has two main forms according to the familial history: patients with at least one first- or second-degree relative who has aura including motor weakness have familial hemiplegic migraine (FHM); patients without such familial history have sporadic hemiplegic migraine (SHM). The prevalence of HM is one in 10,000 with FHM and SHM being equally frequent. Typical HM attacks include a motor weakness that is always associated with other aura symptoms, the most frequent being sensory, visual and speech disorders. In addition, basilar-type symptoms occur in up to 70% of the patients. Severe attacks may occur in FHM as well as in SHM with prolonged hemiplegia, confusion, coma, fever and seizures. The clinical spectrum also includes permanent cerebellar signs (nystagmus, ataxia, dysarthria) and less frequently various types of seizures and intellectual deficiency. FHM is the only variety of the autosomal dominant migraine and all three know genes encode ion-transporters. A genetic diagnosis is now possible by screening the three known genes involved in FHM (CACNA1A, ATP1A2 and SCNA1). Prognosis is usually good. Treatment is similar to approaches used in other varieties of migraine with aura, excepted for triptans that are contraindicated in MHF/MHS. Based on new pathophysiological insight, preventive treatments by various antiepileptic agents seem promising.

  10. Stress, anxiety, depression and migraine.

    Science.gov (United States)

    Wacogne, C; Lacoste, J P; Guillibert, E; Hugues, F C; Le Jeunne, C

    2003-07-01

    This study investigated the intensity of stress, anxiety and depression in a sample of 141 migraineurs compared with a control group of 109 non-migraine workers matched for age and sex. Stress was measured using the Perceived Stress Questionnaire, and anxiety and depression using the Hospital Anxiety and Depression Scale. Results indicated that stress and anxiety were higher in the migraine group than in the control group and above the clinical level. Depression scores remained low in both groups, under clinical relevance. Stress is a primordial factor in the triggering and perpetuation of migraine attacks. The high score of the items 'morning fatigue', 'intrusive thoughts about work', 'feeling under pressure', 'impatience', and 'irritability' of the stress questionnaire in the migraineurs is particularly significant in the intensive stress response. It seems necessary to manage stress to improve the daily life of migraineurs and to study the link between stress, anxiety and migraine.

  11. Características clínicas da enxaqueca sem aura Clinical characteristics of migraine without aura

    Directory of Open Access Journals (Sweden)

    LUIZ PAULO DE QUEIROZ

    1998-03-01

    Full Text Available Um estudo aprofundado das características clínicas da enxaqueca sem aura (ESA revela alguns dados interessantes. Um questionário foi respondido por 200 pacientes que preenchiam os critérios da Sociedade Internacional de Cefaléia para ESA. O pico do início da enxaqueca foi entre 10 e 19 anos de idade. A cefaléia era restrita a um lado em 19%. Era exclusivamente bilateral em 9%. A maioria (86,2% dos pacientes que descreveram cefaléias em um único local localizou-a na área fronto-temporal. Cervicalgia estava associada aos ataques de enxaqueca em 70,5% e dor facial em 73,5%. O caráter latejante foi notado por 81%. Todos os pacientes descreveram a cefaléia como moderada a severa. Somente 55% disseram que a dor era agravada por atividades físicas rotineiras. Náusea ocorreu em 91%, foto e fonofobia em 77% e vômitos em 50%. Este olhar detalhado na ESA demonstra a grande complexidade dos seus sintomas.A detailed study of the clinical characteristics of migraine without aura (MOA reveals some interesting data. A questionnaire was returned by 200 patients who met the International Headache Society criteria for MOA. The peak of onset of migraine was between 10 and 19 years of age. The headache was side-locked in 19%. It was exclusively bilateral in 9%. The majority (86.2% of the patients who described headaches in only one site located them in the fronto-temporal area. Neck pain was associated with migraine attacks in 70.5% and face pain in 73.5%. A pounding quality was noted by 81%. Every patient described the headache as moderate to severe. Only 55% stated that it was aggravated by routine physical activity. Nausea occurred in 91%, photo and phonophobia in 77%, and vomiting in 50%. This close look at MOA uncovers a great complexity of symptoms.

  12. New drugs in migraine treatment and prophylaxis

    DEFF Research Database (Denmark)

    Edvinsson, Lars; Linde, Mattias

    2010-01-01

    Although the triptan drugs provide effective relief from migraine for many patients, a substantial number of affected individuals are unresponsive to these compounds, and such therapy can also lead to a range of adverse effects. Telcagepant represents a new class of antimigraine drug-the calcitonin...... of triptans. Comparisons with triptans in clinical trials for acute treatment of migraine attacks revealed clinical effects similar to those of triptans but better than those of placebo. Telcagepant might provide hope for those who have a poor response to, or are unable to use, older drugs. In patients who...... need prophylaxis because of frequent attacks of migraine, topiramate is a first-line drug for migraine prevention inmany countries; it is generally safe and reasonably well tolerated. Data suggest that topiramate could aid reversion of chronic migraine to episodic migraine....

  13. Migraine and structural abnormalities in the brain

    DEFF Research Database (Denmark)

    Hougaard, Anders; Amin, Faisal Mohammad; Ashina, Messoud

    2014-01-01

    PURPOSE OF REVIEW: The aim is to provide an overview of recent studies of structural brain abnormalities in migraine and to discuss the potential clinical significance of their findings. RECENT FINDINGS: Brain structure continues to be a topic of extensive research in migraine. Despite advances...... in neuroimaging techniques, it is not yet clear if migraine is associated with grey matter changes. Recent large population-based studies sustain the notion of increased prevalence of white matter abnormalities in migraine, and possibly of silent infarct-like lesions. The clinical relevance of this association...... is not clear. Structural changes are not related to cognitive decline, but a link to an increased risk of stroke, especially in patients with aura, cannot be ruled out. SUMMARY: Migraine may be a risk factor for structural changes in the brain. It is not yet clear how factors such as migraine sub-type, attack...

  14. Tainting Decoction in Treating Migraine Clinical Observation%天宁饮治疗偏头痛的临床观察

    Institute of Scientific and Technical Information of China (English)

    邢雪梅

    2011-01-01

    目的天宁饮治疗偏头痛的临床疗效观察。方法将45例各型偏头痛患者,随机分为两组。治疗组给予以天宁饮口服,对照组予以西比灵胶囊口服,连续一月后观察治疗效果,并进行分析。结果服用天宁饮组的患者偏头痛症状改善明显,具有统计学意义。结论天宁饮对偏头痛有较好疗效。%Objective: To observe the clinical curative effect of Tinian Decoction on migraine.Methods: 45 cases of various types of migraine patients,were randomly divided into two groups.The treatment group to be day drinking oral,and control group was treated with oral flunarizine capsules,We will observe the improvement of symptom before and after the 30days of treatment,and carries on the analysis.Results: the group of patients taking Tianning drink migraine symptoms improved significantly,with statistical significance.Conclusion: Tianning Decoction on migraine has better curative effect

  15. Novel Therapeutic Targets for Chronic Migraine

    Science.gov (United States)

    2013-09-01

    These studies were performed in Year 1 of the project (See Appendix 1 ). Amiloride’s effects on multiple migraine mechanisms supports formal clinical...summarized below. Task 1 . Characterization of the effects f memantine on migraine models a. Effects of memantine on CSD- We are continuing to...sensing ion channel 1 : a novel therapeutic target for migraine with aura. Annals of Neurology 2012;72(4):559-63. Pradhan, A., Smith, M

  16. Involvement of astrocyte and oligodendrocyte gene sets in migraine.

    Science.gov (United States)

    Eising, Else; de Leeuw, Christiaan; Min, Josine L; Anttila, Verneri; Verheijen, Mark Hg; Terwindt, Gisela M; Dichgans, Martin; Freilinger, Tobias; Kubisch, Christian; Ferrari, Michel D; Smit, August B; de Vries, Boukje; Palotie, Aarno; van den Maagdenberg, Arn Mjm; Posthuma, Danielle

    2016-06-01

    Migraine is a common episodic brain disorder characterized by recurrent attacks of severe unilateral headache and additional neurological symptoms. Two main migraine types can be distinguished based on the presence of aura symptoms that can accompany the headache: migraine with aura and migraine without aura. Multiple genetic and environmental factors confer disease susceptibility. Recent genome-wide association studies (GWAS) indicate that migraine susceptibility genes are involved in various pathways, including neurotransmission, which have already been implicated in genetic studies of monogenic familial hemiplegic migraine, a subtype of migraine with aura. To further explore the genetic background of migraine, we performed a gene set analysis of migraine GWAS data of 4954 clinic-based patients with migraine, as well as 13,390 controls. Curated sets of synaptic genes and sets of genes predominantly expressed in three glial cell types (astrocytes, microglia and oligodendrocytes) were investigated. Our results show that gene sets containing astrocyte- and oligodendrocyte-related genes are associated with migraine, which is especially true for gene sets involved in protein modification and signal transduction. Observed differences between migraine with aura and migraine without aura indicate that both migraine types, at least in part, seem to have a different genetic background. © International Headache Society 2015.

  17. MIGRAINE FACT SHEET: EDUCATIONAL MATERIAL FOR THE MIGRAINE SUFFERERS AND THEIR CARE GIVERS IN NIGERIA

    Directory of Open Access Journals (Sweden)

    Timothy SY

    2012-08-01

    Full Text Available Migraine is markedly disabling medical condition and the problem is poorly recognized and majority of headache sufferers have not sought medical help even when their problem is severe. The aim of this study is to develop a fact sheet on migraine that can be useful in educating migraine sufferers and the community after evaluating the impact of migraine headache in North-Eastern Nigeria. One hundred migraine sufferers that met the International Headache Society diagnostic criteria for migraine and attends Neurology clinic, University of Maiduguri Teaching Hospital from May, 2007 to April, 2010 and from whom informed consent was obtained were evaluated for this disorder using a structured study questionnaire at which a developed fact sheet was issued to them. It is expected that the fact sheet once used appropriately would go a long way in reducing the negative burden of migraine by improving productivity and social functioning in our community.

  18. Therapeutic Method According to The Menstrual Cycle is Applied by the Clinical Practice of Gynaecology(English abstract)%谈月经周期性用药法在妇科的运用

    Institute of Scientific and Technical Information of China (English)

    齐晓琳

    2001-01-01

    The therapeutic method according to the menstrual cycle has beenin the clinical practice of gynaecology for a long time.The article is about the basis of theory and particularly being used in the clinical practice of gynaecology for the therapeutic method according to the menstrual cycle.We conclude that the therapeutic method according to the menstrual cycle is a important principle of treatment that clinicians must learn and handle very skilfully in the clinical practice of gynaecology.%探讨月经周期用药法在妇科应用的理论依据及在妇科临床中的具体运用,认为月经周期用药法是临床医师在妇科临床中必须掌握的一个重要的治疗原则。

  19. Migraine 101 Quiz

    Science.gov (United States)

    ... for migraine headaches. Dietary triggers for migraines include: Chocolate Cheese Food additives such as MSG Alcohol A, ... F. True. Although many sufferers have a family history of migraine, the exact hereditary nature of this ...

  20. 晚发型偏头痛与青年偏头痛临床特点的比较%Comparison of clinical features in late-onset migraine and younger migraine

    Institute of Scientific and Technical Information of China (English)

    苏歆; 陈春富; 张君; 李继川

    2013-01-01

    目的 比较晚发型偏头痛和青年偏头痛患者的临床特点.方法 对40例晚发型偏头痛患者(晚发型组)和40例青年偏头痛患者(青年组)的临床资料进行收集和比较.结果 晚发型组19例(47.5%)发病有明显诱因,青年组3例(7.5%)有明显诱因,差异有统计学意义(P<0.05).晚发型组中先兆型偏头痛6例(15.0%),无先兆型33例(82.5%),偏瘫型1例(2.5%);青年组先兆型偏头痛15例(37.5%),无先兆型25例(62.5%).晚发型组中先兆型比率显著低于青年组(P<0.05).晚发型组单侧头痛及额部头痛的比率及头痛程度显著低于青年组,双侧头痛及全头痛的比率显著高于青年组(均P<0.05).晚发型组伴面色苍白、厌食及口干的比率显著高于青年组(均P<0.05).晚发型组头痛性质、持续时间、发作频率及缓解因素与青年组比较,差异无统计学意义.结论 与青年偏头痛相比,晚发型偏头痛患者发作有诱因的比率高,出现先兆症状少,头痛程度轻,多为双侧及全头痛;易合并自主神经症状.%Objective To comparison the clinical features in late-onset migraine and younger migraine. Methods The clinical date of 40 late-onset migraine patients (late-onset group) and 40 younger migraine patients (younger group) were collected and compared. Results The onset with inducing factors late-onset group was 19 cases (47. 5% ) and in younger group was 3 cases (7. 5% ) ; the differences was statically significant ( P < 0. 05 ). In late-onset group,the migraine with aura was in 6 cases (15. 0% ) , and without aura in 33 cases (82. 5% ) , cerebral palsy in 1 case (2.5% ). In younger group, 15 cases (37.5% ) had migraine with aura migraine in 15 cases ( 37. 5% ) and without aura in 25 cases (62. 5% ). The rate of migraine with aura in late-onset group was significantly lower than younger group ( P < 0. 05). The rates of unilateral headache, frontal part headache and headache degree in late

  1. Migraine Headaches

    Science.gov (United States)

    ... them. Some people find that cutting back on caffeine intake or drinking a lot of water can help prevent migraines. Make a plan for all the things you have to do — especially during stressful times like final exams — so you don't feel overwhelmed when things ...

  2. Prophylaxis of migraine: general principles and patient acceptance

    Directory of Open Access Journals (Sweden)

    Domenico D’Amico

    2008-12-01

    Full Text Available Domenico D’Amico1, Stewart J Tepper21Headache Center, Department of Neurological Sciences, C Besta Neurological Institute, Milan, Italy; 2Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USAAbstract: Migraine is a chronic neurological condition with episodic exacerbations. Migraine is highly prevalent, and associated with significant pain, disability, and diminished quality of life. Migraine management is an important health care issue. Migraine management includes avoidance of trigger factors, lifestyle modifications, non-pharmacological therapies, and medications. Pharmacological treatment is traditionally divided into acute or symptomatic treatment, and preventive treatment or prophylaxis. Many migraine patients can be treated using only acute treatment. Patients with severe and/or frequent migraines require long-term preventive therapy. Prophylaxis requires daily administration of anti-migraine compounds with potential adverse events or contraindications, and may also interfere with other concurrent conditions and treatments. These problems may induce patients to reject the idea of a preventive treatment, leading to poor patient adherence. This paper reviews the main factors influencing patient acceptance of anti-migraine prophylaxis, providing practical suggestions to enhance patient willingness to accept pharmacological anti-migraine preventive therapy. We also provide information about the main clinical characteristics of migraine, and their negative consequences. The circumstances warranting prophylaxis in migraine patients as well as the main characteristics of the compounds currently used in migraine prophylaxis will also be briefly discussed, focusing on those aspects which can enhance patient acceptance and adherence.Keywords: migraine, prophylaxis, preventive therapy, acceptance, adherence

  3. Coexisting typical migraine in familial hemiplegic migraine

    DEFF Research Database (Denmark)

    Hansen, Jakob Møller; Olesen, Jes; Ashina, Messoud

    2010-01-01

    In contrast to patients with migraine with aura (MA) and migraine without aura (MO), most patients with familial hemiplegic migraine (FHM) do not report migraine-like attacks after pharmacologic provocation with glyceryl trinitrate (GTN), a donor of nitric oxide. In the present study, we examined...... patients with FHM without known gene mutations and hypothesized that 1) GTN would cause more migraine-like attacks in patients with FHM compared to controls, and 2) GTN would cause more migraine attacks in patients with FHM with coexisting MA or MO compared to the pure FHM phenotype....

  4. Coexisting typical migraine in familial hemiplegic migraine

    DEFF Research Database (Denmark)

    Hansen, Jakob Møller; Thomsen, Lise Lykke; Olesen, Jes

    2010-01-01

    In contrast to patients with migraine with aura (MA) and migraine without aura (MO), most patients with familial hemiplegic migraine (FHM) do not report migraine-like attacks after pharmacologic provocation with glyceryl trinitrate (GTN), a donor of nitric oxide. In the present study, we examined...... patients with FHM without known gene mutations and hypothesized that 1) GTN would cause more migraine-like attacks in patients with FHM compared to controls, and 2) GTN would cause more migraine attacks in patients with FHM with coexisting MA or MO compared to the pure FHM phenotype....

  5. Menstrual Cycle: Basic Biology

    Science.gov (United States)

    Hawkins, Shannon M.; Matzuk, Martin M.

    2010-01-01

    The basic biology of the menstrual cycle is a complex, coordinated sequence of events involving the hypothalamus, anterior pituitary, ovary, and endometrium. The menstrual cycle with all its complexities can be easily perturbed by environmental factors such as stress, extreme exercise, eating disorders, and obesity. Furthermore, genetic influences such as fragile X premutations (Chapter X), X chromosome abnormalities (Chapter X), and galactose-1-phosphate uridyltransferase (GALT) point mutations (galactosemia) also contribute to perturbations of the menstrual cycle. Although not perfect, mouse model have helped to identify and confirm additional components and pathways in menstrual cycle function and dysfunction in humans. PMID:18574203

  6. Clinical Characteristics of Benign Recurrent Vestibulopathy: Clearly Distinctive From Vestibular Migraine and Menière's Disease?

    Science.gov (United States)

    van Esch, Babette F; van Wensen, Erik; van der Zaag-Loonen, Hester J; Benthem, Peter Paul G van; van Leeuwen, Roeland B

    2017-10-01

    We aimed to systematically investigate the clinical characteristics of benign recurrent vestibulopathy (BRV), vestibular migraine (VM), and Menière's disease (MD) and to assess whether clinical symptoms exist that are unique to BRV. Prospective cohort study. Tertiary referral center. Between January 2015 and November 2016, patients were prospectively recruited at a specialized dizziness clinic. Patients were included if they met the diagnostic criteria for BRV, VM, or MD which was evaluated by simultaneous consultation of an otorhinolaryngologist and neurologist. All patients received a comprehensive clinical examination that included vestibular tests and pure-tone audiometry. A questionnaire was designed to systematically document symptoms of the three vestibular disorders. A total of 122 patients were included in our study, 65 (53%) were females in whom 29 (24%) were postmenopausal. The mean age was 55.5 ± 13.7 years and the mean age of onset of vertigo attacks was 49.2 ± 14.8 years (n = 119). Forty-five (37%) patients had a clinical diagnosis of BRV, 34 (28%) of VM, and 43 (35%) of MD. No symptom could be identified which was specifically linked to BRV. In patients with BRV, similar to those with VM, we found a female preponderance (p = 0.05 in BRV, p = 0.001 in VM). Patients with VM reported significantly more often a positive history of motion sickness (p = 0.01). In addition, canal paresis was most profound in patients with MD (p = 0.001). We found no clinical characteristics that were distinctive for BRV. However, we did find several distinctive clinical features for VM and MD which may assist the physician in their history taking.

  7. Effect of menstrual cycle on frequency of alveolar osteitis in women undergoing surgical removal of mandibular third molar: a single-blind randomized clinical trial.

    Science.gov (United States)

    Eshghpour, Majid; Rezaei, Naser Mohammadzadeh; Nejat, AmirHossein

    2013-09-01

    To measure the association between the menstrual cycle and the frequency of alveolar osteitis (AO). In a study with a single-blind design, patients with bilateral impacted third molar teeth underwent randomized surgical extraction: one tooth during the menstrual period and one during the middle of the cycle. The postoperative examiner was unaware of the menstrual cycle status of the patients. The predictor variable was the timing of the menstrual cycle and was grouped as mid-cycle and menstrual period. The outcome variable was AO, which was measured (without knowledge of the menstrual cycle timing) at 2 to 7 days postoperatively. Other study variables included oral contraceptive (OC) use, smoking status, irrigation used during surgery, extraction difficulty, surgeon experience, number of local anesthetic cartridges used, and patient age. Appropriate bi- and multivariate statistics were computed, and the level of statistical significance was set at P cycle than during the menstrual period inboth the OC users and nonusers (P menstrual period (P > .05). According to the results of the present study, the menstrual cycle could be a determinant risk factor in the frequency of AO. We recommend that elective procedures be performed during the menstrual period in both OC users and nonusers to eliminate the effect of cycle-related hormonal changes on the development of AO. Copyright © 2013 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

  8. Diagnosis and Development of Screening Items for Migraine in Neurological Practice in Taiwan

    Directory of Open Access Journals (Sweden)

    Shuu-Jiun Wang

    2008-06-01

    Conclusion: Migraine was the most common headache diagnosis in the neurologists’ clinics. Probable migraine was not completely adopted as a migraine spectrum among neurologists. In contrast to ID™, moderate or severe headache intensity replaced headache-related disability as one screening item for migraine in Taiwan.

  9. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

    Science.gov (United States)

    Munakata, Julie; Hazard, Elisabeth; Serrano, Daniel; Klingman, David; Rupnow, Marcia F T; Tierce, Jonothan; Reed, Michael; Lipton, Richard B

    2009-04-01

    To evaluate the impact of incident transformed migraine on health care resource utilization, medication use, and productivity loss. In addition, the study estimates the total direct and indirect costs associated with transformed migraine. Emerging evidence indicates that migraine may be a chronic progressive disorder characterized by escalating frequency of headache attacks, often termed transformed migraine. Little is known about the economic impact of transformed migraine. AMPP is a 5-year, national, longitudinal survey study of headache in the US. The study utilized data from the 2006 follow-up survey based on an initial sample of 14,544 adults identified as having migraine in either the 2004 screening or 2005 baseline survey. A diagnosis of migraine was assigned based on criteria proposed by the International Classification of Headache Disorders, 2nd Edition. Participants completed self-administered, validated questionnaires on headache features, frequency, impairment, resource use, medication use, and productivity loss. Direct and indirect headache-related costs were estimated using unit cost assumptions from the PharMetrics Patient-Centric database, wholesale acquisition costs (Red Book), and wage data from the US Bureau of Labor Statistics. Those who developed transformed migraine were compared with those who did not develop transformed migraine in the 1-2 year interval between screening/baseline and follow-up. A total of 7796 (54%) identified migraine cases completed the 2006 follow-up survey. Of those cases, 359 (4.6%) developed transformed migraine. Participants who developed transformed migraine reported significantly more primary care visits, neurologist or headache specialist visits, pain clinic visits, and emergency room visits compared with participants whose migraine remained episodic. Hospital nights and urgent care visits did not reach statistical significance. Transformed migraine participants reported significantly more time missed at work or

  10. Formaldehyde, aspartame, and migraines: a possible connection.

    Science.gov (United States)

    Jacob, Sharon E; Stechschulte, Sarah

    2008-01-01

    Aspartame is a widely used artificial sweetener that has been linked to pediatric and adolescent migraines. Upon ingestion, aspartame is broken, converted, and oxidized into formaldehyde in various tissues. We present the first case series of aspartame-associated migraines related to clinically relevant positive reactions to formaldehyde on patch testing.

  11. Cognitive impairment in migraine:A systematic review

    Directory of Open Access Journals (Sweden)

    Caroline Martins de Araújo

    Full Text Available ABSTRACT Patients with migraine often report cognitive complaints, especially regarding attention and memory. Objective: To perform a systematic review of the studies available on cognitive evaluation in patients with migraine. Methods: We evaluated all articles containing the key words: "Migraine", "Cognition" and "Cognitive Impairment." Results: The search strategy resulted in 23 articles. Fifteen out of the 23 studies (65.3% retrieved reported abnormalities on neuropsychological tests in migraine patients, notably tests of memory, attention and information processing speed. Most of the studies showing cognitive changes in migraine were carried out in neurological care facilities. Conversely, among community-based studies, migraine patients were less likely to present cognitive changes. Conclusion: Patients with migraine, especially those followed at neurology clinics, show an elevated risk of mild changes in several cognitive domains. Further studies with greater methodological refinement are warranted in order to clearly establish whether this cognitive dysfunction is associated with an underlying migraine pathophysiological process.

  12. Recent Advances of Traditional Chinese Medicine Clinical Therapy on Migraine%偏头痛中医药临床治疗进展

    Institute of Scientific and Technical Information of China (English)

    陈冲; 杨思进

    2011-01-01

    偏头痛是一种原发性头痛,为功能障碍性神经疾病之一,临床常见多发,严重者可致四肢瘫痪.本病属于中医"内伤头痛"、"头风"、"脑风"、"厥头痛"等范畴,中医药治疗本病积累了十分的丰富经验,临床疗效确切显著,手段多样,文章就近年来中医药治疗本病进行综述.%Migraine is a primary headache, and it is one of the functional disturbance nervous diseases,commonly seeing and frequently encountered in clinic. The serious patients may become tetraplegia. It belongs to the traditional Chinese medicine category that are headache with internal injury, wind syndrome of head, encephal wind and so on. There is much experience of the traditional Chinese medicine therapy on migraine. And the therapeutic effect is significant, the instruments are diversity. This article reviewed traditional Chinese medicine clinical therapy of migraine in recent years.

  13. Epigone migraine vertigo (EMV): a late migraine equivalent.

    Science.gov (United States)

    Pagnini, P; Vannucchi, P; Giannoni, B; Pecci, R

    2014-02-01

    Migrainous headache is determined by pathogenetic mechanisms that are also able to affect the peripheral and/or central vestibular system, so that vestibular symptoms may substitute and/or present with headache. We are convinced that there can be many different manifestations of vestibular disorders in migrainous patients, representing true different clinical entities due to their different characteristics and temporal relashionship with headache. Based on such considerations, we proposed a classification of vertigo and other vestibular disorders related to migraine, and believe that a particular variant of migraine-related vertigo should be introduced, namely "epigone migraine vertigo" (EMV): this could be a kind of late migraine equivalent, i.e. a kind of vertigo, migrainous in origin, starting late in the lifetime that substitutes, as an equivalent, pre-existing migraine headache. To clarify this particular clinical picture, we report three illustrative clinical cases among 28 patients collected during an observation period of 13 years (November 1991 - November 2004). For all patients, we collected complete personal clinical history. All patients underwent standard neurotological examination, looking for spontaneous-positional, gaze-evoked and caloric induced nystagmus, using an infrared video camera. We also performed a head shaking test (HST) and an head thrust test (HTT). Ocular motility was tested looking at saccades and smooth pursuit. To exclude other significant neurological pathologies, a brain magnetic resonance imaging (MRI) with gadolinium was performed. During the three months after the first visit, patients were invited to keep a diary noting frequency, intensity and duration of vertigo attacks. After that period, we suggested that they use prophylactic treatment with flunarizine (5 mg per day) and/or acetylsalicylic acid (100 mg per day), or propranolol (40 mg twice a day). All patients were again recommended to note in their diary the frequency

  14. Vestibular Function Tests for Vestibular Migraine: Clinical Implication of Video Head Impulse and Caloric Tests

    Science.gov (United States)

    Kang, Woo Seok; Lee, Sang Hun; Yang, Chan Joo; Ahn, Joong Ho; Chung, Jong Woo; Park, Hong Ju

    2016-01-01

    Vestibular migraine (VM) is one of the most common causes of episodic vertigo. We reviewed the results of multiple vestibular function tests in a cohort of VM patients who were diagnosed with VM according to the diagnostic criteria of the Barany Society and the International Headache Society and assessed the efficacy of each for predicting the prognosis in VM patients. A retrospective chart analysis was performed on 81 VM patients at a tertiary care center from June 2014 to July 2015. Patients were assessed by the video head impulse test (vHIT), caloric test, vestibular-evoked myogenic potentials (VEMPs), and sensory organization test (SOT) at the initial visit and then evaluated for symptomatic improvement after 6 months. Complete response (CR) was defined as no need for continued medication, partial response (PR) as improved symptoms but need for continued medication, and no response (NR) as no symptomatic improvement and requiring increased dosage or change in medications. At the initial evaluation, 9 of 81 patients (11%) exhibited abnormal vHIT results, 14 of 73 (19%) exhibited abnormal caloric test results, 25 of 65 (38%) exhibited abnormal SOT results, 8 of 75 (11%) exhibited abnormal cervical VEMP results, and 20 of 75 (27%) exhibited abnormal ocular VEMP results. Six months later, 63 of 81 patients (78%) no longer required medication (CR), while 18 (22%) still required medication, including 7 PR and 11 NR patients. Abnormal vHIT gain and abnormal caloric results were significantly related to the necessity for continued medication at 6-month follow-up (OR = 5.67 and 4.36, respectively). Abnormal vHIT and caloric test results revealed semicircular canal dysfunction in VM patients and predicted prolonged preventive medication requirement. These results suggest that peripheral vestibular abnormalities are closely related to the development of vertigo in VM patients.

  15. Vestibular Function Tests for Vestibular Migraine: Clinical Implication of Video Head Impulse and Caloric Tests.

    Science.gov (United States)

    Kang, Woo Seok; Lee, Sang Hun; Yang, Chan Joo; Ahn, Joong Ho; Chung, Jong Woo; Park, Hong Ju

    2016-01-01

    Vestibular migraine (VM) is one of the most common causes of episodic vertigo. We reviewed the results of multiple vestibular function tests in a cohort of VM patients who were diagnosed with VM according to the diagnostic criteria of the Barany Society and the International Headache Society and assessed the efficacy of each for predicting the prognosis in VM patients. A retrospective chart analysis was performed on 81 VM patients at a tertiary care center from June 2014 to July 2015. Patients were assessed by the video head impulse test (vHIT), caloric test, vestibular-evoked myogenic potentials (VEMPs), and sensory organization test (SOT) at the initial visit and then evaluated for symptomatic improvement after 6 months. Complete response (CR) was defined as no need for continued medication, partial response (PR) as improved symptoms but need for continued medication, and no response (NR) as no symptomatic improvement and requiring increased dosage or change in medications. At the initial evaluation, 9 of 81 patients (11%) exhibited abnormal vHIT results, 14 of 73 (19%) exhibited abnormal caloric test results, 25 of 65 (38%) exhibited abnormal SOT results, 8 of 75 (11%) exhibited abnormal cervical VEMP results, and 20 of 75 (27%) exhibited abnormal ocular VEMP results. Six months later, 63 of 81 patients (78%) no longer required medication (CR), while 18 (22%) still required medication, including 7 PR and 11 NR patients. Abnormal vHIT gain and abnormal caloric results were significantly related to the necessity for continued medication at 6-month follow-up (OR = 5.67 and 4.36, respectively). Abnormal vHIT and caloric test results revealed semicircular canal dysfunction in VM patients and predicted prolonged preventive medication requirement. These results suggest that peripheral vestibular abnormalities are closely related to the development of vertigo in VM patients.

  16. Vestibular function tests for vestibular migraine: clinical implication of video head impulse and caloric tests

    Directory of Open Access Journals (Sweden)

    Woo Seok Kang

    2016-09-01

    Full Text Available Vestibular migraine (VM is one of the most common causes of episodic vertigo. We reviewed the results of multiple vestibular function tests in a cohort of VM patients who were diagnosed with VM according to the diagnostic criteria of the Barany Society and the International Headache Society and assessed the efficacy of each for predicting the prognosis in VM patients. A retrospective chart analysis was performed on 81 VM patients at a tertiary care center from June 2014 to July 2015. Patients were assessed by the video head impulse test (vHIT, caloric test, vestibular-evoked myogenic potentials (VEMP, and sensory organization test (SOT at the initial visit and then evaluated for symptomatic improvement after 6 months. Complete response (CR was defined as no need for continued medication, partial response (PR as improved symptoms but need for continued medication, and no response (NR as no symptomatic improvement and requiring increased dosage or change in medications. At the initial evaluation, 9 of 81 patients (11% exhibited abnormal vHIT results, 14 of 73 (19% exhibited abnormal caloric test results, 25 of 65 (38% exhibited abnormal SOT results, 8 of 75 (11% exhibited abnormal cervical VEMP results, and 20 of 75 (27% exhibited abnormal ocular VEMP results. Six months later, 63 of 81 patients (78% no longer required medication (CR, while 18 (22% still required medication, including 7 PR and 11 NR patients. Abnormal vHIT gain and abnormal caloric results were significantly related to the necessity for continued medication at 6-month follow-up (OR = 5.67 and 4.36, respectively. Abnormal vHIT and caloric test results revealed semicircular canal dysfunction in VM patients and predicted prolonged preventive medication requirement. These results suggest that peripheral vestibular abnormalities are closely related to the development of vertigo in VM patients.

  17. The Mind-Tranquilizing and Menstruation-Regulating Method for Acupuncture Treatment of Delayed Menstrual Cycle——A Clinical Controlled Study

    Institute of Scientific and Technical Information of China (English)

    CAI Xue-mei; WU Jie

    2009-01-01

    To compare the therapeutic effects of the mind-tranquilizing and menstruation-regulating acupuncture method with the routine acupuncture method in treating delayed menstrual cycle. Methods: 40 patients with delayed menstrual cycle were randomly divided into a treatment group of 23 cases (treated by the mind-tranquilizing and menstruation-regulating acupuncture method),and a control group of 17 cases (treated by the routine acupuncture method for delayed menstrual cycle due to stagnation of the liver-qi). The treatment involved three menstrual cycles. The evaluations were done by scoring the symptoms before treatment and at the end of each menstrual cycle. Results: After treatment,significant differences were found between the two groups in the therapeutic effects (P<0.05). Conclusion: The therapeutic effect of the mind-tranquilizing and menstruation-regulating acupuncture method is significantly superior to that of the routine acupuncture method for delayed menstrual cycle.

  18. Migraine and ischemia

    NARCIS (Netherlands)

    van der Wammes-van der Heijden, E.A.

    2009-01-01

    An association between migraine and ischemic events, especially ischemic stroke, has been debated for many years. Whether migraine is a risk factor for ischemic events or ischemia triggers migraine, or both, is still unclear. This thesis explores different relationships between migraine and ischemia

  19. 针刺治疗偏头痛66例疗效观察%Clinical observation of acupuncture in treating migraine headache

    Institute of Scientific and Technical Information of China (English)

    张银开

    2012-01-01

    目的 观察针刺治疗偏头痛的临床疗效.方法 66例偏头痛患者采用针刺头维和厉兑穴治疗,疗程2周.结果 治疗后总有效率为93.94%,头痛程度VAS积分由治疗前的(7.68±1.10)分降至治疗后的(2.04±0.73)分(P<0.01).结论 针刺治疗偏头痛的临床疗效确切.%Objective To observe the clinical efficacy of acupuncture in the treatment of migraine headache. Methods Sixty-six cases of migraine headache were treated by needling Touwei(ST 8) and Lidui(ST45) for two weeks. Results After treatment, the overall effective rate was 93.94% and the VAS score for headache severity reduced from (7.68 ± 1. 10) points to (2.04 ±0.73) points (P <0.01). Conclusion Acupuncture is quite effective for migraine headache.

  20. Analysis of relationship between age at onset and clinical features of migraine%发病年龄与偏头痛临床特点的关系分析

    Institute of Scientific and Technical Information of China (English)

    冯智英; 李颖; 邹静; 李焰生

    2011-01-01

    目的 分析发病年龄与偏头痛临床特点的关系,为临床判断偏头痛的预后提供参考.方法 收集门诊诊断为偏头痛的连续患者447例,其中先兆性偏头痛(MA组)62例,无先兆性偏头痛(MO组)385例.记录两组患者的年龄、性别、头痛发病年龄(AAO)、首次就诊年龄、病程、家族史以及头痛强度、频率和持续时间等相关资料.两组患者按AAO进行再分组(≤18岁为未成年组,>18岁为成年组),分别对AAO与家族史和头痛强度、频率、持续时间的关系进行统计学分析.结果 MA组和MO组患者中女性分别占81.3%和66.1% (P <0.05),两组患者的首次就诊年龄、病程和头痛持续时间比较,差异均有统计学意义(P<0.05).在MO患者中,未成年组与成年组的首次就诊年龄、病程、家族史及头痛频率和持续时间比较,差异均有统计学意义(P<0.05).多变量Logistic回归分析发现,就诊年龄、病程、家族史、头痛频率是独立危险因素.结论 起病早、家族史明显、头痛严重的偏头痛患者,预后较差;在中国人群中,AAO可作为反映偏头痛预后的指标之一.%Objective To investigate the relationship between age at onset (AAO) and clinical features of migraine so as to provide references for prognosis estimation of migraine. Methods Four hundred and forty-seven consecutive patients with migraine were enrolled, among whom 62 were migraine with aura ( MA group), and 385 were migraine without aura ( MO group). The related data about age, gender, AAO, age of first diagnosis, course of disease, family history, intensity of migraine, frequency of migraine and duration of migraine of patients in two groups were recorded. Patients in both groups were subdivided into immaturity group ( ^ 18 years old) and adult group( > 18 years old) respectively. The relationship between AAO and family history, intensity of migraine, frequency of migraine and duration of migraine was statistically

  1. Menstrual cycle pattern and fertility

    DEFF Research Database (Denmark)

    Kolstad, Henrik A.; Bonde, Jens Peter; Hjøllund, Niels Henrik;

    1999-01-01

    To characterize how the menstrual cycle pattern relates to fertility regardless of potential biases caused by inappropriate coital timing during the menstrual cycle or early embryonal loss.......To characterize how the menstrual cycle pattern relates to fertility regardless of potential biases caused by inappropriate coital timing during the menstrual cycle or early embryonal loss....

  2. Living with chronic migraine: a qualitative study on female patients' perspectives from a specialised headache clinic in Spain.

    Science.gov (United States)

    Palacios-Ceña, Domingo; Neira-Martín, Beatriz; Silva-Hernández, Lorenzo; Mayo-Canalejo, Diego; Florencio, Lidiane Lima; Fernández-de-Las-Peñas, César; García-Moreno, Héctor; García-Azorín, David; Cuadrado, María Luz

    2017-08-21

    The aim of this study was to explore the views and experiences of a group of Spanish women suffering from chronic migraine (CM). Headache clinic at a university hospital in Madrid (Spain). Purposeful sampling of patients that attended a specialised headache clinic for the first time between June 2016 and February 2017 was performed. The patients included were females aged 18-65 and with positive diagnoses of CM according to the International Classification of Headache disorders (third edition, beta version), with or without medication overuse. Accordingly, 20 patients participated in the study with a mean age of 38.65 years (SD 13.85). Qualitative phenomenological study. Data were collected through in-depth interviews, researchers' field notes and patients' drawings. A thematic analysis was performed following appropriate guidelines for qualitative research. Five main themes describing the significance of suffering emerged: (a) the shame of suffering from an invisible condition; (b) treatment: between need, scepticism and fear; (c) looking for physicians' support and sincerity and fighting misconceptions; (d) limiting the impact on daily life through self-control; and (e) family and work: between understanding and disbelief. The disease is experienced as an invisible process, and the journey to diagnosis can be a long and tortuous one. Drug prescription by the physician is greeted with distrust and scepticism. Patients expect sincerity, support and the involvement of their doctors in relation to their disease. Pain becomes the main focus of the patient's life, and it requires considerable self-control. The disease has a strong impact in the work and family environment, where the patient may feel misunderstood. Qualitative research offers insight into the way patients with CM experience their disease and it may be helpful in establishing a more fruitful relationship with these patients. © Article author(s) (or their employer(s) unless otherwise stated in the text

  3. Migraine pathophysiology: lessons from mouse models and human genetics.

    Science.gov (United States)

    Ferrari, Michel D; Klever, Roselin R; Terwindt, Gisela M; Ayata, Cenk; van den Maagdenberg, Arn M J M

    2015-01-01

    Migraine is a common, disabling, and undertreated episodic brain disorder that is more common in women than in men. Unbiased genome-wide association studies have identified 13 migraine-associated variants pointing at genes that cluster in pathways for glutamatergic neurotransmission, synaptic function, pain sensing, metalloproteinases, and the vasculature. The individual pathogenetic contribution of each gene variant is difficult to assess because of small effect sizes and complex interactions. Six genes with large effect sizes were identified in patients with rare monogenic migraine syndromes, in which hemiplegic migraine and non-hemiplegic migraine with or without aura are part of a wider clinical spectrum. Transgenic mouse models with human monogenic-migraine-syndrome gene mutations showed migraine-like features, increased glutamatergic neurotransmission, cerebral hyperexcitability, and enhanced susceptibility to cortical spreading depression, which is the electrophysiological correlate of aura and a putative trigger for migraine. Enhanced susceptibility to cortical spreading depression increased sensitivity to focal cerebral ischaemia, and blocking of cortical spreading depression improved stroke outcome in these mice. Changes in female hormone levels in these mice modulated cortical spreading depression susceptibility in much the same way that hormonal fluctuations affect migraine activity in patients. These findings confirm the multifactorial basis of migraine and might allow new prophylactic options to be developed, not only for migraine but potentially also for migraine-comorbid disorders such as epilepsy, depression, and stroke. Copyright © 2015 Elsevier Ltd. All rights reserved.

  4. Cerebellar and cerebral autoregulation in migraine.

    Science.gov (United States)

    Reinhard, Matthias; Schork, Joscha; Allignol, Arthur; Weiller, Cornelius; Kaube, Holger

    2012-04-01

    Silent ischemic brain lesions frequently occur in migraine with aura and are most often located in cerebellar border zones. This may imply an impairment of cerebellar blood flow autoregulation. This study investigated the characteristics of interictal cerebellar autoregulation in migraine with and without aura. Thirty-four patients (n=17, migraine without aura; n=17, migraine with aura) and 35 age- and sex-matched controls were studied. Triple simultaneous transcranial Doppler monitoring of one posterior inferior cerebellar artery, right posterior cerebral artery, and left middle cerebral artery was performed. Autoregulation dynamics were assessed from spontaneous blood pressure fluctuations (correlation coefficient index Dx) and from respiratory-induced 0.1-Hz blood pressure oscillations (phase and gain). Compared with controls, the autoregulatory index Dx was higher (indicating less autoregulation) in the posterior inferior cerebellar artery (P=0.0062) and middle cerebral artery (P=0.0078) in migraine with aura, but not in migraine without aura. Phase and gain did not significantly differ between migraine patients and controls. No significant associations of autoregulation with clinical factors were found, including frequency of migraine attacks and orthostatic intolerance. This first-time analysis of cerebellar autoregulation in migraine did not show a specific cerebellar dysautoregulation in the interictal period. More static autoregulatory properties (index Dx) are, however, impaired in persons with migraine with aura both in the cerebellar and anterior circulation. The cerebellar predilection of ischemic lesions in migraine with aura might be a combination of altered autoregulation and additional factors, such as the end artery cerebellar angioarchitecture.

  5. The mind-tranquilizing and menstruation-regulating method for acupuncture treatment of delayed menstrual cycle--a clinical controlled study.

    Science.gov (United States)

    Cai, Xue-mei; Wu, Jie

    2009-03-01

    To compare the therapeutic effects of the mind-tranquilizing and menstruation-regulating acupuncture method with the routine acupuncture method in treating delayed menstrual cycle. 40 patients with delayed menstrual cycle were randomly divided into a treatment group of 23 cases (treated by the mind-tranquilizing and menstruation-regulating acupuncture method), and a control group of 17 cases (treated by the routine acupuncture method for delayed menstrual cycle due to stagnation of the liver-qi). The treatment involved three menstrual cycles. The evaluations were done by scoring the symptoms before treatment and at the end of each menstrual cycle. After treatment, significant differences were found between the two groups in the therapeutic effects (Pmenstrual cycle.

  6. Abnormal menstrual periods (image)

    Science.gov (United States)

    ... may have a variety of causes, such as endometrial hyperplasia, endometrial polyps, uterine fibroids, and abnormal thyroid or ... the endometrium becomes unusually thick it is called endometrial ... Hyperplasia may cause profuse or extended menstrual bleeding.

  7. Temporo-mandibular disorders are an important comorbidity of migraine and may be clinically difficult to distinguish them from tension-type headache

    Directory of Open Access Journals (Sweden)

    Ariovaldo Alberto da Silva Júnior

    2014-02-01

    Full Text Available Clinical differentiation between the primary headaches and temporomandibular disorders (TMD can be challenging. Objectives : To investigate the relationship between TMD and primary headaches by conducting face to face assessments in patients from an orofacial pain clinic and a headache tertiary center. Method : Sample consists of 289 individuals consecutively identified at a headache center and 78 individuals seen in an orofacial pain clinic because of symptoms suggestive of TMD. Results : Migraine was diagnosed in 79.8% of headache sufferers, in headache tertiary center, and 25.6% of those in orofacial pain clinic (p<0.001. Tension-type headache was present in 20.4% and 46.1%, while the TMD painful occurred in 48.1% and 70.5% respectively (p<0.001. Conclusion : TMD is an important comorbidity of migraine and difficult to distinguish clinically from tension-type headache, and this headache was more frequent in the dental center than at the medical center.

  8. Coexisting typical migraine in familial hemiplegic migraine.

    Science.gov (United States)

    Hansen, Jakob Møller; Thomsen, Lise Lykke; Olesen, Jes; Ashina, Messoud

    2010-02-16

    In contrast to patients with migraine with aura (MA) and migraine without aura (MO), most patients with familial hemiplegic migraine (FHM) do not report migraine-like attacks after pharmacologic provocation with glyceryl trinitrate (GTN), a donor of nitric oxide. In the present study, we examined patients with FHM without known gene mutations and hypothesized that 1) GTN would cause more migraine-like attacks in patients with FHM compared to controls, and 2) GTN would cause more migraine attacks in patients with FHM with coexisting MA or MO compared to the pure FHM phenotype. The study design was a balanced provocation study. Twenty-three patients with FHM and 11 healthy controls received a continuous IV infusion of 0.5 mug/kg/min GTN over 20 minutes. We found no difference in the incidence of migraine-like attacks comparing all patients with FHM (30%) to controls (9%) (p = 0.15). Patients with FHM with coexisting MA or MO reported more migraine attacks after GTN (55%) than patients with the pure FHM phenotype (8.3%) (p = 0.02). Compared to healthy controls, more patients with FHM with coexisting MA or MO reported migraine-like attacks than controls (p = 0.03), whereas the FHM group with the pure FHM phenotype did not (p > 0.05). Compared to patients with migraine with aura (MA) and migraine without aura (MO), patients with familial hemiplegic migraine (FHM) without known gene mutations display a reduced sensitivity to nitric oxide. A subset of patients with FHM with coexisting nonhemiplegic migraine is more sensitive than controls. These data extend our previous findings that pathophysiologic pathways in FHM may differ from those of MO and MA.

  9. Menstrual Cycle: Basic Biology

    OpenAIRE

    2008-01-01

    The basic biology of the menstrual cycle is a complex, coordinated sequence of events involving the hypothalamus, anterior pituitary, ovary, and endometrium. The menstrual cycle with all its complexities can be easily perturbed by environmental factors such as stress, extreme exercise, eating disorders, and obesity. Furthermore, genetic influences such as fragile X premutations (Chapter X), X chromosome abnormalities (Chapter X), and galactose-1-phosphate uridyltransferase (GALT) point mutati...

  10. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study.

    Science.gov (United States)

    Lipton, Richard B; McGinley, James S; Shulman, Kenneth J; Wirth, R J; Buse, Dawn C

    2017-09-07

    Fast relief of migraine pain, associated symptoms, and migraine-related disability are priorities in the acute treatment of migraine. Efforts to improve the pharmacokinetic profiles of acute migraine treatments with the aim of providing faster relief include the development of non-oral routes of administration. AVP-825 (ONZETRA(®) Xsail(®) ) is a delivery system containing 22 mg sumatriptan powder that uses a patient's own breath to deliver medication intranasally, targeting the upper posterior nasal cavity beyond the narrow nasal valve, an area lined with vascular mucosa conducive to rapid drug absorption into the systemic circulation. While most studies comparing treatments measure differences in proportions of patients achieving a dichotomous endpoint at fixed time intervals, in this study we compare trajectories of migraine pain and disability over time for AVP-825 versus 100 mg oral sumatriptan tablets. We used data from the COMPASS study (NCT01667679, clinicaltrials.gov), a double-blind, double-dummy, active-comparator, cross-over study of people with a diagnosis of migraine. Participants treated up to five qualifying migraine attacks within 1 hour of onset with either AVP-825 plus placebo tablets or 100 mg oral sumatriptan tablets plus placebo delivery system during the first of two 12-week treatment periods, and then switched treatment sequences to treat up to five more attacks in the second treatment period. Patients recorded ordinal migraine pain intensity and migraine-related disability before dosing (predose), and at 10, 15, 30, 45, 60, 90 and 120 minutes. Three-level ordinal multilevel models accounted for unique data structure (repeated measures nested within attacks for each patient) and tested for treatment differences in migraine pain and migraine-related disability through the first 2 hours of attacks post dose. Among 259 study participants (mean age 40.0 years, 84.6% female, 78.4% white), there was significant between and within person

  11. Clinical Characterization and Imaging of Triggered Attacks in Chronic Migraine and Posttraumatic Headache

    Science.gov (United States)

    2016-02-01

    research was to characterize clinical features and changes in brain metabolism associated with attacks of headache triggered by either nitroglycerin (NTG...These studies were not performed Task 6. Comparison of baseline brain connectivity and metabolism between patients with persistent posttraumatic...to develop human models of PTH by characterizing clinical features and correlated changes in brain activity before and during triggered attacks. The

  12. Clinical Analysis of TCM Medicine in the Treatment of Migraine%中医内科治疗偏头痛的临床分析

    Institute of Scientific and Technical Information of China (English)

    陈秀梅

    2014-01-01

    目的:分析探讨中医内科辩证分型治疗偏头痛的临床疗效。方法对2011年1月至2013年8月我院中医内科收治的76例偏头痛患者采用中医辩证分型论治,1个疗程后观察其临床效果。结果76例偏头痛患者治疗1个疗程后,治愈41例(53.96%),显效21例(27.63%),有效10例(13.16%),总有效率为94.74%,临床效果显著。结论中医内科辩证分型治疗偏头痛的临床疗效显著,可有效缓解临床症状,改善脑部血液微循环,降低复发率。%Objective To analyze the clinical efficacy of internal medicine dialectical type treatment on migraine.Methods 76 cases of internal medicine patients with migraine in our hospital from January 2011 to August 2013 were treated medicine dialectical type of treatment,and the clinical effect was observed after one course of treatment.Results After one course of treatment,among 76 patients with migraine,41 cases(53.96%)were cured,21 cases(27.63%)were better treated,10 cases(13.16%)were well treated,and the total effective rate was 94.74%,which showed significant clinical effect.Conclusion Chinese medicine dialectical type is of significant clinical effect on migraine,which can effectively relieve clinical symptoms,improve brain blood circulation,and reduce the relapse rate.

  13. Sleep quality, morningness-eveningness preference, mood profile, and levels of serum melatonin in migraine patients: a case-control study.

    Science.gov (United States)

    Kozak, Hasan Hüseyin; Boysan, Murat; Uca, Ali Ulvi; Aydın, Adem; Kılınç, İbrahim; Genç, Emine; Altaş, Mustafa; Güngör, Dilara Cari; Turgut, Keziban; Özer, Nejla

    2017-03-01

    The melatonin as the pineal gland's secretory product is implicated in the pathophysiology of migraine. Melatonin has critical functions in human physiology, and research underscores the importance of melatonin in circadian rhythm, sleep, and mood regulation. Clinical observations have indicated that migraine attacks have a seasonal, menstrual, and circadian timing, suggesting that chronobiological mechanisms and their alterations may causally involve in the etiology of the disease. However, the topic has received relatively little attention in the migraine literature. Associations between melatonin, circadian preference, sleep, and mood states were investigated in the current study. Fifty-five patients (47 females and 8 males) were compared to 57 gender and age-matched control subjects (40 females and 17 males). A socio-demographical questionnaire, the Beck Depression Inventory, Beck Anxiety Inventory (BAI), Pittsburgh Sleep Quality Index (PSQI), Profile of Mood States (POMS), and Morningness-Eveningness Questionnaire were administered to volunteers. Blood samples were taken from all participants at about 1:00 AM in an unlit room not to hamper melatonin secretion, and blood melatonin levels were measured using quantitative ELISA test. In comparison with controls, melatonin levels were significantly lower among migraine patients. Migraineurs reported significantly greater scores on the BAI, confusion-bewilderment subscale of the POMS, and total and sleep latency subscale of the PSQI. Migraine patients who had nausea during the migraine attacks and who reported bouts relevant to certain food consumption, such as cheese or chocolate, had significantly lower levels of melatonin. Contrarily, groups did not reveal statistically substantial difference in circadian preferences.

  14. Primary intracranial angiomatoid fibrous histiocytoma presenting with anaemia and migraine-like headaches and aura as early clinical features

    DEFF Research Database (Denmark)

    Hansen, Jakob Møller; Larsen, Vibeke Andrée; Scheie, David

    2015-01-01

    A 17-year-old female with migraine with aura complained of fatigue and was diagnosed with anemia. Three years later, changes in her headache pattern prompted hospital referral. Brain MRI showed a bi-lobed extra-axial intracerebral tumor encroaching both parieto-occipital regions. The resection sp...

  15. Cranial Autonomic Symptoms in Pediatric Migraine

    Directory of Open Access Journals (Sweden)

    J Gordon Millichap

    2013-09-01

    Full Text Available Investigators at the University of California, San Francisco, examined the frequency of cranial autonomic symptoms in all pediatric and adolescent patients with migraine seen in 4 different clinical settings during July 2010 to June 2012.

  16. Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine

    Directory of Open Access Journals (Sweden)

    Allais G

    2016-10-01

    Full Text Available Gianni Allais, Chiara Benedetto Department of Surgical Sciences, Women’s Headache Center, University of Turin, Turin, Italy Abstract: Migraine is a common neurovascular disorder, affecting millions of people worldwide. Current guidelines recommend triptans as first-line treatment for moderate-to-severe migraine attacks. Frovatriptan is a second-generation triptan with a longer terminal elimination half-life in blood than other triptans (~26 hours. Three double-blind, randomized crossover preference studies have been recently conducted, assessing efficacy and safety of frovatriptan versus rizatriptan, zolmitriptan, and almotriptan, respectively. Frovatriptan showed favorable tolerability and sustained effect, with a significantly lower rate of relapse over 48 hours versus the other triptans. These findings were confirmed in a series of analyses of patient subsets from the three studies, including patients with menstrually related and oral contraceptive-induced migraine, hypertension, obesity, weekend migraine, as well as patients with migraine with aura. In all patient subsets analyzed, lower headache recurrence rates were observed versus the comparator triptans, indicating a more sustained pain-relieving effect on migraine symptoms. A further randomized, double-blind study demonstrated that frovatriptan given in combination with the fast-acting cyclooxygenase inhibitor dexketoprofen provided improved migraine pain-free activity at 2 hours, and gave more sustained pain-free activity at 24 hours, versus frovatriptan alone. These benefits were observed both when the combination was administered early (<1 hour after symptom onset or late (>1 hour after onset. Different pharmacokinetic, but synergistic, properties between frovatriptan and dexketoprofen may make the combination of these agents particularly effective in migraine treatment, with rapid onset of action and sustained effect over 48 hours. These benefits, together with potential cost

  17. 蒙医治疗偏头痛的临床疗效观察%The clinical effect of Mongolian medicine treatment migraine

    Institute of Scientific and Technical Information of China (English)

    韩图雅; 白龙; 郭玉鸽

    2013-01-01

      目的:观察并探讨蒙医放血疗法结合药物治疗偏头痛的临床疗效。方法:113例偏头痛的患者随机分为两组,即对照组(西药治疗组)和治疗组(蒙医治疗组),对照组56例,治疗组57例,两组进行同步治疗,治疗结束后,对两组总疗效进行对比分析。结果:治疗最多3个疗程后,治疗组治愈率为85.96%;对照组治愈率为44.64%(P<0.05)。结论:运用蒙医放血疗法结合药物治疗偏头痛临床疗效显著。%Objective:To observe and to explore the clinical curative effect of Mongolian medicine bloodletting therapy combined with drug treatment of migraine. Methods:113 patients with migraine were randomly divided into two groups, namely the control group (western medicine treatment group) and treatment group(Mongolian medicine treatment group) and control group in 56 patients, 57 cases in treatment group, two groups of synchronization treatment, after treatment, the two groups of total curative effect were analyzed. Results:after treatment of up to 3 period of treatment, treatment group cure rate was 85.96%; Control group cure rate was 44.64%(P<0.05).Conclusion:use of Mongolian medicine bloodletting therapy combined with migraine drug treatment clinical curative effect is remarkable.

  18. The Clinical Effect Observation of Acupuncture for Migraine%针刺治疗偏头痛临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    梁日楚

    2011-01-01

    Objective:Discuss the clinical effect of acupuncture for Migraine. Methods:80 migraine patients were randomly divided into treatment group of 40 patients,control group of 40 patients. The treatment group selected points in bilateral air pool,Tianzhu,completed the main points of bone,and then did dialectical acupoints. The control group were given dialectical treatment of traditional Chinese medicine, 10d was a course of treatment,3 day course of treatment breaks,evaluated the treatment efficacy after 2 courses. Results:The total effective rate of treatment group is 97.5%,the control group is 67.5%,the comparative differences of two groups are significant,P<0.05.Conclusion:Acupuncture treatment of migraine is with quick effect,significant effect, few side effects,it is worthy of clinical application.%目的:探讨针刺治疗偏头痛的临床疗效.方法:将80名偏头痛患者随机分为治疗组40例,对照组40例.治疗组选穴以双侧风池、天柱、完骨为主穴,再辨证取穴.对照组采用中药辩证治疗,10d为1个疗程,疗程间休息3d,治疗2个疗程后判定疗效.结果:治疗组临床总有效率为97.5%,对照组总有效率为67.5%,两组相比存在显著性差异,P<0.05.结论:针刺治疗偏头痛疗效快、疗效显著、副作用小,值得临床推广应用.

  19. Association between allergic rhinitis and migraine

    Directory of Open Access Journals (Sweden)

    Alia Saberi

    2012-01-01

    Full Text Available Background: Migraine and allergic rhinitis (AR are two common causes of headache and facial pain that inflammatory mediators with vasoactive function play important roles in both of them. The aim of this research was to determine the prevalence of migraine in AR patients. Materials and Methods: In a cross-sectional comparative study performed from June to December 2010 in patients with AR sign and symptoms referred to ear, nose, throat (ENT clinic of a university hospital in Iran-Rasht, 46 patients with positive skin prick test were compared with 60 subject without AR signs and symptoms and with negative skin test. In both the groups, history of migraine according to IHS (International Headache Society criteria were investigated. Analysis of data was performed by chi-sqaure and Fisher exact test by using SPSS16. Odds ratio were estimated for determining the chance of migraine in AR. Results: In case group (14 male, 37 female; mean age: 31.17 ± 8.31 years and control group (23 male, 32 female; mean age: 37.58 ± 12.63 years, the prevalence of migraine was 37% and 5%, respectively. The differences in prevalence of migraine and migraine without aura between cases and controls were significant (P = 0.001. The chance of migraine in AR was 8.227 folds (95% CI: 2.38-28.42. In subjects older than 40 years old, the difference of prevalence of migraine was significant, contrary to subjects younger than 30 years old and between 30 and 39 years old. Conclusions: There is a correlation between migraine especially without aura and AR and this correlation is more powerful with increasing age.

  20. American Migraine Foundation

    Science.gov (United States)

    ... YouTube Follow us on Pinterest Follow us on Instagram DONATE TODAY About Migraine Patient Registry Corporate Roundtable ... YouTube Follow us on Pinterest Follow us on Instagram DONATE TODAY Freedom From Pain The American Migraine ...

  1. Analysis of Clinical Experience of Professor Huang Yongsheng in Treating Migraine%黄永生教授治疗偏头痛临床经验解析

    Institute of Scientific and Technical Information of China (English)

    王月

    2015-01-01

    黄永生教授从事中医临床50余年,在临床上尊《内经》“治病求本”的宗旨,以整体观念为辨证指导思想。在治疗偏头痛方面积极寻找疾病的根本原因,针对病因治疗,临床上取得满意疗效,本文从四个方面总结黄永生老师治疗偏头痛的临床经验。%Professor yong-sheng huang is engaged in TCM clinic more than 50 years,in neijing clinicaly the tenet “cure to look for the cause of the disease”, dialectical guiding thought of the idea as a whole,actively looking for the root cause of the disease in their treatment of migraine,according to etiological treatment,the clinical curative effect is satisfactory,this paper from four aspects,summarizes the yong-sheng huang teacher's clinical experience in the treatment of migraine.

  2. ID migraine questionnaire in temporomandibular disorders with craniofacial pain: a study by using a multidisciplinary approach.

    Science.gov (United States)

    Di Paolo, Carlo; Di Nunno, Anna; Vanacore, Nicola; Bruti, Gianluca

    2009-08-01

    To evaluate the prevalence of migraine and related disability and the role of ID migraine questionnaire as a screening tool in patients with temporomandibular disorders (TMDs) and craniofacial pain (CFP). TMDs patients with CFP underwent stomatognathic (RDC/TMD criteria) and neurological visits (IHS criteria, 2004). ID migraine questionnaire and MIgraine Disability Assessment Scale (MIDAS) were also administered. Out of 45 patients, 69% met diagnosis of migraine plus chronic tension-type headache (CTTH); 9% presented CTTH and 20% were migraineurs. Out of 39 migraineurs who completed MIDAS, 56% presented the highest disability grade. Out of 37 patients who completed ID migraine questionnaire, 32 resulted affected by probable migraine with a diagnostic sensibility and specificity of 94% and 100%, respectively. Our findings showed a clinical association between TMDs and migraine. We support a clinical role of ID migraine and MIDAS in TMDs patients with CFP and we underline the importance of a multidisciplinary evaluation in this group of migraineurs.

  3. [Migraine and other primary headaches in children and adolescents].

    Science.gov (United States)

    Arroyo, Hugo A

    2007-01-01

    Migraine diagnosis only relies on clinical characteristics of the episodes and therefore on the doctor's skill and experience. It is recognized that migraine inclusively in the pediatric group is underdiagnosed and inadequately treated. The International Headache Society recently reviewed the international headache classification and incorporated some clinical criteria according to the different age groups. Pediatricians and pediatric neurologists now have a new document and should become familiar with it. This paper discusses these new criteria for migraine and other primary headaches.

  4. Familial hemiplegic migraine.

    Science.gov (United States)

    Hansen, Jakob Møller

    2010-09-01

    Familial hemiplegic migraine (FHM) is a rare, dominantly inherited subtype of migraine with aura, where hemiplegia occurs during the aura phase. Mutation screening of families with FHM has revealed a range of different mutations. The mutated FHM genes code for ion transport proteins. Animal and cellular studies have associated the mutated FHM genes with disturbed ion homeostasis, altered cellular excitability and altered neurotransmitter release. Abnormal cortical excitability due to dysfunctional ion-channels might facilitate cortical spreading depression (CSD) and thereby migraine aura and migraine headache. Genotyped FHM patients offer us the chance to study the interplay between genotype and phenotype and may be regarded as a genetic migraine model. FHM studies might open for a better understanding of the molecular migraine pathology, and potentially help to unravel the pathogenesis of the more common migraine forms. We have therefore studied genotyped FHM patients to understand the effect of genotype on the response to migraine provoking substances. We show here that two known migraine triggers failed to induce more migraine aura or migraine headache in FHM-patients than in healthy controls, thus indicating that the FHM genotype does not confer hypersensitivity to these migraine triggers. This has implications for our understanding of the headache mechanisms and raises the question whether FHM share neurobiological background with the common types of migraine. The aims of the present thesis were to test the hypothesis that FHM mutations might be associated with hypersensitivity to known migraine triggers and, thereby, share pathophysiological pathways with the common types of migraine, but our results disprove this hypothesis. Thus, FHM seems very different from MO and MA, both genetically and pathophysiologically. The fact that FHM genes regulate ion homeostasis cannot be extrapolated to the common types of migraine.

  5. Rizatriptan in the treatment of migraine.

    Science.gov (United States)

    Láinez, Miguel J A

    2006-09-01

    Migraine is a common, disabling disorder associated with considerable personal and societal burden. Current guidelines recommend triptans for the acute treatment of migraine unlikely to respond to less effective therapies. Rizatriptan is a second-generation triptan available in tablet or orally disintegrating tablet (wafer) formulations that offers several advantages over other members of its class. Rizatriptan is rapidly absorbed from the gastrointestinal tract and achieves maximum plasma concentrations more quickly than other triptans, providing rapid pain relief. Clinical trials have shown that rizatriptan is at least as effective or superior to other oral migraine-specific agents in the acute treatment of migraine, and has more consistent long-term efficacy across multiple migraine attacks. Rizatriptan has a favorable tolerability profile, and patients have reported greater satisfaction and a preference for rizatriptan over other migraine-specific agents. Improvements in quality of life reported with rizatriptan are consistent with its favorable efficacy and tolerability profiles. Notably, multi-attribute decision models that combine clinical data with patient- and physician-reported treatment preferences have identified rizatriptan as one of three triptans closest to a hypothetical "ideal". The efficacy and tolerability of rizatriptan for the acute treatment of migraine have thus been well established.

  6. Neurovascular pharmacology of migraine

    NARCIS (Netherlands)

    MaassenVanDenBrink, Antoinette; Chan, Kayi Y.

    2008-01-01

    Migraine is a paroxysmal neurovascular disorder, which affects a significant proportion of the population. Since dilation of cranial blood vessels is likely to be responsible for the headache experienced in migraine, many experimental models for the study of migraine have focussed on this feature. T

  7. Migraine Associated Vertigo

    OpenAIRE

    Cha, Yoon-Hee; Baloh, Robert W.

    2007-01-01

    The interrelations of migraine and vertigo are complex, eluding a simple localization either centrally or peripherally. Spontaneous episodic vertigo, benign paroxysmal positional vertigo, and Meniere's disease all occur more frequently in patients with migraine than in those without. Family studies support a hereditary predisposition to migraine associated vertigo. In this review, we discuss definitions, epidemiology, associated syndromes, neurootological abnormalities, genetics and treatment...

  8. Neurovascular pharmacology of migraine

    NARCIS (Netherlands)

    MaassenVanDenBrink, Antoinette; Chan, Kayi Y.

    2008-01-01

    Migraine is a paroxysmal neurovascular disorder, which affects a significant proportion of the population. Since dilation of cranial blood vessels is likely to be responsible for the headache experienced in migraine, many experimental models for the study of migraine have focussed on this feature. T

  9. Premonitory symptoms in migraine

    DEFF Research Database (Denmark)

    Laurell, Katarina; Artto, Ville; Bendtsen, Lars

    2016-01-01

    AIM: To describe the frequency and number of premonitory symptoms (PS) in migraine, the co-occurrence of different PS, and their association with migraine-related factors. METHODS: In this cross-sectional study, a validated questionnaire was sent to Finnish migraine families between 2002 and 2013...

  10. 针药并用治疗运动性月经失调临床观察%Clinical observation on treating exercise-induced menstrual disorders by acupuncture and medication

    Institute of Scientific and Technical Information of China (English)

    郑美玲; 刘克锋

    2013-01-01

    Objective:To observe the clinical effect of the electrical stimulation on specific point acupuncture combined with TCM oral treatment on treating exercise-induced menstrual disorders. Methods: For athlete with exercise-induced menstrual disorders, EA on Guanyuan, Qihai, Sanyinjiao and other points, orally TCM Siwu Yimu pills, continuous treatment 4~6 menstrual cycles. Results: 86 patients after outpatient 4~6 menstrual cycle of treatment, cure 11 cases, obvious effective in 41 cases, effective in 26 cases, 8 cases were invalid, the total efficiency was 90.7%. Conclusion: Acupuncture and medication was effective in treating exercise-induced menstrual disorders, suitable for young female athletes.%目的:观察电针刺激特定腧穴配合内服中成药治疗运动性月经失调的疗效。方法:针对患有运动性月经失调的运动员,电针关元、气海、三阴交等腧穴,内服纯中药制剂四物益母丸,连续治疗4~6个月经周期。结果:门诊86例患者经过4~6个月经周期治疗后,治愈11例、显效41例、有效26例、无效8例,总有效率90.7%。结论:针药并用治疗运动性月经失调,疗效满意,适合青少年女运动员需求。

  11. Tackling chronic migraine: current perspectives

    Directory of Open Access Journals (Sweden)

    Carod-Artal FJ

    2014-04-01

    Full Text Available Francisco Javier Carod-Artal Neurology Department, Raigmore Hospital, Inverness, UK; Universitat Internacional de Catalunya, Barcelona, Spain Abstract: In the last decade, several diagnostic criteria and definitions have been proposed for chronic migraine (CM. The third edition of the International Classification of Headache Disorders–3 beta, published in 2013, has revised CM diagnostic criteria. CM is defined as “headache occurring on 15 or more days per month for more than 3 months, which has the features of migraine headache on at least 8 days per month.” Patients who meet the criteria for CM and for medication-overuse headache should be given both diagnoses. Worldwide, CM prevalence ranges 1%–3%, and its incidence has been estimated to be 2.5% per year. CM is associated with disability and poor quality of life. Modifiable risk factors include (among others: migraine progression (defined as an increase in frequency and severity of migraine attacks; medication and caffeine overuse; obesity; stressful life events; and snoring. CM patients have a significantly higher frequency of some comorbid conditions, including chronic pain, psychiatric disorders, respiratory illness, and some vascular risk factors. Management includes identification and control of comorbidities and risk factors that predispose to CM; treatment and prevention for medication overuse; early treatment for migraine attacks; and an adequate preventive therapy for CM. Several randomized controlled clinical trials have shown the efficacy of topiramate, amitriptyline, onabotulinumtoxinA, and cognitive-behavioral therapy in CM. Keywords: chronic daily headache, chronic migraine, epidemiology, medication overuse headache, risk factors, treatment

  12. Clinical study of Migraine according to the collateral disease theory%从络病论治偏头痛的临床观察

    Institute of Scientific and Technical Information of China (English)

    杜彦侠; 杨立波; 马静; 杨超

    2011-01-01

    Objective: To observe the clinical application of Migraine according to the collateral disease theory.Methods: 100 patients with Migraine were randomly divided into two groups. Patients in treatment groups(n=50) were treated by Tongxinluo capsule. Patients in control groups(n=50) were treated by Flunarizine Hydrochloride Capsules.The therapeutic course in both groups was 4 weeks. Results: In the treatment groups the total effective rate was 86.0%. in the control groups the total effective rate was 68.0%.The difference between the two groups was statistically significant (P<0.05) Conclusion: According to the collateral disease theory,Tongxinluo capsule can improve the sings of the patients with Migraine,and its effect was superior to that of Flunarizine Hydrochloride Capsules.%目的:观察采用中医药从络病论治偏头痛的临床疗效.方法:100例偏头痛患者,随机分为两组,治疗组50例应用通心络胶囊,对照组50例应用盐酸氟桂嗪胶囊,疗程均为4周.结果:治疗组总有效率为86.0%,对照组总有效率为68.0%,组间比较差异有统计学意义(P<0.05).结论:采用中医药从络病论治偏头痛可以明显改善患者的症状,其疗效明显优于盐酸氟桂嗪.

  13. Clinical research progress of chronic migraine%试论慢性偏头痛患者的临床研究进展

    Institute of Scientific and Technical Information of China (English)

    徐沙沙

    2016-01-01

    Objective to investigate the clinical effect of the treatment of chronic migraine. Methods from January 2015 to June 2014, 126 patients with chronic migraine were randomly divided into experimental group and control group. The experimental group was treated with comprehensive and individualized treatment. Results comparing the two groups of patients with the effect of treatment, can be found in the experimental group of patients with good results in the treatment of the control group of patients. Conclusion the use of comprehensive and individualized treatment for chronic migraine patients can effectively improve the treatment efficiency, and it is worth promoting.%目的:探讨患有慢性偏头痛患者进行治疗的临床效果。方法以我院从2014年6月到2015年1月收治的126名慢性偏头痛患者为研究对象,将其随机分为:实验组和对照组,对实验组患者使用综合性及个体化的治疗方法进行治疗,对对照组患者使用药物治疗方法进行治疗。结果对比两组患者的治疗效果,可以发现实验组患者的治疗效果好于对照组患者的治疗效果。结论对慢性偏头痛患者使用综合性及个体化的治疗方法进行治疗,可以有效提高治疗效率,值得进行大力推广。

  14. Pubertal development in adolescents with menstrual disorders

    Directory of Open Access Journals (Sweden)

    Alberto Roteta Dorado

    2010-07-01

    Full Text Available Introduction: Abnormal uterine bleeding is the presence of an excessive and prolonged menstrual bleeding over several consecutive cycles. It is one of the first complaints in pediatric gynecology and is the most common cause dysfunctional uterine bleeding. Objective: To characterize adolescents with menstrual disorders attending gynecology clinic in child and adolescent onset of puberty. Method: A descriptive, longitudinal and prospective. Universe: 88 adolescents seen at the gynecology children and youth in the province of Cienfuegos with menstrual disorders in 2008. Sample: 64 patients with rhythm disturbances of the menstrual cycle and excessive bleeding. Procedure: During the first consultation was found in the following medical records: age, onset of puberty, age at menarche, breast development and pubic hair development. The data were processed by SPSS program and expressed as numbers and percentages. Results: 43.8% of the adolescents studied were between 14 and 16 years, 29.7% began puberty at age 9, 31.3% had their menarche at age 11, 46, 87% were in Tanner stage IV of breast development and 56.25% in Tanner stage IV for pubic hair. Conclusion: There were no alterations in pubertal development in adolescents with menstrual disorders studied.

  15. An analysis of clinical features of 226 vestibular migraine patients%前庭性偏头痛226例症候分析

    Institute of Scientific and Technical Information of China (English)

    邱峰; 黄鑫; 王晓风; 刘建国; 戚晓昆

    2014-01-01

    Objective To explore the clinical characteristics of vestibular migraine in patients from the clinic and ward of the neurological department in comprehensive hospitals.Methods A total of 226 patients diagnosed as vestibular migraine were enrolled in the study.Clinical data were collected and analyzed,including the medical history,clinical symptoms and signs,as well as the result of diagnostic examinations.Results The mean age of the patients at the visit was 51.7 years old,with the male to female ratio of 1:1.48.The occurrence of vertigo and migraine varied in order,with 53.1% (120/226) patients presented migraine several years before vertigo.The duration time of vertigo ranged from seconds to days,with 1.8% (4/226) patients presented no headache during the whole course.Several punctate long T2 or high FLARE (fluid attented inversion recovery) signals scattered at the centrum ovale.Conclusions Vestibular migraine has complex mechanism and presents multiple clinical manifestations with certain regularities of the onset.Differential diagnosis should be made from the similar diseases.%目的 分析综合医院神经内科门诊以及住院的前庭性偏头痛(VM)患者的症候特点,以减少临床误诊和漏诊.方法 连续收集2007年11月至2013年1 1月海军总医院神经内科诊断的226例VM患者的临床资料,根据病史、临床症状和体征、相应的辅助检查结果,分析本组患者的临床症候.结果 本组患者平均就诊年龄51.7岁,男、女性别比1∶1.48.头痛与眩晕首次发作的时间前后顺序不固定,其中53.1% (120/226)的患者头痛早于眩晕数年出现,症候发作持续时间从数十秒至数天不等.1.8%(4/226)患者整个病程中除眩晕症候外,无头痛症状.头颅MRI显示42例(43.3%)患者半卵圆中心内可见多个散在点状的长T2或液体衰减反转恢复(FLAIR)序列上呈高信号.结论 VM发病机制复杂,临床表现多样,发作形式有一定规律性,需注意与类似疾病的鉴别.

  16. Current treatment options in vestibular migraine

    Directory of Open Access Journals (Sweden)

    Mark eObermann

    2014-12-01

    Full Text Available Approximately 1% of the general population in western industrialized countries suffers from vestibular migraine. However, it remains widely unknown and often under diagnosed even despite the recently published diagnostic criteria for vestibular migraine. Treatment trials that specialize on vestibular migraine are scarce and systematic randomized controlled clinical trials are only now emerging.This review summarizes the knowledge on the currently available treatment options that were tested specifically for vestibular migraine and gives an evidence-based, informed treatment recommendation with all its limitations.To date only two randomized controlled treatment trials provide limited evidence for the use of rizatriptan and zolmitriptan for the treatment of vestibular migraine attacks because of methodological shortcommings. There is an on-going a multicenter randomized placebo-controlled trial testing metoprolol 95 mg vs. placebo (PROVEMIG-trial. Therefore, the therapeutic recommendations for the prophylactic treatment of vestibular migraine are currently widely based on the guidelines of migraine with and without aura as well as expert opinion.

  17. Migraine and epilepsy: review of the literature.

    Science.gov (United States)

    Nye, Barbara L; Thadani, Vijay M

    2015-03-01

    Migraine and epilepsy are disorders that are common, paroxysmal, and chronic. In many ways they are clearly different diseases, yet there are some pathophysiological overlaps, and overlaps in clinical symptomatology, particularly with regard to visual and other sensory disturbances, pain, and alterations of consciousness. Epidemiological studies have revealed that the two diseases are comorbid in a number of individuals. Both are now recognized as originating from electrical disturbances in the brain, although their wider manifestations involve the recruitment of multiple pathogenic mechanisms. An initial excess of neuronal activity in migraine leads to cortical spreading depression and aura, with the subsequent recruitment of the trigeminal nucleus leading to central sensitization and pain. In epilepsy, neuronal overactivity leads to the recruitment of larger populations of neurons firing in a rhythmic manner that constitutes an epileptic seizure. Migraine aura and headaches may act as a trigger for epileptic seizures. Epilepsy is not infrequently accompanied by preictal, ictal, and postictal headaches that often have migrainous features. Genetic links are also apparent between the two disorders, and are particularly evident in the familial hemiplegic migraine syndromes where different mutations can produce either migraine, epilepsy, or both. Also, various medications are found to be effective for both migraine and epilepsy, again pointing to a commonality and overlap between the two disorders. © 2015 American Headache Society.

  18. Refractory chronic migraine

    DEFF Research Database (Denmark)

    Martelletti, Paolo; Katsarava, Zaza; Lampl, Christian

    2014-01-01

    and in the uncontrolled application of therapeutic techniques not yet validated.The European Headache Federation Expert Group on rCM presents hereby the updated definition criteria for this harmful subset of headache disorders. This attempt wants to be the first impulse towards the correct identification......The debate on the clinical definition of refractory Chronic Migraine (rCM) is still far to be concluded. The importance to create a clinical framing of these rCM patients resides in the complete disability they show, in the high risk of serious adverse events from acute and preventative drugs...... of these patients, the correct application of innovative therapeutic techniques and lastly aim to be acknowledged as clinical entity in the next definitive version of the International Classification of Headache Disorders 3 (ICHD-3 beta)....

  19. From Childhood Migraine Headache to Pheochromocytoma

    Directory of Open Access Journals (Sweden)

    Y. M. Hazimeh

    2014-01-01

    Full Text Available Pheochromocytoma may have multiple clinical manifestations including paroxysmal hypertension, tachycardia, sweating, nausea, and headache (Phillips et al., 2002. Migraine has some of the manifestations seen with pheochromocytoma. We describe a patient who had a history of migraine headaches since childhood and was found to have pheochromocytoma. Resection of her tumor significantly improved her headache. The diagnoses of pheochromocytoma subsequently lead to diagnosing her with medullary thyroid cancer (MTC and multiple endocrine neoplasia type 2A (MEN-2A.

  20. Menstrual disturbances and fertility in chronic alcoholic women

    DEFF Research Database (Denmark)

    Becker, U; Tønnesen, H; Kaas-Claesson, N

    1989-01-01

    of both menstrual cycle and menstrual flow was recorded in the chronic alcoholic women during active alcoholism. A higher frequency (P less than 0.05) of menstrual disturbances (70% vs. 55%) and uterine curettages (38% vs. 16%) were found in the alcoholic women. The latter reported more abortions (63% vs......Data on menstrual pattern, gynecological disorders and infertility were obtained from 51 chronic alcoholic women aged 20--42 years attending an outpatient clinic for alcoholics, using 51 randomly drawn age-matched healthy women as controls. A higher variability (P less than 0.05) in the duration...... conception. Social classification had no independent influence on the results. The study shows that chronic alcoholic women are more prone to menstrual abnormalities and are at greater risk of gynecological interventions, while they do not seem to have reduced fertility....

  1. Migraine with aura and patent foramen ovale: myth or reality?

    Science.gov (United States)

    Finocchi, C; Del Sette, M

    2015-05-01

    Several observational studies report that subjects with migraine with aura have a higher prevalence of right-to left shunt, commonly due to patent foramen ovale, and that patent foramen ovale is more prevalent in subjects with migraine with aura. Although migraine without aura has been less extensively studied, it does not seem to be associated with an increased prevalence of right-to left shunt. The mechanism that underlies the possible relationship between patent foramen ovale and migraine with aura remains speculative. The proposed mechanisms are migraine-triggering vasoactive chemicals bypassing the pulmonary filter and reaching the cerebral circulation and paradoxical microembolization. However, it is unclear, at this time, if there is a causal or comorbid association between the two conditions. In some families atrial shunts show a dominant inheritance that seems to be linked to inheritance of migraine with aura. Migraine with aura is an independent risk factor for ischemic stroke, and patent foramen ovale is present more frequently in patients with cryptogenic stroke than in controls. At this moment, there is no convincing evidence that excess stroke risk of migraine is simply mediated by patent foramen ovale through paradoxical embolism. Several non-controlled studies suggest that closure of the foramen ovale significantly reduces attack frequency in migraine patient, but the only prospective placebo-controlled trial does not support these results. Patent foramen ovale closure, at present, is not indicated as a treatment for migraine in clinical practice.

  2. Epidemiological characteristics of childhood migraine syndrome in Serbia

    Institute of Scientific and Technical Information of China (English)

    Marija Kne(z)evi(c)-Pogan(c)ev; Neboj(s)a Jovi(c); Vesna Iveti(c); Danka Filipovi(c); Dragan Katani(c)

    2011-01-01

    This study investigated childhood migraine, examining the clinical characteristics of different childhood migraine types, predisposing factors, and possible medical treatments in a sample of children in Serbia. This was the first epidemiological study in Serbia using the operational diagnostic criteria of the International Headache Society. The present study examined 30 636 children between 1988 and 2006, including 15 434 (50.38%) males and 15 202 (49.62%) females, in nine towns in Vojvodina, a northern province in Serbia. Migraine was reported in 2 644 (8.63%) children aged 3 to 7 years, consisting of 1 189 (8.0%) males and 1 455 (9.6%) females. Migraine with aura accounted for 25.55%, migraine without aura for 67.21% and other migraine syndromes for 7.23% of reported migraine sufferers. The mean age of first migraine attack across groups was 5 years and 1.8 months. Migraine with aura was associated with an earlier onset than migraine without aura.Migraine was more frequent among younger groups of children who were breastfed for a shorter period of time. Child healthcare in Vojvodina has a high level of specialization, with more than half of the children reporting migraine diagnosed and treated by neuropediatricians. Socioeconomic status,duration of breastfeeding, birth order, and age of entering full-day nursery care were found to be important factors for childhood migraine. These findings suggest that healthcare providers should educate parents about these predisposing factors, so they can be identified and avoided early.

  3. Menstrual management in developmentally delayed adolescent females.

    Science.gov (United States)

    Chuah, Irene; McRae, Alexandra; Matthews, Kim; Maguire, Ann M; Steinbeck, Katharine

    2017-06-01

    Requests for assistance in menstrual management and menstrual suppression are a common, emotive and sometimes controversial aspect of adolescent disability care. To review the uptake and outcomes of menstrual suppression among adolescent patients with developmental delay. A retrospective review of the medical records of adolescent females with intellectual disability referred for menstrual management to the Paediatric and Adolescent Gynaecology Clinic, Children's Hospital at Westmead, Sydney, for the three-year period between January 1, 2010 and January 1, 2013. Eighty adolescent patients with developmental delay were identified. A third (n = 28) of the patients were pre-menarcheal at first review with parent/caregivers seeking anticipatory advice. Of the post-menarcheal patients, the median age of menarche was 12 years (range 10-15 years). First and second line interventions were documented as were reasons for change where applicable. The combined oral contraceptive pill (COCP) was the most frequently used therapy (67%), and 19 patients in total had a levonorgestrel releasing intrauterine system (LNG-IUS) inserted (31%). Our study population differs from similar previously published groups in the marked absence of the use of depot medroxyprogesterone acetate or the subdermal etonogestrel releasing device. As a paediatrician, it is important to address menstrual management issues and allay caregiver concerns with appropriate advice. Our study supports the use of the COCP as sound first line management in achieving menstrual suppression. The LNG-IUS appears to be a favourable second line option. Further investigation into longer-term outcomes and potential complications of device insertion is recommended. © 2017 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

  4. Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data.

    Directory of Open Access Journals (Sweden)

    Muhammed Murtaza

    Full Text Available BACKGROUND: Morbidity associated with primary headache disorders is a major public health problem with an overall prevalence of 46%. Tension-type headache and migraine are the two most prevalent causes. However, headache has not been sufficiently studied as a cause of morbidity in the developing world. Literature on prevalence and classification of these disorders in South Asia is scarce. The aim of this study is to describe the classification and clinical features of headache patients who seek medical advice in Pakistan. METHODS AND RESULTS: Medical records of 255 consecutive patients who presented to a headache clinic at a tertiary care hospital were reviewed. Demographic details, onset and lifetime duration of illness, pattern of headache, associated features and family history were recorded. International Classification of Headache Disorders version 2 was applied. 66% of all patients were women and 81% of them were between 16 and 49 years of age. Migraine was the most common disorder (206 patients followed by tension-type headache (58 patients, medication-overuse headache (6 patients and cluster headache (4 patients. Chronic daily headache was seen in 99 patients. Patients with tension-type headache suffered from more frequent episodes of headache than patients with migraine (p<0.001. Duration of each headache episode was higher in women with menstrually related migraine (p = 0.015. Median age at presentation and at onset was lower in patients with migraine who reported a first-degree family history of the disease (p = 0.003 and p<0.001 respectively. CONCLUSIONS/SIGNIFICANCE: Patients who seek medical advice for headache in Pakistan are usually in their most productive ages. Migraine and tension-type headache are the most common clinical presentations of headache. Onset of migraine is earlier in patients with first-degree family history. Menstrually related migraine affects women with headache episodes of longer duration than other patients

  5. Migraine with benign episodic unilateral mydriasis

    Directory of Open Access Journals (Sweden)

    Jabr FI

    2011-06-01

    Full Text Available Nedaa Skeik1, Fadi I Jabr21Mayo Clinic, Rochester, MN, USA; 2Horizon Medical Center, Hospital Medicine, Dickson, TN, USAAbstract: Pupil asymmetry or anisocoria can have benign or malignant causes, and be categorized as acute or chronic. It can also be a normal finding in about 20% of cases. Benign episodic unilateral mydriasis is an isolated benign cause of intermittent pupil asymmetry. The exact pathophysiology is not always understood. According to one hypothesis, it is due to discordance between the sympathetic and parasympathetic systems. It is occasionally seen in patients with migraine. Some authors consider it a limited form of ophthalmoplegic migraine. We report a case of benign episodic unilateral mydriasis diagnosed in a 30-year-old lady with a history of migraine who had extensive negative neurological evaluation.Keywords: anisocoria, migraine, unilateral episodic mydriasis

  6. What efficacy measures are clinically relevant and should be used in Cochrane reviews of acute migraine trials? An alternative viewpoint.

    Science.gov (United States)

    Steiner, T J

    2015-04-01

    I briefly review the purposes of efficacy measures, which go far beyond supporting new drug development. I use vignettes to illustrate the importance of functional recovery during the migraine attack, and argue that headache relief provides this. Sustained headache relief (SHR) is therefore a very worthwhile outcome when the alternative is a day of debilitating pain. As a measure, SHR may not be ideal for new drug development but it is informative to individuals, health care providers and politicians, and serves cost-effectiveness analysis better than any other. Cochrane are absolutely right to use it in systematic reviews along with the IHS-recommended measures.

  7. Clinical characteristics of migraine and episodic tension-type headache in relation to old and new diagnostic criteria

    DEFF Research Database (Denmark)

    Iversen, Helle Klingenberg; Langemark, M; Andersson, P G

    1990-01-01

    Headache Society (IHS). In every patient the original diagnosis fulfilled also the IHS criteria, but in 9 patients the criteria were only fulfilled in half or less of the attacks, and applying the IHS criteria they also achieved an additional diagnosis. In one patient these attacks did not fulfill the pain...... criteria and in 8 (4 migraine, 4 tension headache) they did not fulfill the criteria for accompanying symptoms. Overall the IHS criteria are sensitive and specific, but they may possibly be improved with regard to accompanying symptoms. The present study suggests that recording of frequency and graded...

  8. [Migrainous aura subtypes in hospitalized children].

    Science.gov (United States)

    Biedroń, Agnieszka; Steczkowska, Małgorzata; Zajac, Anna; Stolarska, Urszula; Kroczka, Sławomir

    2009-01-01

    Migraine with aura is characterized by reversible focal neurological symptoms preceding or accompanying headache. Visual aura is the most common type of aura and its patognomic symptoms are scintillating fortification migrating across the visual field or scintillating scotoma. However, the symptoms are not always so typical and clinical doubts are greater when negative symptoms (loss of vision, numbness or paresis) are present. Differential diagnosis of migraine with aura includes in the first place transient ischemic attack (TIA) as well as epilepsy. Diagnosis of migraine in the developmental age is more difficult and associated with unprecise description of the symptoms. Thorough history taking is crucial in migraine diagnosis and following management. Knowledge of migraine with aura symptoms, clinical differences associated with developmental age and features enabling differentiation with other disorders imitating migraine is very important. Description of aura types and characteristics of migraine headache and their accompanying symptoms in children. 30 children were included, aged 8-17 years (mean 13,6 years), hospitalized at Department of Pediatric Neurology Chair of Pediatric and Adolescent Neurology, Jagiellonian University in 14 months of years 2008 and 2009. Clinical analysis was based on inquiry addressed to the patients and their parents. Migraine with visual aura was established in 9 patients, with somatosensory aura in 4, visual and somatosensory in 5, visual and dysphasic in 1, visual, somatosensory and dysphasic in 5, somatosensory and dysphasic in 2 and basilar type migraine in 4 patients. Consequently, symptoms of visual aura were present in 20/30 patients, in 9 of them it was the only type of aura and in 11 coexisted with other aura types. In more than half cases it manifested as simple visual phenomenons (spots, dots, frills, lines). Blurred vision was found in 5 patients (bilateral in 3, unilateral in 3) and hemianopia in 2 (bilateral in aura

  9. Familial Hemiplegic Migraine and Recurrent Episodes of Psychosis

    DEFF Research Database (Denmark)

    LaBianca, Sonja; Jensen, Rigmor; van den Maagdenberg, Arn M J M

    2015-01-01

    Familial hemiplegic migraine (FHM) is a rare autosomal dominant form of migraine with motor aura. We present a case report of a father and son with very similar attacks of hemiplegic migraine and recurrent episodes of accompanying psychoses. Previously, such episodes led to hospitalization...... and extended clinical examinations, which further worsened the psychoses. Since the episodes were recognized as related to the hemiplegic migraine, a treatment strategy combining sleep and sedation was initiated and progression onto psychosis was almost completely avoided in both father and son. Genetic...

  10. Migraine induced by hypoxia

    DEFF Research Database (Denmark)

    Arngrim, Nanna; Schytz, Henrik Winther; Britze, Josefine

    2016-01-01

    Migraine with aura is prevalent in high-altitude populations suggesting an association between migraine aura and hypoxia. We investigated whether experimental hypoxia triggers migraine and aura attacks in patients suffering from migraine with aura. We also investigated the metabolic and vascular...... response to hypoxia. In a randomized double-blind crossover study design, 15 migraine with aura patients were exposed to 180 min of normobaric hypoxia (capillary oxygen saturation 70-75%) or sham on two separate days and 14 healthy controls were exposed to hypoxia. Glutamate and lactate concentrations...... in the visual cortex were measured by proton magnetic resonance spectroscopy. The circumference of cranial arteries was measured by 3 T high-resolution magnetic resonance angiography. Hypoxia induced migraine-like attacks in eight patients compared to one patient after sham (P = 0.039), aura in three...

  11. [Genetic aspects of migraine].

    Science.gov (United States)

    Kopishinskaya, S V; Gustov, A V

    2015-01-01

    Migraine is a common disease characterized by severe headache with nausea, vomiting and hypersensitivity to sounds, light, smell. Neurological symptoms during aura period develop in 25% of patients. Genes responsible for migraine development have been identified. The mutations in familial hemiplegic migraine are better investigated. The serotonin system plays a key role in the migraine pathogenesis. It was described the syndrome of migraine-like headache occurring due impaired serotonin metabolism in patients with celiac disease. Celiac disease is a chronic polysyndrome disease, enteropathy. Arteriopathies associated with migraine are cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (syndrome CADASIL), retinal vasculopathy with cerebral leukodystrophy (RVCL), hereditary systemic angiopathy (HSA), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS).

  12. 立愈汤治疗偏头痛临床观察%Clinical observation of Liyu decoction in the treatment of migraine

    Institute of Scientific and Technical Information of China (English)

    秦治国

    2015-01-01

    Objective To observe clinical effect by Liyu decoction in the treatment of migraine. Methods A total of 90 migraine patients were randomly divided into control group and treatment group, with 45 cases in each group. The control group received flunarizine capsule for treatment, and the treatment group received Liyu decoction for modified treatment. Curative effects were compared between the two groups. Results The control group contained 7 cured cases, 14 improved cases, 13 effective cases, and 11 ineffective cases, with the total effective rate as 75.6%. The treatment group contained 12 cured cases, 17 improved cases, 12 effective cases, and 4 ineffective cases, with the total effective rate as 91.1%. The difference of total effective rate between the two groups had statistical significance (P<0.05). Conclusion Liyu decoction provides precise effect in treating migraine, and it is worth clinical promotion.%目的:观察立愈汤治疗偏头痛的临床疗效。方法90例偏头痛患者,随机分为对照组和治疗组,各45例。对照组予以氟桂利嗪胶囊治疗,治疗组予以立愈汤加减治疗,比较两组疗效。结果对照组中痊愈7例,好转14例,有效13例,无效11例,总有效率为75.6%;治疗组中痊愈12例,显效17例,有效12例,无效4例,总有效率为91.1%。两组总有效率比较差异有统计学意义(P<0.05)。结论立愈汤治疗偏头痛效果显著,值得临床推广。

  13. Cerebellar function and ischemic brain lesions in migraine patients from the general population

    NARCIS (Netherlands)

    Koppen, Hille; Boele, Henk-Jan; Palm-Meinders, Inge H; Koutstaal, Bastiaan J; Horlings, Corinne Gc; Koekkoek, Bas K; van der Geest, Jos; Smit, Albertine E; van Buchem, Mark A; Launer, Lenore J; Terwindt, Gisela M; Bloem, Bas R; Kruit, Mark C; Ferrari, Michel D; De Zeeuw, Chris I

    2017-01-01

    Objective The objective of this article is to obtain detailed quantitative assessment of cerebellar function and structure in unselected migraine patients and controls from the general population. Methods A total of 282 clinically well-defined participants (migraine with aura n = 111; migraine witho

  14. Cerebellar function and ischemic brain lesions in migraine patients from the general population

    NARCIS (Netherlands)

    Koppen, H.; Boele, H.J.; Palm-Meinders, I.H.; Koutstaal, B.J.; Horlings, G.C.; Koekkoek, B.K.; Geest, J. van; Smit, A.E.; Buchem, M.A. van; Launer, L.J.; Terwindt, G.M.; Bloem, B.R.; Kruit, M.C.; Ferrari, M.D.; Zeeuw, C.I. De

    2017-01-01

    Objective The objective of this article is to obtain detailed quantitative assessment of cerebellar function and structure in unselected migraine patients and controls from the general population. Methods A total of 282 clinically well-defined participants (migraine with aura n = 111; migraine witho

  15. 偏头痛从肝风瘀论治的理论探析及临床应用%Theoretical analysis and clinical application of migraine treatment from the liver, the wind and blood stasis

    Institute of Scientific and Technical Information of China (English)

    付彩红; 邹忆怀

    2016-01-01

    Objective] To discuss the theoretical basis of migraine treatment from the liver, the wind and blood stasis, and summarize the clinical application for providing thoughts for clinical prevention and treatment of migraine. [Methods] From the perspective of etiology and pathogenesis of traditional Chinese medicine, the present review emphasizes on the theoretical basis of migraine treatment from the liver, the wind and blood stasis. Then the composition and therapeutic feature of some effective prescriptions commonly used in clinic will be summarized. [Results] The study provides some evidence and traditional Chinese prescriptions for migraine treatment from the liver, the wind and blood stasis. [Conclusion] The attack of migraine is closely related to the liver, wind and blood stasis, and these treatments have satisfactory clinical effect in prevention and treatment of migraine. Nevertheless, the evaluation criterion of curative effect and the research of modern mechanism in migraine is needed further exploration.%[目的]讨论偏头痛从肝风瘀论治的理论依据,并对其临床应用情况予以概述,为临床防治偏头痛提供指导思路。[方法]从病因病机学角度,结合偏头痛的发病特点,重点介绍偏头痛从肝、从风、从瘀论治的理论依据,并对临床常用的有效方剂的组成和临床疗效特点进行了总结。[结果]为临床从“肝、风、瘀”论治偏头痛提供了理论依据和部分代表方剂。[结论]偏头痛治疗多“从肝风瘀论治”,疗效较佳,但关于偏头痛疗效评价标准的规范和现代机制的研究仍需要不断探索。

  16. New drugs for migraine

    OpenAIRE

    Stovner, Lars Jacob; Tronvik, Erling; Hagen, Knut

    2009-01-01

    After the triptans, a calcitonin gene-related peptide blocker (telcagepant) is the first acute medicine that has been developed primarily for treatment of acute migraine. Otherwise, the new drugs have been developed first for other purposes, like anticonvulsants, antihypertensives and antidepressants used for migraine prophylaxis. For acute attacks, a new way to administer a traditional drug like dihydroergotamine is under way, and documentation of efficacy in migraine has been gained for som...

  17. Calcium channels and migraine.

    Science.gov (United States)

    Pietrobon, Daniela

    2013-07-01

    Missense mutations in CACNA1A, the gene that encodes the pore-forming α1 subunit of human voltage-gated Ca(V)2.1 (P/Q-type) calcium channels, cause a rare form of migraine with aura (familial hemiplegic migraine type 1: FHM1). Migraine is a common disabling brain disorder whose key manifestations are recurrent attacks of unilateral headache that may be preceded by transient neurological aura symptoms. This review, first, briefly summarizes current understanding of the pathophysiological mechanisms that are believed to underlie migraine headache, migraine aura and the onset of a migraine attack, and briefly describes the localization and function of neuronal Ca(V)2.1 channels in the brain regions that have been implicated in migraine pathogenesis. Then, the review describes and discusses i) the functional consequences of FHM1 mutations on the biophysical properties of recombinant human Ca(V)2.1 channels and native Ca(V)2.1 channels in neurons of knockin mouse models carrying the mild R192Q or severe S218L mutations in the orthologous gene, and ii) the functional consequences of these mutations on neurophysiological processes in the cerebral cortex and trigeminovascular system thought to be involved in the pathophysiology of migraine, and the insights into migraine mechanisms obtained from the functional analysis of these processes in FHM1 knockin mice. This article is part of a Special Issue entitled: Calcium channels. Copyright © 2012 Elsevier B.V. All rights reserved.

  18. Migraine in women.

    Science.gov (United States)

    Lay, Christine L; Broner, Susan W

    2009-05-01

    Of the nearly 32 million Americans with migraine, 24 million are women. It is a disorder affecting women throughout their lifetimes, from childhood and puberty through the postmenopausal years. In childhood, before puberty girls are afflicted with migraine at approximately the same rate as boys, but after puberty, there is an emerging female predominance. Estrogen plays a key role in this epidemiologic variation but is not the only factor. There are numerous times when hormonal influences have an impact on migraine and its pattern, including menarche, oral contraceptive use, pregnancy, perimenopause, and menopause. Hence practitioners treating women with migraine need to have a clear understanding of these special considerations.

  19. Acupoint Injection of Onabotulinumtoxin A for Migraines

    Directory of Open Access Journals (Sweden)

    Min Hou

    2015-10-01

    Full Text Available Onabotulinumtoxin A (BoNTA has been reported to be effective in the therapy for migraines. Acupuncture has been used worldwide for the treatment of migraine attacks. Injection of a small amount of drug at acupuncture points is an innovation as compared to traditional acupuncture. The purpose of this study was to evaluate and compare the effectiveness of fixed (muscle-site and acupoint-site injections of BoNTA for migraine therapy in a randomized, double-blinded, placebo-controlled clinical trial extending over four months. Subjects with both episodic and chronic migraines respectively received a placebo (n = 19 or BoNTA (2.5 U each site, 25 U per subject injection at fixed-sites (n = 41 including occipitofrontalis, corrugator supercilii, temporalis and trapeziue, or at acupoint-sites (n = 42 including Yintang (EX-HN3, Taiyang (EX-HN5, Baihui (GV20, Shuaigu (GB8, Fengchi (GB20 and Tianzhu (BL10. The variations between baseline and BoNTA post-injection for four months were calculated monthly as outcome measures. BoNTA injections at fixed-sites and acupoint-sites significantly reduced the migraine attack frequency, intensity, duration and associated symptoms for four months compared with placebo (p < 0.01. The efficacy of BoNTA for migraines in the acupoint-site group (93% improvement was more significant than that in the fixed-site group (85% improvement (p < 0.01. BoNTA administration for migraines is effective, and at acupoint-sites shows more efficacy than at fixed-sites. Further blinded studies are necessary to establish the efficacy of a low dose toxin (25 U introduced with this methodology in chronic and episodic migraines.

  20. Prophylaxis of Childhood Migraine: Topiramate Versus Propranolol

    Directory of Open Access Journals (Sweden)

    Seyed Hassan TONEKABONI

    2013-01-01

    Full Text Available ObjectiveHeadache is a common disabling neurological disorder and migraine comprises more than half the causes of recurrent headaches in children. Despite extended prevalence of this type of headache there is lack of evidence about best drug treatment for migraine. So we aimed to compare the therapeutic effects of these drugs on childhood migraine.Materials & MethodsIn the current study, a randomized clinical trial consisting of 78 patients according to 2004 International Headache Association criteria were randomly assigned to two groups that matched by age and sex. One of these two groups was treated with Topiramate, while the other was given Propranolol. After one and four months, the efficiency of these treatments was measured in terms of frequency, severity and duration of migraine attacks.ResultsResults obtained from the data collected showed that of these 78 studied patients, 38 patients received Topiramate treatment (group A and the rest (40 patients; group B was treated with Propranolol. The average age of group A was 8.5± 2.9 years and that of group B was 8.3 ± 2.8 years. No significant difference was observed between these two groups in terms of reduction in frequency, severity and duration of migraine attacks.ConclusionResults showed that both treatments had the same efficiency in healing migraine headaches and there was no significant difference between their treating results. However, further studies are needed to examine medical effects of these two medicines.

  1. Migraine and erythrocyte biology: a review.

    Science.gov (United States)

    Lippi, G; Cervellin, G; Mattiuzzi, C

    2014-12-01

    Migraine is a common disabling headache disorder that is conventionally classified according to the presence or absence of aura. The pathogenesis of this disorder entails a complex interplay of neurovascular factors, that trigger reduction of cerebral blood flow followed by reactive vasodilatation. Despite major emphasis has been placed on the investigation of putative biomarkers that could predict response to specific treatments and prophylaxis, less focus has been directed at the association between migraine and erythrocytosis. Erythrocytosis is typically accompanied by hyperviscosity, that is now considered a crucial determinant in the pathogenesis of migraine. The results of some epidemiological investigations are in substantial agreement to confirm the existence of a significant relationship between increased haemoglobin levels and migraine, whereas some case reports have also reported an effective improvement of symptoms after reduction of erythrocyte count by therapeutic venesection. Interesting evidence has recently emerged from the assessment of red blood cell distribution width (RDW), a simple and inexpensive measure of anysocytosis that has been also associated with a variety of ischaemic and thrombotic disorders other than migraine. The aim of this review was to provide an overview of the current clinical and epidemiological evidence linking migraine and erythrocyte biology.

  2. 自拟头痛方治疗偏头痛60例临床观察%Clinical Study of Headache Decoction on Migraine Insufficiency

    Institute of Scientific and Technical Information of China (English)

    何泮; 郑粤文; 廖蔚茜; 李桂云; 阙艳

    2013-01-01

    目的 观察头痛方治疗偏头痛的临床疗效.方法 将60例患者随机分为治疗组与对照组各30例,均予灯盏细辛注射液静滴,治疗组加服头痛方(药用川芎、白芷、防风、细辛、葛根等),对照组加服氟桂利嗪.结果 治疗组总体疗效及平均起效时间与对照组相近,治疗组中气虚血瘀亚组疗效优于对照组,平均起效时间较对照组短.结论 头痛方能有效改善偏头痛患者症状及发作频率.对气虚血瘀证效果更显著.%Alstract:Objective To observe effect of Headache decoction on Migraine insufficiency patients.Methods 60 patients with Migraine insufficiency were randomly divided into 2 groups.30 eases were in the control group.30 cases were in treatment group which was divided into subgroup of Qi Deficiency and Blood Stasis(20cases),and subgroup of Non-Qi Deficiency and Blood Stasis(10 cases).Patients received intravenous dripping with Erigerontis Injection,while those in treatment group took Headache decoction,in control group took flunarizine in addition.The course of treatment of both groups was 4 weeks.Effectiveness and the effect-acting periodwere observed.Results The overall efficacy and average effect-acting period in treatment group were similar to those in control group after treatment.Effectiveness in subgroup of Qi Deficiency and Blood Stasis of treatment group was superior to those of control group,and average effect-acting period was shorter than that of control group.Conclusion Headache decoction can effectively improve clinical symptoms of Migraine,especially on the patients of Qi Deficiency and Blood Stasis.

  3. On the methodology of drug trials in migraine with aura

    DEFF Research Database (Denmark)

    Hauge, Anne Werner; Hougaard, Anders; Olesen, Jes

    2010-01-01

    INTRODUCTION: Specific problems occur in clinical treatment trials for migraine with aura that differ from those encountered in treatment trials for migraine without aura. DISCUSSION: Based on our experience with four such trials, we point to a number of possible solutions and outline areas...

  4. Migraine and obesity: metabolic parameters and response to a weight loss programme.

    Science.gov (United States)

    Verrotti, A; Carotenuto, M; Altieri, L; Parisi, P; Tozzi, E; Belcastro, V; Esposito, M; Guastaferro, N; Ciuti, A; Mohn, A; Chiarelli, F; Agostinelli, S

    2015-06-01

    Weight loss can determine significant improvement of migraine in obese patients. Herein, we evaluated a clinical sample of adolescent migraineurs with obesity who participated in an interdisciplinary programme for weight loss, in order to identify possible metabolic parameters associated with good migraine control. Using a cross-sectional design, we evaluated 112 out of 135 adolescents who previously underwent our intervention programme. Based on persistence of headache, subjects for comparison were 40 migraine-free and 72 not migraine-free adolescents. Participants underwent anthropometric evaluations and biochemical tests. Patients with persistence of migraine had significantly higher weight (P weight loss, patients who did not become migraine-free showed higher adiposity values than those who became migraine-free. Patients with insulin resistance had 3.5 times the odds of having persistence of migraine compared with those without. © 2014 The Authors. Pediatric Obesity © 2014 World Obesity.

  5. Gastrointestinal disorders associated with migraine: A comprehensive review

    Science.gov (United States)

    Cámara-Lemarroy, Carlos R; Rodriguez-Gutierrez, Rene; Monreal-Robles, Roberto; Marfil-Rivera, Alejandro

    2016-01-01

    Migraine is a recurrent and commonly disabling primary headache disorder that affects over 17% of women and 5%-8% of men. Migraine susceptibility is multifactorial with genetic, hormonal and environmental factors all playing an important role. The physiopathology of migraine is complex and still not fully understood. Many different neuropeptides, neurotransmitters and brain pathways have been implicated. In connection with the myriad mechanisms and pathways implicated in migraine, a variety of multisystemic comorbidities (e.g., cardiovascular, psychiatric and other neurological conditions) have been found to be closely associated with migraine. Recent reports demonstrate an increased frequency of gastrointestinal (GI) disorders in patients with migraine compared with the general population. Helicobacter pylori infection, irritable bowel syndrome, gastroparesis, hepatobiliary disorders, celiac disease and alterations in the microbiota have been linked to the occurrence of migraine. Several mechanisms involving the gut-brain axis, such as a chronic inflammatory response with inflammatory and vasoactive mediators passing to the circulatory system, intestinal microbiota modulation of the enteric immunological milieu and dysfunction of the autonomic and enteric nervous system, have been postulated to explain these associations. However, the precise mechanisms and pathways related to the gut-brain axis in migraine need to be fully elucidated. In this review, we survey the available literature linking migraine with GI disorders. We discuss the possible physiopathological mechanisms, and clinical implications as well as several future areas of interest for research. PMID:27688656

  6. Suicidal ideation and risk factors in Korean migraine patients.

    Science.gov (United States)

    Kim, Sun-Young; Park, Sung-Pa

    2014-10-01

    Population-based studies have reported an increased risk of suicidal ideation in patients with migraine. However, there is some controversy as to whether migraine itself is a risk factor for suicidal ideation after adjusting for psychiatric comorbidities. We calculated the frequency of suicidal ideation among patients with migraine visiting a tertiary care hospital and determined its risk factors. Patients with migraine and healthy controls completed self-report questionnaires to assess depression, anxiety, and suicidal ideation, and the frequency of suicidal ideation. Risk factors for suicidal ideation were investigated in terms of demographic, clinical, and psychiatric variables. One hundred eighty-five patients with migraine (156 females and 29 males; mean age 39.1 years) and 53 age and education-matched healthy controls participated in the study. The frequency of suicidal ideation was significantly greater in patients with migraine than healthy controls (odds ratio [OR]=5.09, 95% confidence interval [CI] 1.17-22.10, p=0.003), but this significance was not sustained after adjusting for comorbid depression and anxiety. The risk of suicidal ideation in patients with migraine was associated with lower education levels, higher frequency of migraine attacks, stronger intensity of headaches, and presence of phonophobia, chronic migraine, depression, and anxiety. The strongest predictor was depression (OR=15.36, 95% CI 5.39-43.78, psuicidal ideation is trivial compared to that of depression and headache intensity.

  7. Gastrointestinal disorders associated with migraine: A comprehensive review.

    Science.gov (United States)

    Cámara-Lemarroy, Carlos R; Rodriguez-Gutierrez, Rene; Monreal-Robles, Roberto; Marfil-Rivera, Alejandro

    2016-09-28

    Migraine is a recurrent and commonly disabling primary headache disorder that affects over 17% of women and 5%-8% of men. Migraine susceptibility is multifactorial with genetic, hormonal and environmental factors all playing an important role. The physiopathology of migraine is complex and still not fully understood. Many different neuropeptides, neurotransmitters and brain pathways have been implicated. In connection with the myriad mechanisms and pathways implicated in migraine, a variety of multisystemic comorbidities (e.g., cardiovascular, psychiatric and other neurological conditions) have been found to be closely associated with migraine. Recent reports demonstrate an increased frequency of gastrointestinal (GI) disorders in patients with migraine compared with the general population. Helicobacter pylori infection, irritable bowel syndrome, gastroparesis, hepatobiliary disorders, celiac disease and alterations in the microbiota have been linked to the occurrence of migraine. Several mechanisms involving the gut-brain axis, such as a chronic inflammatory response with inflammatory and vasoactive mediators passing to the circulatory system, intestinal microbiota modulation of the enteric immunological milieu and dysfunction of the autonomic and enteric nervous system, have been postulated to explain these associations. However, the precise mechanisms and pathways related to the gut-brain axis in migraine need to be fully elucidated. In this review, we survey the available literature linking migraine with GI disorders. We discuss the possible physiopathological mechanisms, and clinical implications as well as several future areas of interest for research.

  8. Pharmacological migraine provocation: a human model of migraine

    DEFF Research Database (Denmark)

    Ashina, Messoud; Hansen, Jakob Møller

    2010-01-01

    for migraine mechanisms. So far, however, animal models cannot predict the efficacy of new therapies for migraine. Because migraine attacks are fully reversible and can be aborted by therapy, the headache- or migraine-provoking property of naturally occurring signaling molecules can be tested in a human model....... If a naturally occurring substance can provoke migraine in human patients, then it is likely, although not certain, that blocking its effect will be effective in the treatment of acute migraine attacks. To this end, a human in vivo model of experimental headache and migraine in humans has been developed...

  9. Clinical features of 36 cases of epilepsy combined with migraine%癫痫并发偏头痛患者36例临床特点分析

    Institute of Scientific and Technical Information of China (English)

    王明华

    2012-01-01

    Objective To analyze the clinical features of epilepsy patients with or without migraine. Methods We analyzed 190 epilepsy inpatients and outpatients from Oct 2009 to Mar 2011,including 154 cases without migraine and 36 cases with migraine, and compared the clinical features of patients in the two groups. Results Differences were significant between the two groups in the proportion of female, incidence of epilepsy and the average disease course of epilepsy (P 0.05). Conclusions There is a relation and interaction between epilepsy and migraine. Migraine might aggravate the epilepsy and have a negative effect on the prognosis of epilepsy.%目的 分析癫痫合并偏头痛患者和单纯癫痫患者的临床特点.方法 2009年10月至2011年3月我院神经内科住院及门诊诊断为癫痫以及癫痫合并偏头痛的患者190例,其中单纯癫痫患者(E组)154例,偏头痛合并癫痫患者(EM组)36例.比较两组患者的临床特点.结果 EM组女性比例、癫痫发作频率、平均癫痫病程与E组比较,差异均有统计学意义(P0.05).结论 癫痫与偏头痛可能存在相互联系及作用,偏头痛可能加重癫痫疾病严重程度,给癫痫治疗带来负面效果.

  10. Women's experiences with medication for menstrual regulation in Bangladesh.

    Science.gov (United States)

    Marlow, Heather M; Biswas, Kamal; Griffin, Risa; Menzel, Jamie

    2016-01-01

    Menstrual regulation has been legal in Bangladesh since 1974, but the use of medication for menstrual regulation is new. In this study, we sought to understand women's experiences using medication for menstrual regulation in Bangladesh. We conducted 20 in-depth interviews with rural and urban women between December 2013 and February 2014. All interviews were audiotaped, transcribed, translated, computer recorded and coded for analysis. The majority of women in our study had had positive experiences with medication for menstrual regulation and successful outcomes, regardless of whether they obtained their medication from medicine sellers/pharmacies, doctors or clinics. Women were strongly influenced by health providers when deciding which method to use. There is a need to educate not only women of reproductive age, but also communities as a whole, about medication for menstrual regulation, with a particular emphasis on cost and branding the medication. Continued efforts to improve counselling by providers about the dose, medication and side-effects of medication for menstrual regulation, along with education of the community about medication as an option for menstrual regulation, will help to de-stigmatise the procedure and the women who seek it.

  11. Menstrual cycle effects on psychological symptoms in women with PTSD.

    Science.gov (United States)

    Nillni, Yael I; Pineles, Suzanne L; Patton, Samantha C; Rouse, Matthew H; Sawyer, Alice T; Rasmusson, Ann M

    2015-02-01

    The menstrual cycle has been implicated as a sex-specific biological process influencing psychological symptoms across a variety of disorders. Limited research exists regarding the role of the menstrual cycle in psychological symptoms among women with posttraumatic stress disorder (PTSD). The current study examined the severity of a broad range of psychological symptoms in both the early follicular (Days 2-6) and midluteal (6-10 days postlutenizing hormone surge) phases of the menstrual cycle in a sample of trauma-exposed women with and without PTSD (N = 49). In the sample overall, total psychological symptoms (d = 0.63), as well as depression (d = 0.81) and phobic anxiety (d = 0.81) symptoms, specifically, were increased in the early follicular compared to midluteal phase. The impact of menstrual cycle phase on phobic anxiety was modified by a significant PTSD × Menstrual Phase interaction (d = 0.63). Women with PTSD reported more severe phobic anxiety during the early follicular versus midluteal phase, whereas phobic anxiety did not differ across the menstrual cycle in women without PTSD. Thus, the menstrual cycle appears to impact fear-related symptoms in women with PTSD. The clinical implications of the findings and future research directions are discussed.

  12. Hiccups as a migraine aura.

    Science.gov (United States)

    Chaudhry, Priyanka; Friedman, Deborah I

    2015-08-01

    To report a case series of hiccup as a migraine aura. Hiccup is a syndrome of inappropriate muscle contraction. To our knowledge, hiccup as a migraine aura has not been reported. We describe series of patients who presented with hiccups as their migraine aura symptom. Hiccups can present as a primary aura symptom in patients with migraine. © International Headache Society 2014.

  13. Pathophysiology of migraine

    Directory of Open Access Journals (Sweden)

    Peter J Goadsby

    2012-01-01

    Full Text Available Migraine is a common disabling brain disorder whose pathophysiology is now being better understood. The study of anatomy and physiology of pain producing structures in the cranium and the central nervous system modulation of the input have led to the conclusion that migraine involves alterations in the sub-cortical aminergic sensory modulatory systems that influence the brain widely.

  14. Patients' preference in migraine

    NARCIS (Netherlands)

    Dekker, François (Frans)

    2014-01-01

    This thesis is about migraine. Three elements are discussed. First element is preventive treatment, second element is attack treatment and the third part focuses on medication overuse headache. The preventive treatment of migraine is a valuable intervention in primary care. If preventive treatment i

  15. Migraine Infarction. Case Report

    Directory of Open Access Journals (Sweden)

    Yoany Mesa Barrera

    2015-03-01

    Full Text Available Migraine is considered like a risk factor for ischemic ictus in adult young people. In spite of the criteria established for the treatment of the migraine infarct, they are not always fulfilled strictly, permitting certain flexibility in the aforementioned treatment. The case of a patient with a background of migraine with auras, who suffers an ischemic cerebral migraine infarct at the course of a migraine crisis, is presented. The ictus was manifested like an especial right hemiparesis of the female sex in fertile age. The prognosis is good with low risk of recurrence, with unstable disorders and dysarthria. The laboratories studies were normal and the cerebral infarct was detected in the magnetic resonance, at the half left cerebral artery's territory. The patient had favorable evolution without sequel.

  16. Metabolic syndrome and migraine

    Directory of Open Access Journals (Sweden)

    Amit eSachdev

    2012-11-01

    Full Text Available Migraine and metabolic syndrome are highly prevaleirnt and costly conditions.The two conditions coexist, but it is unclear what relationship may exist between the two processes. Metabolic syndrome involves a number of findings, including insulin resistance, systemic hypertension, obesity, a proinflammatory state, and a prothrombotic state. Only one study addresses migraine in metabolic syndrome, finding significant differences in the presentation of metabolic syndrome in migraineurs. However, controversy exists regarding the contribution of each individual risk factor to migraine pathogensis and prevalence. It is unclear what treatment implications, if any, exist as a result of the concomitant diagnosis of migraine and metabolic syndrome. The cornerstone of migraine and metabolic syndrome treatments is prevention, relying heavily on diet modification, sleep hygiene, medication use, and exercise.

  17. [Unusual Migraine Manifestations].

    Science.gov (United States)

    Schipper, Sivan; Gantenbein, Andreas R; Sandor, Peter S

    2016-06-01

    Migraine is a complex neurologic disorder by which several systems of the central nervous system (autonomous system, affective, cognitive, sensoric and motoric system) may be affected on different levels. Around a fourth of the patients have migraine aura. The most common aura is the visual aura, followed by sensoric aura. But motoric deficits as well as deficits of higher cortical centers (disorders of thinking, orientation, coherence or concentration) may occur as well. In analogy with a headache calendar, an aura calendar can deliver important help in the diagnostic process of rare migraine manifestations and prevent underdiagnosis of unusual migraine manifestations. Complex migraine manifestations are diagnoses of exlusion, and a broad diagnostic work-up is warranted in order to exclude dangerous neurologic pathologies. There are no specific therapeutic recommendations, as there is a lack of randomized controlled studies.

  18. Migraine and cardiovascular disease

    Directory of Open Access Journals (Sweden)

    Marcelo E. Bigal

    2011-02-01

    Full Text Available Migraine, especially migraine with aura is an established risk factor for ischemic lesions of the brain. Recent evidence has also linked migraine with and without aura to a broader range of ischemic vascular disorders including angina, myocardial infarction, coronary revascularization, claudication and cardiovascular mortality. The topic is therefore of considerable interest. Accordingly, herein we review the association between migraine and cardiovascular disease. We start by briefly presenting diagnostic criteria for migraine and revising its pathophysiology. We follow by summarizing the evidence on the topic. We then briefly present the results of a recent meta-analysis. We close by highlighting results of a large epidemiological study conducted after the publication of the meta-analysis.

  19. Understanding migraine: Potential role of neurogenic inflammation

    Directory of Open Access Journals (Sweden)

    Rakesh Malhotra

    2016-01-01

    Full Text Available Neurogenic inflammation, a well-defined pathophysiologial process is characterized by the release of potent vasoactive neuropeptides, predominantly calcitonin gene-related peptide (CGRP, substance P (SP, and neurokinin A from activated peripheral nociceptive sensory nerve terminals (usually C and A delta-fibers. These peptides lead to a cascade of inflammatory tissue responses including arteriolar vasodilation, plasma protein extravasation, and degranulation of mast cells in their peripheral target tissue. Neurogenic inflammatory processes have long been implicated as a possible mechanism involved in the pathophysiology of various human diseases of the nervous system, respiratory system, gastrointestinal tract, urogenital tract, and skin. The recent development of several innovative experimental migraine models has provided evidence suggestive of the involvement of neuropeptides (SP, neurokinin A, and CGRP in migraine headache. Antidromic stimulation of nociceptive fibers of the trigeminal nerve resulted in a neurogenic inflammatory response with marked increase in plasma protein extravasation from dural blood vessels by the release of various sensory neuropeptides. Several clinically effective abortive antimigraine medications, such as ergots and triptans, have been shown to attenuate the release of neuropeptide and neurogenic plasma protein extravasation. These findings provide support for the validity of using animal models to investigate mechanisms of neurogenic inflammation in migraine. These also further strengthen the notion of migraine being a neuroinflammatory disease. In the clinical context, there is a paucity of knowledge and awareness among physicians regarding the role of neurogenic inflammation in migraine. Improved understanding of the molecular biology, pharmacology, and pathophysiology of neurogenic inflammation may provide the practitioner the context-specific feedback to identify the novel and most effective therapeutic

  20. Clinical Comparative Analysis of Tongxinluo and Flunarizine Treatment of Migraine%通心络胶囊与盐酸氟桂嗪治疗偏头痛的临床对比分析

    Institute of Scientific and Technical Information of China (English)

    石昌成

    2015-01-01

    Objective Clinical study on the therapeutic effect of Tongxinluo capsule and flunarizine in treatment of migraine. Methods Select between September 2012-May 2014 in our hospital treated 288 cases of migraine patients were randomly divided into two groups and the control group, 144 cases of patients in each group. Observed in patients taking Tongxinluo treatment;con-trol group of patients taking fluoride flunarizine hydrochloride capsules. Comparative effects of treatment, after treatment. Results Observation group migraine patients before treatment score for (17.61±1.32), (6.14±2.11) score after treatment; migraine patients in the control group before the score was (16.94±1.59), after treatment score was (10.51±3.12), two groups of migraine patients have significant data difference (P0.05) after receiving therapeutic effect, but the size of the observation group control rate and effective rate than the control group, and the difference was significant (P0.05),但观察组控制率明显优于对照组,且差异有统计学意义(P<0.05)。结论通心络胶囊与盐酸氟桂嗪对偏头痛患者均有着较好的治疗效果,但通心络胶囊综合方面优势明显,患者控显率较高,治疗后评分优于盐酸氟桂嗪。

  1. Bian Zheng Lun Zhi as a Complementary and Alternative Treatment for Menstrual Cramps in Women with Dysmenorrhea: A Prospective Clinical Observation

    Directory of Open Access Journals (Sweden)

    Pin-Yi Lin

    2014-01-01

    Full Text Available Background. Limited scientific evidence supports the positive effects of traditional Chinese medicine (TCM for treating dysmenorrhea. Thus, an observation period of 3 months could verify the ancient indication that TCM treatments effectively alleviate menstrual cramps in women with primary dysmenorrhea or endometriosis. Methods. A prospective, nonrandomized study (primary dysmenorrhea and endometriosis groups was conducted in women with dysmenorrhea for more than three consecutive menstrual cycles. All patients received TCM prescriptions based on bian zheng lun zhi theory 14 days before menstruation for a period of 12 weeks. Pain intensity was evaluated using a 10-cm visual analogue scale and two validated questionnaires (the Menstrual Distress Questionnaire and the World Health Organization Quality of Life questionnaire. Results. Of the initial 70 intent-to-treat participants, the women with dysmenorrhea reported significant alleviation of cramps during menstruation after the 12-week TCM treatment. Mixed model analysis revealed that TCM prescriptions were more effective in alleviating fatigue, hot flashes, dizziness, painful breasts, excitement, and irritability in the primary dysmenorrhea group (N=36 than in the endometriosis group (N=34. Conclusion. TCM prescriptions based on syndrome differentiation theory might be a potentially viable choice for treating painful menstruation and premenstrual symptoms after ruling out endometriosis.

  2. Frequency of Migraine as a Chief Complaint in Otolaryngology Outpatient Practice

    Science.gov (United States)

    Muhammad Ali, Maria; Al Zayer, Maha

    2015-01-01

    Objective. To identify the frequency of typical (headache and dizziness) and common atypical (ear fullness, pressure, pain, tinnitus, facial fullness, and nasal congestion) migraine symptoms as chief complaints among patients presenting to otolaryngology clinic. Methods. This is a descriptive study of prospectively collected data from a general otolaryngology practice. Typical migraine presentations were diagnosed by applying international headache society (IHS) criteria for migraine headache and Neuhauser's criteria for migrainous vertigo. Atypical otologic and rhinologic migraine symptoms were diagnosed using individualized criteria. Charts were reviewed at 6-month interval from the first presentation. Results. Out of 1002 consecutive patients, 10.8% presented with “migrainous chief complaint.” All migrainous chief complaint patients had a history of headache but not all of them presented with headache. Corrected female to male ratio in the migraine group was 3 to 1; age distributions were significantly different between the migraine and nonmigraine groups by applying t-test. Out of the atypical complaints, 86% of the patients had a history of concomitant typical presentation. Conclusion. Actual diagnostic criteria for migraine do not satisfy the diversity of its presentation. Investigating the history of migraine is enough to diagnose most atypical presentations. Sound knowledge about migraine seems essential for any ENT practitioner. PMID:25695049

  3. Migraine education brochures and patient-perceived satisfaction.

    Science.gov (United States)

    Medrano Martínez, V; Callejo-Domínguez, J M; Beltrán-Lasco, I; Pérez-Carmona, N; Abellán-Miralles, I; González-Caballero, G; Más-Sesé, G; López-Hernández, N; Pérez-Sempere, A; Moltó-Jordá, J M

    2015-10-01

    Brochures are commonly used as educational tools in daily neurological practice. They are provided to increase the general population's knowledge of a specific disease and also to combat sources of erroneous information. Surveys are the most commonly used method of ascertaining user satisfaction with services received. This study will assess patient-perceived satisfaction and provide feedback to measure the comprehensibility and overall utility of an educational brochure on migraine. Open prospective multicentre study of a group of patients diagnosed with migraine in neurology clinics in Alicante province. During the initial visit, each patient received a migraine brochure prepared by the Valencian Society of Neurology's study group for headaches (CEFALIC). During a follow-up visit, they were then asked to fill out a personal survey on the overall quality of the information in the brochure. We included a total of 257 patients diagnosed with migraine (83% episodic migraine; 17% chronic migraine); mean age was 37.6 years. Two hundred seven patients confirmed having read the brochure (80.5%); 50 patients (19.5%) either forgot to read it or had no interest in doing so. The brochure seemed interesting and easy to understand according to 90% of the patients. Seventy-six per cent of the respondents stated that reading the brochure increased their overall knowledge of migraine, while 50% of the patients found the brochure useful for improving migraine control. Patients found the migraine educational brochure to be comprehensible, a means of increasing overall knowledge of the disease, and useful for increasing control over migraines. Evaluations of the educational brochures that we provide to our patients with migraine should be studied to discover the causes of dissatisfaction, determine the level of quality of service, and investigate potential areas for improvement. Copyright © 2014 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. All rights

  4. Behavioural management of migraine

    Directory of Open Access Journals (Sweden)

    Helen Brown

    2012-01-01

    Full Text Available It is important to recognise that migraine is a ′biological′ and not a ′psychological′ entity. However, psychological factors can be involved in migraine in 4 different ways:- 1 Migraines can be triggered by psychological stressors; 2 Severe migraine can itself be a cause of significant psychological stress which can, in turn, exacerbate the problem; 3 Even if psychological stress is not significantly involved in the genesis of the headache, pain management techniques can help people cope with their pain more effectively; 4 Longitudinal data demonstrate a complex bidirectional association between mood disorders and migraine. Treatment of a co-existing mood disorder, for example with cognitive behavioural techniques, may therefore reduce the impact of migraine. It would thus appear logical to view medical and psychological approaches as potentially synergistic rather than mutually exclusive. Functional imaging indicates that cognition, emotions, and pain experiences change the way the brain processes pain inputs. This may provide a physiological rationale for psychological interventions in pain management. As most studies of psychological management of migraine have been relatively small and the approach often varies between clinicians, the magnitude of benefit, optimum method of delivery, and the length of intervention are uncertain.

  5. Migraine genetics: Part II.

    Science.gov (United States)

    Silberstein, Stephen D; Dodick, David W

    2013-09-01

    Migraine clusters in families and is considered to be a strongly heritable disorder. Hemiplegic migraine is a rare subtype of migraine with aura that may occur as a familial or a sporadic condition. Three genes have been identified studying families with familial hemiplegic migraine (FHM). The first FHM gene that was identified is CACNA1A. A second gene, FHM2, has been mapped to chromosome 1 q 21-23. The defect is a new mutation in the α2 subunit of the Na/K pump (ATP1A2). A third gene (FHM3) has been linked to chromosome 2q24. It is due to a missense mutation in gene SCN1A (Gln1489Lys), which encodes an α1 subunit of a neuronal voltage-gated Na+ channel. Genome-wide association studies have identified many non-coding variants associated with common diseases and traits, like migraine. These variants are concentrated in regulatory DNA marked by deoxyribonuclease I hypersensitive sites. A role has been suggested for the two-pore domain potassium channel, TWIK-related spinal cord potassium channel. TWIK-related spinal cord potassium channel is involved in migraine by screening the KCNK18 gene in subjects diagnosed with migraine. © 2013 Oxford University Press Headache: The Journal of Head and Face Pain © 2013 American Headache Society.

  6. [Sporadic hemiplegic migraine in a 14-year-old boy--a case report].

    Science.gov (United States)

    Lemka, Małgorzata; Pilarska, Ewa; Szmuda, Marta; Pienczk-Recławowicz, Karolina

    2009-01-01

    Hemiplegic migraine is a specific form of migraine with aura including hemiparesis. It is a rare condition of unclear aetiology. The authors present a case of a 14-year-old boy with persistent foramen ovale, suffering from sporadic hemiplegic migraine. The authors broadly describe the symptoms and types of hemiplegic migraine as well as underlining diagnostic and therapeutic difficulties of the attacks. The patient suffered from recurrent severe headaches, vomiting and co-existing focal neurological symptoms, including alternant hemiparesis. On the basis of the history, thorough clinical observation and numerous accessory investigations a diagnosis of sporadic hemiplegic migraine was established. However, the last attack, with prolonged neurological deficits, was treated as a complication of migraine and defined as persistent aura without infarction. The authors also broadly discuss a differential diagnosis, including other stroke-like incidents, vascular diseases, immunological and mitochondrial disorders that mimic the symptoms and clinical course of sporadic hemiplegic migraine.

  7. A genome-wide linkage study of bipolar disorder and co-morbid migraine

    DEFF Research Database (Denmark)

    Oedegaard, K. J.; Greenwood, T. A.; Lunde, Asger

    2010-01-01

    Migraine and Bipolar Disorder (BPAD) are clinically heterogeneous disorders of the brain with a significant, but complex, genetic component. Epidemiological and clinical studies have demonstrated a high degree of co-morbidity between migraine and BPAD. Several genomewide linkage studies in BPAD...... that using migraine comorbidity to look at subsets of BPAD families in a genetic linkage analysis would prove useful in identifying genetic susceptibility regions in both of these disorders. We used BPAD with comorbid migraine as an alternative phenotype definition in a re-analysis of the NIMH Bipolar...... osome 4 (not co-segregating with BPAD) in a sample of BPAD families with comorbid migraine, and suggest a susceptibility locus on chromosome 20, harboring a gene for the migraine/BPAD phenotype. Together these data suggest that some genes may predispose to both bipolar disorder and migraine....

  8. Clinical Study onToutongning Formula in Treatment of Migraine%头痛宁方治疗偏头痛临床研究

    Institute of Scientific and Technical Information of China (English)

    任珊; 陈志刚

    2016-01-01

    Objective To observe the clinical efficacy ofToutongning Formula in the treatment of migraine. Methods Totally 100 cases of migraine patients (wind disturbance, blood stasis syndrome) were randomly divided into two groups. Patients in the experimental group were treated withToutongning Formula orally, and patients in the control group were treated with flunarizine capsules 5 mg orally, for 30 d. The scores of number, degree, duration and accompanying symptoms of episodes before and after treatment were observed, the total scores were calculated, and adverse reactions were recorded, to evaluate the clinical efficacy and safety.Results Clinical total efficiency was 92.0% (46/50) in experimental group and 64.0% (32/50) in the control group; the incidence rate of adverse reactions was 20.0% (10/50) in experimental group and 80.0% (40/50) in the control group; there was statistical significant differences in efficacy and adverse reactions between the two groups (P<0.05). After the treatment, the differences in the scores of number, degree, duration and accompanying symptoms of episodes, and in the total scores between the two groups was statistically significant (P<0.05). There was statistical significance in the different value of above indexes before and after treatment between the two groups (P<0.05).ConclusionToutongning Formula can not only improve symptoms significantly in patients with migraine (wind disturbance, blood stasis syndrome), but also reduce adverse reactions, with more safety and efficacy than flunarizine capsules.%目的:观察头痛宁方治疗偏头痛的临床疗效。方法将100例偏头痛风邪上扰、瘀血阻络证患者随机分为试验组和对照组各50例。试验组予头痛宁方口服,对照组予氟桂利嗪胶囊5 mg口服,疗程30 d。观察2组患者治疗前后偏头痛发作次数、程度、持续时间、伴随症状分值及总分,记录药物不良反应,评价临床疗效及安全性。结

  9. Treatment in chronic migraine: choice of reabilitation strategies

    Directory of Open Access Journals (Sweden)

    Ioana STANESCU

    2015-12-01

    Full Text Available Migraine is a disabling neurologic condition with a spontaneous clinical evolution into a chronic form. Migraine progression from an episodic into a chronic form is realized through a period of time involving several months or years, during which an increase attack frequency occurs. .According to the International Classification of Headache Disorders (ICHD-3 chronic migraine is a type of primary headache occurring on 15 or more days per month for more than 3 months, in which more than 8 days per month headache meet criteria for migraine with or without aura or respond to specific migraine treatment. The prevalence of chronic migraine is estimated between 1- 3% of general population. Persons with chronic migraine are more likely to suffer from severe disability; chronic migraine has an important socio-economic impact. Diagnostic approach in chronic migraine includes exclusion of a secondary headache disorder and confirmation of a primary episodic headache. When a patient is found to overuse pain medication, diagnosis of both chronic migraine and MOH should be considered. Treating episodic migraine early and managing attack frequency using preventive medication and behavioural interventions will be benefic in reducing the risk of chronicisation. Lifestyle changes are important for avoiding triggers for migraine attacks; treatment of comorbidities is equally important because these conditions exacerbate patient’s tendency to have headaches. The initial relief step for drug abusers always relies in drug withdrawal. For migraine attacks treatment begins with non-pharmacologic interventions (staying in a quiet, dark room, pressure on painful areas, applying cold compresses , simple OTC analgetics (NSAIDs, paracetamol, aspirin, acetaminophen. If these are not effective, triptans are the drugs of choice. Preventive treatment is always recommended in patients with chronic migraine because the high frequency of headache attacks. Treatment should be

  10. Human migraine models

    DEFF Research Database (Denmark)

    Iversen, Helle Klingenberg

    2001-01-01

    The need for experimental models is obvious. In animal models it is possible to study vascular responses, neurogenic inflammation, c-fos expression etc. However, the pathophysiology of migraine remains unsolved, why results from animal studies not directly can be related to the migraine attack......, which is a human experience. A set-up for investigations of experimental headache and migraine in humans, has been evaluated and headache mechanisms explored by using nitroglycerin and other headache-inducing agents. Nitric oxide (NO) or other parts of the NO activated cascade seems to be responsible...

  11. Migraine vestibulaire 

    DEFF Research Database (Denmark)

    Lempert, T; Olesen, J; Furman, J

    2014-01-01

    This paper presents diagnostic criteria for vestibular migraine, jointly formulated by the Committee for Classification of Vestibular Disorders of the Bárány Society and the Migraine Classification Subcommittee of the International Headache Society (IHS). The classification includes vestibular mi....... Symptoms that qualify for a diagnosis of vestibular migraine include various types of vertigo as well as head motion-induced dizziness with nausea. Symptoms must be of moderate or severe intensity. Duration of acute episodes is limited to a window of between 5minutes and 72hours....

  12. Fisiopatologia da enxaqueca Migraine pathophysiology

    Directory of Open Access Journals (Sweden)

    MAURICE B. VINCENT

    1998-12-01

    Full Text Available A fisiopatologia da enxaqueca ainda não foi completamente elucidada. As principais estruturas envolvidas parecem ser o sistema nervoso central (córtex e tronco cerebral, o sistema trigeminovascular e os vasos correspondentes, outras fibras autonômicas que inervam estes vasos, e os vários agentes vasoativos locais, como a SP, CGRP, NO, VIP, NPY, ACh, NA, NKA, entre outros. A depressão alastrante é o fenômeno neurológico que provavelmente justifica achados experimenais e clínicos na enxaqueca. Ela tem velocidade de propagação semelhante à aura, ativa o núcleo espinhal do trigêmeo e está relacionada à liberação de CGRP e NO. Alterações circulatórias detectadas por métodos complementares reforçam o papel da depressão alastrante. A identificação de anormalidades em pelo menos três loci (cromossomas 19 e 1 na enxaqueca hemiplégica familiar ocorreu recentemente. Elas estão relacionadas a anormalidades nos canais de cálcio voltagem dependentes tipo P/Q, específicos do sistema nervoso central, que regulam a liberação de vários neurotransmissores, incluindo possivelmente a serotonina. A exemplo de outras anormalidades neurológicas paroxísticas que resultam da hiperexcitabilidade da membrana plasmática, é possível que a enxaqueca ocorra devido a uma desordem de canais iônicos.The pathophysiology of migraine is not yet fully understood. The most important structures involved seem to be the central nervous system (cortex and brain stem, the trigeminovascular system and related cranial arteries, other autonomic fibres innervating such vessels, and various local vasoactive agents, including SP, CGRP, NO, VIP, NPY, ACh, NA, NKA, among others. The spreading depression phenomenon may explain clinical as well experimental findings in migraine. Its propagation velocity mirrors what is found in clinical aura, it may activate the spinal trigeminal nucleus and may induce CGRP and NO release. Circulatory changes detected with

  13. 基于文本挖掘技术的偏头痛临床诊疗规律分析%Analysis of Regularity of Clinical Medication for Migraine with Text Mining Approach

    Institute of Scientific and Technical Information of China (English)

    杨静; 蔡峰; 谭勇; 郑光; 李立; 姜淼; 吕爱平

    2013-01-01

    Objective To analyze the regularity of clinical medication in the treatment of migraine with text mining approach. Methods The data set of migraine was downloaded from Chinese BioMedical Literature Database (CBM). Rules of TCM pattern, symptoms, Chinese herbal medicines (CHM), Chinese patent medicines (CPM) and western medicines on migraine were mined out by data slicing algorithm, the results were demonstrated in both frequency tables and two-dimension based network. Results A total of 7 921 literatures were searched. The main syndrome classification in TCM of migraine included liver-yang hyperactivity syndrome, stagnation of liver qi syndrome and qi deficiency to blood stasis syndrome, et al. The core symptoms of migraine included headache, vomit, nausea, swirl, photophobia, et al. Traditional Chinese medicine for migraine contained Chuanxiong, Tianma, Danshen, Chaihu, Danggui, Baishao and Baizhi, et al. For Chinese patent medicine, Yangxueqingnao granule, Toutongning capsule and Zhengtian pill were used in treating migraine. In western medicine, flunarizine, nimodipine and aspirin were used frequently. For the integrated treatment of TCM and western medicine, the combination of Yangxueqingnao granule and nimodipine was most commonly used. Conclusion Text mining approach provides a novel method in the summary of treatment rules on migraine in both TCM and western medicine. To some' extent, the migraine results from texting mining has significance for clinical practice.%目的 探索偏头痛中西医临床诊疗的规律.方法 应用中国生物医学文献服务系统,收集治疗偏头痛的文献数据,采用基于敏感关键词频数统计的数据分层算法,并结合原文献回溯、人工阅读分析等方法,挖掘有关偏头痛证候、症状、中药、中成药以及西药联用的规律,并通过一维频次表及二维的网络图对结果进行展示.结果 共检索到偏头痛文献7 921篇.文本挖掘结果显示,肝阳上亢、肝气郁

  14. Headaches during pregnancy in women with a prior history of menstrual headaches Cefaléia durante a gestação em mulheres com história de cefaléia menstrual

    Directory of Open Access Journals (Sweden)

    Eliana Melhado

    2005-12-01

    Full Text Available OBJECTIVE: To evaluate the presence of menstrual headaches prior to pregnancy according to the International Headache Society (IHS classification criteria, 2004, and also study the outcome (frequency and intensity of these pre-existing headaches during the gestational trimesters. METHOD: This study involved 1,101 pregnant women (12 to 45 years old. A semi-structured questionnaire was used to interview the women during the first, second and third gestational trimesters as well as after delivery. All the interviews were conducted by one of the researchers by applying the IHS Classification (IHSC-2004. RESULTS: A 1,029 women out of the 1,101 women interviewed presented headaches prior to gestation, which made it possible to study headaches in 993 women during the gestational trimesters. Menstrually related headaches were presented by 360 of the 993 women. Migraine was reported by 332/360 women (92.22% with menstrual headaches and 516/633 women (81.51% without menstrual headaches, respectively, prior to gestation. The majority of the women with menstrual migraine presented a headache improvement or disappearance during gestation (62.22% during the first trimester; 74.17% during the second trimester; 77.78% during the third trimester. CONCLUSION: Most of the pregnant women with menstrual or non-menstrual headaches prior to gestation presented migraine, which either improved or disappeared during pregnancy. Women who suffered from non-menstrual headaches improved during pregnancy but not as much as women with menstrual headaches.OBJETIVO: Avaliar a presença de cefaléia relacionada ao ciclo menstrual, antes da gestação, classificá-las, segundo os critérios da Sociedade Internacional de Cefaleia (SIC de 2004, e estudar o comportamento (freqüência e intensidade dessas cefaléias pré-existentes à gestação durante os trimestres gestacionais. MÉTODO: Foram estudados 1101 mulheres grávidas (12 a 45 anos entrevistadas através de question

  15. Epilepsy and migraine headache: is there a connection?

    Science.gov (United States)

    Stevenson, Sharon B

    2006-01-01

    This study investigated the prevalence of migraine headache in pediatric patients with epilepsy and the incidence of these two disorders in the family history. A retrospective chart review was conducted on 475 patients with a primary diagnosis of epilepsy between January 2003 and June 2004. The patients were managed in a pediatric neurology outpatient clinic at a major teaching hospital. Cases were selected using the ICD-9-CM definition for epilepsy. Data collected included age, sex, headache, migraine, and family history. The study revealed a higher prevalence of migraine in epilepsy patients (14.7%) than in the general population (2.7% to 11%). Only 4.7% had a family history of migraine, but 20.6% had a positive family history of epilepsy, supporting current ideas of the genetic etiology of some epilepsies. This study specifically addressed epilepsy and migraine in children, but whenever a primary diagnosis is made, the potential for a coexisting disorder should be investigated.

  16. 联用都梁软胶囊治疗偏头痛疗效Meta分析%Meta Analysis of Clinical Efficacy of Combining Douliang Soft Capsules on Migraine

    Institute of Scientific and Technical Information of China (English)

    黄金路; 万丽丽; 郁静; 周蓉敏; 孟祥乐; 赵宁; 赵赟; 郭澄

    2015-01-01

    Objective To explore clinical efficacy of combining Douliang Soft Capsules with others drugs on migraine. Methods Search-ing CNKI database with typing keywords"Douliang Soft Capsules"and"migraine"from 1999 to June 20th, 2015. Data from included publications with the treatment of migraine with combining Douliang Soft Capsules were meta analyzed by Revman 5. 3 software. Results 6 pubilications were included from 99 retrieved results. 258 cases with migraine were orally given combined therapy with Douliang Soft Capsules and other drugs ( nimodipine or flunarizine ) , while 247 patients as the control group. Meta analysis reveals that combination of Douliang Soft Capsules with other drugs can effectively improve the symptoms of migraine [ OR=0. 27, 95% CI ( 0. 16, 0. 44 ) ] . The effectiveness was ( 90. 6 ± 2. 3 )% and ( 71. 3 ± 4. 4 )% , respectively ( P < 0. 01 ) . Conclusion Combination of Douliang Soft Capsules with other drugs ( eg. nimodipine, flunarizine, etc ) can significantly increases the clinical efficacy in patients with migraine.%目的 考察都梁软胶囊联合其他药物治疗偏头痛的临床疗效.方法 检索中国知网期刊数据库,关键词"都梁软胶囊""头痛",检索时间1999年至2015年,提取符合联合用药治疗偏头痛纳入标准的文献数据,运用Revman 5. 3版软件进行Meta分析.结果 共检索到99条结果,最终纳入6篇文献.都梁软胶囊联合其他药物(尼莫地平或氟桂利嗪)治疗偏头痛共258例,对照组247例.Meta分析结果显示,都梁软胶囊联合其他药物能有效治疗偏头痛[ OR=0. 27,95% CI(0. 16,0. 44)] ,有效率分别为(90. 6 ± 2. 3)%和(71. 3 ± 4. 4)%( P<0. 01).结论 都梁软胶囊与其他药物(如尼莫地平、氟桂利嗪等)联用治疗偏头痛,能显著增强临床疗效.

  17. The role of triptans in the management of migraine

    Directory of Open Access Journals (Sweden)

    Meiyanti Meiyanti

    2016-02-01

    Full Text Available Migraine is one of the most prevalent disorders seen in clinical practice today and also a major cause of disability in the workplace. The prevalence of migraine is highest during the years of peak productivity, ie, between the ages of 25 and 55 years. The triptans are a group of selective 5-hydroxtriptamine (HT1 serotonin receptor agonists that activate the 5-HT1B/1D receptor and possibly also the 5-HT1A dan 5-HT1F receptors. To date 7 subclasses of serotonin receptors have been identified, namely subclasses 5-HT1 to 5-HT7. Triptan causes cranial vasoconstriction, inhibits peripheral trigeminal activity and the trigeminal afferents. With its triple action, triptans can control acute attacks of migraine. Triptan is contraindicated in patients with previous ischemic or coronary artery disease, cerebral or peripheral vascular disease and other cardiovascular disorders. Triptans should be given immediately after an acute attack of migraine. The triptans are useful in the management of an acute migraine, but are not indicated for preventive therapy of migraine. Several new advances in migraine management have been made in regard to the recognition of the disease, the pathogenesis of migraine, and the phenomenon of central sensitization. More treatment options become available to patients and prescribers, the impact of such therapy on worker productivity will become more important in determining the value of such interventions.

  18. The role of triptans in the management of migraine

    Directory of Open Access Journals (Sweden)

    Meiyanti

    2009-04-01

    Full Text Available Migraine is one of the most prevalent disorders seen in clinical practice today and also a major cause of disability in the workplace. The prevalence of migraine is highest during the years of peak productivity, ie, between the ages of 25 and 55 years. The triptans are a group of selective 5-hydroxtriptamine (HT1 serotonin receptor agonists that activate the 5-HT1B/1D receptor and possibly also the 5-HT1A dan 5-HT1F receptors. To date 7 subclasses of serotonin receptors have been identified, namely subclasses 5-HT1 to 5-HT7. Triptan causes cranial vasoconstriction, inhibits peripheral trigeminal activity and the trigeminal afferents. With its triple action, triptans can control acute attacks of migraine. Triptan is contraindicated in patients with previous ischemic or coronary artery disease, cerebral or peripheral vascular disease and other cardiovascular disorders. Triptans should be given immediately after an acute attack of migraine. The triptans are useful in the management of an acute migraine, but are not indicated for preventive therapy of migraine. Several new advances in migraine management have been made in regard to the recognition of the disease, the pathogenesis of migraine, and the phenomenon of central sensitization. More treatment options become available to patients and prescribers, the impact of such therapy on worker productivity will become more important in determining the value of such interventions.

  19. Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.

    Science.gov (United States)

    Aurora, Sheena K; Brin, Mitchell F

    2017-01-01

    Several lines of research support the hypothesis that migraine is a spectrum of illness, with clinical symptoms that vary along a continuum from episodic migraine to chronic migraine. Physiologic changes may result in episodic migraine evolving into chronic migraine over months to years in susceptible individuals. With chronification, headache frequency increases, becoming more disabling and less responsive to therapy. Neurophysiologic and functional imaging research has reported that chronic migraine may be associated with severity-specific metabolic, functional, and structural abnormalities in the brainstem. Without longitudinal studies, it is unclear whether these changes may represent a continuum of individual progression and/or are reversible. Furthermore, chronic migraine is associated with larger impairments in cortical processing of sensory stimuli when compared with episodic migraine, possibly caused by more pronounced cortical hyperexcitability. Progressive changes in nociceptive thresholds and subsequent central sensitization due to recurrent migraine attacks in vulnerable individuals contribute to the chronic migraine state. This may result in changes to baseline neurologic function between headache attacks, evident in both electrophysiological and functional imaging research. Patients experiencing migraine chronification may report increased non-headache pain, fatigue, psychiatric disorders (eg, depression, anxiety), gastrointestinal complaints, and other somatic conditions associated with their long-term experience with migraine pain. Recent research provides a foundation for differentiating episodic and chronic migraine based on neurophysiologic and neuroimaging tools. In this literature review, we consider these findings in the context of models designed to explain the physiology and progression of episodic migraine into chronic migraine, and consider treatment of chronic migraine in susceptible individuals. Advances in pharmacotherapy provide

  20. Genetic heterogeneity of familial hemiplegic migraine

    Energy Technology Data Exchange (ETDEWEB)

    Ophoff, R.A.; Van Eijk, R.; Sandkuijl, L.A. [Leiden Univ. (Netherlands)] [and others

    1994-07-01

    Familial hemiplegic migraine (FHM) is a distinctive form of migraine with an autosomal dominant mode of inheritance. The migraine-like attacks are associated with transient hemiparesis. A locus for FHM has recently been assigned to chromosome 19 by linkage mapping. In the present study, five unrelated pedigrees with multiple members suffering from hemiplegic migraine were investigated. In two of the pedigrees additional symptoms, cerebellar ataxia and benign neonatal convulsions, respectively, were observed in affected members. Three pedigrees showed linkage to loci D19S391, D19S221, and D19S226 at chromosome 19p13. Haplotyping suggested a location of a FHM gene between D19S391 and D19S221. In the two remaining families, evidence against linkage was found. These results confirm the localization of a gene for familial hemiplegic migraine to the short arm of chromosome 19, but locus heterogeneity not corresponding to the observed clinical heterogeneity is likely to exist. 19 refs., 3 figs., 3 tabs.

  1. Almotriptan in the treatment of migraine

    Directory of Open Access Journals (Sweden)

    Giorgio Sandrini

    2007-01-01

    Full Text Available Giorgio Sandrini, Armando Perrotta, Natalia L Arce Leal, Simona Buscone, Giuseppe NappiUniversity Centre for Adaptive Disorders and Headache, IRCCS “C. Mondino Institute of Neurology” Foundation, University of Pavia, Pavia, ItalyAbstract: Almotriptan is an orally administered, highly selective serotonin 5-HT(1B/1D receptor agonist that is effective in the acute treatment of moderate to severe migraine attacks. Since its introduction on to the market in 2001, several studies involving a large number of migraine patients have confirmed its efficacy and tolerability profile. Almotriptan, was found to be among the best-responding triptans in terms of pain relief and pain-free rate at 2 h. It has been reported that almotriptan has the best sustained pain-free (SPF rate and the lowest adverse events (AEs rate of all the triptans. When these clinical characteristics were combined to form the composite endpoint SPF and no AEs (SNAE, almotriptan emerged as the triptan with the best efficacy and tolerability profile. It also showed a good efficacy profile during the early treatment (within 1 h of onset of migraine attacks characterized by moderate pain intensity. On the basis of these findings, almotriptan may be considered a therapeutic option for the acute treatment of migraine attacks.Keywords: almotriptan, triptans, migraine, treatment

  2. Perfusion patterns in migraine with aura.

    Science.gov (United States)

    Förster, Alex; Wenz, Holger; Kerl, Hans U; Brockmann, Marc A; Groden, Christoph

    2014-10-01

    Migraine with aura is a common neurological disorder, and differentiation from transient ischemic attack or stroke based on clinical symptoms may be difficult. From an MRI report database we identified 33 patients with migraine with aura and compared these to 33 age-matched ischemic stroke patients regarding perfusion patterns on perfusion-weighted imaging (PWI)-derived maps: time to peak (TTP), mean transit time (MTT), and cerebral blood flow and volume (CBF, CBV). In 18/33 (54.5%) patients with migraine with aura, TTP showed areas of hypoperfusion, most of these not limited to the territory of a specific artery but affecting two or more vascular territories. In patients with migraine with aura, TTP (1.09 ± 0.05 vs. 1.47 ± 0.40, p aura is usually associated with a perfusion deficit not limited to a specific vascular territory, and only a moderate increase of TTP. Thus, hypoperfusion restricted to a single vascular territory in combination with a marked increase of TTP or MTT may be regarded as atypical for migraine aura and suggestive of acute ischemic stroke. © International Headache Society 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

  3. Migraine treatment: a chain of adverse effects.

    Science.gov (United States)

    Veloso, Tiago Sousa; Cambão, Mariana Seixas

    2015-01-01

    This clinical vignette presents a 14 years old female, with a past medical history relevant only for migraine with typical aura of less than monthly frequency, complaining of a severe unilateral headache with rising intensity for the previous 4 h, associated with nausea, vomiting, photophobia and phonophobia. This episode of migraine with aura in a patient with recurrent migraine was complicated by side effects of medical diagnostic and therapeutic procedures (extrapyramidal symptoms, delirium, post-lumbar puncture headache, hospital admission) all of which could have been prevented-quaternary prevention. This case illustrates several important messages in migraine management: (1) use of acetaminophen is not based in high-quality evidence and better options exist; (2) among youngsters, domperidone should be preferred over metoclopramide because it does not cross the blood-brain barrier; (3) moderate to severe migraine crisis can be managed with triptans in teenagers over 12 years old; (4) it is important to recognize adverse drug effects; (5) harmful consequences of medical interventions do occur; (6) the school community must be informed about chronic diseases of the young.

  4. Menstrual cycle and skin reactivity

    DEFF Research Database (Denmark)

    Agner, T; Damm, P; Skouby, S O

    1991-01-01

    The hypothesis was tested that a cyclic variation exists in skin reactivity to irritant stimuli. Twenty-nine healthy women with regular menstrual cycles were challenged with sodium lauryl sulfate as an irritant patch test at day 1 and at days 9 through 11 of the menstrual cycle. The skin response...... in the menstrual cycle as evaluated by visual scoring (p less than 0.05) as well as by measurement of transepidermal water loss (p less than 0.05) and edema formation (p less than 0.005)....

  5. Aspartame-Triggered Migraine

    OpenAIRE

    J Gordon Millichap

    2001-01-01

    Two patients with known aspartame-triggered and rizatriptan-responsive migraine had their headaches worsened following use of an aspartame-containing formulation of rizatriptan (Maxalt-MLT), in a report from Albert Einstein College of Medicine, Bronx, NY.

  6. One hundred years of migraine research

    DEFF Research Database (Denmark)

    Tfelt-Hansen, Peer C; Koehler, Peter J

    2011-01-01

    Pain research, and headache research in particular, during the 20th century, has generated an enormous volume of literature promulgating theories, questions, and temporary answers. This narrative review describes the most important events in the history of migraine research between 1910 and 2010....... Based on the standard textbooks of headache: Wolff's Headache (1948 and 1963) and The Headaches (1993, 2000, and 2006) topics were selected for a historical review. Most notably these included: isolation and clinical introduction of ergotamine (1918); further establishment of vasodilation in migraine...... and the constrictive action of ergotamine (1938); identification of pain-sensitive structures in the head (1941); Lashley's description of spreading scotoma (1941); cortical spreading depression (CSD) of Leão (1944); serotonin and the introduction of methysergide (1959); spreading oligemia in migraine with aura (1981...

  7. Management of sporadic and familial hemiplegic migraine.

    Science.gov (United States)

    Russell, Michael Bjørn

    2010-03-01

    Sporadic and familial hemiplegic migraines (SHM and FHM) are rare paroxysmal disorders characterized by motor aura and headache. The distinction is based on whether other family members are affected. The majority of FHM families have a mutation in one of the ion channels CACNA1A, ATP1A2 and SCN1A. SHM is sometimes caused by a de novo mutation in one of the genes. Clinical trials of SHM and FHM have not been conducted. Seizure in FHM is secondary to cerebral edema and fever among other factors. The regional cerebral blood flow is reduced during the reversible aura symptoms. Triptans and ergotamine are contraindicated in the management of SHM and FHM based on the pathophysiology. Nimodipine is contraindicated. Acute and prophylactic management are otherwise based on the management principle of the migraine without aura and migraine with aura.

  8. Clinical study on nape cluster acupuncture for 50 cases of migraine%项丛刺治疗偏头痛50例临床观察

    Institute of Scientific and Technical Information of China (English)

    齐丽珍

    2015-01-01

    Objective:To observe the clinical efficacy of nape cluster acupuncture in treating migraine. Methods:Fifty patients with confirmed diagnosis of migraine were intervened by using nape cluster acupuncture, and were evaluated at the outset and after 2-month treatment by the short-form of McGill pain questionnaire (SP-MPQ) and self-rating depression scale (SDS). Results:After treatment, the number of positive words, sensory pain rating index (S-PRI), affective pain rating index (A-PRI), total pain rating index (T-PRI), visual analogue scale (VAS), and present pain intensity (PPI) were significantly changed (P0.05). Conclusion:Nape cluster acupuncture is effective in treating migraine, significantly improving headache and depression.%目的:观察项丛刺治疗偏头痛的临床疗效。方法:对50例诊断明确的偏头痛患者采用项丛刺治疗,并于入选时和治疗2个月后分别采用简化McGill疼痛问卷(short-form of McGill pain questionnaire, SF-MPQ)和抑郁自评量表(self-rating depression scale, SDS)进行临床评定。结果:患者治疗前后选词阳性项目数、疼痛分级指数(pain rating index, PRI)感觉分、PRI情绪分、PRI总分、视觉模拟量表评分(visual analogue scale, VAS)、现时疼痛强度(present pain intensity, PPI)差异均有统计学意义(均P<0.01);治疗前SDS评分为(56.42±8.12)分,治疗后为(41.08±5.73)分,治疗前后SDS评分差异有统计学意义(P<0.01)。治疗结束后总有效率为86.0%;病程短的患者疗效优于病程长者(P<0.05);轻中度头痛患者疗效优于重度头痛患者(P<0.01);不伴抑郁的患者总有效率优于伴抑郁的患者,但疗效差异无统计学意义(P>0.05)。结论:项丛刺治疗偏头痛疗效确切,对患者头痛和抑郁程度有明显的改善作用。

  9. Clinical efifcacy ofTCM differentiation on migraine%探讨中医辨证治疗偏头痛的临床疗效

    Institute of Scientific and Technical Information of China (English)

    余永远

    2016-01-01

    Objective: To observe clinical efifcacy of TCM differentiation on migraine. Methods: 212 cases were divided into the control group (102 cases), given TCM, and observed group (110 cases), given western medicine. In the observed group, 110 cases were divided into types of Yuzu Naoluo, Ganshen Kuixu, Fengyang Shangrao, Ganyu Qizhi, Ganyang Shangkang. Results: The total efifcacy of 70.59% in the control group was lower than 92.73% in the observed group (P<0.05). The total efifciency was similar in the 5 types in the observed group, without statistically signiifcant difference. The recurrence efifciency of 34.72% in the control group was obviously higher than 11.76% in the observed group. Conclusion: TCM differentiation was effective on migraine, suitable for different types of migraine, with lower recurrence efifciency, and worthy of promotion.%目的:研究探讨中医辨证治疗偏头痛的临床疗效。方法:回顾性分析2012年1月-2014年1月期间我院神经内科收治的212例偏头痛患者的临床资料,将接受西医治疗的102例患者设为对照组,接受中医治疗的110例患者设为观察组。在观察组中,按照中医病因又将110例患者分成瘀阻脑络型、肝肾亏虚型、风阳上扰型、肝郁气滞型、肝阳上亢型等五种类型偏头痛,经过一段时间的治疗,比较两组之间以及观察组中不同类型之间的总有效率,并比较一年后两组患者的复发率。结果:西医治疗偏头痛的总有效率(70.59%)明显低于中医治疗的总有效率(92.73%),且差异具有统计学意义(P<0.05)。中医治疗各型偏头痛的总有效率有细微差异,且差异不具有统计学意义。西医治疗偏头痛的复发率(34.72%)明显高于中医治疗的复发率(11.76%)。结论:中医辨证治疗偏头痛的临床疗效显著,适用于各种中医分型的偏头痛的治疗,且治疗后复发率低,应当在今后偏头痛的临床治疗中予以推广。

  10. Analysis of the MTHFR C677T variant with migraine phenotypes

    Directory of Open Access Journals (Sweden)

    Haupt Larisa M

    2010-07-01

    Full Text Available Abstract Background The methylenetetrahydrofolate reductase (MTHFR gene variant C677T has been implicated as a genetic risk factor in migraine susceptibility, particularly in Migraine with Aura. Migraine, with and without aura (MA and MO have many diagnostic characteristics in common. It is postulated that migraine symptomatic characteristics might themselves be influenced by MTHFR. Here we analysed the clinical profile, migraine symptoms, triggers and treatments of 267 migraineurs previously genotyped for the MTHFR C677T variant. The chi-square test was used to analyse all potential relationships between genotype and migraine clinical variables. Regression analyses were performed to assess the association of C677T with all migraine clinical variables after adjusting for gender. Findings The homozygous TT genotype was significantly associated with MA (P P = 0.002. While the CT genotype was significantly associated with physical activity discomfort (P P = 0.002. Females with the TT genotype were significantly associated with unilateral head pain (P P P = 0.002, and the use of natural remedy for migraine treatment (P = 0.003. Conversely, male migraineurs with the TT genotype experienced higher incidences of bilateral head pain (63% vs 34% and were less likely to use a natural remedy as a migraine treatment compared to female migraineurs (5% vs 20%. Conclusions MTHFR genotype is associated with specific clinical variables of migraine including unilateral head pain, physical activity discomfort and stress.

  11. Understanding migraine using dynamic network biomarkers

    NARCIS (Netherlands)

    Dahlem, M.A.; Kurths, J.; Ferrari, M.D.; Aihara, K.; Scheffer, M.; May, A.

    2015-01-01

    Background: Mathematical modeling approaches are becoming ever more established in clinical neuroscience. They provide insight that is key to understanding complex interactions of network phenomena, in general, and interactions within the migraine-generator network, in particular. Purpose: In this s

  12. 偏头痛治疗曙光初现5-HT1B/1D受体激动剂的临床应用%Clinical application of 5-HT1B/1D receptor agonist(triptan) to the treatment of migraine--a ray of sunlight

    Institute of Scientific and Technical Information of China (English)

    张石革; 马国辉

    2004-01-01

    OBJECTIVE:Migraine is a common and frequently-occurring disease in neuromedicine.with understading of mechanism of migraine,new anti-migraine drugs have been found constantly to summarize the aspect of clinical application and progress on 5-HT1B/1D receptor agonist(Triptan).METHODS: To collecte medical literatures in recent years at home and abroad.CONCLUSION:Advance in 5-HT1B/1D receptor agonist has been swiftly in recent years, it has higher selectivity to 5-HT1B/1D receptor, contraction of cerebral vessel and arteriae temporalis, efficacy being related to dosage, promoting distribution of blood flow,so 5-HT1B/1D receptor agonist(triptan) plays an important roles in treatment of migraine.

  13. Menstrual hygiene among adolescent girls

    Directory of Open Access Journals (Sweden)

    Rakesh Sharma

    2015-09-01

    Full Text Available Background: Menstruation and menstrual practices are still clouded by taboos and socio-cultural restrictions resulting in adolescent girls remaining ignorant of the scientific facts and hygienic health practices, which sometimes result into adverse health outcomes. Objective: To assess knowledge and practice regarding menstrual hygiene before and after teaching program among adolescent girls. Materials and Methods: A true experimental study was conducted among 50 adolescent girls of a secondary school situated in the Bhaniyawala of Dehradun district, Uttarakhand, with the help of a pre-designed and pre-tested questionnaire. Participants were randomly assigned into control (n=25 and experimental group (n=25. Adolescent girls from both groups were assessed for knowledge and practice regarding menstrual hygiene on day 1 and on 15th day.  Participants of experimental group were administered educational programme regarding menstrual hygiene on day 1 after assessment for knowledge and practice regarding menstrual hygiene. Data were analysed statistically by simple proportions. Results: The mean age of the adolescent girl was 13.88± 1.5 and age of menarche 12.74±0.98. Out of 50, 32 (64% mothers’ of adolescent girls were educated at graduate level.  The mean pre-test knowledge and practice in experimental group 8.04±1.54, 3.52±1.0 and control group 8.02±2.0, 3.24±1.0 respectively. The level of knowledge and practice regarding menstrual hygiene of subjects who participated in educational program was significantly better than that of the control group. Conclusions: Menstrual hygiene, a very important risk factor for reproductive tract infections, is a vital aspect of health education for adolescent girls. Educational television programmes, trained school nurses/health personnel, motivated school teachers and knowledgeable parents can play a very important role in transmitting the vital message of correct menstrual hygiene to the adolescent girl

  14. Spinal Cord Injury and Migraine Headache: A Population-Based Study.

    Directory of Open Access Journals (Sweden)

    Freda M Warner

    Full Text Available Migraine headaches are a common neurological condition, negatively impacting health and quality of life. The association between migraines and spinal cord injury (SCI is intriguing to consider from the perspective that migraine headaches may be acquired in response to damage in the spinal cord [corrected].The primary objective of this study was to further examine the association between SCI and migraine headache, controlling for potential confounding variables. A secondary objective was to determine the impact of migraine headaches on self-perceived health. Data from a sample of 61,047 participants were obtained from the cross-sectional Canadian Community Health Survey. Multivariable logistic regression was used to explore the association between SCI and migraine headache using probability weights and adjusting for confounders. The multivariable age- and sex-adjusted model revealed a strong association between SCI and migraine headache, with an adjusted odds ratio for migraine of 4.82 (95% confidence interval [3.02, 7.67] among those with SCI compared to those without SCI. Further, individuals who experienced both SCI and migraine tended to report poorer perceived general health compared with the other groups (i.e., SCI and no migraine. In conclusion, this study established a strong association between SCI and migraine headache. Further research is needed to explore the possible mechanisms underlying this relationship. Improvements in clinical practice to minimize this issue could result in significant improvements in quality of life.

  15. The borderland of migraine and epilepsy in children.

    Science.gov (United States)

    Rajapakse, Thilinie; Buchhalter, Jeffrey

    2016-06-01

    To provide a review on the spectrum of migraine-epilepsy disorders in children. The migraine-epilepsy continuum covers a fascinating array of disorders that share many clinical similarities but also differ fundamentally in pathophysiology. In the pediatric population, its study can be complicated by the young age of those affected and the lack of clear understanding of the neurobiology of these disorders within the developing brain. This review serves to discuss the borderland of migraine and epilepsy in children. It will focus on epidemiology and comorbidity of the two disorders, possible mechanisms for shared pathophysiology informed by basic and translational science, and an overview of clinical similarities and differences. It will also discuss differentiation of migraine aura from childhood occipital epilepsies. Finally, the review concludes with a discussion of current classification methods for capturing cases on the migraine-epilepsy spectrum and a call for a united approach towards a better definition of this spectrum of disorders. Recent advances examining the migraine-epilepsy spectrum show clinicopathological similarities between the two disorders in children. Epidemiology demonstrates reciprocally increased incidences of epilepsy in migraineurs and of migraines in children with epilepsy, however, prospective longitudinal in children are currently lacking. Clinically, the two disorders show similarity in preictal, ictal, and postictal phenomena, with close temporal association of the two conditions described by the controversial term of "migralepsy." Basic science research has contributed significant improvements in understanding the generation of both of these episodic neurological conditions, with common links seen at a cellular level involving synaptic glutamate release and the provocation of varying propagation methods including cortical spreading depression in migraine and the paroxysmal depolarizing shift in epilepsy. Despite these significant

  16. Clinical Observation on Migraine Treated with Combination of 25-ingredient Coral Pills and Fluorine%二十五味珊瑚丸联合氟桂利嗪治疗偏头痛临床观察

    Institute of Scientific and Technical Information of China (English)

    赵新春

    2011-01-01

    目的 探讨二十五味珊瑚丸联合氟桂利嗪胶囊治疗偏头痛的临床意义.方法 将112例偏头痛患者随机分为两组,治疗组给予二十五味珊瑚丸联合氟桂利嗪治疗偏头痛,对照组单用氟桂利嗪治疗.结果 治疗后,治疗组的收缩期峰值较治疗前明显改善,差异有统计学意义(P<0.05);对照组的收缩期峰值与治疗前比较差异无统计学意义(P>0.05).两组疗效比较差异有统计学意义(P<0.05).结论 二十五味珊瑚丸联合氟桂利嗪治疗偏头痛,较之单用氟桂利嗪疗效明显增高.%Objective To explore the clinical significance of 25-ingredient coral pills combined with fluorine in treatment for migraine.Methods 112 cases of patients with Migraine randomly were divided into two groups :the treatment group receiving 25-ingredient coral pills combined with fluorine, and the contrasl group receiving migraine alone.Results Compared with before the treatment, the peak systolic velocity increased markedly after treatment in the treatment group( P < 0.05 ); There was no obvious change in the control group( P > 0.05 ).The curative rate was significiant differences in the treatment group comparing with the control group( P < 0.05 ).Conclusion The therapeutic effect of 25-ingredient coral pills combined with fluorine in treatment for migraine was obviously higher than single use of fluorine.

  17. OCCIPITAL LOBE EPILEPSY OR MIGRAINE HEADACHE

    Directory of Open Access Journals (Sweden)

    Skrijelj Fadil E

    2016-12-01

    Full Text Available Introduction: Occipital lobe epilepsies are rarely met in clinical practice, but when they occur, they can be misdiagnosed as migraine-like headache. Their prevalence ranges from 5%to 10% of all epilepsies. Seizures can occur at any age; etiologically speaking they can be symptomatic, cryptogenic and idiopathic (most often onsetis in childhood. Clinical symptomatology is manifested by partial epileptic seizures in the sense of visual elementary and/or complex manifestations, palinopsia, amaurosis, tonic head deviation, bulbus, nistagmus and headache. Propagation discharge to neighbour areas (temporal, parietal and frontal is a frequent occurrence appearing with complex partial seizures frequently finishing with secondary generalized tonic-clonic (GTC seizures. Case report: We are presenting a17-year-old male patient who has suffered from attacks of visual problemswith headache since 10 years of age. All the time it is treated as a migraine headache. During the last attack of headache the patient also had a loss of consciousness, EEG that was performed for the first time evidenced epileptic discharges of the occipital area. The therapy also included treatment with antiepileptic drug pregabalin resulting in seizure withdrawal. Conclusion: The appearance of visual symptoms followed by headache is most frequently qualified as migraine triggered headache. However, when antimigraine therapy does not give favorable results epileptic headache should be suspected, with obligatory performance of EEG recording. Occipital lobe epilepsy often presents diagnostic dilemmas due to clinical manifestations that are similar to that of non-migraine headache.

  18. Potential Beneficial Effects of Probiotics on Human Migraine Headache: A Literature Review.

    Science.gov (United States)

    Dai, Yu-Jie; Wang, Hai-Yan; Wang, Xi-Jian; Kaye, Alan D; Sun, Yong-Hai

    2017-02-01

    Recent studies have shown that migraine headache is often associated with concomitant gastrointestinal diseases. There is a higher prevalence of headaches in patients with gastrointestinal disorders. These associations between migraine and gastrointestinal disorders suggest a potential link to a bidirectional modulation of gut microbiota and brain function. The underlying working mechanistic links between migraine and gastrointestinal diseases may include increased intestinal epithelial permeability and inflammation. This review presents an overview of the relationship between gut microbiota and brain function, especially with regard to migraine headache. Literature review. Anesthesia and Operation Center, Department of Anesthesiology, Chinese PLA General Hospital. The present investigation included a PubMed search using the following terms: migraine headache, gut microbiota, brain function, and probiotics. In this literature review, we mainly discussed the relationship between gut microbiota and brain function, especially with regard to migraine headache. The potential effects of probiotics supplement on migraine headache were also included. There is limited evidence from clinical studies of the positive effects of probiotics in patients with migraine headache. Large-scale randomized, placebo-controlled clinical trials are warranted to evaluate the clinical efficacy and safety of probiotics in patients with migraine headache. Similar to migraine headache, disorders of the brain involving depression and anxiety have been demonstrated to be associated with increased gut permeability. An improvement in gut microbiota and reduction of inflammation can have positive effects on strengthening gut and brain function. Moreover, it can be inferred that probiotics may have a beneficial effect on the frequency and severity of migraine headache attacks. Large-scale randomized, placebo-controlled studies are warranted in the future to evaluate the clinical efficacy and safety

  19. Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine

    Science.gov (United States)

    Allais, Gianni; Benedetto, Chiara

    2016-01-01

    Migraine is a common neurovascular disorder, affecting millions of people worldwide. Current guidelines recommend triptans as first-line treatment for moderate-to-severe migraine attacks. Frovatriptan is a second-generation triptan with a longer terminal elimination half-life in blood than other triptans (~26 hours). Three double-blind, randomized crossover preference studies have been recently conducted, assessing efficacy and safety of frovatriptan versus rizatriptan, zolmitriptan, and almotriptan, respectively. Frovatriptan showed favorable tolerability and sustained effect, with a significantly lower rate of relapse over 48 hours versus the other triptans. These findings were confirmed in a series of analyses of patient subsets from the three studies, including patients with menstrually related and oral contraceptive-induced migraine, hypertension, obesity, weekend migraine, as well as patients with migraine with aura. In all patient subsets analyzed, lower headache recurrence rates were observed versus the comparator triptans, indicating a more sustained pain-relieving effect on migraine symptoms. A further randomized, double-blind study demonstrated that frovatriptan given in combination with the fast-acting cyclooxygenase inhibitor dexketoprofen provided improved migraine pain-free activity at 2 hours, and gave more sustained pain-free activity at 24 hours, versus frovatriptan alone. These benefits were observed both when the combination was administered early (1 hour after onset). Different pharmacokinetic, but synergistic, properties between frovatriptan and dexketoprofen may make the combination of these agents particularly effective in migraine treatment, with rapid onset of action and sustained effect over 48 hours. These benefits, together with potential cost-effectiveness advantages versus other triptans could drive selection of the most appropriate treatment for acute migraine attacks. PMID:27757013

  20. Pizotifen relieves acute migraine symptoms

    Directory of Open Access Journals (Sweden)

    A.S.M. Kamrul Huda

    2008-01-01

    Full Text Available To The Editor: Various pharmacological agents are used for the treatment of migraine. In the last five years, various drug companies in Bangladesh have been marketing pizotifen as a preventive treatment of all types of migraine. Pizotifen is a serotonin antagonist acting mainly at the 5-HT1, 5-HT2A and 5HT2C receptors. It also has some activity as an antihistamine (1. Pizotifen is a well-established preventative therapy of migraine. I would like to report my own experience in using pizotifen in treating the acute attacks of migraine. Pizotifen was prescribed as acute therapy in 11 patients, 6 females (4 had migraine without aura and 2 had migraine with aura and 5 males (all had migraine without aura. Three female and 5 male patients, who had migraine without aura, reported no beneficial effect of pizotifen as treatment for the acute attacks. Three female patients (two with migraine with aura and one with migraine without aura had their headache relieved by use of pizotifen as treatment for the acute attacks. This is an initial observation about the effectiveness of pizotifen as acute therapy in migraine. However, this could be simply a placebo affect. Nevertheless, it will be worth exploring the role of pizotifen as a therapeutic agent for acute attacks of migraine by conducting well-designed randomized, controlled studies.

  1. Tetra-ataxiometric Posturography in Patients with Migrainous Vertigo.

    Science.gov (United States)

    Ongun, Nedim; Atalay, Nilgun S; Degirmenci, Eylem; Sahin, Fusun; Bir, Levent Sinan

    2016-01-01

    Migraine is a common disorder characterized by headache attacks frequently accompanied by vestibular symptoms like dizziness, vertigo, and balance disorders. Clinical studies support a strong link between migraine and vertigo rather than between other headache types and vertigo or nonvertiginous dizziness. There is a lack of consensus regarding the pathophysiology of migrainous vertigo. Activation of central vestibular processing during migraine attacks and vasospasm-induced ischemia of the labyrinth are reported as the probable responsible mechanisms. Because vestibular examination alone does not provide enough information for diagnosis of migrainous vertigo, posturography systems which provide objective assessment of somatosensory, vestibular, and visual information would be very helpful to show concomitant involvement of the vestibular and somato-sensorial systems. There are few posturographic studies on patients with migraine but it seems that how balance is affected in patients with migraine and/or migrainous vertigo is still not clear. We want to investigate balance function in migraineurs with and without vertigo with a tetra-ataxiometric posturography system and our study is the first study in which tetra-ataxiometric static posturography was used to evaluate postural abnormalities in a well-defined population of patients with migrainous vertigo. To investigate balance functions in migraineurs with and without vertigo with a tetra-ataxiometric posturography system. Prospective, nonrandomized, controlled study. Pamukkale University Hospital, Neurology and Physical Therapy and Rehabilitation outpatient clinics. Sixteen patients with migrainous vertigo, 16 patients with migraine without aura and no vestibular symptoms, and 16 controls were included in the study. Computerized static posturography system was performed and statistical analyses of fall, Fourier, Stability, and Weight distribution indexes were performed. The tetra-ataxiometric posturography device

  2. Vestibular characterization in the menstrual cycle Caracterização vestibular no ciclo menstrual

    Directory of Open Access Journals (Sweden)

    Cintia Ishii

    2009-06-01

    Full Text Available Hormonal disorders in the menstrual cycle can affect labyrinthine fluid homeostasis, causing balance and hearing dysfunctions. STUDY DESIGN: Clinical prospective. AIM: compare the results from vestibular tests in young women, in the premenstrual and postmenstrual periods. MATERIALS AND METHODS: twenty women were selected with ages ranging from 18 to 35 years, who were not using any kind of contraceptive method for at least six months, and without vestibular or hearing complaints. The test was carried out in each subject before and after the menstrual period, respecting the limit of ten days before or after menstruation. RESULTS: there was a statistically significant difference in the menstrual cycle phases only in the following vestibular tests: calibration, saccadic movements, PRPD and caloric-induced nystagmus. We also noticed that age; a regular menstrual cycle; hearing loss or dizziness cases in the family; and premenstrual symptoms such as tinnitus, headache, sleep disorders, anxiety, nausea and hyperacusis can interfere in the vestibular test. CONCLUSION: there are differences in the vestibular tests of healthy women when comparing their pre and postmenstrual periods.As alterações hormonais do ciclo menstrual podem comprometer a homeostase dos fluidos labirínticos, gerando alterações no equilíbrio e na audição. FORMA DO ESTUDO: Clínico prospectivo. OBJETIVO: Comparar os resultados dos testes do exame vestibular em mulheres jovens, nos períodos pré e pós-menstrual. MATERIAL E MÉTODO: Foram selecionadas vinte mulheres, entre dezoito e trinta e cinco anos, que não fizessem uso de qualquer tipo de anticoncepcional, com audição normal e sem queixas vestibulares. O exame vestibular foi realizado em cada participante no período pré e no período pós-menstrual, em ordem aleatória, e respeitando o limite de até dez dias antes do início da menstruação e até dez dias após o início da menstruação. RESULTADO: Foi observada

  3. Calcitonin gene-related peptide and migraine with aura

    DEFF Research Database (Denmark)

    Hansen, Jakob M; Ashina, Messoud

    2014-01-01

    BACKGROUND: Calcitonin gene-related peptide (CGRP) is a key molecule in migraine pathophysiology. Most studies have focused on CGRP in relation to migraine without aura (MO). About one-third of migraine patients have attacks with aura (MA), and this is a systematic review of the current literature...... on CGRP and MA. METHODS: We performed a systematic literature search on MEDLINE for reports of CGRP and MA, covering basic science, animal and human studies as well as randomized clinical trials. RESULTS: The literature search identified 594 citations, of which 38 contained relevant, original data. Plasma...

  4. A naturalistic glyceryl trinitrate infusion migraine model in the rat

    DEFF Research Database (Denmark)

    Ramachandran, Roshni; Bhatt, Deepak Kumar; Ploug, Kenneth Beri

    2012-01-01

    Glyceryl trinitrate (GTN) infusion is a reliable method to provoke migraine-like headaches in humans. Previous studies have simulated this human model in anaesthetized or in awake rodents using GTN doses 10,000 times higher than used in humans. The relevance of such toxicological doses to migraine...... is not certain. Anaesthesia and low blood pressure caused by high GTN doses both can affect the expression of nociceptive marker c-fos. Therefore, our aim was to simulate the human GTN migraine model in awake rats using a clinically relevant dose....

  5. Adult-onset hemiplegic migraine with cortical enhancement and oedema.

    Science.gov (United States)

    Cha, Y-H; Millett, D; Kane, M; Jen, J; Baloh, R

    2007-10-01

    We present genetically identical twin patients who experienced late-onset migraine with visual and somatosensory auras and later developed hemiplegic migraines associated with severe cortical oedema and enhancement. Both positron emission tomography and electroencephalography showed an increase in activity contralateral to the hemiplegic side. Brain biopsy during the attack showed reactive astrogliosis and microgliosis. Mutations in CACNA1A, ATP1A2, SLC1A3 and NOTCH3 were ruled out by sequencing. This report shows the clinical and genetic evaluation of a severe form of familial hemiplegic migraine as well as the evolution of the imaging changes.

  6. Trigger factors in migraine patients Fatores desencadeantes de enxaqueca

    Directory of Open Access Journals (Sweden)

    Patrícia Timy Fukui

    2008-09-01

    Full Text Available BACKGROUND: Migraine is a chronic neurological disease with several trigger factors, including dietary, hormonal and environmental factors. PURPOSE: To analyse precipitating factors in a sample of migraine patients. METHOD: Two hundred consecutive migraine patients were interviewed about possible trigger factors for migraine attacks. RESULTS: Most patients showed at least one dietary trigger, fasting was the most frequent one, followed by alcohol and chocolate. Hormonal factors appeared in 53% , being the pre-menstrual period the most frequent trigger. Physical activities caused migraine in 13%, sexual activities in 2.5% and 64% reported emotional stress a trigger factor. 81% related some sleep problem as a trigger factor. Regarding environmental factors, smells were reported by 36.5%. CONCLUSION: Trigger factors are frequent in migraine patients, its avoidance may decrease headache frequency and also improve patients' quality of life.INTRODUÇÃO: A enxaqueca é uma doença neurológica crônica que apresenta diversos desencadeantes como fatores alimentares, hormonais e ambientais. OBJETIVO: Analisar os fatores desencadeantes em uma amostra de pacientes com enxaqueca. MÉTODO: Duzentos pacientes com diagnóstico de enxaqueca foram questionados sobre fatores que pudessem desencadear suas crises. RESULTADOS: 83,5% apresentaram algum fator alimentar, jejum foi o fator mais freqüente, seguido de álcool e chocolate. Dos fatores hormonais, o período pré-menstrual foi o mais freqüente. Atividade física causou enxaquecas em 13%, atividade sexual em 2,5%, estresse em 64% e 81% relataram o sono como fator desencadeante. Em relação aos fatores ambientais, odores foram desencadeantes em 36,5%. CONCLUSÃO: Os fatores desencadeantes são freqüentes em enxaqueca e a sua detecção deve ser pormenorizada para que se reduza a freqüência de crises e melhore a qualidade de vida do paciente.

  7. Prolonged symptoms in sporadic hemiplegic migraine: aura or migrainous infarction?

    Science.gov (United States)

    Lai, Tzu-Hsien; Hong, Chien-Tai

    2012-09-01

    Sporadic hemiplegic migraine is a rare form of migraine associated with motor weakness during the aura phase. While the aura usually lasts less than 1 hour, patients with sporadic hemiplegic migraine frequently have prolonged weakness. A 60-year-old male had sporadic hemiplegic migraine after a head injury at the age of 14. He presented to our emergency department with a typical migraine attack except prolonged right limbs weakness and numbness (>1 day). Brain magnetic resonance imaging showed an acute infarction in the left posterior medial pons. He recovered completely from motor weakness but still complained of residual numbness in his right limbs three months later. We report the first adult case of sporadic hemiplegic migraine with migrainous infarction located in the pons. Since patients with hemiplegic migraine often have prolonged aura, it is easy to be confused with a migrainous infarction. The case report highlights that migrainous infarction is a complication difficult to diagnose and treat early, especially in patients with hemiplegic migraine.

  8. Migraine - Prophylactic Treatment

    Directory of Open Access Journals (Sweden)

    Chowdhury Debashish

    2002-01-01

    Full Text Available Preventive therapy in migraine constitutes an important aspect of migraine management especially in patients who are not controlled or have significant disability despite taking drugs for acute management. In spite of te recent advances in understanding of the pathophysiology of migraine, the mechanisms of action of many preventive drugs are largely unknown. Further, these provide only about 50% reduction in frequency in about 2/3rds of migraine sufferers. Hence, risk-benefit ratio must be considered while prescribing these agents. Recent efforts to undertake large-scale meta-analysis to assess the efficacy of these agents have been rewarding and consensus guidelines have evolved. Propanolol, metoprolol, amitriptyline, sodium valproate, flunarizine and lisuride have emerged as first line drugs. The role of newer anti-convulsants and botox injections in refractory cases are being investigated. Availability, co-morbidities, medical contraindications, concomitant acute therapy and costs are important determinants for choosing a particular agent. This article reviews the guidelines to be followed in choosing the prophylactic treatment options for migraine.

  9. Pharmacological migraine provocation: a human model of migraine

    DEFF Research Database (Denmark)

    Ashina, Messoud; Hansen, Jakob Møller

    2010-01-01

    In vitro studies have contributed to the characterization of receptors in cranial blood vessels and the identification of possible new antimigraine agents. Animal models enable the study of vascular responses, neurogenic inflammation, and peptide release, and thus have provided leads in the search...... for migraine mechanisms. So far, however, animal models cannot predict the efficacy of new therapies for migraine. Because migraine attacks are fully reversible and can be aborted by therapy, the headache- or migraine-provoking property of naturally occurring signaling molecules can be tested in a human model....... If a naturally occurring substance can provoke migraine in human patients, then it is likely, although not certain, that blocking its effect will be effective in the treatment of acute migraine attacks. To this end, a human in vivo model of experimental headache and migraine in humans has been developed...

  10. RECENT ADVANCES IN MIGRAINE PROPHYLAXIS

    Directory of Open Access Journals (Sweden)

    Pandey Gulshan

    2012-01-01

    Full Text Available Migraine is a chronic neurological disorder with heterogeneous characteristics resulting in a range of symptom profiles, burden, and disability. Migraine affects nearly 12% of the adult population in occidental countries, imposing considerable economic and social losses. The pharmacologic treatment of migraine includes preventive and acute strategies. A better understanding of the migraine pathophysiology along with the discovery of novel molecular targets has lead to a growing number of upcoming therapeutic proposals. This review focuses on new and emerging agents for the treatment of migraine.

  11. Renin angiotensin system: A novel target for migraine prophylaxis

    Directory of Open Access Journals (Sweden)

    Ruchika Nandha

    2012-01-01

    Full Text Available Migraine constitutes 16% of primary headaches affecting 10-20% of general population according to International Headache Society. Till now nonsteroidalanti-inflammatory drugs (NSAIDS, opioids and triptans are the drugs being used for acute attack of migraine. Substances with proven efficacy for prevention include β-blockers, calcium channel blockers, antiepileptic drugs and antidepressants. All the already available drugs have certain limitations. Either they are unable to produce complete relief or 30-40% patients are no responders or drugs produce adverse effects. This necessitates the search for more efficacious and well-tolerated drugs. A new class of drugs like angiotensin-converting enzyme inhibitors (ACE inhibitors and angiotensin II receptor antagonists have recently been studied for their off label use in prophylaxis of migraine. Studies, done so far, have shown results in favour of their clinical use because of the ability to reduce number of days with headache, number of days with migraine, hours with migraine, headache severity index, level of disability, improved Quality of life and decrease in consumption of specific or nonspecific analgesics. This article reviews the available evidence on the efficacy and safety of these drugs in prophylaxis of migraine and can give physician a direction to use these drugs for chronic migraineurs. Searches of pubmed, Cochrane database, Medscape, Google and clinicaltrial.org were made using terms like ACE inhibitors, angiotensin II receptor antagonists and migraine. Relevant journal articles were chosen to provide necessary information.

  12. Current migraine management – patient acceptability and future approaches

    Directory of Open Access Journals (Sweden)

    Jean Schoenen

    2008-10-01

    Full Text Available Arnaud Fumal, Jean SchoenenDepartments of Neurology and Functional Neuroanatomy, Headache Research Unit, University of Liège, BelgiumAbstract: Despite its high prevalence and individual as well as societal burden, migraine remains underdiagnosed and undertreated. In recent years, the options for the management of migraine patients have greatly expanded. A number of drugs belonging to various pharmacological classes and deliverable by several routes are now available both for the acute and the preventive treatments of migraine. Nevertheless, disability and satisfaction remain low in many subjects because treatments are not accessible, not optimized, not effective, or simply not tolerated. There is thus still considerable room for better education, for more efficient therapies and for greater support from national health systems. In spite of useful internationally accepted guidelines, anti-migraine treatment has to be individually tailored to each patient taking into account the migraine subtype, the ensuing disability, the patient’s previous history and present expectations, and the co-morbid disorders. In this article we will summarize the phenotypic presentations of migraine and review recommendations for acute and preventive treatment, highlighting recent advances which are relevant for clinical practice in terms of both diagnosis and management.Keywords: migraine, disability, acute treatment, preventive treatment, management

  13. Audiological evaluation of hearing levels in patients diagnosed with migraine

    Directory of Open Access Journals (Sweden)

    Müjde Karadag

    2015-01-01

    Full Text Available Introduction: Based on the hypothesis that neurovascular events involving in the pathophysiology of migraine can cause hearing loss by influencing blood flow of inner ear, it was aimed to determine whether migraine with or without aura in our clinics patients are at risk for hearing loss by assessing hearing levels via a high-frequency audiometry, acoustic reflex and transient otoacoustic emission responses; to discriminate whether hearing loss is cochlear or retrocochlear originated, if present; and to evaluate whether or not migraine treatment affect hearing level in patients received treatment for migraine in this study. Materials and Methods: The study included patients who were diagnosed as migraine between December 2011 and December 2012 at Neurology Department of Cumhuriyet University, Medicine School according to ICD-II classification and accepted to receive medical therapy. In all patients, hearing levels were measured at baseline and after treatment by using high-frequency audiometry, transient otoacoustic emission and acoustic reflex tests. Results: In the present study, hearing thresholds measured in the right ear was normal in migraine patients with or without aura at baseline, while mild hearing loss was detected in right ear at the frequency of 500 Hz after treatment when hearing thresholds at different frequencies were compared. This difference was significant (P 0, 05. Conclusion: Differently from literature, hearing loss in our patients developed at lower frequencies and after treatment. The results we obtained from our study also presented that there might be a relationship between migraine disease and sensorineural hearing loss.

  14. Infratentorial Microbleeds: Another Sign of Microangiopathy in Migraine.

    Science.gov (United States)

    Arkink, Enrico B; Terwindt, Gisela M; de Craen, Anton J M; Konishi, Junya; van der Grond, Jeroen; van Buchem, Mark A; Ferrari, Michel D; Kruit, Mark C

    2015-07-01

    Migraine is a risk factor for clinical stroke and for subclinical white matter hyperintensities and infratentorial infarcts. These subclinical lesions are linked to small-vessel pathology. Cerebral microbleeds (CMBs) are another biomarker of small-vessel disease but have not yet been studied in migraine. Identification of CMBs in 63 migraineurs (25 with aura/35 without aura/3 unknown aura status) and 359 controls (aged, 73-85 years) from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) magnetic resonance imaging study. We assessed the modifying role of migraine in the co-occurrence of CMBs, infarcts, and white matter hyperintensity-load. Infratentorial microbleeds were more prevalent in migraine without aura patients than controls (14% versus 4%). Prevalence of other CMBs, infarcts, and white matter hyperintensities did not differ between groups. Migraineurs with CMBs had more often infarcts than controls with CMBs (65% versus 43%). In comparison with controls with infarcts, migraineurs with infarcts had more commonly CMBs (55% versus 30%). Migraine, notably without aura, is associated with infratentorial CMBs at older age. CMBs and infarcts co-occur more often in migraine than in controls. This supports the hypothesis of small-vessel involvement in migraine pathophysiology. © 2015 American Heart Association, Inc.

  15. Menstrual bleeding after cardiac surgery.

    Science.gov (United States)

    Hjortdal, Vibeke Elisabeth; Larsen, Signe Holm; Wilkens, Helena; Jakobsen, Anja; Pedersen, Thais Almeida Lins

    2014-01-01

    We investigated whether open-heart surgery with the use of extracorporeal circulation has an impact on menstrual bleeding. The menstrual bleeding pattern was registered in fertile women undergoing open-heart surgery in 2010-12. Haematocrit and 24-h postoperative bleeding were compared with those of men undergoing cardiac surgery. Women (n = 22), with mean age of 36 (range 17-60) years, were operated on and hospitalized for 4-5 postoperative days. The mean preoperative haematocrit was 40% (range 32-60%), and mean haematocrit at discharge was 32% (range 26-37%). Mean postoperative bleeding in the first 24 h was 312 (range 50-1442) ml. They underwent surgery for atrial septal defect (n = 5), composite graft/David procedure (n = 4), pulmonary or aortic valve replacement (n = 6), myxoma (n = 2), mitral valvuloplasty (n = 2), ascending aortic aneurysm (n = 1), aortic coarctation (n = 1) and total cavopulmonary connection (n = 1). Unplanned menstrual bleeding (lasting 2-5 days) was detected in 13 (60%) patients. Of them, 4 were 1-7 days early, 4 were 8-14 days early, 3 were 1-7 days late and 2 had menstruation despite having had menstrual bleeding within the last 2 weeks. None had unusually large or long-lasting menstrual bleeding. Ten women took oral contraceptives, 8 of whom had unexpected menstrual bleeding during admission. Men (n = 22), with a mean age of 35 (range 17-54) years, had mean bleeding of 331 (range 160-796) ml postoperatively, which was not statistically significantly different from the women's. The mean preoperative haematocrit was 40% (range 29-49%) among men, while haematocrit at discharge was 32% (28-41), not significantly different from that seen in the female subgroup. Menstrual bleeding patterns are disturbed by open-heart surgery in the majority of fertile women. Nevertheless, the unexpected menstrual bleeding is neither particularly long-lasting nor of large quantity, and the postoperative surgical bleeding is unaffected. We recommend that

  16. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment

    DEFF Research Database (Denmark)

    Edvinsson, Lars

    2015-01-01

    Recently developed calcitonin gene-related peptide (CGRP) receptor antagonistic molecules have shown promising results in clinical trials for acute treatment of migraine attacks. Drugs from the gepant class of CGRP receptor antagonists are effective and do not cause vasoconstriction, one...... for treatment of chronic migraine (attacks >15 days/month). Initial results from phase I and II clinical trials have revealed promising results with minimal side effects and significant relief from chronic migraine as compared with placebo. The effectiveness of these various molecules raises the question...... to understand the localization of CGRP and the CGRP receptor components in these possible sites of migraine-related regions and their relation to the BBB....

  17. Animal models of monogenic migraine.

    Science.gov (United States)

    Chen, Shih-Pin; Tolner, Else A; Eikermann-Haerter, Katharina

    2016-06-01

    Migraine is a highly prevalent and disabling neurological disorder with a strong genetic component. Rare monogenic forms of migraine, or syndromes in which migraine frequently occurs, help scientists to unravel pathogenetic mechanisms of migraine and its comorbidities. Transgenic mouse models for rare monogenic mutations causing familial hemiplegic migraine (FHM), cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and familial advanced sleep-phase syndrome (FASPS), have been created. Here, we review the current state of research using these mutant mice. We also discuss how currently available experimental approaches, including epigenetic studies, biomolecular analysis and optogenetic technologies, can be used for characterization of migraine genes to further unravel the functional and molecular pathways involved in migraine. © International Headache Society 2016.

  18. 中医内科治疗偏头痛的临床方法及效果%Clinical Methods and Related Effects of Traditional Chinese Medicine in the Treatment of Migraine

    Institute of Scientific and Technical Information of China (English)

    朱瑞海

    2016-01-01

    目的:探究分析中医内科治疗偏头痛的临床方法及相关效果。方法选取在2014年6月~2015年6月内于我院治疗偏头痛的患者50例,随机将其分为两组。对照组25例,采用西医治疗偏头痛的方法,治疗组25例,采用中医治疗偏头痛的方法。治疗2~3个疗程后,比较两组的治疗效果。结果治疗组有效率92.0%,高于对照组的80.0%,对两组患者进行1年的追踪回访,未发现复发者。结论中医内科治疗偏头痛是一种高效,副作用小,费用更少的治疗方法。%Objective To explore and analyze the clinical methods and related effects of traditional Chinese medicine in the treatment of migraine. Methods 50 patients with migraine in our hospital from June 2014 to June 2015 were randomly divided into two groups. The control group of 25 cases, the use of Western medicine treatment of migraine method, the treatment group of 25 cases, the use of traditional Chinese medicine treatment of migraine. After 2 to 3 treatment, the therapeutic effect of the two groups were compared. ResultsThe effective rate of the treatment group was 92%, higher than that of the control group of 80%, the two groups of patients for 1 years of follow-up, no recurrence was found.Conclusion TCM internal medicine treatment of migraine is a kind of high efifciency, little side effect, less cost.

  19. A note on the digiti quinti sign in hemiplegic migraine.

    Science.gov (United States)

    Vincent, M B

    2009-05-01

    The digiti quinti sign (DQS) was described as an indication of mild hemiparesis. It consists of a wider space between the fourth and fifth fingers at the affected side when the patient extends both arms horizontally to the front with the palms down. The three successively examined sporadic hemiplegic migraine patients presented herein disclosed no other neurological abnormality except the interictally present DQS on the same side of the motor deficits. This sign is perhaps clinically useful for the diagnosis of hemiplegic migraine.

  20. 自拟头痛方治疗无先兆偏头痛的临床观察%Clinical Observation of Self-made Headache Prescription on Migraine without Aura

    Institute of Scientific and Technical Information of China (English)

    皇甫烨辉

    2014-01-01

    [目的]观察头痛方治疗无先兆偏头痛的临床疗效。[方法]选取本院54例无先兆头痛患者,随机分成两组:对照组27例予以消炎痛、麦角胺咖啡因片等西药常规治疗;治疗组27例服用自拟头痛方。两组均治疗5d后判定疗效。[结果]治疗组27例,临床治愈6例,显效14例,有效6例,无效1例,总有效率为96.30%;对照组27例,临床治愈2例,显效8例,有效9例,无效8例,总有效率为70.37%。两组总有效率比较,差异有统计学意义(P<0.05)。[结论]自拟头痛方治疗无先兆偏头痛疗效优于对照组,具有临床推广应用价值。%[Objective] To observe the therapeutic effects of headache prescription on migraine without aura. [Methods] 54 patients with migraine were randomly divided into two groups: Patients in control group(n=27) were treated by nimodipine and flunarine,etc; Patients in treatment group(n=27) were treated by self made headache prescription, the treatment period was both 5 days; then determine efficacy.[Results] 27 patients in treatment group had 6 cases in clinical cure,14 in excellent,6 in effect,1 in vain, the clinical total effective rate of Chinese medicine group was 96.30%,while,27 patients in treatment group had 2 cases in clinical control ed,8 in excellent,9 in effect,8 in vain, the clinical total effective rate of Chinese medicine group was 70.37%. The difference between the two groups had the remarkable significance.[Conclusion] The therapeutic effects of headache prescription on migraine without aura has better therapeutic effects on migraine.

  1. High prevalence of Dopaminergic Premonitory Symptoms in migraine patients with Restless Legs Syndrome: a pathogenetic link?

    Science.gov (United States)

    Cologno, Daniela; Cicarelli, Giulio; Petretta, Vittorio; d'Onofrio, Florindo; Bussone, Gennaro

    2008-05-01

    In order to assess the prevalence of Dopaminergic Premonitory Symptoms (DPS) in migraine patients with Restless Legs Syndrome (RLS), we chose migraine patients from a large Italian clinical headache population previously investigated for an association between primary headaches and RLS. We evaluated a total sample of 164 patients with migraine, in particular 114 with migraine without aura (MO), 10 with migraine with aura (MA) and 40 with MO and MA in various combinations between them or with episodic tension-type headache (ETTH), defined as a "mixed group". About 20% of all migraine patients referred at least one of the following DPS: yawning, nausea, somnolence or food craving, confirming data already indicated in the literature. Among migraine patients with RLS (25.6%), DPS were referred from about half of the patients (47.6%) compared to those without RLS (47.6% vs. 13.1%; panxiety, depression, sleep disorders, body mass index). It is interesting that the chances of having RLS in migraine patients were more than 5 times higher in the presence of DPS. These results could support a hypothetical dopaminergic imbalance in RLS and migraine, as the dopamine is involved in the pathogenesis of both disorders and it is responsible for the migraine DPS reported above.

  2. Aberrant neuromagnetic activation in the motor cortex in children with acute migraine: a magnetoencephalography study.

    Science.gov (United States)

    Guo, Xinyao; Xiang, Jing; Wang, Yingying; O'Brien, Hope; Kabbouche, Marielle; Horn, Paul; Powers, Scott W; Hershey, Andrew D

    2012-01-01

    Migraine attacks have been shown to interfere with normal function in the brain such as motor or sensory function. However, to date, there has been no clinical neurophysiology study focusing on the motor function in children with migraine during headache attacks. To investigate the motor function in children with migraine, twenty-six children with acute migraine, meeting International Classification of Headache Disorders criteria and age- and gender-matched healthy children were studied using a 275-channel magnetoencephalography system. A finger-tapping paradigm was designed to elicit neuromagnetic activation in the motor cortex. Children with migraine showed significantly prolonged latency of movement-evoked magnetic fields (MEF) during finger movement compared with the controls. The correlation coefficient of MEF latency and age in children with migraine was significantly different from that in healthy controls. The spectral power of high gamma (65-150 Hz) oscillations during finger movement in the primary motor cortex is also significantly higher in children with migraine than in controls. The alteration of responding latency and aberrant high gamma oscillations suggest that the developmental trajectory of motor function in children with migraine is impaired during migraine attacks and/or developmentally delayed. This finding indicates that childhood migraine may affect the development of brain function and result in long-term problems.

  3. Aberrant neuromagnetic activation in the motor cortex in children with acute migraine: a magnetoencephalography study.

    Directory of Open Access Journals (Sweden)

    Xinyao Guo

    Full Text Available Migraine attacks have been shown to interfere with normal function in the brain such as motor or sensory function. However, to date, there has been no clinical neurophysiology study focusing on the motor function in children with migraine during headache attacks. To investigate the motor function in children with migraine, twenty-six children with acute migraine, meeting International Classification of Headache Disorders criteria and age- and gender-matched healthy children were studied using a 275-channel magnetoencephalography system. A finger-tapping paradigm was designed to elicit neuromagnetic activation in the motor cortex. Children with migraine showed significantly prolonged latency of movement-evoked magnetic fields (MEF during finger movement compared with the controls. The correlation coefficient of MEF latency and age in children with migraine was significantly different from that in healthy controls. The spectral power of high gamma (65-150 Hz oscillations during finger movement in the primary motor cortex is also significantly higher in children with migraine than in controls. The alteration of responding latency and aberrant high gamma oscillations suggest that the developmental trajectory of motor function in children with migraine is impaired during migraine attacks and/or developmentally delayed. This finding indicates that childhood migraine may affect the development of brain function and result in long-term problems.

  4. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials

    Directory of Open Access Journals (Sweden)

    Papadopoulos George

    2007-10-01

    Full Text Available Abstract Background Topiramate is approved for the prophylaxis (prevention of migraine headache in adults. The most common adverse events in the three pivotal, randomized, double-blind, placebo-controlled trials were paresthesia, fatigue, cognitive impairment, anorexia, nausea, and taste alteration. In these trials, topiramate 100 mg/d significantly improved Migraine-Specific Questionnaire (MSQ scores versus placebo (p Methods Mean MSQ and Medical Outcome Study Short Form 36 (SF-36 change scores (baseline to each double-blind assessment point were calculated for pooled intent-to-treat (ITT patients. Additionally, pooled ITT patients receiving topiramate 100 mg/d or placebo were combined and divided into two responder groups according to percent reduction in monthly migraine frequency: Results Of 756 patients (mean age 39.8 years, 86% female, 384 received topiramate 100 mg/d and 372 placebo. Topiramate significantly improved all three MSQ domains throughout the double-blind phase versus placebo (p = 0.024 [week 8], p Conclusion Topiramate 100 mg/d significantly improved daily activities and patient functioning at all time points throughout the double-blind phase. Daily function and health status significantly improved for those achieving a ≥ 50% migraine frequency reduction.

  5. Chronic migraine: current concepts and ongoing treatments.

    Science.gov (United States)

    Negro, A; Rocchietti-March, M; Fiorillo, M; Martelletti, P

    2011-12-01

    Migraine is an episodic painful disorder occasionally developing into a chronic form. Such disorder represents one of the most common neurological diseases in clinical practice. Chronicization is often accompanied by the appearance of acute drugs overuse. Chronic migraine (CM) constitutes migraine's natural evolution in its chronic form and involves headache frequency of 15 days/month, with features similar to those of migraine attacks. Medication Overuse Headache (MOH) has been defined as a headache present on > or = 15 days/month, with regular overuse for > 3 months of one or more drugs used for acute and/or symptomatic headache management. Subtypes of MOH attributed to different medications were delineated. Misuse of ergots, triptans, opioids or combination analgesics on > or = 10 days/month was required to make the diagnosis of MOH, while > or = 15 days/month were needed for simple analgesic-overuse headache. CM's low prevalence produces an extremely high disability grade. Therefore, special attention should be paid to both control and reduction of risk factors which might favour the migraine chronicization process and/or the outbreak of MOH. In MOH sufferers, the only treatment of choice is represented by drug withdrawal. Successful detoxification is necessary to ensure improvement in the headache status when treating patients who overuse acute medications. Different procedures have been suggested for withdrawal namely at home, at the hospital, with or without the use of steroids, with re-prophylaxis performed immediately or at the end of the washout period. At the moment we have not a total agreement whether prophylactic treatment should be started before, during, or after discontinuation of the overuse drug. Both drugs have been approved for CM treatment in view of their well-defined resistance to previous prophylaxis drugs. Recently, the PREEMPT clinical program has confirmed onabotulinumtoxinA as an effective, safe, and well-tolerated prophylactic

  6. Tratamento da disforia pré-menstrual com antidepressivos: revisão dos ensaios clínicos controlados Treatment of premenstrual dysphoria with antidepressants: review of controlled clinical trials

    Directory of Open Access Journals (Sweden)

    Elie Cheniaux

    2006-01-01

    Full Text Available INTRODUÇÃO: A disforia pré-menstrual (DPM, que acomete entre 3% e 8% das mulheres em idade fértil, representa uma forma mais grave de síndrome pré-menstrual, na qual predominam as alterações do humor e do comportamento. Acredita-se que haja algum tipo de ligação entre a DPM e os transtornos do humor. OBJETIVO: Estudar a eficácia dos antidepressivos na DPM. MÉTODOS: Foi realizada uma revisão dos ensaios clínicos controlados com antidepressivos no tratamento da DPM, utilizando-se as seguintes bases de dados: Medline, Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS, psycINFO e Biblioteca Cochrane. RESULTADOS: A clomipramina, a fluoxetina, a sertralina, a paroxetina e a venlafaxina se mostraram superiores ao placebo em diversos estudos. DISCUSSÃO: As mulheres que sofrem de DPM possivelmente apresentam uma disfunção serotoninérgica. CONCLUSÃO: Alguns antidepressivos, especialmente os inibidores seletivos da recaptação da serotonina (ISRS, parecem ser eficazes no tratamento da DPM.INTODUCTION: Premenstrual dysphoria (PMD, which affects between 3% and 8% of women during reproductive years, represents a more severe type of premenstrual syndrome. Mood and behavior changes are predominant in PMD. It is believed that there is some kind of link between PMS and mood disorders. OBJECTIVE: Studying the efficacy of antidepressants in PMD. METHODS: We elaborated a review of controlled clinical trials with antidepressants in the treatment of PMD, using the following databases: Medline, LILACS, psycINFO and Cochrane Library. RESULTS: Clomipramine, fluoxetine, sertraline, paroxetine and venlafaxine were superior to placebo in various studies. DISCUSSION: Women with PMD possibly present a serotonergic dysfunction. CONCLUSION: Some antidepressants, specialy SSRIs, seem to be effective in the treatment of PMD.

  7. Migraine and restless legs syndrome: current perspectives

    Directory of Open Access Journals (Sweden)

    Ferreira KS

    2015-12-01

    Full Text Available Karen dos Santos Ferreira, Fabíola Dach, Alan L Eckeli, José Geraldo SpecialiDepartment of Neurosciences and Behavioral Sciences, Division of Neurology, University Hospital, Medical School of Ribeirao Preto, University of São Paulo, São Paulo, BrazilAbstract: The relationship between migraine and restless legs syndrome (RLS has been described in the literature for some years, based on clinical findings and pathophysiological considerations. There are some possible factors relating migraine and RLS. Both are diseases involving the central nervous system, the two diseases seem to share a dopaminergic mechanism, and it is also believed that they may share a genetic origin. At present, doctors who work with these two diseases should be encouraged not to simply investigate the simultaneous presence of both, but should also apply a treatment better adapted to this possibility. Research should be directed at some still unanswered questions for a better understanding of the association between migraine and RLS.Keywords: migraine, restless legs syndrome, physiopathology, comorbidities

  8. Quantitative oculomotor findings in migrainous patients.

    Directory of Open Access Journals (Sweden)

    Sara Momtaz

    2014-12-01

    Full Text Available Neurotologic signs and symptoms, especially vestibular symptoms are common in migrainous patients. Involvement of the visual system in migrainures has received a great deal of attention in recent years, but the oculomotor part of the visual system has been largely ignored. The goal of this study was to investigate some parts of the central vestibular system using the oculomotor part of videonystagmographic evaluation, including spontaneous nystagmus, gaze-evoked nystagmus, smooth pursuit, saccade and optokinetic ystagmus interictally in migrainous patients.In this case-control study, 30 patients with migraine and 38 healthy volunteers within the age range of 18-48 years old were included spontaneous nystagmus; gaze-evoked nystagmus in right, left and up sides, smooth pursuit, optokinetic nystagmus using three different velocities and saccade test performed in both groups. The data were analyzed using SPSS for Windows 18.0.Some parameters of gain and phase and also morphology of the smooth pursuit, velocity of the saccade and slow phase velocity of optokinetic were significantly different in migrainures, although the statistical differences of these parameters were not clinically important as they were in the normal range of a defined device.These results may suggest the presence of subtle otoneurologic abnormalities in migrainous patients that is probably due to the efficiency of oculomotor function with vestibulocerebellar origin.

  9. Menstrual cycle pattern and fertility

    DEFF Research Database (Denmark)

    Kolstad, Henrik A.; Bonde, Jens Peter; Hjøllund, Niels Henrik;

    1999-01-01

    OBJECTIVE: To characterize how the menstrual cycle pattern relates to fertility regardless of potential biases caused by inappropriate coital timing during the menstrual cycle or early embryonal loss. DESIGN: Prospective follow-up study. SETTING: Healthy couples recruited throughout Denmark. PATI...... 0.09-0.68). When the combined effect of cycle variation and cycle length was assessed, cycle variation was a persistent strong predictor of fecundity. CONCLUSION(S): The mechanisms of the present findings probably are female functional disturbances in ovulation, conception, implantation...

  10. Menstrual cycle and skin reactivity

    DEFF Research Database (Denmark)

    Agner, T; Damm, P; Skouby, S O

    1991-01-01

    The hypothesis was tested that a cyclic variation exists in skin reactivity to irritant stimuli. Twenty-nine healthy women with regular menstrual cycles were challenged with sodium lauryl sulfate as an irritant patch test at day 1 and at days 9 through 11 of the menstrual cycle. The skin response...... to the applied irritant stimulus was evaluated by visual scoring and also quantified by measurements of transepidermal water loss, edema formation, and blood flow in the skin. The skin response to challenge with sodium lauryl sulfate was found to be significantly stronger at day 1 than at days 9 through 11...

  11. 21 CFR 884.5400 - Menstrual cup.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Menstrual cup. 884.5400 Section 884.5400 Food and... OBSTETRICAL AND GYNECOLOGICAL DEVICES Obstetrical and Gynecological Therapeutic Devices § 884.5400 Menstrual cup. (a) Identification. A menstrual cup is a receptacle placed in the vagina to collect...

  12. Toward Personalized Cell Therapies: Autologous Menstrual Blood Cells for Stroke

    Directory of Open Access Journals (Sweden)

    Maria Carolina O. Rodrigues

    2011-01-01

    Full Text Available Cell therapy has been established as an important field of research with considerable progress in the last years. At the same time, the progressive aging of the population has highlighted the importance of discovering therapeutic alternatives for diseases of high incidence and disability, such as stroke. Menstrual blood is a recently discovered source of stem cells with potential relevance for the treatment of stroke. Migration to the infarct site, modulation of the inflammatory reaction, secretion of neurotrophic factors, and possible differentiation warrant these cells as therapeutic tools. We here propose the use of autologous menstrual blood cells in the restorative treatment of the subacute phase of stroke. We highlight the availability, proliferative capacity, pluripotency, and angiogenic features of these cells and explore their mechanistic pathways of repair. Practical aspects of clinical application of menstrual blood cells for stroke will be discussed, from cell harvesting and cryopreservation to administration to the patient.

  13. The Effect of Yoga on Menstrual Disorders: A Systematic Review.

    Science.gov (United States)

    Oates, Jennifer

    2017-06-01

    To summarize and evaluate evidence for the effect of yoga on menstrual disorders. PubMed, CINAHL/MEDLINE, Web of Science, AMED, and Scopus were searched for English-language literature relevant to the review question. All primary research studies were included. Fifteen studies described in 18 papers were included in the review. A range of yoga interventions were used. Some studies used a combination of Asana, Pranayama, and other yogic relaxation or meditation techniques. All included studies reported some change in their outcome measures, suggesting reduced symptoms of menstrual distress following a yoga intervention; however, the heterogeneity and intensity of the interventions and outcome measures meant that findings have limited generalizability and applicability in practice settings. Further research on the relationship between yoga practice and menstrual disorders is warranted, but there must be both consistency in the methods, measures, and quality of studies and a shift toward research on yoga practices that are replicable outside of the clinical trial setting.

  14. Genetics Home Reference: sporadic hemiplegic migraine

    Science.gov (United States)

    ... weakness, often affecting one side of the body (hemiparesis). Additional features of an aura can include difficulty ... sporadic hemiplegic migraine , some experience migraine headaches without hemiparesis. A related condition, familial hemiplegic migraine , has signs ...

  15. Pharmacogenomics and migraine

    DEFF Research Database (Denmark)

    Tfelt-Hansen, Peer; Brøsen, Kim

    2008-01-01

    cases pharmacodynamic variability we mention possible implications for the acute and preventive treatment of migraine. Pharmacogenomics will most likely in the future be one part of our therapeutic armamentarium and will provide a stronger scientific basis for optimizing drug therapy on the basis...

  16. Analysis of the Clinical Curative Effect of Flunarizine Combined With Nimodipine in the Treatment of Migraine%氟桂利嗪联合尼莫地平治疗偏头痛的临床疗效分析

    Institute of Scientific and Technical Information of China (English)

    朱平华

    2016-01-01

    Objective In order to investigate the efficacy of flunarizine and nimodipine in migraine. Methods 72 cases of migraine patients were selected from 2014 to 2015, they were randomly divided into two groups, the control group received flunarizine, study group received nimodipine and flunarizine. The clinical efficacy and side effects were compared. ResultsAfter treatment, the total efficiency of the observation group is higher than that of control group (P 0.05).Conclusion Nimodipine and flunarizine combination therapy can effectively relieve clinical symptoms of migraine patients, improve the overall effciency of the treatment.%目的:探讨氟桂利嗪与尼莫地平联合治疗偏头痛的临床效果。方法选取我院于2014~2015年收治的72例偏头痛患者作为研究对象,随机分成两组,对照组给予氟桂利嗪治疗,观察组接受尼莫地平和氟桂利嗪治疗。比较两组患者的临床疗效与不良反应发生情况。结果治疗后,观察组治疗总有效率高于对照组(P<0.05),且两组间不良反应发生率差异无统计学意义(P>0.05)。结论尼莫地平与氟桂利嗪联合治疗可有效缓解偏头痛患者的临床症状,提高治疗总有效率,且不良反应发生率低,患者预后较好。

  17. Analysis the Clinical Curative Effect and the Safety of Candesartan Cilexetil Prevention Migraine%坎地沙坦酯预防治疗偏头痛临床疗效及安全性分析

    Institute of Scientific and Technical Information of China (English)

    李淞

    2016-01-01

    Objective To study the candesartan ester prevention and treatment of migraine and safety.Methods94 cases of migraine, from January 2013 to January 2015 as a clinical study, patients were randomized different group, each group had 47 cases, the observation group was uses the candesartan ester treatment, the control group, uses the flunarizine treatment. Comparative efficacy and safety of two groups of patients. ResultsThe two groups of treatment efifciency in patients with no signiifcant difference (P>0.05), observe the groups of patients with adverse reactions were signiifcantly lower than the control group, was difference had statistically signiifcance (P<0.05).Conclusion The clinical effect of Candesartan cilexetil prevention of migraine, high security, and promote the use of.%目的:探讨坎地沙坦酯预防及治疗偏头痛的疗效与安全性。方法抽取我院2013年1月~2015年1月收治的偏头痛患者94例作为临床研究对象,对患者进行随机分组,各47例。观察组采用坎地沙坦酯进行治疗;对照组采用氟桂利嗪进行治疗,比较两组患者的疗效与安全性。结果两组患者治疗总有效率比较,差异无统计学意义(P>0.05);观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论坎地沙坦酯防治偏头痛的临床效果良好,安全性高。

  18. Prophylaxis of Childhood Migraine: Topiramate Versus Propranolol

    Directory of Open Access Journals (Sweden)

    Seyed Hassan TONEKABONI

    2013-02-01

    Full Text Available How to Cite this Article: Tonekaboni SH, Ghazavi A, Fayyazi A, Khajeh A, Taghdiri MM, Abdollah Gorji F, Azargashb E. Prophylaxis of Childhood Migraine: Topiramate Versus Propranolol. Iran J Child Neurol. 2013 Winter; 7 (1:9-14. ObjectiveHeadache is a common disabling neurological disorder and migraine comprises more than half the causes of recurrent headaches in children. Despite extended prevalence of this type of headache there is lack of evidence about best drug treatment for migraine. So we aimed to compare the therapeutic effects of these drugs on childhood migraine.Materials & MethodsIn the current study, a randomized clinical trial consisting of 78 patients according to 2004 International Headache Association criteria were randomly assigned to two groups that matched by age and sex. One of these two groups was treated with Topiramate, while the other was given Propranolol. After one and four months, the efficiency of these treatments was measured in terms of frequency, severity and duration of migraine attacks.ResultsResults obtained from the data collected showed that of these 78 studied patients, 38 patients received Topiramate treatment (group A and the rest (40 patients; group B was treated with Propranolol. The average age of group A was 8.5± 2.9 years and that of group B was 8.3 ± 2.8 years. No significant difference was observed between these two groups in terms of reduction in frequency, severity and duration of migraine attacks.ConclusionResults showed that both treatments had the same efficiency in healing migraine headaches and there was no significant difference between their treating results. However, further studies are needed to examine medical effects of these two medicines. ReferencesAbu-Arefeh  I,  Russell  G.  Prevalence  of  headache  and migraine in schoolchildren. BMJ 1994 Sep 24; 309 (6957: 765-9.Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache 1994 Jun; 34 (6

  19. Unique Migraine Subtypes, Rare Headache Disorders, and Other Disturbances.

    Science.gov (United States)

    Goadsby, Peter J

    2015-08-01

    The medical aphorism that common things happen commonly makes unique (and less common) migraine subtypes especially appropriate to review for the general neurologist. This article also identifies some rare headache disorders and other disturbances, and offers strategies to manage them. This article discusses migraine with brainstem aura, which is troublesome clinically and has had a change in terminology in the International Classification of Headache Disorders, Third Edition, beta version (ICHD-3 beta), and hemiplegic migraine, which is also troublesome in practice. The rare headache disorder hypnic headache and the exploding head syndrome are also discussed. When hypnic headache is recognized, it is eminently treatable, while exploding head syndrome is a benign condition with no reported consequences. Unique migraine subtypes, rare headache disorders, and other disturbances present to neurologists. When recognized, they can often be managed very well, which offers significant benefits to patients and practice satisfaction to neurologists.

  20. Migraine strikes as neuronal excitability reaches a tipping point.

    Directory of Open Access Journals (Sweden)

    Marten Scheffer

    Full Text Available Self-propagating waves of cerebral neuronal firing, known as spreading depolarisations, are believed to be at the roots of migraine attacks. We propose that the start of spreading depolarisations corresponds to a critical transition that occurs when dynamic brain networks approach a tipping point. We show that this hypothesis is consistent with current pathogenetic insights and observed dynamics. Our view implies that migraine strikes when modulating factors further raise the neuronal excitability in genetically predisposed subjects to a level where even minor perturbations can trigger spreading depolarisations. A corollary is that recently discovered generic early warning indicators for critical transitions may be used to predict the onset of migraine attacks even before patients are clinically aware. This opens up new avenues for dissecting the mechanisms for the onset of migraine attacks and for identifying novel prophylactic treatment targets for the prevention of attacks.

  1. Correlates of the menstrual problems among rural college students of Satara district

    Directory of Open Access Journals (Sweden)

    Rajsinh V. Mohite

    2013-07-01

    Full Text Available Background: Menstruation, an important part of female reproductive cycle but menstrual dysfunction in adolescent girls may affect normal life of adolescent and young adult women. Objectives: To study the frequency of common menstrual problems and to determine the association between patterns of menstrual cycles with common menstrual problems, nutritional and economic status of rural college girls. Methodology: Cross Sectional study was conducted among college girls of rural area of Satara district, western Maharashtra, India during month of Jan- February 2011.107, age between 17-20 years from educational course of first year B.A. & B.COM. Data was collected by personal interview method and clinical examination of respondents with the help of pretested structured proforma, Weighing machine, Height measuring scale, Haemoglobin assessment strips. Results: Out of 107 girls,79 girls (73.8% had regular menstrual cycles whereas 28 (26.1% had irregular menstruation cycles with mean age at menarche 14.1 yrs. 40(37.3% girls had normal (average menstrual bleeding whereas scanty and heavy bleeding was seen in 61(57% and 6(5.6% girls. Duration of menstrual bleeding for 1-2 days was seen in 75(70% girls whereas >5 days in 7(6.5% girls. Dysmenorrhoea observed in 24(22.4% girls, Anemia seen in 62(57.9% girls, Under nutrition in 52(48.5% girls, Obesity in 7(6.5% while 42(39.2% girls belonged to lower socioeconomic class. Significant statistical association existed between type of menstrual cycle and anemia, nutritional status, amount of bleeding and dysmenorrhoea. Conclusion: Menstrual health is fundamental to women’s sexual and reproductive health. The present study has established mean age at menarche 14.1year. Poor nutritional status, anemia, low socioeconomic status often associated with menstrual problems, menstrual cycle regularity and mean age at menarche.

  2. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury

    DEFF Research Database (Denmark)

    Lauritzen, Martin; Dreier, Jens Peter; Fabricius, Martin

    2011-01-01

    Cortical spreading depression (CSD) and depolarization waves are associated with dramatic failure of brain ion homeostasis, efflux of excitatory amino acids from nerve cells, increased energy metabolism and changes in cerebral blood flow (CBF). There is strong clinical and experimental evidence...... treatment strategies, which may be used to prevent or attenuate secondary neuronal damage in acutely injured human brain cortex caused by depolarization waves....

  3. Minority Representation in Migraine Treatment Trials.

    Science.gov (United States)

    Robbins, Nathaniel M; Bernat, James L

    2017-03-01

    Minorities have historically been underrepresented in clinical research trials despite having comparatively poor health indicators. Recognizing the dual inequalities of increased disease burden and decreased research participation, the National Institute of Health (NIH) Revitalization Act of 1993 mandated the inclusion and reporting of women and minorities in NIH-funded research. While progress has been made in the subsequent decades, this underrepresentation of minorities in research trials persists and has been documented in multiple disciplines. However, the extent of adequate representation and reporting of minority inclusion in clinical trials for migraine remains unknown. In this systematic review and study, we review the literature examining the representation of women and minorities in migraine clinical research trials METHODS: First we searched PubMed for pertinent articles examining the inclusion of women and minorities in migraine clinical research trials. Second, we identified controlled-trials for migraine published since 2011 in major neurology, headache, and general medicine journals using the terms "migraine randomized controlled trial." We then reviewed the results manually and excluded pilot studies and those with fewer than 50 participants. We next determined (a) how frequently representation of minorities and women were reported in these major trials; (b) what factors correlated with reporting; and (c) whether women and minority inclusion comprised their ratios in the general population. We identified 128 relevant clinical trials, of which 36 met our inclusion criteria. All 36 trials (100%) reported gender frequency, and 25 of 36 (69.4%) reported ethnicity or race. Among all studies, women and Whites represented 84.2 and 82.9% of participants (mean), respectively. Studies conducted in the United States and funded by a private company were more likely to report race than studies conducted exclusively outside of the U.S. or with a public sponsor

  4. 偏头痛患者行电针穴位治疗临床疗效探讨%Clinical Efficacy of Electric Acupuncture Therapy in the Treatment of Pa-tients with Migraine

    Institute of Scientific and Technical Information of China (English)

    刘波

    2016-01-01

    Objective To evaluate the clinical efficacy of migraine patients with electric acupuncture therapy. Methods 116 cases with migraine admitted in our hospital from February 2014 to February 2015 were selected as the subjects and ran-domly divided into the control group and the observation group with 58 cases in each. Both groups were treated by aspirin and nimodipine, and the observation group were additionally treated by electric acupuncture therapy. The syndromes score of the two groups before and after treatment were compared. And the clinical efficacy of the two groups was evaluated com-prehensively. Results After treatment, the syndromes scores were significantly lower in the observation group than those be-fore treatment(P0.05). The total clinical effective rate was 91.38%in the observation group, and 75.86%in the control group, the difference between the groups was statistically significant (P0.05);观察组临床总有效率为91.38%,对照组临床总有效为75.86%;两组数据比较差异有统计学意义(P<0.05). 结论 偏头痛患者行电针穴位治疗的临床疗效确切,可明显延缓偏头痛的症状,改善患者的预后,治疗效果显著,具有临床可行性.

  5. Haemostatic variables during normal menstrual cycle A systematic review

    NARCIS (Netherlands)

    Knol, H. Marieke; Kemperman, Ramses F. J.; Kluin-Nelemans, Hanneke C.; Mulder, Andre B.; Meijer, Karina

    For a number of haemostatic factors menstrual cycle variation has been studied. Such variation could have clinical implications for the timing of haemostatic testing in women. It was our objective to systematically review the literature about evidence for timing of haemostatic testing during

  6. Haemostatic variables during normal menstrual cycle A systematic review

    NARCIS (Netherlands)

    Knol, H. Marieke; Kemperman, Ramses F. J.; Kluin-Nelemans, Hanneke C.; Mulder, Andre B.; Meijer, Karina

    2012-01-01

    For a number of haemostatic factors menstrual cycle variation has been studied. Such variation could have clinical implications for the timing of haemostatic testing in women. It was our objective to systematically review the literature about evidence for timing of haemostatic testing during menstru

  7. Menstrual cycle characteristics in women with persistent schizophrenia.

    Science.gov (United States)

    Gleeson, Pia C; Worsley, Roisin; Gavrilidis, Emorfia; Nathoo, Shainal; Ng, Elisabeth; Lee, Stuart; Kulkarni, Jayashri

    2016-05-01

    Oestradiol has been implicated in the pathogenesis of schizophrenia. Women with schizophrenia often suffer with menstrual dysfunction, usually associated with low oestradiol levels, but whether menstrual dysfunction has an effect on their psychiatric symptoms is not well researched. The aim of this study is to document the menstrual characteristics of women with chronic schizophrenia with focus upon menstrual regularity, menstrual cycle length and menstrual symptoms. To determine which patient characteristics are associated with irregular menses and whether irregular menses are associated with the severity of psychotic symptoms, menstrual symptoms or depressive symptoms. Cross-sectional analyses using baseline data of women enrolled in a clinical trial. Inclusion criteria include Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition, Text Revision diagnosis of schizophrenia, schizoaffective or schizophreniform disorder; aged between 18 and 51 years; residual symptoms of psychosis despite treatment with a stable dose of antipsychotic medication for at least 4 weeks. Menstrual cycle characteristics including regularity, cycle length and menstrual associated symptoms were documented. Symptoms of schizophrenia were measured using Positive and Negative Syndrome Scale, cognition was measured using Repeatable Battery for the Assessment of Neuropsychological Status and depression was assessed using the Montgomery-Asberg Depression Rating Scale. Blood samples were collected at baseline for hormone assays. Of the 139 women, 77 (55.4%) had regular menses, 57 (41%) had irregular menses and 5 (3.6%) women had missing data on their menstrual cycle. Use of atypical antipsychotics associated with hyperprolactinaemia was positively associated with irregular menses (odds ratio = 4.4, 95% confidence interval = [1.8, 10.9], p = 0.001), while age more than 30 years was negatively associated (odds ratio = 0.3, 95% confidence interval = [0.1, 0.6], p = 0.004). Women with

  8. Trigger factors mainly from the environmental type are reported by adolescents with migraine

    Directory of Open Access Journals (Sweden)

    Marcela Dalla Bernardina Fraga

    2013-05-01

    Full Text Available Migraine can be triggered by many factors such as stress, sleep, fasting and environmental causes. There are few studies that evaluated migraine trigger factors in the adolescent population. Methods: A total of 100 participants from 10 to 19 years were subjected to a detailed headache questionnaire, with demographic and clinical data, and a headache diary including trigger factors during a two-month period was asked. Results: Fifty of the participants exhibited chronic migraine and the other 50 participants demonstrated episodic migraine. The most common group of trigger factors reported was the environmental one, mainly sun/clarity, followed by hot weather and the smell of perfume. Conclusions: Ninety-one percent of children and adolescents with migraine reported a trigger factor precipitating the migraine attack.

  9. Obesity and Headache/Migraine: The Importance of Weight Reduction through Lifestyle Modifications

    Directory of Open Access Journals (Sweden)

    Alberto Verrotti

    2014-01-01

    Full Text Available The aim of this study is to determine a possible relationship between prevalence, frequency, and severity of migraine and obesity. All pertinent data from the literature have been critically examined and reviewed in order to assess the possible relationship between obesity and migraine, in particular migraine frequency and disability in children, as well as in adult population studies. Prevalence, frequency, and severity of migraine appear to increase in relation to the body mass index, although this evidence is not supported by all the studies examined. Data from literature suggest that obesity can be linked with migraine prevalence, frequency, and disability both in pediatric and adult subjects. These data have important clinical implications and suggest that clinicians should have a special interest for weight reduction of obese children suffering from migraine, prescribing and supporting intensive lifestyle modifications (dietary, physical activities, and behavioral for the patient and the entire family.

  10. Advances in Migraine Mechanisms and Treatment

    Directory of Open Access Journals (Sweden)

    J Gordon Millichap

    2004-02-01

    Full Text Available Migraine mechanisms are discussed in relation to familial hemiplegic migraine (FHM genotypes by investigators from the Massachusetts General Hospital, Boston, and Universities in Ankara, Turkey.

  11. Calcitonin gene-related peptide targeted immunotherapy for migraine: progress and challenges in treating headache.

    Science.gov (United States)

    Peroutka, Stephen J

    2014-06-01

    A role for calcitonin gene-related peptide (CGRP) in the pathophysiology of migraine has been established over the past 25 years. There have now been at least five different small-molecule CGRP antagonists that have demonstrated statistical proof of efficacy in the acute treatment of migraine. At present, multiple clinical trials are underway that are assessing the ability of long-acting antibodies against CGRP to prevent frequent migraine attacks. This review summarizes the existing data concerning the role of CGRP in migraine and attempts to highlight some possible outcomes from the ongoing anti-CGRP antibody trials.

  12. Bipolar Affective Disorder and Migraine

    Directory of Open Access Journals (Sweden)

    Birk Engmann

    2012-01-01

    Full Text Available This paper consists of a case history and an overview of the relationship, aetiology, and treatment of comorbid bipolar disorder migraine patients. A MEDLINE literature search was used. Terms for the search were bipolar disorder bipolar depression, mania, migraine, mood stabilizer. Bipolar disorder and migraine cooccur at a relatively high rate. Bipolar II patients seem to have a higher risk of comorbid migraine than bipolar I patients have. The literature on the common roots of migraine and bipolar disorder, including both genetic and neuropathological approaches, is broadly discussed. Moreover, bipolar disorder and migraine are often combined with a variety of other affective disorders, and, furthermore, behavioural factors also play a role in the origin and course of the diseases. Approach to treatment options is also difficult. Several papers point out possible remedies, for example, valproate, topiramate, which acts on both diseases, but no first-choice treatments have been agreed upon yet.

  13. 尼莫地平联合多虑平治疗偏头痛的临床疗效观察%Clinical effect of Nimodipine and Doxepin in Treatment of Migraine

    Institute of Scientific and Technical Information of China (English)

    窦智

    2016-01-01

    Objective To observe the clinical effect of nimodipine and doxepin in the treatment of migraine. Methods 76 cases of patients with migraine in our hospital were selected, randomly divided into the control group ( n=38) , given nimodipine for treatment. The treatment group ( n=38 cases) was given nimodipine and doxepin for treatment. After the end of treatment, compare the therapeutic effects of two groups.Results The migraine symptoms of two groups after treatment were improved, but the improvement of frequency, duration and intensity of headache in the treatment group were better than the control group, the difference between the two groups was statistically significant (P<0.05).Conclusions The treatment of migraine by using nimodipine and small dose of doxepin is safe, reliable and obtain obvious efficacy, is worthy of clinical application.%目的:观察尼莫地平联合多虑平治疗偏头痛的临床治疗效果。方法选取我院收治的76例偏头痛患者为研究对象,随机分为对照组( n=38例)和治疗组( n=38例)。对照组给予尼莫地平进行治疗,治疗组在此基础上加用多虑平治疗,对比两组治疗效果。结果两组治疗后偏头痛症状均有改善,但治疗组治疗后头痛发作次数、持续时间及头痛强度改善明显优于对照组,两组疗效比较差异有统计学意义( P<0.05)。结论联合使用尼莫地平和小剂量多虑平治疗偏头痛安全可靠,且效果明显优于单用尼莫地平,临床上值得推广。

  14. Clinical evaluation of long-term safety and effectiveness of a third-generation thermal uterine balloon therapy system for heavy menstrual bleeding.

    Science.gov (United States)

    Cash, Charles; Garza-Leal, Jose; Donovan, Arthur; Guidry, Cyrus; Romanowski, Christine; Patel, Bababhai

    2012-01-01

    To estimate the incidence of amenorrhea at 36 months after treatment using a third-generation thermal uterine balloon therapy (UBT) system and to compare it with the first-generation UBT system. The secondary objective was to estimate the effect of post-procedure curettage on patient outcomes at 36 months after endometrial ablation. Multicenter controlled study (Canadian Task Force classification I). Thirteen hospitals: 12 in the United States and 1 in Mexico. Two-hundred fifty premenopausal women aged at least 30 years with heavy menstrual bleeding not responsive to previous medical therapy for at least 3 months. After treatment with a third-generation thermal UBT system, patients were randomly assigned to receive post-procedure curettage (PPC) or no PPC. Amenorrhea was estimated at 12 months using individual success defined by a pictorial blood loss assessment chart score of 0, and at 24- and 36-month follow-up by patient response of amenorrhea on a 5-point scale (amenorrhea, spotting, and light, normal, or excessive bleeding). In the intention-to-treat population, at 36 months after ablation, the amenorrhea rate was 26.8% with the third-generation UBT system, and 13.0% with the first-generation UBT system. Results by assigned intervention were 29.8% in the no PPC group vs 23.8% in the PPC group. At extended 36-month follow-up, results were similar to the previously reported results at 1 year using prospectively defined matched-pair analysis, and demonstrated superiority in treating amenorrhea using the third-generation UBT system vs the first-generation UBT system. Copyright © 2012 AAGL. Published by Elsevier Inc. All rights reserved.

  15. Abnormal Connectivity Within Executive Resting-State Network in Migraine With Aura.

    Science.gov (United States)

    Tessitore, Alessandro; Russo, Antonio; Conte, Francesca; Giordano, Alfonso; De Stefano, Manuela; Lavorgna, Luigi; Corbo, Daniele; Caiazzo, Giuseppina; Esposito, Fabrizio; Tedeschi, Gioacchino

    2015-06-01

    To evaluate the executive control network connectivity integrity in patients with migraine with aura, in the interictal period, in comparison to patients with migraine without aura and healthy controls. Using resting-state functional magnetic resonance imaging, we compared executive control network functional connectivity in 20 patients with migraine with aura vs 20 sex and age-matched patients with migraine without aura and 20 healthy controls, and assessed the correlation between executive control network functional connectivity and clinical features of patients with migraine. We used voxel-based morphometry and diffusion tensor imaging to investigate potential structural or microstructural changes. Neuropsychological data revealed no significant executive dysfunction in patients with migraine. Resting-state functional magnetic resonance imaging showed significant group differences in right middle frontal gyrus (Talairach coordinates x, y, z: +26, +2, +48) and dorsal anterior cingulate cortex (Talairach coordinates x, y, z: +6, +13, +49), indicating that these areas had a decreased component activity in both patients with migraine with and without aura when compared with healthy controls. Conversely, there were no significant differences in the executive control network functional connectivity between patients with migraine with and without aura (P aura, in the interictal period. Although this functional phenomenon is present in the absence of clinically relevant executive deficits, it may reflect a vulnerability to executive high-demanding conditions of daily living activities in patients with migraine. © 2015 American Headache Society.

  16. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients

    Directory of Open Access Journals (Sweden)

    White Linda R

    2008-03-01

    Full Text Available Abstract Background The main objective of this study was to investigate the angiotensin converting enzyme (ACE genotype as a possible risk factor for migraine (both with and without aura compared to controls. We also wanted to examine whether a clinical response to an ACE inhibitor, lisinopril, or an angiotensin II receptor blocker, candesartan, in migraine prophylaxis was related to ACE genotype. Methods 347 migraine patients aged 18–68 (155 migraine without aura (MoA, 187 migraine with aura (MwA and 5 missing aura subgroup data and 403 healthy non-migrainous controls > 40 years of age were included in the study. A polymerase chain reaction (PCR was performed on the genomic DNA samples to obtain the ACE insertion (I/deletion(D polymorphisms. Results No significant differences between migraine patients and controls were found with regard to ACE genotype and allele distributions. Furthermore, there was no significant difference between the controls and the MwA or MoA subgroups. Conclusion In our sample there is no association between ACE genotype or allele frequency and migraine. In addition, ACE genotype in our experience did not predict the clinical response to lisinopril or candesartan used as migraine prophylactics.

  17. Lateral pterygoid muscle volume and migraine in patients with temporomandibular disorders

    Energy Technology Data Exchange (ETDEWEB)

    Castro Lopes, Sergio Lucio Pereira [Dept. of Diagnosis and Surgery, Sao Jose dos Campos Dental School, Sao Paulo (Brazil); Ferreira Costa, Andre Luiz [Dept. of Pediatric Dentistry and Orthodontics, University of Sao Paulo, Sao Paulo (Brazil); Oliveira Gamba, Thiago; Flores, Isadora Luana [Dept. of ral Diagnosis, School of Dentistry, Sao Paulo (Brazil); Cruz, Adriana Dibo [Dept. of Specific Formation, Area of Radiology, Nova Friburgo Dental School, Fluminense Federal University, Rio de Janeiro (Brazil); Min, Li Li [Laboratory of Neuroimaging, Dept. of Neurology, Faculty of Medical Sciences, Sao Paulo (Brazil)

    2015-03-15

    Lateral pterygoid muscle (LPM) plays an important role in jaw movement and has been implicated in Temporomandibular disorders (TMDs). Migraine has been described as a common symptom in patients with TMDs and may be related to muscle hyperactivity. This study aimed to compare LPM volume in individuals with and without migraine, using segmentation of the LPM in magnetic resonance (MR) imaging of the TMJ. Twenty patients with migraine and 20 volunteers without migraine underwent a clinical examination of the TMJ, according to the Research Diagnostic Criteria for TMDs. MR imaging was performed and the LPM was segmented using the ITK-SNAP 1.4.1 software, which calculates the volume of each segmented structure in voxels per cubic millimeter. The chi-squared test and the Fisher's exact test were used to relate the TMD variables obtained from the MR images and clinical examinations to the presence of migraine. Logistic binary regression was used to determine the importance of each factor for predicting the presence of a migraine headache. Patients with TMDs and migraine tended to have hypertrophy of the LPM (58.7%). In addition, abnormal mandibular movements (61.2%) and disc displacement (70.0%) were found to be the most common signs in patients with TMDs and migraine. In patients with TMDs and simultaneous migraine, the LPM tends to be hypertrophic. LPM segmentation on MR imaging may be an alternative method to study this muscle in such patients because the hypertrophic LPM is not always palpable.

  18. Food and migraine in adolescents

    Directory of Open Access Journals (Sweden)

    Magda Bouhairet

    2011-08-01

    Full Text Available Background Migraine headaches are a common problem worldwide, especially in adolescents. They are usually chronic, with frequent relapses. Therefore, any dietary risk factor for headaches has important implications on migraineurs. However, the association between migraine and diet needs to be examined further. Objective To investigate the association between diet and migraine in adolescents. Methods We conducted a cross-sectional study in August to September 2009 on 13 - 18 year old adolescents in a senior high school in Medan, North Sumatera. We included subjects diagnosed with migraine, according to the International Headache Society (IHS criteria. Ninety participants completed the questionnaire. Foods we observed for a link to migraine included milk, chocolate, ice cream, cheese, bread, instant noodles, meatballs, chili sauce, sweetener, yoghurt, pizza, and other foods and beverages. Results Of the 90 participants with migraines, there were more females (61.1% than males. There were statistically significant associations between migraine and triggering foods (P = 0.045, 95% CI 0.59 to 0.79 as well as between migraine and family history of migraine (P = 0.043, 95% CI 0.46 to 0.66. Stress (P = 0.164, menstruation (P = 0.369, and sound or light (P= 0.577 had no significant association with migraine. A wide variety of foods and beverages were implicated as migraine precipitants. The most common were chili sauce (75.8%, ice cream (71.0%, milk (67.7%, instant noodles (67.7%, chocolate (61.3%, peanuts (59.7%, cheese (54.8% and meatballs (54.8%. Conclusion Food and family history have a significant association with the occurrence of migraine in adolescents.

  19. Analysis of the Application Effect of TCM Internal Medicine Therapy in Clinical Migraine%中医内科疗法在临床偏头痛中的应用效果分析

    Institute of Scientific and Technical Information of China (English)

    李术先

    2016-01-01

    目的:分析在偏头痛患者临床治疗中,中医内科疗法的应用效果。方法选取我院于2015年1月~2016年1月收治的84例偏头痛患者为对象并将其随机均分为对照组和实验组,对照组患者接受推拿治疗,实验组患者则在此基础上接受中医内科疗法治疗,对比两组患者治疗效果。结果实验组患者治疗效果好于对照组,两组患者数据对比差异存在统计学意义(P<0.05)。结论对于偏头痛患者的治疗,中医内科疗法效果较好。%Objective Analysis the clinical treatment of patients with migraine,and the application effect of medical treatment of traditional Chinese medicine.Methods Our hospital from January 2015 to January 2016,84 patients with migraine for the object and randomly divided into control group and experimental group and control group in patients receiving the massage treatment,the experimental group patients were on the basis of medical treatment of traditional Chinese medicine treatment,compared two groups of patients with the treatment effect.Results The experimental group was better than the control group,the difference was statistically significant between the two groups(P<0.05).Conclusion For the treatment of patients with migraine,traditional Chinese medicine treatment of effect is good.

  20. Synesthesia and Migraine: Case Report

    Directory of Open Access Journals (Sweden)

    Alstadhaug Karl B

    2010-12-01

    Full Text Available Abstract Background Synesthesia is, as visual migraine aura, a common and fascinating perceptual phenomenon. Here we present a unique case with synesthesias exclusively during visual migraine auras. Case presentation A 40-year-old woman with a cyclic mood disorder had suffered from migraine with visual aura for several years. On several occasions she had experienced "mixing of senses" during the aura phase. Staring at strong bright light she could experience intense taste of lemon with flow from the salivary glands. Conclusion Acquired synesthesia, exclusively coincident with migraine aura, gives support to the idea of an anomalous cortical processing underlying the phenomenon.

  1. Lymphocyte subsets in pediatric migraine.

    Science.gov (United States)

    Cseh, Aron; Farkas, Kristof Mark; Derzbach, Laszlo; Muller, Katalin; Vasarhelyi, Barna; Szalay, Balazs; Treszl, Andras; Farkas, Viktor

    2013-07-01

    Aseptic inflammation due to activated immune cells has been implicated in the pathomechanism of migraine. We measured the prevalence of regulatory T cells (Tregs), along with that of CD4(+)/CD8(+) lymphocytes and their Th1/Th2 commitment in pediatric migraine. Children and adolescents suffering from migraine without aura, migraine with aura and hemiplegic migraine ictally (n = 53, 27, and 20, respectively), also interictally (n = 33) were recruited and compared to 24 healthy children. Our results indicated comparable prevalence of Tregs, CD4(+) and Th1/Th2 committed cells. CD8(+) prevalence was lower, and CD4(+)/CD8(+) ratio was higher in ictal phase irrespective of the subtype of migraine. No association between CD8(+) prevalence and gender, body weight, disease onset and attack duration in migraine subtypes was found. CD8(+) prevalence was normal in patients in interictal phase. These results suggest the absence of major systemic alteration of adaptive immunity in children and adolescents suffering from migraine; however, a transient decrease of CD8(+) prevalence during the ictal phase was detected irrespective of the subtype of migraine.

  2. 偏头痛采用阿司匹林和尼莫地平治疗的临床比较%Migraine treated with Aspirin and Nimodipine clinical comparison

    Institute of Scientific and Technical Information of China (English)

    陈雄颜

    2016-01-01

    Objective To explore in the treatment of migraine has the effect of Aspirin and Nimodipine,provides the experimental basis for the treatment of migraine. Methods This study selected in May 2012 to May 2014 in our hospital treatment of 114 patients with migraine, and all of the patients were randomly divided into two groups, each group has 57 patients, named as the experimental group and control group, the patients in the control group using Nimodipine for migraine headache, the experimental group of patients using aspirin treatment of migraine, record the curative effect of two groups of patients, the complications and the recurrence and a half years, etc. The experimental data, and analyze the data. Results Two groups of patients after a period of treatment, including the treatment of patients with experimental group total effective rate significantly higher than the control group patients, and with a lower rate of complications and recurrence of half a year is lower than the control group (P<0.05), there is a significant difference between two groups. Conclusion In the treatment of migraine using aspirin effect is remarkable, complications and recurrence rates are low, high safety, is worth popularizing in clinical use.%目的:探讨在治疗偏头痛方面阿司匹林和尼莫地平的效果。方法选取2012年5月—2014年5月来我院治疗的114例偏头痛患者,随机分为2组各57例,命名为试验组和对照组。对照组患者采用尼莫地平治疗,试验组患者采用阿司匹林治疗,记录2组患者的治疗效果、并发症发生情况及半年内的复发情况等,并进行对比分析。结果经过一段时间治疗后,试验组患者的治疗总有效率明显高于对照组(P<0.05),且并发症发生率、半年内复发率明显低于对照组(P<0.05)。结论阿司匹林治疗偏头痛的效果显著,并发症发生率和复发率也都比较低,安全性高,值得在临床上推广使用。

  3. Inducible nitric oxide synthase haplotype associated with migraine and aura.

    Science.gov (United States)

    de O S Mansur, Thiago; Gonçalves, Flavia M; Martins-Oliveira, Alisson; Speciali, Jose G; Dach, Fabiola; Lacchini, Riccardo; Tanus-Santos, Jose E

    2012-05-01

    Migraine is a complex neurological disorder with a clear neurogenic inflammatory component apparently including enhanced nitric oxide (NO) formation. Excessive NO amounts possibly contributing to migraine are derived from increased expression and activity of inducible NO synthase (iNOS). We tested the hypothesis that two functional, clinically relevant iNOS genetic polymorphisms (C(-1026)A-rs2779249 and G2087A-rs2297518) are associated with migraine with or without aura. We studied 142 healthy women without migraine (control group) and 200 women with migraine divided into two groups: 148 with migraine without aura (MWA) and 52 with aura (MA). Genotypes were determined by real-time polymerase chain reaction using the Taqman(®) allele discrimination assays. The PHASE 2.1 software was used to estimate the haplotypes. The A allele for the G2087A polymorphism was more commonly found in the MA group than in the MWA group (28 vs. 18%; P 0.05). The haplotype combining both A alleles for the two polymorphisms was more commonly found in the MA group than in the control group or in the MWA group (19 vs. 10 or 8%; P = 0.0245 or 0.0027, respectively). Our findings indicate that the G2087A and the C(-1026)A polymorphism in the iNOS gene affect the susceptibility to migraine with aura when their effects are combined within haplotypes, whereas the G2087A affects the susceptibility to aura in migraine patients. These finding may have therapeutic implications when examining the effects of selective iNOS inhibitors.

  4. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine.

    Science.gov (United States)

    Cloarec, Robin; Bruneau, Nadine; Rudolf, Gabrielle; Massacrier, Annick; Salmi, Manal; Bataillard, Marc; Boulay, Clotilde; Caraballo, Roberto; Fejerman, Natalio; Genton, Pierre; Hirsch, Edouard; Hunter, Alasdair; Lesca, Gaetan; Motte, Jacques; Roubertie, Agathe; Sanlaville, Damien; Wong, Sau-Wei; Fu, Ying-Hui; Rochette, Jacques; Ptácek, Louis J; Szepetowski, Pierre

    2012-11-20

    Whole genome sequencing and the screening of 103 families recently led us to identify PRRT2 (proline-rich-transmembrane protein) as the gene causing infantile convulsions (IC) with paroxysmal kinesigenic dyskinesia (PKD) (PKD/IC syndrome, formerly ICCA). There is interfamilial and intrafamilial variability and the patients may have IC or PKD. Association of IC with hemiplegic migraine (HM) has also been reported. In order to explore the mutational and clinical spectra, we analyzed 34 additional families with either typical PKD/IC or PKD/IC with migraine. We performed Sanger sequencing of all PRRT2 coding exons and of exon-intron boundaries in the probands and in their relatives whenever appropriate. Two known and 2 novel PRRT2 mutations were detected in 18 families. The p.R217Pfs*8 recurrent mutation was found in ≈50% of typical PKD/IC, and the unreported p.R145Gfs*31 in one more typical family. PRRT2 mutations were also found in PKD/IC with migraine: p.R217Pfs*8 cosegregated with PKD associated with HM in one family, and was also detected in one IC patient having migraine with aura, in related PKD/IC familial patients having migraine without aura, and in one sporadic migraineur with abnormal MRI. Previously reported p.R240X was found in one patient with PKD with migraine without aura. The novel frameshift p.S248Afs*65 was identified in a PKD/IC family member with IC and migraine with aura. We extend the spectrum of PRRT2 mutations and phenotypes to HM and to other types of migraine in the context of PKD/IC, and emphasize the phenotypic pleiotropy seen in patients with PRRT2 mutations.

  5. CGRP antagonists and antibodies for the treatment of migraine.

    Science.gov (United States)

    Vécsei, László; Szok, Délia; Csáti, Anett; Tajti, János

    2015-01-01

    Introduction: Migraine is a highly devastating neurovascular disorder that affects up to 16% of the population worldwide. In spite of intensive research, its origin remains enigmatic with no therapeutic option appropriate for all migraine patients. One of the leading hypotheses is related to the function of the calcitonin gene-related peptide (CGRP). Regardless, the pharmaceutical options currently applied for the acute and prophylactic treatment of migraine are not appropriate for all migraine patients. Areas covered: This article is based on a literature review using the PubMed database and highlights the CGRP theory of the pathomechanism of migraine. Expert opinion: Since migraine is a CGRP-related disorder, it appeared obvious to develop CGRP receptor antagonists that exert high efficacy, both intravenously and orally. Unfortunately, the frequent use of these antagonists results in an elevated liver transaminase level. In an attempt to bypass these harmful side effects, efforts should be made to modify these pharmacons. The use of fully humanized monoclonal antibodies (mAbs) that target CGRP and its receptors may also be possible. However, while Phase I and II clinical trials are promising, a long-term follow-up of these therapies is still needed.

  6. Advances in migraine management: implications for managed care organizations.

    Science.gov (United States)

    Dodick, David W; Lipsy, Robert J

    2004-05-01

    Migraine headache is a disabling disease that poses a significant societal burden. Stratified care and early intervention are current strategies for migraine management. It has been shown that early treatment with triptans in select patients can improve treatment outcomes. Triptans are selective 5-HT receptor agonists that are specific and effective treatments in the management of migraine, and they meet the acute treatment goal of rapid relief with minimal side effects. Triptans are associated with improved quality of life. Factors such as speed of onset, need for a second triptan dose, and patient satisfaction should be considered in the selection of a specific triptan treatment. Appropriate treatment can decrease costs. The patient's migraine history and response to prior therapy should be considered when selecting acute treatment. Cost-effectiveness models can be used to understand the effect of treatment choices on health care budgets. The direct cost per migraine episode, driven primarily by the need for rescue medications, is important to include in economic models. All aspects of effectiveness (efficacy, tolerability, and cost) should be considered to reduce overall managed care expenditures for migraine treatment. The improved clinical profiles of the triptans provide substantial value to managed care organizations.

  7. Efficacy and tolerability of topiramate in pediatric migraine.

    Science.gov (United States)

    Cruz, Marcos J; Valencia, Ignacio; Legido, Agustín; Kothare, Sanjeev V; Khurana, Divya S; Yum, Sabrina; Hardison, Huntley H; Melvin, Joseph J; Marks, Harold G

    2009-09-01

    About 5-10% of school-age children manifest migraine headaches. Treatment options for pediatric migraine are limited. Topiramate is approved for migraine prophylaxis in adults, but its use in children is limited. We retrospectively reviewed the records of 37 patients, i.e., 22 (60%) girls and 15 (40%) boys (mean age, 14 years; range, 7.3-20.5 years), diagnosed with migraine without aura in 30 (81%), with aura in four (11%), and abdominal, ophthalmoplegic, and catamenial in one each. The mean follow-up was 12 +/- 5 months standard deviation (S.D.). Clinical response was qualified as excellent, good, no change, or worse. Numbers of headaches per month were 15 +/- 7 S.D. prior to treatment and 3 +/- 3.4 S.D. (P 50% migraine reduction) was attained in 28 patients (76%). Ten (27%) patients exhibited adverse effects. Patients taking >2 mg/kg/day were more likely to demonstrate side effects. The mean dose for patients without adverse effects was 1.27 +/- 0.7 mg/kg/day S.D. Those who reported adverse effects were taking a mean dose of 2.8 +/- 1.5 mg/kg/day S.D. This study demonstrated that topiramate is an effective, safe alternative for the prophylaxis of pediatric migraine. An acceptable risk/benefit maintenance dose was < or =2 mg/kg/day.

  8. Preventive treatment in migraine and the new US guidelines

    Directory of Open Access Journals (Sweden)

    Estemalik E

    2013-05-01

    Full Text Available E Estemalik, S TepperCleveland Clinic, Neurological Center for Pain, Cleveland, Ohio, USAAbstract: Migraine headaches are among the most common headache disorders seen in various practices. The prevalence of migraine headaches is 18% in women and 6% in men. While millions of Americans suffer from migraine headaches, roughly 3%–13% of identified migraine patients are on preventive therapy, while an estimated 38% actually need a preventive agent. The challenge among physicians is not only when to start a daily preventive agent but which preventive agent to choose. Circumstances warranting prevention have been described in the past, and in 2012, a new set of guidelines with an evidence review on preventive medications was published. A second set of guidelines provided evidence on nonsteroidal anti-inflammatory drugs, herbs, minerals, and vitamins for prevention of episodic migraine. This article describes the updated US guidelines for the prevention of migraines and also outlines the major studies from which these guidelines were derived.Keywords: US guidelines, Canadian guidelines, classification, preventive medication

  9. Impact of physician empathy on migraine disability and migraineur compliance

    Directory of Open Access Journals (Sweden)

    Hatim S Attar

    2012-01-01

    Full Text Available Aims: We aim to establish the role that perceived physician empathy plays in determining migraineurs′ outcomes and compliance with migraine management plans. We checked for associations between perceived physician empathy and clinical outcomes as well as compliance with management plans. Materials and Methods: 63 migraineurs were enrolled between July and September 2011. Questionnaire administered at the time of inclusion into the study included self-assessment of disability due to migraine (Migraine Disability Assessment Test followed by migraineurs′ assessment of physician empathy (Consultation and Relational Empathy Measure. Three months later, a telephonic questionnaire ascertained changes in disability due to migraine and compliance with migraine treatment. Statistical Analysis: Data was entered in Microsoft Excel 2010 and analyzed using SPSS 17. Pearson′s correlation was employed to analyze the significance of relationship between variables. P-value of less than 0.05 has been considered statistically significant. Results: Statistically significant positive Pearson′s correlations are seen between perceived empathy and decrease in migraine disability and symptoms over three months (P < 0.05. Significant positive relationships are also seen between perceived empathy and compliance with diet/meal timings, exercising, de-stressing/sleep pattern modification and medications (P < 0.05. Self-reported compliance is significantly correlated with improved patient outcomes (P < 0.05. Conclusions: Substantial positive associations are found between perceived physician empathy and migraineurs′ outcomes and compliance with management plans. This emphasizes the importance of empathy in migraineur-physician communication.

  10. The migraine-stroke connection: A genetic perspective.

    Science.gov (United States)

    Malik, Rainer; Winsvold, Bendik; Auffenberg, Eva; Dichgans, Martin; Freilinger, Tobias

    2016-06-01

    A complex relationship between migraine and vascular disease has long been recognized. The pathophysiological basis underlying this correlation is incompletely understood. The aim of this review is to focus on the migraine-vascular disorders connection from a genetic perspective, illustrating potentially shared (molecular) mechanisms. We first summarize the clinical presentation and genetic basis of CADASIL and other monogenic vascular syndromes with migraine as a prominent disease manifestation. Based on data from transgenic mouse models for familial hemiplegic migraine, we then discuss cortical spreading depression as a potential mechanistic link between migraine and ischemic stroke. Finally, we review data from genome-wide association studies, with a focus on overlapping findings with cervical artery dissection, ischemic stroke in general and cardiovascular disease. A wealth of data supports a genetic link between migraine and vascular disease. Based on growing high-throughput data-sets, new genotyping techniques and in-depth phenotyping, further insights are expected for the future. © International Headache Society 2015.

  11. [Tactics of acupuncture for migraine prophylaxis].

    Science.gov (United States)

    Guo, Jia

    2010-03-01

    In order to provide some more scientific and practical advice and tactics for acupuncture in prevention of migraine in clinic, a computer-based information search was conducted in MEDLINE database, and the current reports of clinical trials were summarized and a comparison of Western and Chinese research designs was made. The significant role of acupuncture for prevention of migraine has not been applied in wide range in China until the present day. However, it has been paid great attention in Western countries. This situation might be related to the differences of efficacy assessment of acupuncture between China and Western countries; meanwhile, in the past traditional acupuncturists put much stress on the therapeutic approaches for acute attacks of headache but less on prevention. It is necessary for Chinese doctors to learn from research method in the West and emphasize more on acupuncture for preventing migraine and conduct high-level clinical trials as well. The author recommends that Chinese doctors should select acupuncture points mainly according to meridian syndrome differentiation and apply long term intermittent interventions.

  12. Sleep quality and the menstrual cycle.

    Science.gov (United States)

    Romans, Sarah E; Kreindler, David; Einstein, Gillian; Laredo, Sheila; Petrovic, Michele J; Stanley, James

    2015-04-01

    This study aimed to assess the temporal relationship of subjective sleep quality to menstrual cycle phase in a community (non help-seeking) sample of adult women over six months. Previous work has produced contradictory results and often used student samples. This was a cohort study, using daily electronic data collection in the Greater Toronto Area, Ontario, Canada; 76 women aged 18-42 years recruited by random digit telephone dialing, recorded mood, sleep quality, and other health variables on a daily basis for 24 weeks. Using linear mixed models, we assessed the relationship between subjective sleep quality and three menstrual cycle phases (menses, premenstrual and midcycle) over 395 cycles. Premenstrual sleep quality was poorer than during the rest of the cycle, with a mean difference of 1.32 between premenstrual and midcycle reference phase, on a 1-100 quality scale (higher score denotes poorer quality). This difference held when the independent variables of daily exercise and physical health were added to the model; it became non-significant when perceived stress and later, social support were also added to the model. Sleep quality in adult non-help seeking women is statistically poorer in the premenstruum but the size of the difference is of little clinical significance and was no longer statistically significant with inclusion of the potentially confounding variables, perceived stress and social support. Copyright © 2014. Published by Elsevier B.V.

  13. Clinical Observation of Sibelium joint Toutongning Capsule Treatment of Migraine Headache%西比灵联合头痛宁胶囊治疗偏头痛的临床效果观察

    Institute of Scientific and Technical Information of China (English)

    孙鹏

    2014-01-01

    Objective To investigate sibelium joint Toutongning capsule treatment of migraine headache clinical observation. Methods Clinical data randomly selected 84 cases of patients with migraine hospital in May 2010-June 2011 a total of diagnosis and treatment were randomly divided into two groups, with each study group, 42 cases in which the West than the control group Toutongning capsule treatment, research group sibelium joint capsule headache treatment. Results The study group patients after clinical treatment, the effective rate was 95.24%, significantly higher than the efficiency of 76.19%, the clinical statistical analysis, there was a significant difference (P<0.05). Conclusion Sibelium joint Toutongning capsule treatment of migraine headache patients, the clinical effect is significant, no adverse reactions, safe and effective, it is worth the long-term clinical application.%目的:探讨西比灵联合头痛宁胶囊治疗偏头痛的临床效果观察。方法随机抽取本院2010年5月至2011年6月共诊治的84例偏头痛患者的临床资料,将其随机分为两组,对照组与研究组各42例,其中对照组采用西比灵胶囊治疗,研究组西比灵联合头痛宁胶囊治疗。结果研究组患者经临床治疗后,有效率为95.24%,明显高于对照组有效率76.19%,经临床统计学分析,有显著统计学差异(P<0.05)。结论西比灵联合头痛宁胶囊治疗偏头痛患者,其临床疗效显著,无不良反应,安全有效,值得临床长期推广应用。

  14. Hormonal Contraceptives and Migraine With Aura-Is There Still a Risk?

    Science.gov (United States)

    Calhoun, Anne H

    2017-02-01

    Unnecessary confusion still surrounds the use of combined hormonal contraceptives (CHCs) in the setting of migraine with aura (MwA). Clearing this confusion is a key issue for headache specialists, since most women with migraine have menstrual-related migraine (MRM), and some CHCs can prevent this particularly severe migraine. Their use, however, is still restricted by current guidelines due to concerns of increased stroke risk - concerns that originated over half a century ago in the era of high dose contraceptives. Yet studies consistently show that stroke risk is not increased with today's very low dose CHCs containing 20-25 µg ethinyl estradiol (EE), and continuous ultra low-dose formulations (10-15 µg EE) may even reduce aura frequency, thereby potentially decreasing stroke risk. This article clarifies the stroke risk of CHCs and examines their impact on migraine. It also examines how stroke risk is altered by the estrogen content of the CHC, by contributing factors such as smoking, age and hypertension, and by aura frequency. And finally, it puts these risks into a meaningful context with a risk/benefit assessment. © 2016 American Headache Society.

  15. A Markov approach to characterising the PK-PD relationship of anti-migraine drugs

    NARCIS (Netherlands)

    Maas, Hugo J.

    2007-01-01

    The objective of the investigations described in this thesis was the development of novel PK-PD modelling for the characterisation and prediction of the effects of anti-migraine drugs in clinical investigations. The Markov approach has first been applied to migraine data by Hassani and Ebutt. They

  16. Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine.

    NARCIS (Netherlands)

    Castro, M.J.; Stam, A.H.; Lemos, C.; Barros, J.; Gouveia, R.G.; Martins, I.P.; Koenderink, J.B.; Molkot, K.R. van; Mendes, A.P.; Frants, R.R.; Ferrari, M.D.; Sequeiros, J.; Pereira-Monteiro, J.M.; Maagdenberg, A.M.J.M. van den

    2007-01-01

    Familial hemiplegic migraine is a rare autosomal dominant subtype of migraine with aura. Three genes have been identified, all involved in ion transport. There is considerable clinical variation associated with FHM mutations. Genotype-phenotype correlation studies are needed, but are challenging mai

  17. Clinical Curative Effect Observation of Deanxit Joint Sibelium Treatment in Patients with Migraine%黛力新联合西比灵治疗偏头痛患者的临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    蒋永昆

    2013-01-01

    Objective To study and to explore deanxit joint sibelium treatment in patients with migraine of clinical therapeutic effect. Methods A total of 120 cases of our were migraine patients as the research object, and using the random grouping ways of putting all of the patients were divided into two groups, namely the treatment group and the control group of 60 cases and control of the patients with traditional treatments for treatment, and the treatment group of patients are using deanxit joint sibelium way to treatment, compared to two sets of patients clinical therapeutic effect. Results Ttreatment group patients after treatment, the number of migraine headache was (0.88±0.25), duration was (1.75±0.04), and control group patients after treatment, the number of migraine headache was (0.98±0.38), continuous time was (1.72±0.86), compared to P<0.05, with statistical significance. In addition, the treatment group patients after treatment, appear adverse reaction of the patients for 2 cases, and control group appeared adverse reaction of the patients for 5 cases, contrast P<0.05, has the remarkable statistical significance. Conclusion For patients with migraine in use deanxit joint sibelium way to treatment not only very safe and reliable, and has significant clinical therapeutic effect, it is worth in the modern clinical in strong popularization and application.%  目的研究并探讨黛力新联合西比灵治疗偏头痛患者的临床治疗效果。方法以我院共收治的120例偏头痛患者为研究对象,并运用随机分组的方式将所有的患者分为两组,即治疗组和对照组各60例,对照组的患者运用传统的治疗方式进行治疗,而治疗组的患者则运用黛力新联合西比灵的方式来进行治疗,对比两组患者的临床治疗效果。结果治疗组患者治疗后,其偏头痛的发作次数为(0.88±0.25),持续时间为(1.75±0.04),而对照组患者治疗后,其

  18. Calcitonin gene-related peptide does not cause migraine attacks in patients with familial hemiplegic migraine

    DEFF Research Database (Denmark)

    Hansen, Jakob M; Thomsen, Lise L; Olesen, Jes

    2011-01-01

    Calcitonin gene-related peptide (CGRP) is a key molecule in migraine pathogenesis. Intravenous CGRP triggers migraine-like attacks in patients with migraine with aura and without aura. In contrast, patients with familial hemiplegic migraine (FHM) with known mutations did not report more migraine-...

  19. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.

    Science.gov (United States)

    Deokar, Amit M; Jackson, Wendy; Omar, Hatim A

    2011-01-01

    Etonogestrel (ENG) implant is an effective method of contraception. The implant is designed to provide contraceptive efficacy for 3 years with a relatively quick return of fertility upon its removal. Menstrual irregularities are not uncommon on long-acting progestins and can often be the factor for discontinuation or removal. A retrospective chart analysis was done on 58 patients who chose to be on the ENG implant. Age ranged from 12 to 24 years. The cycle ranged from 1 to 17 months. The mean length of use of the implant was 10.9 months. Over the 20-month period, 13 ENG implants were removed because of menstrual bleeding problems. We conducted a chart review of the adolescent patients who received the ENG implant in our adolescent clinic. An analysis was done based on symptoms experienced by patients who were on the ENG implant and their management, which in some cases resulted in its removal. The data is presented on adolescent and young adult patients who receive their reproductive care in the Adolescent Medicine Clinic at the University of Kentucky, Lexington, KY, USA. ENG implant when used correctly and as indicated is extremely effective in providing contraception for up to 3 years. However, menstrual irregularities can be very troublesome and often a reason for its removal. In our experience, 22.4% (13 out of the 58 subjects) had menstrual problems post-insertion that led to its removal. It is crucial for a clinician to inform and be informed about such side effects.

  20. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis.

    Science.gov (United States)

    Hazard, Elisabeth; Munakata, Julie; Bigal, Marcelo E; Rupnow, Marcia F T; Lipton, Richard B

    2009-01-01

    Migraine is often perceived as a low-impact condition that imposes a limited burden to society and the health-care system. This study reviews the current understanding of the burden of migraine in the U.S., the history of economic understanding of migraine treatment and identifies emergent trends for future studies evaluating clinical and economic outcomes of migraine treatment. This study traced the history of economic articles published on migraine by performing a literature search using PubMed MEDLINE database and ancestral searches of relevant articles. The intention was not to provide an exhaustive review of every article or adjudicate between studies with different findings. Migraine affects millions of individuals worldwide, generally during the most productive years of a person's life. Studies show that migraineurs are underdiagnosed, undertreated, and experience substantial decreases in functioning and productivity, which in turn translates into diminished quality of life for individuals, and financial burdens to both health-care systems and employers. Economic evaluations of migraine therapies have evolved with new clinical developments beginning with cognitive-behavioral therapy, introduction of triptans, concern over medication overuse, and emergence of migraine prophylaxis. Now recent clinical studies suggest that migraine may be a progressive disease with cardiovascular, cerebrovascular, and long-term neurologic effects. Migraine imposes a substantial burden on patients, families, employers and societies. The economic standards by which migraine and treatment are evaluated have evolved in response to clinical developments. Emerging evidence suggests that migraine is a chronic and progressive disease. If confirmed, approaches to acute and prophylactic treatments and economic evaluations of migraine treatment may require major reconsideration.

  1. Effect of Helicobacter Pylori Treatment on the Number and Intensity of Migraine Attacks

    Directory of Open Access Journals (Sweden)

    Alireza Bakhshipour

    2012-06-01

    Full Text Available Background: Migraine is a common headache with an unknown cause. Migraine is about three times more common in women (18.2% than in men (6.2%. The recent studies have posed the possible relationship between the Helicobacter pylori infection and migraine headache. This study tries to analyze the effect of treating H. pylori infection on number and severity of migraine attacks.Materials and Methods: In this clinical pilot study, a number of 60 patients with migraine were examined in terms of infecting with H. pylori. Patients with the infections were treated by H. pylori eradication treatment standard triple regimen and the frequency and severity of their migraine attacks were measured for three months and finally the average of frequency and severity of attacks before and after treatment were compared. Results: The average frequency of the migraine attacks in patients with the H.pylori infection who have been treated was 7.1 before treatment and 2.7 after treatment (p=0.001. Likewise, the severity rate of such attacks in such patients was 9 which decreased to 4.5 after treatment (p=0.002. Conclusion: According to our study, patients with migraine attacks are preferred to be examined tested in terms of infecting with H. pylori. Thus, and eradication of this infection can be effective in decreasing of the migraine attacks.

  2. The Relationship between Attention Deficit Hyperactivity Disorder and Personality Characteristics in Migrainous Patients

    Directory of Open Access Journals (Sweden)

    Abdol Reza Sabahi

    2014-08-01

    Full Text Available Background: World Health Organization reports described migraine as one of the 4 most disabling chronic medical disorders. A day with migraine is as disabling as a day with quadriplegia, schizophrenia, or dementia in who is view 87% of people with migraine has some degree of disability. Migraine headaches are associated with psychological factors and personality characteristics. This study compares the personality characteristics of migraine patients with Attention Deficit Hyperactivity Disorder (ADHD and without ADHD. Materials and Methods: Eighty patients with migraine were evaluated in this cross sectional study with simple sampling method. All participants were assessed with semi structured clinical interview, adult ADHD self-report scale (ASRS and Millone clinical multiaxial inventory questionnaire. The migraine patients were divided into two groups, with and without ADHD. The correlation of variables was tested by χ2 test and t-test with 0.05 significance with the use of software SPSS-20. Results: Our participants were 80% female, 56% married and 36.2% with at least graduation from high school. Patients with migraine and ADHD were younger and their first headache experience had occurred in lower age compared with non-ADHD patients (p<0.05. In current study, we showed that there is a significant correlation between ADHD and depressive and independent personality traits and dysthymic clinical syndrome in migraine patients (p<0.05. Conclusion: Our results demonstrate that personality characteristics in migraine patients may be affected by some other mental disorders such as ADHD. These findings might be helpful in early treatment and prevention of dysfunctioning in patients with migraine.

  3. Vestibular migraine: the most frequent entity of episodic vertigo.

    Science.gov (United States)

    Dieterich, Marianne; Obermann, Mark; Celebisoy, Nese

    2016-04-01

    Vestibular migraine (VM) is the most common cause of episodic vertigo in adults as well as in children. The diagnostic criteria of the consensus document of the International Bárány Society for Neuro-Otology and the International Headache Society (2012) combine the typical signs and symptoms of migraine with the vestibular symptoms lasting 5 min to 72 h and exclusion criteria. Although VM accounts for 7% of patients seen in dizziness clinics and 9% of patients seen in headache clinics it is still underdiagnosed. This review provides an actual overview on the pathophysiology, the clinical characteristics to establish the diagnosis, the differential diagnosis, and the treatment of VM.

  4. Rheoencephalographic observations in migraine

    Directory of Open Access Journals (Sweden)

    B. G. L. Von Almay

    1971-12-01

    Full Text Available The pathophysiological concept of migraine presently held attributes the major changes to vascular factors. Therefore, it seemed appropriate to use rheoencephalography to test cerebral hemodynamics in cases of migraine. This very harmless and well suited method revealed: (1 on routine tracings during the painless intervall only 1/7 of the cases showed significant changes, while more than 2/3 could be classified with the help of an orthostatic stress test under REG-observation; (2 REG is more often correct for diagnosis than EEG and this does not surprise since REG monitors cerebral hemodynamics directly while EEG records activity for parenchyma and thus only secondarily depends on circulation; (3 similar conditions were previously seen in Meniere's disease where EEG also is less efficient than REG. According to the results of this study, it should be interesting to include REG in the work-up of migrainous patients. In these and under similar conditions, REG will be of diagnostic value.

  5. Discussion of clinical characteristics of epilepsy patients with migraine in 42 cases%癫痫并发偏头痛患者42例临床特点探讨

    Institute of Scientific and Technical Information of China (English)

    郭素凤; 郭丽

    2014-01-01

    目的:观察并探讨癫痫并发偏头痛的临床特点,为临床后期诊治提供参考。方法:2013年1月-2014年5月收治癫痫合并偏头痛患者42例,作为观察组;另于同期收治单纯性癫痫患者35例,作为对照组。比较患者病情、临床分型等。结果:观察组与对照组在临床分型上比较,差异无统计学意义(P>0.05);组间在癫痫的发作频率、病程上比较,P<0.05差异具有统计学意义。结论:偏头痛可能导致癫痫患者病情加重,且具有与癫痫的相似症状,患者病情复杂,临床治疗难度大。%Objective:To observe and discuss the clinical characteristics of epilepsy patients with migraine,to provide the reference for the clinical diagnosis and treatment of the late.Methods:42 epilepsy patients with migraine were selected from January 2013 to May 2014 as the observation group.35 patients with idiopathic epilepsy were selected at the same time as the control group.The disease and clinical classification of patients were compared.Results:The patients of the observation group and the control group were compared in clinical classification,and there was no statistical significance(P>0.05).The epileptic seizure frequency, the duration of symptoms were compared between groups,and P<0.05 there was statistical difference.Conclusion:Migraine may cause epilepsy patients aggravating.It has similar symptoms with epilepsy.The patients' condition is complex,and clinical treatment is difficult.

  6. Shared mechanisms of epilepsy, migraine and affective disorders.

    Science.gov (United States)

    Zarcone, Davide; Corbetta, Simona

    2017-05-01

    Since the nineteenth century several clinical features have been observed in common between migraine and epilepsy (such as episodic attacks, triggering factors, presence of aura, frequent familiarity), but only in recent years researchers have really engaged in finding a common pathogenic mechanism. From studies of disease incidence, we understand how either migraine among patients with epilepsy or epilepsy among migraine patients are more frequent than in the general population. This association may result from a direct causality, by the same environmental risk factors and/or by a common genetic susceptibility. Ischemic events are the most frequent direct causes, especially among women and elderly people: migraine can lead to silent or clinically considerable strokes, and these ones could explain the increased risk of developing epilepsy in people with a history of migraine. Head injuries can lead headache, often with migraine characteristics, and seizures. But there are also many idiopathic cases. The comorbidity migraine-epilepsy might be explained in these cases by a neuronal hyperexcitability, which increases the risk of both diseases: a higher concentration of extracellular glutamate, the main excitatory neurotransmitter, leads in fact as a result a Cortical Spreading Depression (the pathophysiological mechanism at the base of aura) and convulsions; antiepileptic drugs such as topiramate are, therefore, used also in migraine prophylaxis. A genetic link between these two diseases is particularly evident in familial hemiplegic migraine: mutations of ATP1A2, SCN1A and CACNA1A genes, identified in this disease, have also been involved in different types of epilepsy and febrile seizures. The channelopathies, especially engaging sodium and potassium ions, can be the common pathogenic mechanism of migraine and epilepsy. Both migraine and epilepsy also have, compared to the general population, a higher prevalence and incidence of affective disorders such as anxiety

  7. Automatic Dehumanization Across Menstrual Cycle

    OpenAIRE

    Piccoli, Valentina; Carnaghi, Valentina; Foroni, Francesco; Hvastja Stefani, Loredana

    2014-01-01

    In the current study we address the role of hormonal fluctuations across menstrual cycle in female dehumanization of women and men. Using a sequential priming procedure in a lexical decision task, we test whether increased levels of conception risk lead to dehumanization of other women and men on both animal and human dimensions. Results showed that for word woman as the prime, animal words were more accessible in the high than in the low conception risk of the menstru...

  8. Trigger factors for familial hemiplegic migraine

    DEFF Research Database (Denmark)

    Hansen, Jakob Møller; Hauge, Anne Werner; Ashina, Messoud

    2011-01-01

    The aim was to identify and describe migraine trigger factors in patients with familial hemiplegic migraine (FHM) from a population-based sample.......The aim was to identify and describe migraine trigger factors in patients with familial hemiplegic migraine (FHM) from a population-based sample....

  9. Trigger factors for familial hemiplegic migraine

    DEFF Research Database (Denmark)

    Hansen, Jakob Møller; Hauge, Anne Werner; Ashina, Messoud

    2011-01-01

    The aim was to identify and describe migraine trigger factors in patients with familial hemiplegic migraine (FHM) from a population-based sample.......The aim was to identify and describe migraine trigger factors in patients with familial hemiplegic migraine (FHM) from a population-based sample....

  10. The Psychometric Properties of the Persian Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraines

    Directory of Open Access Journals (Sweden)

    Alireza Zandifar

    2013-01-01

    Full Text Available Background. Migraine-specific quality of life (MSQ is a valid and reliable questionnaire. Linguistic validation of Persian MSQ questionnaire, analysis of psychometric properties between chronic and episodic migraine patients, and capability of MSQ to differentiate between chronic and episodic migraines were the aims of this study. Method. Participants were selected from four different neurology clinics that were diagnosed as chronic or episodic migraine patients. Baseline data included information from MSQ v. 2.1, MIGSEV, SF-36, and symptoms questionnaire. At the third week from the baseline, participants filled out MSQ and MIGSEV. Internal consistency (Cronbach alpha and test-retest reproducibility (intraclass correlation coefficients were used to assess reliability. Convergent and discriminant validities were also assessed. Results. A total of 106 participants were enrolled. Internal consistencies of MSQ among all patients, chronic and episodic migraines, were 0.92, 0.91, and 0.92, respectively. Test-retest correlation of MSQ dimensions between visits 1 and 2 varied from 0.41 to 0.50. Convergent, item discriminant, and discriminant validities were approved. In all visits MSQ scores were lower in chronic migraine than episodic migraine; however, the difference was not statistically significant. Conclusion. Persian translation of MSQ is consistent with original version of MSQ in terms of psychometric properties in both chronic and episodic migraine patients.

  11. Familial Hemiplegic Migraine and Spreading Depression

    Directory of Open Access Journals (Sweden)

    Hadi KAZEMI

    2014-07-01

    Full Text Available How to Cite This Article: Kazemi H, Speckmann EJ, Gorji A. Familial Hemiplegic Migraine and Spreading Depression. Iran J Child Neurol. 2014 Summer;8(3: 6-11. AbstractObjectiveFamilial hemiplegic migraine (FHM is an autosomal dominantly inherited subtype of migraine with aura, characterized by transient neurological signs and symptoms. Typical hemiplegic migraine attacks start in the first or second decade of life. Some patients with FHM suffer from daily recurrent attacks since childhood. Results from extensive studies of cellular and animal models have indicated that gene mutations in FHM increase neuronal excitability and reduce the threshold for spreading depression (SD. SD is a transient wave of profound neuronal and glial depolarization that slowly propagates throughout the brain tissue and is characterized by a high amplitude negative DC shift. After induction of SD, S218L mutant mice exhibited neurological signs highly reminiscent of clinical attacks in FHM type 1 patients carrying this mutation. FHM1 with ataxia is attributable to specific mutations that differ from mutations that cause pure FHM1 and have peculiar consequences on cerebellar Cav2.1 currents that lead to profound Purkinje cell dysfunction and neuronal loss with atrophy. SD in juvenile rats produced neuronal injury and death. Hormonal factors involved in FHM affect SD initiation and propagation. The data identify SD as a possible target of treatment of FHM. In addition, FHM is a useful model to explore the mechanisms of more common types of migraine. ReferencesRussell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011 (5:457-70.The International Classification of Headache Disorders, 3rd edition (beta version.Headache Classification Committee of the International Headache Society (IHS. Cephalalgia2013;33(9:629-808.Thomsen LL, Eriksen MK, Roemer SF

  12. Cerebral angiography in patients with complicated migraine

    Energy Technology Data Exchange (ETDEWEB)

    Zeiler, K.; Wessely, P.; Holzner, F.

    1985-08-01

    38 patients (mean age: 29 years) were investigated by means of complete 4-vessel angiography: all of them were suffering from complicated migraine without detectable vascular malformation. Stenoses of the great craniocervical vessels were found in 11 patients (28.9%), but there was not a single case of vascular occlusion. A correlation between the localization of the stenosis, the localization of the headache and the presumed region of the transient cerebral function disturbance was found only in a few patients. Concerning the morphological changes of the small intracranial arterial branches, there was hardly an difference between clinically affected and non-affected territories of the middle cerebral artery. The angiograms of the 38 cases of complicated migraine were compared with the angiograms of 40 patients suffering from strokes in the young and those of 49 patients with transient ischaemic attacks. There were remarkably fewer stenoses or occlusions in the great craniocervical arteries of patients suffering from complicated migraine (28.9%) than in the vessels of cases of stroke in the young (52.5%). However, the incidence was comparable with the results in patients with transient ischaemic attacks (34.7%). The degree of morphological changes in the small intracranial arterial branches is likely to depend primarily on the patient's age and less on the diagnosis. The results suggest that in almost 30% of patients with complicated migraine - even at juvenile age-stenoses of the great craniocervical vessels might be found. However, considering the fact that most of the stenoses are without haemodynamic significance and their localization is not in agreement with the clinical data, the pathogenetic value of these vessel wall changes is highly questionable. (Author).

  13. Ion channelopathies and migraine pathogenesis.

    Science.gov (United States)

    Albury, Cassie L; Stuart, Shani; Haupt, Larisa M; Griffiths, Lyn R

    2017-08-01

    Migraine is a common neurological disorder that affects approximately 12-20% of the general adult population. Migraine pathogenesis is complex and not wholly understood. Molecular genetic investigations, imaging and biochemical studies, have unveiled a number of interconnected neurological pathways which seem to have a cause and effect component integral to its cause. Much weight of migraine attack initiation can be placed on the initial trigger and the pathways involved in its neuronal counter reaction. Ion channels play a large role in the generation, portrayal and mitigation of the brains response to external triggers. Several genetic studies have identified and implicated a number of ion channelopathy genes which may contribute to this generalised process. This review will focus on the genetics of migraine with particular emphasis placed on the potentially important role genes HEPH (responsible for iron transport and homeostasis) and KCNK18 (important for the transport and homeostasis of potassium) play in migraine cause.

  14. Analysis of Clinical Characteristics of Patients with Epileptic Patients with Migraine%神经内科癫痫并发偏头痛患者临床特点分析

    Institute of Scientific and Technical Information of China (English)

    王立崚; 钟志强; 刘建勋; 吴尉; 朱春雨; 周秀玉

    2015-01-01

    Objective To explore the clinical treatment of epilepsy with analysis of patients with migraine,looking for a suitable treatment method for this kind of patients,improve the clinical condition. Methods In 2012 ~2014 year my courtyard has a total of 156 cases of epilepsy patients receiving treatment, these patients were grouped into the observation group and the control group, the observation group of 86 cases of complicated migraine patients, the control group of 70 patients with epilepsy, analysed on two groups of patients with clinical, clinical characteristics of two groups of patients. Results The observation group and the comparison between the groups of patients with epilepsy type has no significant dif erence, no statistical significance, and the >0.05, with comparable;in the proportion of women, and the average duration of seizure frequency of epilepsy and other aspects, the dif erence between the two groups of patients significantly, and 0.05,具有可比性;在女性比例、癫痫发作频率以及平均癫痫病程等方面,两组患者之间差异显著,且<0.05,具有统计学意义。结论在为癫痫患者提供治疗的时候发现,如果患者并发偏头痛,则会让病情更加严重,对临床治疗产生一定影响,所以,治疗的时候需要对患者的临床症状给予了解,提供针对性的措施。

  15. Precipitating and Relieving Factors of Migraine Headache in 200 Iraqi Kurdish Patients

    Directory of Open Access Journals (Sweden)

    Ehsan K. Al-Shimmery

    2010-07-01

    Full Text Available Objectives: To study the precipitating and relieving factors of migraine headache in a group of Iraqi Kurdish patients including the effect of fasting in Ramadan, and to estimate the percentage of family history of migraine. Methods: A series of 200 migraine cases from different parts of the Kurdistan region in the North of Iraq attending the out-patient Neurology clinic at Rizgary Teaching Hospital and a private Neurology clinic at Erbil City was carried out between October 2007 and May 2008 were reviewed. The precipitating factors and relieving factors for migraine headache were registered and tabulated to be compared with others. Case definition of migraine was based on the International Headache Society (IHS criteria.Results: 33% of the patients were aged between 30-39 years, while 40.5% of patients experienced their first attack aged between 20-29 years. Stress or psychological upset was the commonest triggering factor (80%, followed by increasing physical activity (68%, change in weather (65.5%, and in relation to fasting (65%. Fasting in Ramadan was a triggering factor for headaches in 65% of patients. However, there was no significant association between the triggering factors with regards to sex difference. Relief of migraine in the studied sample was achieved using NSAIDs in 50% of patients, and sleep (45.5%. Hence, 61% of the study population had positive family history of migraine, 32.5% of them reported maternal history of migraine. Conclusion: Psychological upset, stress and excessive physical activity were the commonest triggering factors of migraine headache, while NSAID was the commonest relieving factor of migraine in this population. Family history was present in 61% of migraine patients based mainly from maternal root.

  16. Comorbidity of migraine in children presenting with epilepsy to a tertiary care center.

    Science.gov (United States)

    Kelley, Sarah A; Hartman, Adam L; Kossoff, Eric H

    2012-07-31

    Migraine and epilepsy are 2 of the most common neurologic disorders in children. In this cross-sectional study we investigated a population of children with epilepsy to determine if children with a greater seizure burden or certain epilepsy syndromes had a higher risk of migraines. We also examined how often migraine is addressed and treated in a pediatric epilepsy cohort. Between January 2010 and March 2011 we distributed questionnaires regarding headache symptoms and treatment to consecutive children with epilepsy seen in clinic at Johns Hopkins Hospital (400 children were studied). Records were subsequently reviewed for seizure type, age at onset, and treatment. The prevalence of migraine in our pediatric epilepsy population was 25%, which is greater than reported for children without epilepsy (3%-23%). Migraine was more prevalent in children ≥10 years (p = 0.0009), children with benign epilepsy with centrotemporal spikes (BECTS) (p = 0.003), and children with juvenile myoclonic epilepsy (JME) (p = 0.008). Migraine onset was more likely to have occurred after epilepsy was diagnosed (p = 0.0002), but was not more prevalent in those with intractable epilepsy. Only 50% of patients with weekly or greater migraines had documented discussions regarding headaches with their neurologist. Migraine was comorbid in one-quarter of children with epilepsy in a tertiary care center. Children who were older or who had BECTS or JME were more likely to have migraines. Migraines were infrequently addressed within the neurology clinic. It is imperative to address comorbid migraine in treating children with epilepsy.

  17. Clinical Study of Exemption Decoct Chinese Traditional Medicine in the Treatment of Migraine%免煎中药治疗偏头痛的的临床研究

    Institute of Scientific and Technical Information of China (English)

    侯继承

    2016-01-01

    Objective This project is mainly to avoid Fried oral medicine clinical research for the treatment of migraine. Methods Randon selection our hospital on April 2010 — July 2011 in and outpatient therapy, diagnosis and treatment of 100 patients with migraine patients, were randomly divided into two groups: treatment group and control group, 56 cases in the treatment group and 44 cases in the control group, the treatment group treated with calming the liver to stop the wind, Tongluozhitong effect of free Decoction; control group with Zhengtian pill in the treatment, effect of treatment of two groups were observed and compared between two groups, through scientific statistics. Analysis concluded, it is demonstrated that the free decoct Chinese traditional medicine treatment of migraine method advantage. Results Through the clinical observa-tion, the treatment group efficiency is 71%. In the control group efficiency is 63%. In terms of efficacy of TCM syndrome, treatment group was significantly higher than that of the control group. Comparing the result of two groups, the efficiency difference is significant (P< 0.05). Conclusion Avoid Fried oral medicine for the treatment of migraine than other safe and convenient method to treat the disease, cheap, and greatly improve the cure rate and effective. Opens a new way of tradi-tional Chinese medicine treatment of migraine.%目的:该项目主要探讨免煎中药口服治疗偏头痛的临床疗效。方法随机选取该院在2010年5月—2011年7月在门诊及疗区诊治的100例偏头痛的患者,随机分为治疗组和对照组两组,治疗组56例,对照组44例,治疗组单纯应用具有平肝熄风,通络止痛作用的免煎中药;对照组应用正天丸治疗,观察和比较两组患者治疗的效果,通过科学的统计,分析得出结论,论证出免煎中药治疗偏头痛方法的优势。结果通过临床病例观察,治疗组的有效率为71%;对照组的有效率为63%

  18. 中医辨证治疗偏头痛40例疗效分析%Effect of dialectical traditional Chinese medicine therapy in 40 cases of migraine

    Institute of Scientific and Technical Information of China (English)

    杨东妮

    2002-01-01

    @@ Background: Migraine is a common clinical symptom of paroxysmal nerve- vessel dysfunction.There have been 80 cases of migraine in this report, including 40 cases treated by dialectical traditional Chinese medicine.

  19. Multiple sclerosis presenting initially with a worsening of migraine symptoms.

    Science.gov (United States)

    Lin, Guan-Yu; Wang, Chih-Wei; Chiang, Tsung-Ta; Peng, Giia-Sheun; Yang, Fu-Chi

    2013-08-09

    Multiple sclerosis (MS) is a chronic autoimmune disease that targets myelinated axons in the central nervous system. Headache has been reported as a subtle symptom of the onset of MS, with a variable frequency of 1.6-28.5%; however, it remains unclear whether headache is a true symptom of MS onset. Here, we report the case of a female patient who had a history of migraine without aura and experienced worsening of migraine-headache symptoms as the initial manifestation of MS. Three similar cases were reported previously; however, unlike this case, those cases had no history of migraine without aura. In our case, we excluded factors that could trigger migraine attacks, such as changes in weather, drugs, alcohol, caffeine withdrawal, stress, fatigue, lack of sleep, hormonal therapy, diet, and hunger. The patient had one episode of MS attack with the simultaneous presence of asymptomatic gadolinium-enhancing and non-enhancing lesions, including hyperintense lesions in the bilateral periventricular white matter, body of the corpus callosum, and periaqueductal grey matter, as observed on the T2-weighted images obtained at the first brain magnetic resonance imaging. In addition, after the injection of gadolinium contrast, ring enhancement over these lesions was noted in T1-weighted images, which was suggestive of active demyelination. MS was diagnosed according to the McDonald criteria (2010 revision). We conclude that MS with periaqueductal grey matter involvement may present with worsening migraine. It is important to be cautious if any secondary causes exist, especially when the patient has a history of migraine without aura. MS should be one of the differential diagnoses in young women showing a change in headache pattern or poor clinical drug response to migraine treatment accompanied by episodes of focal neurological deficit. Failure to recognize MS may lead to inappropriate treatment and worse prognosis; early diagnosis in patients with MS is essential to improve

  20. Menstrual phase effects on smoking cessation: a pilot feasibility study.

    Science.gov (United States)

    Carpenter, Matthew J; Saladin, Michael E; Leinbach, Ashley S; Larowe, Steven D; Upadhyaya, Himanshu P

    2008-03-01

    A growing body of research suggests that nicotine withdrawal and cigarette craving may vary across the menstrual cycle and that the luteal phase of the cycle may be associated with increases in each. This potential relationship suggests that careful timing of quit attempts during the menstrual cycle may improve initial success at abstinence, although there are no direct tests of this approach yet published. Our objectives were to preliminarily test the effect of timing of quit attempts for smoking cessation relative to menstrual cycle and to identify methodological procedures that could guide subsequent, larger clinical trials. In this pilot study, we randomized female smokers aged 18-40 who were not currently using hormonal contraception to quit smoking during either the follicular (n = 25) or luteal phase (n = 19) of their menstrual cycle. Participants were provided with two sessions of smoking cessation counseling (90 minutes total). All participants were provided with a transdermal nicotine patch contingent on maintenance of abstinence throughout the course of the 6-week study. Among participants who initiated treatment, received the patch, and made a quit attempt (n = 35), carbon monoxide-verified repeated point prevalence abstinence 2 weeks after the target quit date was higher in the follicular than the luteal group (32% vs. 19%, respectively; OR = 2.0, 95% CI = 0.4-9.8). Within the overall study population, this difference was slightly lower (24% vs. 16%; OR = 1.7, 95% CI = 0.4-7.8). Timing quit attempts based on menstrual phase is feasible. Insights gained from this study and the recommendations made herein may inform future research on this important clinical question.

  1. 血府逐瘀胶囊与西比灵联合治疗偏头痛60例临床观察%Clinical Observation of Xuefuzhuyu Capsule and Sibelius Capsule on 60 cases of Migraine

    Institute of Scientific and Technical Information of China (English)

    张艳

    2014-01-01

    Objective: To observe the clinical efficacy of Xuefuzhuyu capsule Sibelius capsule on Migraine. Methods: The 120 patients with migraine were randomly divided into two groups; the 60 patients were given oral treatment Sibelius capsule in control group, and the 60 patients were treated Xuefuzhuyu capsule as well as Sibelius capsule in treatment group. Both groups were treated for 30 consecutive days. The clinical symptoms, signs, blood theology and TCD examination results were analyzed. Results: The total effective rate was 78.3% in control group, and 93.3% in treatment group, which was significantly better than the control group (P<0.05). Conclusion: Xuefuzhuyu capsules can provide significant effect for migraine, and the combination with Sibelius was able to achieve a more favorable clinical outcomes.%目的:观察血府逐瘀胶囊联合西比灵治疗偏头痛的临床疗效。方法:将120例偏头痛患者随机分为两组,对照组60例给予西比灵口服治疗;治疗组60例在此基础上加用血府逐瘀胶囊治疗;两组均连续治疗30 d。观察两组患者临床症状及体征,并对血液流变学指标和TCD检查结果进行对比分析。结果:对照组总有效率为78.3%,治疗组总有效率为93.3%,治疗组临床疗效明显优于对照组(P<0.05)。结论:血府逐瘀胶囊治疗偏头痛具有显著疗效,其与西比灵联合使用临床疗效更好。

  2. College Women's Perceptions of Anxiety and Menstrual Distress across the Menstrual Cycle

    Science.gov (United States)

    Szollos, Alex; Thyrum, Elizabeth; Martin, Betty

    2006-01-01

    This study investigated fluctuations in anxiety and menstrual distress across the menstrual cycle. Female college students (N = 318) completed self-report measures of symptoms across the menstrual cycle and measures of general psychological adjustment. A subgroup (n = 56) of Anxious participants who reported high levels of anxiety was identified.…

  3. Calcitonin gene-related peptide does not cause migraine attacks in patients with familial hemiplegic migraine

    DEFF Research Database (Denmark)

    Hansen, Jakob M; Thomsen, Lise L; Olesen, Jes

    2011-01-01

    Calcitonin gene-related peptide (CGRP) is a key molecule in migraine pathogenesis. Intravenous CGRP triggers migraine-like attacks in patients with migraine with aura and without aura. In contrast, patients with familial hemiplegic migraine (FHM) with known mutations did not report more migraine......-like attacks compared to controls. Whether CGRP triggers migraine-like attacks in FHM patients without known mutations is unknown....

  4. Clinical Treatment Experience of Xuefu Zhuyu Decoction in Treatment of Migraine%血府逐瘀汤治疗偏头痛的临床体会

    Institute of Scientific and Technical Information of China (English)

    刘玉红

    2015-01-01

    Objective Treatment approach and its effect of Xuefu Zhuyu decoction in treatment of migraine are to be investigated. Methods We chose 69 migraine patients who were treated in hospital from July 2013 to August 2014 and separated them into control group and study group at random,38 patients in study group were given xuefu zhuyu decoction treatment,while 31 patients in control group were given topiramate medication treatment, and then compared treatment effects as well as treatment safety between two groups. Results Treatment effect in study group was up to 94.74%,while treatment effect in control group was 80.65% and in addition,patients’ migraine attack times and its average attack duration in study group were less than those in control group. There was a treatment differential between two groups and such a differential had statistic value(P <0.05). Conclusion Xuefu zhuyu decoction is of efficacy in treatment of migraine,it is conducive to relieving patients’ illness symptoms with higher medication safety and less complication incidence.%目的:探究偏头疼患者采用血府逐瘀汤治疗的方法和效果。方法选取2013年7月~2014年8月收治的69例偏头痛患者进行治疗,随机分组,实验组38例患者选择血府逐瘀汤的治疗,对照组31例患者选择托吡酯的治疗,对比患者的治疗效果和安全度。结果实验组患者治疗有效率为94.74%,对照组患者治疗有效率为80.65%。且实验组患者的发作次数和平均每次发作的持续时间小于对照组,治疗效果差异有统计学意义(P<0.05)。结论偏头痛患者采用血府逐瘀汤的治疗,可促使偏头痛症状得到缓解,药物的安全性高,不良反应较少,效果显著。

  5. Migraine: a comprehensive review of new treatment options.

    Science.gov (United States)

    Weitzel, K W; Thomas, M L; Small, R E; Goode, J V

    1999-08-01

    Headaches are among the most common complaints reported to health care professionals and are classified by the International Headache Society as migraine, tension-type, or cluster, with additional subtypes. Classification and etiology of headache should be determined after thorough review of the patient's history. Once diagnosed, migraine can be treated by preventive or abortive measures. Recent developments add new options, including availability of drugs for intranasal administration (sumatriptan, dihydroergotamine) and 5-HT1B/1D agonists (rizatriptan, zolmitriptan, naratriptan, eletriptan). Although placebo-controlled trials are available, few comparative clinical trials of these agents have been conducted; however, important pharmacologic, pharmacokinetic, and clinical differences exist among the drugs.

  6. Optimal timing for performing hysterectomy according to different phase of menstrual cycle: Which is best?

    Science.gov (United States)

    Kim, Jeong Jin; Kang, Jun Hyeok; Lee, Kyo Won; Kim, Kye Hyun; Song, Taejong

    2017-05-01

    The aim of this study was to determine whether the different phases of the menstrual cycle could affect operative bleeding in women undergoing laparoscopic hysterectomy. This was a retrospective comparative study. Based on the adjusted day of menstrual cycle, 212 women who underwent laparoscopic hysterectomy were classified into three groups: the follicular phase (n = 51), luteal phase group (n = 125), and menstruation group (n = 36). The primary outcome measure was the operative bleeding. There was no difference in the baseline characteristics of the patients belonging to the three groups. For the groups, there were no significant differences in operative bleeding (p = .469) and change in haemoglobin (p = .330), including operative time, length of hospital stay and complications. The menstrual cycle did not affect the operative bleeding and other parameters. Therefore, no phase of the menstrual cycle could be considered as an optimal timing for performing laparoscopic hysterectomy with minimal operative bleeding. Impact statement What is already known on this subject: the menstrual cycle results in periodic changes in haemostasis and blood flow in the reproductive organs. What the results of this study add: the menstrual cycle did not affect the operative bleeding and other operative parameters during laparoscopic hysterectomy. What the implications are of these findings for clinical practice and/or further research: no phase of the menstrual cycle could be considered as an optimal timing for performing laparoscopic hysterectomy with minimal operative bleeding.

  7. Clinical Analysis of Fluoxetine in the Treatment of Migraine with Emotional Disorder%氟西汀治疗伴情绪障碍偏头痛36例临床观察

    Institute of Scientific and Technical Information of China (English)

    朱勇冬

    2015-01-01

    目的:观察氟西汀在伴情绪障碍偏头痛中的临床疗效。方法:选取71例伴情绪障碍偏头痛患者为研究对象,并随机分为对照组(n =35例)和观察组(n =36例),两组均给予盐酸硫必利治疗,观察组在此基础上再给予氟西汀治疗,对比两组的 SAS 评分、SDS 评分、症状改善情况。结果:观察组治疗后 SAS 评分、SDS 评分显著低于对照组(P <0.05);治疗3周末、6周末,观察组偏头痛发作次数和发作时间显著低于对照组(P <0.05);头痛改善程度方面,观察组“+++”例数、“++”例数显著少于对照组(P <0.05)。结论:氟西汀能够显著地改善伴情绪障碍偏头痛患者的焦虑、抑郁症状,降低偏头痛发作次数、发作时间,有效地缓解偏头痛症状。%Objective To investigate clinical effect of fluoxetine in the treatment of migraine with emotional disorder.Methods 71 cases of migraine patients from 2012 April to 2014 July in our hospital were collected,and were randomly divided into control group (n=35 cases)and observation group (n =36 cases).The control group was given tiapride ,and the observation group was given tia-pride and fluoxetine .The treatment effect of two groups were compared.Results After treatment,the SAS score,SDS score of the ob-servation group was significantly lower than that of control group (P <0.05).After 3 weeks’treatment and 6 weeks’treatment,the frequency and duration of migraine attack in the observation group was significantly lower than that in control group (P <0.05).The number of “+”and “-”in observation group was significantly more than that in control group (P <0.05).The number of “++”and “+++”in observation group was significantly less than that in control group (P <0.05).Conclusion Fluoxetine can signifi-cantly improve the symptoms of anxiety and depression,reduce the frequency and duration of migraine attack

  8. Relationship Between Migraine and Abnormal EEG Findings in Children

    Directory of Open Access Journals (Sweden)

    Habibe NEJAD BIGLARI

    2012-09-01

    , Andermann F, Bernasconi A.Characteristics of headache associated with intractable partial epilepsy. Epilepsia 2005 Aug;46(8:1241-5.The International Classification of Headache Disorders:2nd edition. Cephalalgia 2004; 24 Suppl 1:9-160.Forderreuther S, Henkel A, Noachtar S, Straube A. Headache associated with epileptic seizures:epidemiology and clinical characteristics. Headache 2002 Jul-Aug;42(7:649-55.Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 2004 Mar;44(3:230-7.Holguin J, Fenichel G. Migraine. J Pediatrics 1967 Feb;70(2:290-7.Chu ML, Shinnar S. Headaches in children younger than7 years of age. Arch Neurol 1992 Jan;49(1:79-82.Friedman E, Pampiglione G. Recurrent headache inchildren (a clinical and electroencephalographic study.Arch Neurobiol 1974;37 SUPPL:115-76.Kramer U, Nevo Y, Neufeld MY, Harel S. The valueof EEG in children with chronic headaches. Brain Dev1994 Jul-Aug;16(4:304-8.Schon F, Blau JN. Post-epileptic headache and migraine.J Neurol Neurosurg Psychiatry 1987 Sep;50(9:1148-52.

  9. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

    DEFF Research Database (Denmark)

    Hansen, Jakob Møller; Hauge, Anne Werner; Olesen, J.

    2010-01-01

    Calcitonin gene-related peptide (CGRP) is a key molecule in migraine pathogenesis. Intravenous CGRP infusion triggers delayed migraine-like attacks in patients with migraine without aura (MO). In contrast to patients with MO, in prior studies patients with familial hemiplegic migraine (FHM) did...... not report more migraine-like attacks compared to controls. Whether CGRP triggers migraine in patients with typical (non-hemiplegic) migraine with aura is (MA) unknown. In the present study we examined the migraine inducing effect of CGRP infusion in patients suffering from MA and healthy controls....

  10. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

    DEFF Research Database (Denmark)

    Hansen, Jakob Møller; Hauge, Anne Werner; Olesen, Jes

    2010-01-01

    Calcitonin gene-related peptide (CGRP) is a key molecule in migraine pathogenesis. Intravenous CGRP infusion triggers delayed migraine-like attacks in patients with migraine without aura (MO). In contrast to patients with MO, in prior studies patients with familial hemiplegic migraine (FHM) did...... not report more migraine-like attacks compared to controls. Whether CGRP triggers migraine in patients with typical (non-hemiplegic) migraine with aura is (MA) unknown. In the present study we examined the migraine inducing effect of CGRP infusion in patients suffering from MA and healthy controls....

  11. Straight Talk about Migraines, Cindy McCain Speaks Out

    Science.gov (United States)

    ... Migraine Headaches Straight Talk About Migraines, Cindy McCain Speaks Out Past Issues / Fall 2015 Table of Contents Photo: ... Headaches" Articles Straight Talk About Migraines, Cindy McCain Speaks Out / What is Migraine? / Treatment & Research Fall 2015 Issue: ...

  12. Peculiarities of Hemiplegic Migraine in Children

    Directory of Open Access Journals (Sweden)

    S. L. Moiseeva

    2015-01-01

    Full Text Available The article describes the individual peculiarities of a rare disease — hemiplegic migraine — in 3 patients (two girls aged 2 and 14 years old and a boy of 16 years. In common clinical aspect there was a correlation between the migraine-attack and the slight head trauma in all patients. Attack symptoms were almost identical: hemiparesis, aphasia, ataxia. The family history for migraine was burdened in both girls. A genetic testing in the boy and in the smallest girl demonstrated CACNA1A gene mutation, in the teen girl — ATP1A2 gene mutation. The electroencephalograms in all patients during the acute phase presented signs of hemipcortical brain dysfunction. The magnetic resonance imaging revealed prominent but reversible hemicortical oedema. The repeated MRI studies diagnosed nonrelevant for this disease hemicortical atrophy (girl 2 years and atrophy of the cerebellum (the boy. Due to the rarity of the disease so far there are no clear guidelines for its treatment and prevention. In view of the pathogenesis for the prevention patients were prescribed medications changing the activity of cytoplasmic calcium and sodium canals.

  13. The digiti quinti sign in hemiplegic migraine.

    Science.gov (United States)

    Vincent, Maurice B; Carvalho-e-Silva, Fernanda M L; Luiz, Ronir R

    2011-01-01

    The digiti quinti sign (DQS), described originally as a clinical indication of subtle motor deficit, consists of a relatively greater abduction of the fifth finger on the affected side when both arms are extended forwards. This sign was previously observed interictally in three consecutive hemiplegic migraine (HM) patients. To verify whether the DQS specifically discriminates HM from non-hemiplegic migraine (nHM), the angle between the fourth and fifth fingers (ANG) was measured interictally in 10 HM patients, 44 migraine with aura and migraine without aura patients, and 45 healthy controls. The ANG was significantly wider at the symptomatic side in HM as compared with nHM and controls. The differences between the symptomatic and non-symptomatic (for HM) or between the right and left sides (absolute values for nHM and controls) were, respectively, 10.10° ± 9.58°, 4.15° ± 3.95° and 5.37° ± 4.74° (p = .007). The optimal cutoff point for ANG was 15° at the symptomatic side (sensitivity and specificity of 80.0% and 72.2%, respectively), 10.5° at the non-symptomatic side (sensitivity and specificity of 60.0% and 52.3%), and 3° for the difference between sides (sensitivity and specificity of 90.0% and 79.5%). Data show that the DQS discriminates HM from nHM and controls.

  14. 'Visual snow' - a disorder distinct from persistent migraine aura.

    Science.gov (United States)

    Schankin, Christoph J; Maniyar, Farooq H; Digre, Kathleen B; Goadsby, Peter J

    2014-05-01

    were common comorbidities over time. Eight patients had first degree relatives with visual snow. Clinical investigations were not contributory. Only a few treatment trials have been successful in individual patients. Our data suggest that 'visual snow' is a unique visual disturbance clinically distinct from migraine aura that can be disabling for patients. Migraine is a common concomitant although standard migraine treatments are often unhelpful. 'Visual snow' should be considered a distinct disorder and systematic studies of its clinical features, biology and treatment responses need to be commenced to begin to understand what has been an almost completely ignored problem.

  15. From migraine genes to mechanisms.

    Science.gov (United States)

    Tolner, Else A; Houben, Thijs; Terwindt, Gisela M; de Vries, Boukje; Ferrari, Michel D; van den Maagdenberg, Arn M J M

    2015-04-01

    Migraine is a common multifactorial episodic brain disorder with strong genetic basis. Monogenic subtypes include rare familial hemiplegic migraine, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, familial advanced sleep-phase syndrome (FASPS), and retinal vasculopathy with cerebral leukodystrophy. Functional studies of disease-causing mutations in cellular and/or transgenic models revealed enhanced (glutamatergic) neurotransmission and abnormal vascular function as key migraine mechanisms. Common forms of migraine (both with and without an aura), instead, are thought to have a polygenic makeup. Genome-wide association studies have already identified over a dozen genes involved in neuronal and vascular mechanisms. Here, we review the current state of molecular genetic research in migraine, also with respect to functional and pathway analyses. We will also discuss how novel experimental approaches for the identification and functional characterization of migraine genes, such as next-generation sequencing, induced pluripotent stem cell, and optogenetic technologies will further our understanding of the molecular pathways involved in migraine pathogenesis.

  16. Circadian rhythms, sleep, and the menstrual cycle.

    Science.gov (United States)

    Baker, Fiona C; Driver, Helen S

    2007-09-01

    Women with ovulatory menstrual cycles have a circadian rhythm superimposed on the menstrual-associated rhythm; in turn, menstrual events affect the circadian rhythm. In this paper, we review circadian rhythms in temperature, selected hormone profiles, and sleep-wake behavior in healthy women at different phases of the menstrual cycle. The effects on menstrual cycle rhythmicity of disrupted circadian rhythms, for example, with shiftwork and altered circadian rhythms in women with menstrual-related mood disturbances, are discussed. Compared to the follicular phase, in the post-ovulation luteal phase, body temperature is elevated, but the amplitude of the temperature rhythm is reduced. Evidence indicates that the amplitude of other rhythms, such as melatonin and cortisol, may also be blunted in the luteal phase. Subjective sleep quality is lowest around menses, but the timing and composition of sleep remains relatively stable across the menstrual cycle in healthy women, apart from an increase in spindle frequency activity and a minor decrease in rapid eye movement (REM) sleep during the luteal phase. Disruption of circadian rhythms is associated with disturbances in menstrual function. Female shiftworkers compared to non-shiftworkers are more likely to report menstrual irregularity and longer menstrual cycles. There also is accumulating evidence that circadian disruption increases the risk of breast cancer in women, possibly due to altered light exposure and reduced melatonin secretion. Further investigations into the biological consequences of circadian disruption in women will offer insight into some menstrual-associated disorders, including mood changes, as well as reproductive function and possible links with breast cancer.

  17. Age at menarche and the menstrual pattern of secondary school adolescents in northwest Ethiopia

    OpenAIRE

    Megabiaw Berihun; Zegeye Desalegn; Mulu Abay

    2009-01-01

    Abstract Background Population studies on normal and dysfunctional characteristics of menstrual cycles are scarce in Ethiopia. In addition variability in menarcheal age and menstrual characteristics are common. Knowledge on this variability is necessary for patient education and to guide clinical evaluation. Methods A cross sectional study was conducted in two small towns called Dabat and Kola Diba, northwest Ethiopia between April and May 2007. Systematic sampling method was used to select 6...

  18. How menstrual shame affects birth.

    Science.gov (United States)

    Moloney, Sharon

    2010-12-01

    In Western, industrialised culture, menstruation and birth are commonly seen as unstable, pathological processes requiring medical control. Girls learn to see menstruation as shameful and secretive. Menarche is a nodal event around which girls' beliefs and attitudes to being female are organised. The perception of menstruation as a liability has foundational implications for future female experiences, particularly birth. Other cultures have recognised menstruation and birth as spiritual phenomena, with menarche and childbirth experienced as powerful initiatory processes. My PhD research explored the links between cultural attitudes to menstruation and spirituality, and women's experiences of birth. My feminist perspective recognised the power imbalances, patriarchal controls and structural inequities that oppress women in their intimate body experiences. Menstrual shame was identified as a core patriarchal organising principle that inculcates and perpetuates male dominance and female subordination. Engendering the perception of female physiology - and thus womanhood - as inherently flawed, menstrual shame was a key factor that predisposed women to approach birth feeling fearful, disempowered and vulnerable to intervention. However, my research also unearthed a counter-cultural group of women who had transformed their relationship with both menstruation and birth. Redesignating menstruation as a spiritual phenomenon enabled these women to dismantle their menstrual shame, connect with their female spirituality and give birth fearlessly and powerfully. For others, the profound spirituality of birth transformed their understanding of menstruation. Contrary to cultural norms, both menstruation and birth can be sacred female experiences which are sources of authority and empowerment. Copyright © 2010 Australian College of Midwives. Published by Elsevier Ltd. All rights reserved.

  19. Jews, Jesus, and Menstrual Blood

    Directory of Open Access Journals (Sweden)

    Marienberg Evyatar

    2016-12-01

    Full Text Available This article examines how concepts related to menstruation and menstrual blood were used by medieval Jews to insult the Christians’ God and his mother. One of the central concepts used in these exchanges was the claim that Jesus was conceived while Mary was menstruating. The article checks this and similar claims when they appear, among other places, in polemic works, such as the rather famous Toledot Yeshu (“The Genealogy of Jesus”, and in the Jewish chronicles about the massacres of Rhineland Jews during the first crusade of 1096.

  20. Menstrual regulation with prostaglandin analogues.

    Science.gov (United States)

    Hagenfeldt, K; Bygdeman, M

    1981-01-01

    The development of generally applicable, simple non-surgical methods for menstrual regulation has been desired for a long time. Such an approach to fertility control depends on the availability of a suitable therapeutic agent that should be effective, reliable, simple to administer and free from disturbing side effects. The classical prostaglandins have shown the capability but are unsuitable mainly due to high incidence of side effects. Most of these drawbacks seem to be overcome when prostaglandin analogues are used; however, vaginal administration caused appreciable pain in 10-30% of women, and so severely limits self-administration of these analogues.

  1. Women's Comedy Preferences during the Menstrual Cycle.

    Science.gov (United States)

    Meadowcroft, Jeanne M.; Zillman, Dolf

    1987-01-01

    Indicates that premenstrual and menstrual women preferred comedy over alternative choices more strongly than did women midway through the cycle. Suggests that this preference reflects a desire to overcome the hormonally mediated noxious mood states that are characteristically associated with the premenstrual and menstrual phases of the cycle. (JD)

  2. [The menstrual cycle in women with gonorrhea].

    Science.gov (United States)

    Kuntsevich, L D

    1989-01-01

    Various abnormalities of the menstrual cycle have been revealed in 9.57% of the 763 patients with gonorrhea. When the disease takes a chronic course, a wider spectrum of the cycle abnormalities develops, because of hypoestrogenia characteristic of a prolonged course of a gonococcal infection. Menstrual cycle disorders are more frequent in the women with manifest gonorrhea.

  3. The Menstrual Cycle and the Female Athlete.

    Science.gov (United States)

    Kolka, Margaret A.; Stephenson, Lou A.

    1982-01-01

    The effects of the menstrual cycle on the performance, heart rate, and body temperature of female athletes are discussed. Biological causes of menstrual problems such as dysmenorrhea and amenorrhea are explained. Research indicates that the higher the level of training achieved, the less effect each cycle phase has on physical performance. (PP)

  4. Prevalence of bruxism in children with episodic migraine - a case–control study with polysomnography

    Science.gov (United States)

    2014-01-01

    Background Parents of children with migraine have described a higher prevalence of sleep bruxism and other sleep disturbances in their children. The objective of this study was to use polysomnography to investigate the prevalence of bruxism during sleep in children with episodic migraine relative to controls. Findings Controls and patients were matched by sex, age, years of formal education, presence of snoring, arousals per hour, and respiratory events per hour. A total of 20 controls, between 6 and 12 years old, with no history of headache, recruited from public schools in Sao Paulo between 2009 and 2012, and 20 patients with episodic migraine recruited from the Headache Clinic at the Federal University of Sao Paulo between 2009 and 2012 underwent polysomnography. No intervention was performed before sleep studies. Among migraine patients, 27.5% experienced aura prior to migraine onset. The sleep efficiency, sleep latency, REM sleep latency, arousals per hour, percentage of sleep stages, and breathing events per hour were similar between groups. Five children (25%) with episodic migraine exhibited bruxism during the sleep study while this finding was not observed in any control (p = 0.045). Conclusions Our data demonstrate that bruxism during sleep is more prevalent in children with episodic migraine. Further prospective studies will help elucidate the underlying shared pathogenesis between bruxism and episodic migraine in children. PMID:24886343

  5. Higher P-Wave Dispersion in Migraine Patients with Higher Number of Attacks

    Directory of Open Access Journals (Sweden)

    A. Koçer

    2012-01-01

    Full Text Available Objective and Aim. An imbalance of the sympathetic system may explain many of the clinical manifestations of the migraine. We aimed to evaluate P-waves as a reveal of sympathetic system function in migraine patients and healthy controls. Materials and Methods. Thirty-five episodic type of migraine patients (complained of migraine during 5 years or more, BMI < 30 kg/m2 and 30 controls were included in our study. We measured P-wave durations (minimum, maximum, and dispersion from 12-lead ECG recording during pain-free periods. ECGs were transferred to a personal computer via a scanner and then used for magnification of x400 by Adobe Photoshop software. Results. P-wave durations were found to be similar between migraine patients and controls. Although P WD (P-wave dispersion was similar, the mean value was higher in migraine subjects. P WD was positively correlated with P max (P<0.01. Attacks number per month and male gender were the factors related to the P WD (P<0.01. Conclusions. Many previous studies suggested that increased sympathetic activity may cause an increase in P WD. We found that P WD of migraine patients was higher than controls, and P WD was related to attacks number per month and male gender. Further studies are needed to explain the chronic effects of migraine.

  6. The Comparison between Conceived Stress and Personality traits, in People Suffering from Migraine and Healthy People

    Directory of Open Access Journals (Sweden)

    B Peymannia

    2014-06-01

    Full Text Available Introduction: Migraine is a common familial disease and is diagnosed with recurring throbbing headache. Investigation of biological and psychological factors in the initiation and aggravation of migraine headaches have shown that there is a relationship between the psychological factors, personality, and migraine headache. Therefore, this study aimed to compare the conceived stress and Personality traits between ill persons suffering from Migraine and healthy people. Methods: This is an analytical cross-sectional study which involves a sample including 30 migrainours and 30 healthy people. The migraine-suffering participants were chosen among the people who referred to specialized clinic of migraine in Ardabil in the first half of 2012. The study participants filled the Eysenck's personality questionnaire and Kohen' s Perceived stress scale. Descriptive statistics as well as MANOVA were utilized to analyze the research data. Results: The results showed that migraine-suffering participants conceived the stress negatively (P<0.01, F=11 compared to healthy participants. Moreover, migrainours scored significantly higher in regard to Neuroticism score compared to healthy people (P<0.05, F=5.91. Also, there was a significant difference between migrainours and healthy people in their extroversion score (P<0.05, F=6.57. Conclusion: According to the study findings, it appears that migraine patients are more vulnerable to the neurotic disease. Therefore, considering the psychological and personality characteristics may impact on the prognosis of disease.

  7. Tratamento da disforia pré-menstrual com antidepressivos: revisão dos ensaios clínicos controlados Treatment of premenstrual dysphoria with antidepressants: review of controlled clinical trials

    OpenAIRE

    Elie Cheniaux

    2006-01-01

    INTRODUÇÃO: A disforia pré-menstrual (DPM), que acomete entre 3% e 8% das mulheres em idade fértil, representa uma forma mais grave de síndrome pré-menstrual, na qual predominam as alterações do humor e do comportamento. Acredita-se que haja algum tipo de ligação entre a DPM e os transtornos do humor. OBJETIVO: Estudar a eficácia dos antidepressivos na DPM. MÉTODOS: Foi realizada uma revisão dos ensaios clínicos controlados com antidepressivos no tratamento da DPM, utilizando-se as seguintes ...

  8. Clinical effcet of migraine treated by Yangxue Qingnao Granula combined with Flunarizine Hydrochloride Capsules%养血清脑颗粒加盐酸氟桂利嗪胶囊治疗偏头痛疗效

    Institute of Scientific and Technical Information of China (English)

    苏锦兴

    2011-01-01

    Objective: To explore the effect of Yangxueqingnao Granula combined with Flunarizine Hydrochloride Capsules treating patients with migraine. Methods: 108 patients with migraine were randomly divided into the study group(56 cases) and control group (52 cases), study group were given Flunarizine Hydrochloride Capsules and Yangxue Qingnao Granula, control group were given only Flunarizine Hydrochloride Capsules. To observe curative effect after one month treatment. Results: The total clinical effective rate was 89.3% of study group and 73.1% of control group.The difference was between two groups was statistically significant(P<0.05). Conclusion: Effect of Yangxueqingnao Granula combined with Flunarizine Hydrochloride Capsules treating patients with migraine is better than Flunarizine Hydrochloride Capsules used alone.%目的:观察养血清脑颗粒加盐酸氟桂利嗪(西比灵)胶囊治疗偏头痛的疗效.方法:将108例偏头痛患者分为观察组56例和对照组52例,观察组口服养血清脑颗粒每次1袋(4 g),每日3次,加盐酸氟桂利嗪胶囊10 mg,睡前顿服;对照组睡前顿服盐酸氟桂利嗪胶囊10 mg,两组均连用1个月,观察疗效.结果:观察组总有效率为89.3%,对照组总有效率为73.1%,两组总有效率比较,差异有统计学意义(P<0.05).结论:养血清脑颗粒加盐酸氟桂利嗪胶囊治疗偏头痛的疗效明显优于单独应用盐酸氟桂利嗪胶囊.

  9. Clinical observation of treating migraine patients by Toutongning capsule combined with acupuncture%头痛宁胶囊联合针刺治疗偏头痛的临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    赵宏廷; 曹骅; 刘志军

    2015-01-01

    Objective: To observe the curative effect on the migraine treated by Toutongning capsule combined with acupuncture. Methods:70 cases of migraine were divided into the control group (n=35,each group) and the treatment group.The treatment group was treated by Toutongning capsule combined with acupuncture for 30 days,while the control group was treated by acupuncture for 30 days in which the clinical effect and pain score were compared between the treatment group and the control group. Results:The total cure rate of the treatment group was 88.6%,and the total cure rate of the control group was 68.6%in which there was significant differences between two groups (P<0.05). The pain score of the treatment group was significantly lower than that of the control group in which there was significant differences between two groups (P<0.05). Conclusion: The migraine has more better treatment effect by using Toutongning capsule combined with acupuncture which is worth of applicating in the hospital.%目的:观察头痛宁胶囊联合针刺治疗偏头痛的临床疗效。方法:将70例偏头痛患者随机分为治疗组(35例)和对照组(35例),治疗组给予头痛宁胶囊联合针刺,对照组给予针刺,两组均治疗30天,对比两组患者的临床疗效和疼痛评分。结果:总有效率治疗组和对照组分别为88.6%、68.6%,疗效有明显差异(P<0.05);疼痛评分治疗组(2.21±1.65)分明显低于对照组(3.80±1.51)分,有统计学差异(P<0.05)。结论:头痛宁胶囊联合针刺治疗偏头痛安全、有效,值得临床推广应用。

  10. Psychiatric comorbidity and suicide risk in patients with chronic migraine

    Directory of Open Access Journals (Sweden)

    Maurizio Pompili

    2010-04-01

    Full Text Available Maurizio Pompili1,2, Gianluca Serafini1, Daniela Di Cosimo1, Giovanni Dominici1, Marco Innamorati1, David Lester3, Alberto Forte1, Nicoletta Girardi1, Sergio De Filippis4, Roberto Tatarelli1, Paolo Martelletti41Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy; 2McLean Hospital, Harvard Medical School, Boston,  Massachusetts, USA; 3The Richard Stockton College of New Jersey, USA; 4Department of Medical Sciences, Second School of Medicine, Sant’Andrea Hospital, Sapienza University of Rome, Rome, ItalyAbstract: The aim of this study was to explore the impact of mental illness among patients with migraine. We performed MedLine and PsycINFO searches from 1980 to 2008. Research has systematically documented a strong bidirectional association between migraine and psychiatric disorders. The relationship between migraine and psychopathology has often been clinically discussed rather than systematically studied. Future research should include sound methodologically-based studies focusing on the interplay of factors behind the relationship between migraine, suicide risk, and mental illness.Keywords: headache, migraine, suicide*, psychiatric disorders

  11. Precipitating and relieving factors of migraine versus tension type headache

    Directory of Open Access Journals (Sweden)

    Haque Badrul

    2012-08-01

    Full Text Available Abstract Background To determine the differences of precipitating and relieving factors between migraine and tension type headache. Methods This is a cross sectional study. We retrospectively reviewed the records of 250 migraine patients and 250 patients diagnosed as tension type headache from the specialized headache clinic in Dept. of Neurology, Dhaka Medical College Hospital. Data were collected through a predesigned questionnaire containing information on age, sex, social status and a predetermined list of precipitating and relieving factors. Results In this study, the female patients predominated (67%. Most of the patients were within 21–30 years age group (58.6%. About 58% of them belonged to middle class families. The common precipitating factors like stress, anxiety, activity, journey, reading, cold and warm were well distributed among both the migraine and tension type headache (TTH patients. But significant difference was demonstrated for fatigue (p  Conclusion The most frequent precipitating factors for headache appear to be identical for both migraine and TTH patients. Even though some factors like fatigue, sleep deprivation, sunlight and food significantly precipitate migraine and drug, massage are effective maneuver for relieving pain among migrianeurs.

  12. Efficacy of type a botulinum toxin injections and infrared polarized light on treating chronic migraine.

    Science.gov (United States)

    Song, J-H; Zhang, G-B; Ding, X-D; Huang, L; Hong, Y; Chen, H-X

    2015-01-01

    To investigate the clinical value of the combination of ultrasound-and-hyponome-guided type A botulinum toxin injection and infrared polarized light on treating chronic migraine. Ninety-one patients with chronic migraine were randomly divided into four groups: in the control group (group A, 22 cases in total), nimodipine was used in the treatment of chronic migraine for two months; in the infrared polarized light therapy group (group B, 22 cases in total), infrared polarized light was adopted in the treatment of chronic migraine for 50-60d; in the botulinum toxin treatment group (group C, 24 cases in total), ultrasound-and-hyponome-guided type A botulinum toxin was injected into frontal, temporal, and occipital muscles in treating chronic migraine; in the joint treatment group (group D, 23 cases in total), ultrasound-and-hyponome-guided type A botulinum toxin injection in group C and infrared polarized light in group B were both used here in the treatment of chronic migraine. Infrared polarized light therapy lasted 50-60d and the time of study lasted six months. The survey would include the conditions of patients with chronic migraine three months before treatment and at one, three and six months after treatment. Patients were asked to fill the MIDAS (migraine disability assessment questionnaire) and were graded on the evaluation scale of life quality, so that the researchers would be able to compare attack frequency, duration of attack, attack severity, the use of painkillers and their recovery from chronic migraine, and then observe their adverse reactions. Eleven cases dropped out during the treatment, three cases in A group, two cases in group B, four cases in group C and two cases in group D. One, three and six months after treatment, the MIDAS scores in group A, B, C and D were significantly lower than before the treatment. Hence, the differences were statistically significant (p polarized light on treating chronic migraine demonstrated a significant clinical

  13. Correlation Between Migraine Headaches and Obsessive-Compulsive Disorder: A Two Year Study

    Directory of Open Access Journals (Sweden)

    Zarabian MK

    2012-03-01

    Full Text Available Background: Migraine is the most common cause of headache which affects 15% of female and 6% of male populations. Patients with migraine may have psychological problems, thus, association of migraine with depression, anxiety and other psychological disorders should be considered for choosing the best management approach. Methods: In this case-control analytical study, one hundred and twenty patients with migraine were recruited among patients who attended the Psychiatry Clinic of Farshchian Hospital in Hamedan, Iran during 2008- 2009. The patients met the IHS criteria for migraine and none had disorders, such as Huntington disease, that are associated with obsessive-compulsive disorder (OCD. The people who accompanied patients attending the Internal Medicine Clinic of the Hospital and had no history of migraine headaches were recruited as the controls. Maudsleys inventory was used for the diagnosis of OCD. Finally, the data were analyzed by SPSS software. Results: In the control group, 3 (2.5% and in the case group 11 (9.17% people had OCD (P=0.024. All of those with OCD in the control group and 9 out of 11 in the case group were female. There were no cases of OCD among patients with mild migraine. Among 36 patients with moderate headache 5 (13.89% people had OCD and among 62 people with severe migraine 6 (9.68% had OCD (P=0.510. Conclusion: The prevalence of OCD in patients with migraine was significantly higher than the normal population. Special attention to comorbid conditions such as OCD is necessary in the management of migraine headaches.

  14. Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.

    Science.gov (United States)

    Alebić, Miro Šimun; Stojanović, Nataša; Baldani, Dinka Pavičić; Duvnjak, Lea Smirčić

    2016-12-01

    This cross-sectional study aimed to investigate the association between menstrual cycle lenght and metabolic parameters in non-hyperandrogenic women with polycystic ovarian morphology, n = 250. Metabolic profiles of all participants were evaluated using anthropometric parameters (body mass index, waist circumference), parameters of dyslipidemia (total cholesterol, HDL-cholesterol, triglycerides) and markers of insulin resistance (fasting insulin, homeostasis model assessment for insulin resistance index). The associations between menstrual cycle lenght and cardiometabolic risk factors such as insulin resistance, dyslipidemia, and obesity were investigated. In non-hyperandrogenic women with polycystic ovarian morphology, menstrual cycle lenght was associated with hypertriglyceridemia and insulin resistance independently of body mass index. Moreover, menstrual cycle lenght added value to body mass index in predicting hypertriglyceridemia. The optimal menstrual cycle lenght cut-off value for identifying of non-hyperandrogenic women with polycystic ovarian morphology at metabolic risk was found to be 45 days. Metabolic profile of non-hyperandrogenic women with polycystic ovarian morphology (n = 75) with menstrual cycle lenght >45 days was similar to that of hyperandrogenic women with polycystic ovarian morphology (n = 138) while metabolic profile of non-hyperandrogenic women with polycystic ovarian morphology with menstrual cycle lenght ≤45 days (n = 112) was similar to that of controls (n = 167). Non-hyperandrogenic women with polycystic ovarian morphology with menstrual cycle lenght >45 days had higher prevalence of cardiometabolic risk factors compared to those with menstrual cycle lenght ≤45 days. Non-hyperandrogenic women with polycystic ovarian morphology are not metabolically homogeneous. Menstrual cycle lenght is an easy-to-obtain clinical parameter positively associated with the probability of unfavorable metabolic status in non

  15. Childhood epileptic seizures imitating migraine and encephalitis

    Directory of Open Access Journals (Sweden)

    Kravljanac Ružica

    2012-01-01

    Full Text Available Introduction. Paroxismal events can resemble epileptic seizures, however, some epileptic seizures, especially benign occipital childhood epilepsies can imitate migraine, cycling vomiting or encephalitis. Objective. The aim of this study was evaluation of clinical and electroencephalographic (EEG features and outcome in children with benign occipital childhood epilepsies. Methods. Investigation included 18 patients with benign occipital childhood epilepsies hospitalized in the period from 2007 to 2010. The diagnosis was based on clinical and EEG characteristics of seizures, while treatment included acute therapy for seizures and chronic antiepileptic drugs. Prognosis was analyzed in terms of neurological outcome and seizure recurrence rate. Results. Benign occipital childhood epilepsy with early onset was diagnosed in 15 children. Vegetative symptoms, mostly ictal vomiting (13, eye deviation and loss of consciousness (13 dominated in the clinical presentation. The most frequent EEG findings showed occipital epileptic discharges. Benign occipital childhood epilepsy with late onset was diagnosed in three cases. Seizures were manifested by visual hallucinations, headache and secondary generalized convulsions. All three patients were administered chronic antiepileptic drugs and had good outcome. Conclusion. In our patients, clinical manifestations of benign occipital epilepsies had some similarities with clinical features of migraine and encephalitis. It could explain misdiagnosis in some of them. Knowledge about main features and differences between each of these disorders is crucial for making appropriate diagnosis.

  16. Management of migraine in adolescents

    Directory of Open Access Journals (Sweden)

    Marielle A Kabbouche

    2008-06-01

    Full Text Available Marielle A Kabbouche1,2, Deborah K Gilman31Department of Pediatrics, Department of 2Neurology, Cincinnati Children’s Hospital Medical Center; 3Department of Psychology, Columbus Children’s Hospital, OH, USAAbstract: Headaches in children and adolescents are still under-diagnosed. 75% of children are affected by primary headache by the age of 15 with 28% fitting the ICHD2 criteria of migraine. Migraine is considered a chronic disorder that can severely impact a child’s daily activities, including schooling and socializing. Early recognition and aggressive therapy, with acute and prophylactic treatments, as well as intensive biobehavioral interventions, are essential to control the migraine attacks and reverse the progression into intractable disabling headache.Keywords: migraine, children, adolescents, headache, biofeedback

  17. Arterial responses during migraine headache

    DEFF Research Database (Denmark)

    Iversen, Helle Klingenberg; Nielsen, T H; Olesen, J

    1990-01-01

    The superficial temporal artery has been thought to be the main focus of pain during migraine attacks, but its diameter has never been measured directly. The use of a new, high-resolution ultrasound machine to measure arterial size in 25 migraine patients with unilateral head pain showed...... that the lumen was wider on the painful than on the non-painful side during a migraine attack. The diameters of both radial arteries and the temporal artery on the non-painful side were smaller during than between attacks. The generalised vasoconstriction was not shared by the temporal artery on the affected...... side, which suggests a local vasodilatory response. The findings suggest that cephalic arteries may play a role in migraine pathogenesis....

  18. Study on the clinical effect of acupuncture on migraine and its biochemical mechanism%针刺治疗偏头痛的临床疗效及生化机制

    Institute of Scientific and Technical Information of China (English)

    孙忠人; 吴燕璟; 李晓捷

    2004-01-01

    背景:中医治疗偏头痛方法较多,其中针刺治疗偏头痛的疗效显著,往往收到针到痛止之奇效,故值得进一步研究.目的:明确针刺治疗偏头痛的临床疗效,并探讨针刺治疗偏头痛的生化学机制.设计:以诊断为依据的病例对照研究.地点、对象和干预:将63例偏头痛患者按随机抽签法分为针刺组(32例)和对照组(31例),观察临床疗效及治疗前后血中血小板活化因子(platelet activatingfactor,PAF),血栓烷B2,6-酮-PGF1α含量,并选择20例健康人作为正常对照组.主要观察指标:针刺对偏头痛症状的作用和对其血中PAF,血栓烷B2,6-酮-前列腺素F1α含量的影响.结果:针刺治疗对偏头痛疗效明显,总有效率达90.6%,优于对照组(x2=3.9459,P<0.05);偏头痛患者在治疗前血中PAF、血栓烷B2、6-酮-前列腺素F1α含量均高于正常对照组(t=6.416~13.144,P<0.01),而针刺组在治疗后血中PAF、血栓烷B2、6-酮-前列腺素F1α含量[(18.13±1.90)μg/L,(99.65±36.43),(20.71±4.65)ng/L]低于对照组[(22.41±2.44)μg/L,(130.56±49.74),(29.67±6.78)ng/L](t=2.807~7.752,P<0.01).结论:针刺治疗偏头痛疗效明显;PAF、血栓烷B2、6-酮-前列腺素F1α均参与偏头痛的病理过程,针刺对偏头痛患者血中PAF、血栓烷B2、6-酮-前列腺素F,α有调节作用.%BACKGROUND: Acupuncture therapy is a kind of remarkable curative means of Traditional Chinese Medicine(TCM) in the treatment of migraine, and the pain can often be alleviated as soon as the needle is inserted. Consequently, it is worth making further study.OBJECTIVE: To study the clinic effect and the biochemical mechanism of acupuncture in the treatment of migraine.DESIGN: Case-control study on the basis of diagnosis.SETTING, PARTICIPANTS and INTERVENTION: Totally 63 patients with migraine were enrolled and divided into 2 groups at random: acupuncture group(32 cases) and control group(31 cases) . The effect of the acupuncture therapy was

  19. 川菊止痛汤治疗70例偏头痛的临床观察%Clinical observation on treating 140 cases of migraine with the Chuanju Zhitong decoction

    Institute of Scientific and Technical Information of China (English)

    谢欧

    2012-01-01

      The Chuanjuzhitong decoction can significantly reduce migraine patients with levels of plasma ET treatment of migraine efficacy.%  川菊止痛汤能明显降低偏头痛患者血浆 ET 水平,治疗偏头痛疗效确切。

  20. Clinical features and relevant factors of patients with medication-overuse migraine%偏头痛患者药物过度使用性头痛的相关因素及临床特点

    Institute of Scientific and Technical Information of China (English)

    刘国勤

    2015-01-01

    Objective To explore the relevant factors and clinical features of patients with medication‐overuse mi‐graine.Methods 60 patients with medication‐overuse migraine (observation group) and another 60 patients with non‐drug ex‐cessive migraine (control group) were selected in the department of neurology in our hospital from August 2012 to August 2014.Visualanaloguescale(VAS)andtheMigrainedisabilityassessment(MIDAS)werecomparedinthetwogroup.Thecon‐tents included general data and the above clinical trial data ,which were imported into Excel 2013 and analyzed by SPSS 19.0. Results Patients'age ,disease duration of observation group compared with control group ,the difference had obviously statisti‐cal significance (P<0.01) ,and patients with a family history was statistically significant (P<0.05). The VAS score and MI‐DAS score in observation group were significantly higher than that in control group (P< 0.01).After stopping medication , 61.67% of the patients in observation group had withdrawal symptoms including irritability ,depression ,anxiety ,palpitation and so on ,and withdrawal symptoms disappeared within 3‐14d after giving symptomatic treatment timely.Conclusion The main factors of patients with medication‐overuse migraine related are age ,duration and family history.It is suggested that the levels of headache and disability are very high resulted from medication‐overuse migraine ,which could easily cause withdrawal symptoms after stopping the drug.%目的:探讨偏头痛患者药物过度使用性头痛的相关因素,并总结其临床特点。方法选取我院神经内科于2012‐08—2014‐08收治的60例药物过度使用性头痛患者以及60例非药物过度使用性头痛患者作为研究对象,对比观察2组患者的视觉模拟评分及偏头痛致残程度评分。结果观察组年龄、病程明显高于对照组(P<0.01),有家族史患者明显多于对照组(P<0.05)。观察组 VAS评分及 MIDAS

  1. Clinical Study of Deanxit Combined with Psychological Intervention in Treatment of Migraine%黛力新联合心理干预治疗偏头痛的临床研究

    Institute of Scientific and Technical Information of China (English)

    赵伟; 胡光秀; 胡新国

    2012-01-01

    Objective To investigate the curative effect of deanxit combined with psychological intervention for the treatment of migraine patients. Methods 60 migraine patients were divided into two groups, control group with conventional treatment for migraine while the case group combined with deanxit and psychological treatment, all treatment continued for 8 weeks, of the two groups, before and after treatment 8 weeks. Both groups were recorded clinic symptoms and were assessed by symptom checklist-90( SCL-90 )score,plasma5-HT was also detected at the same time. All of patients were followed-up for 1 year. Results In treatment group,the effective rate was 90.0% while 73.3% in the control group,the difference was statistically significant( X2 = 4.565, P <0.05 );with 1-year follow-up,in the treatment group,all 30 cases had no recurrence,while the control group 6 cases of recurrence,the difference was statistically significant( X2 =5. 163,P <0. 05 ). After 8 weeks of the treatment,the decline of SCL-90 total score and blood 5-HT in treatment group were significantly higher than that in control group. Conclusion Clinical symptoms improved significantly when comprehensive anti-anxiety drugs combined with psychological treatment for patients with migraine,are administered the recurrence rate and side effects are lower.%目的 探讨黛力新联合心理干预治疗对偏头痛患者的疗效.方法 随机将60例偏头痛患者分为两组,对照组常规治疗,治疗组联用黛力新和心理治疗,疗程8周.两组在入组前及治疗后8周分别记录临床症状,观察药物的不良反应,并同步进行90项症状自评量表(SCL-90)总分评定和5-羟色胺含量的测定,随访1年.结果 治疗组有效率90.0%,对照组有效率73.3%,两组比较差异具有统计学意义(χ2=4.565,P<0.05);1年后随访,治疗组30例无一例复发,而对照组6例复发,差异具有统计学意义(χ2=5.163,P<0.05).治疗8周后两组SCL-90总分和血5-羟色胺的下降

  2. Serial MRI in a case of familial hemiplegic migraine

    Energy Technology Data Exchange (ETDEWEB)

    Butteriss, D.J.A.; Birchall, D. [Department of Neuroradiology, Regional Neurosciences Centre Newcastle General Hospital, Westgate Road, NE4 6BE, Newcastle upon Tyne (United Kingdom); Ramesh, V. [Department of Paediatric Neurology, Regional Neurosciences Centre Newcastle General Hospital, Westgate Road, NE4 6BE, Newcastle upon Tyne (United Kingdom)

    2003-05-01

    We report MRI findings in a patient with familial hemiplegic migraine (FHM) with repeated episodes of hemiparesis. FHM is caused by a penetrant autosomal dominant genetic mutation; several mutations have been genotyped, involving brain-expressed ion channels. We found cerebral oedema, dilatation of intracerebral vessels and decreased water diffusion contralateral to the hemiparesis, not respecting vascular territories, with subsequent complete resolution of both clinical and imaging abnormalities. These results are thought to be consistent with an underlying primary neuronal pathology with secondary vascular effects, as opposed to the traditional, primarily vascular, model of migraine aetiology. (orig.)

  3. On the methodology of drug trials in migraine with aura

    DEFF Research Database (Denmark)

    Hauge, Anne Werner; Hougaard, Anders; Olesen, Jes

    2010-01-01

    INTRODUCTION: Specific problems occur in clinical treatment trials for migraine with aura that differ from those encountered in treatment trials for migraine without aura. DISCUSSION: Based on our experience with four such trials, we point to a number of possible solutions and outline areas...... for future inquiry. We make recommendations about subject selection; the choice, definition and assessment of outcome measures; optimal treatments in relation to aura and headache; and we provide samples of study report forms used to record occurrence of aura and headache in this population....

  4. Personality traits, personality disorders, and migraine: a review.

    Science.gov (United States)

    Davis, Rachel E; Smitherman, Todd A; Baskin, Steven M

    2013-05-01

    The personality trait of neuroticism has been associated with migraine, although research is needed to clarify potential moderators of this relationship and the extent to which neuroticism reflects a stable disposition or instead is a function of general somatic distress or situational influences. With the possible exception of harm avoidance, research has not consistently identified any other personality trait unique among migraineurs. Personality disorders have been researched less extensively, but existing data suggests that borderline personality disorder, in particular, is associated with increased negative impact of migraine, risk for medication overuse, and poor response to treatment that is likely of greater clinical importance than any personality trait per se.

  5. Migraine patients consistently show abnormal vestibular bedside tests

    Directory of Open Access Journals (Sweden)

    Eliana Teixeira Maranhão

    2015-01-01

    Full Text Available Migraine and vertigo are common disorders, with lifetime prevalences of 16% and 7% respectively, and co-morbidity around 3.2%. Vestibular syndromes and dizziness occur more frequently in migraine patients. We investigated bedside clinical signs indicative of vestibular dysfunction in migraineurs.Objective To test the hypothesis that vestibulo-ocular reflex, vestibulo-spinal reflex and fall risk (FR responses as measured by 14 bedside tests are abnormal in migraineurs without vertigo, as compared with controls.Method Cross-sectional study including sixty individuals – thirty migraineurs, 25 women, 19-60 y-o; and 30 gender/age healthy paired controls.Results Migraineurs showed a tendency to perform worse in almost all tests, albeit only the Romberg tandem test was statistically different from controls. A combination of four abnormal tests better discriminated the two groups (93.3% specificity.Conclusion Migraine patients consistently showed abnormal vestibular bedside tests when compared with controls.

  6. The neurobehaviour research on migraine

    Institute of Scientific and Technical Information of China (English)

    Yin Wengang,Ph.D

    2000-01-01

    Neurobehaviour research on migrame has made progress in recont years and this is an important area where attention has been paid on the neuropsycluatrie and neuropsychological symptoms Some migratneurs especially the typical ones (the patients with aura) not only have psychiatric symptoms but also show neuropsychological dysfunction in pereeption, memciy and language. As a consequence, in clirical neurobehaviout field rese,ch has been conducted on these aspects and much more work need to be done. Migraine and amnesia. The finding about the link between GTA and migraine is not a new one, but sone recent studies have made effort on the mechanism of this link. Migraine and dysphasia. There have been some reports which show some relationships belween migraine and aphasia. Case study indicates some migraineurs suffer from motor-aphasia-like language diffculties before headache atteck. Moreover, rite language problems are more evitlent as headache attack the lefl side of the head. Migraine and mood. Reseach using EPQ, MMPI, and SDS have showed that migraineurs have highet score in neurosis. Their inoon are more imstable comtared with normal subjects and more introversed than nonnals. Migraine and perception. It is not only in the visual passway where perceptual problem is indjcated but also in other sensory modulily such as taste, smell, anti bodysensation, the perceptual fifficulities are revealed somctimes. Migraine equivalent More cases have been reportcd in this aspect. It is olear that this special type of migraine could provide a window to see the nenropsychological mecharusm of the syndroms. Finally, the possible relationship between 5-HT and cognitive dysfunctions are discussed with some new findings.

  7. The neurobehaviour research on migraine

    Institute of Scientific and Technical Information of China (English)

    Yin Wengang,Ph.D

    2000-01-01

    Neurobehaviour research on migrame has made progress in recont years and this is an important area where attention has been paid on the neuropsycluatrie and neuropsychological symptoms Some migratneurs especially the typical ones (the patients with aura) not only have psychiatric symptoms but also show neuropsychological dysfunction in pereeption, memciy and language. As a consequence, in clirical neurobehaviout field rese,ch has been conducted on these aspects and much more work need to be done. Migraine and amnesia. The finding about the link between GTA and migraine is not a new one, but sone recent studies have made effort on the mechanism of this link. Migraine and dysphasia. There have been some reports which show some relationships belween migraine and aphasia. Case study indicates some migraineurs suffer from motor-aphasia-like language diffculties before headache atteck. Moreover, rite language problems are more evitlent as headache attack the lefl side of the head. Migraine and mood. Reseach using EPQ, MMPI, and SDS have showed that migraineurs have highet score in neurosis. Their inoon are more imstable comtared with normal subjects and more introversed than nonnals. Migraine and perception. It is not only in the visual passway where perceptual problem is indjcated but also in other sensory modulily such as taste, smell, anti bodysensation, the perceptual fifficulities are revealed somctimes. Migraine equivalent More cases have been reportcd in this aspect. It is olear that this special type of migraine could provide a window to see the nenropsychological mecharusm of the syndroms. Finally, the possible relationship between 5-HT and cognitive dysfunctions are discussed with some new findings.

  8. Effect of the menstrual cycle on inflammatory cytokines in the periodontium.

    Science.gov (United States)

    Khosravisamani, M; Maliji, G; Seyfi, S; Azadmehr, A; Abd Nikfarjam, B; Madadi, S; Jafari, S

    2014-12-01

    The effects of different levels of steroid hormones, as experienced during puberty, pregnancy and menopause, on the periodontium have been demonstrated, but changes in sex hormone levels during the menstrual cycle, and the influence of these changes on the periodontium, remain unresolved. The aim of this study was to investigate the effect of the menstrual cycle on the levels of interleukin-1beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) in gingival crevicular fluid and on periodontal clinical parameters, including the gingival bleeding index (GBI) and the modified gingival index (MGI), in periodontally healthy women. Twenty-seven periodontally healthy women with a regular menstrual cycle were included in the study. Clinical parameters, including the GBI, the MGI and the simplified oral health index, were recorded during menstruation, ovulation and premenstruation phases (e.g. on days 1-2, 12-14 and 22-24, respectively) of the menstrual cycle. Gingival crevicular fluid and unstimulated saliva were collected, at each study phase, for assessment of IL-1β, TNF-α, estrogen and progesterone. Both the GBI and the MGI increased significantly during the menstrual cycle, and were significantly higher during ovulation than during menstruation or premenstruation (p menstrual cycle ( p = 0.18). The levels of IL-1β and TNF-α increased during the different phases of the menstrual cycle, but only the change in the TNF-α concentration was significant ( p menstrual cycle influence the periodontium and induce inflammatory conditions. © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

  9. Auditory function in vestibular migraine

    Directory of Open Access Journals (Sweden)

    John Mathew

    2016-01-01

    Full Text Available Introduction: Vestibular migraine (VM is a vestibular syndrome seen in patients with migraine and is characterized by short spells of spontaneous or positional vertigo which lasts between a few seconds to weeks. Migraine and VM are considered to be a result of chemical abnormalities in the serotonin pathway. Neuhauser′s diagnostic criteria for vestibular migraine is widely accepted. Research on VM is still limited and there are few studies which have been published on this topic. Materials and Methods: This study has two parts. In the first part, we did a retrospective chart review of eighty consecutive patients who were diagnosed with vestibular migraine and determined the frequency of auditory dysfunction in these patients. The second part was a prospective case control study in which we compared the audiological parameters of thirty patients diagnosed with VM with thirty normal controls to look for any significant differences. Results: The frequency of vestibular migraine in our population is 22%. The frequency of hearing loss in VM is 33%. Conclusion: There is a significant difference between cases and controls with regards to the presence of distortion product otoacoustic emissions in both ears. This finding suggests that the hearing loss in VM is cochlear in origin.

  10. Migraine attacks the Basal Ganglia

    Directory of Open Access Journals (Sweden)

    Bigal Marcelo

    2011-09-01

    Full Text Available Abstract Background With time, episodes of migraine headache afflict patients with increased frequency, longer duration and more intense pain. While episodic migraine may be defined as 1-14 attacks per month, there are no clear-cut phases defined, and those patients with low frequency may progress to high frequency episodic migraine and the latter may progress into chronic daily headache (> 15 attacks per month. The pathophysiology of this progression is completely unknown. Attempting to unravel this phenomenon, we used high field (human brain imaging to compare functional responses, functional connectivity and brain morphology in patients whose migraine episodes did not progress (LF to a matched (gender, age, age of onset and type of medication group of patients whose migraine episodes progressed (HF. Results In comparison to LF patients, responses to pain in HF patients were significantly lower in the caudate, putamen and pallidum. Paradoxically, associated with these lower responses in HF patients, gray matter volume of the right and left caudate nuclei were significantly larger than in the LF patients. Functional connectivity analysis revealed additional differences between the two groups in regard to response to pain. Conclusions Supported by current understanding of basal ganglia role in pain processing, the findings suggest a significant role of the basal ganglia in the pathophysiology of the episodic migraine.

  11. Menstrual disturbance and galactorrhea in people taking conventional antipsychotic medications.

    Science.gov (United States)

    Thangavelu, Karthik; Geetanjali, S

    2006-11-01

    Endocrine disturbances are emerging as major side effects of antipsychotic medications. Of particular note is the profile of menstrual disturbance and galactorrhea as a consequence of hyperprolactinemia (A. Weick & P. M. Haddad, 2003), a sequela of antidopaminergic action at the hypothalamopituitary axis. Research into the clinical aspects of this sensitive issue is sparse. The authors completed a cross-sectional descriptive study of 50 patients on conventional antipsychotic medications. The prevalence of menstrual disturbance was 54%, and the prevalence of amenorrhea was 12%. Symptoms of galactorrhea were present in 32% of patients. A history of pregnancy and childbirth was noted to be significantly associated with the development of galactorrhea (p = .01). The authors hypothesized that pregnancy and lactation might sensitize the hypothalamopituitary axis for further development of hyperprolactinemia due to medications.

  12. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults

    DEFF Research Database (Denmark)

    Silberstein, S.; Tfelt-Hansen, P.; Dodick, D.W.

    2008-01-01

    In 1991 the Clinical Trials Subcommittee of the International Headache Society (IHS) developed and published its first edition of the Guidelines on controlled trials of drugs in episodic migraine because only quality trials can form the basis for international collaboration on drug therapy...... to assist in the design of well-controlled clinical trials of chronic migraine in adults, and do not apply to studies in children or adolescents Udgivelsesdato: 2008/5...

  13. 21 CFR 884.5470 - Unscented menstrual tampon.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Unscented menstrual tampon. 884.5470 Section 884... § 884.5470 Unscented menstrual tampon. (a) Identification. An unscented menstrual tampon is a device... absorb menstrual or other vaginal discharge. This generic type of device does not include...

  14. 21 CFR 884.5435 - Unscented menstrual pad.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Unscented menstrual pad. 884.5435 Section 884.5435... § 884.5435 Unscented menstrual pad. (a) Identification. An unscented menstrual pad is a device that is a pad made of cellulosic or synthetic material which is used to absorb menstrual or other...

  15. 21 CFR 801.430 - User labeling for menstrual tampons.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false User labeling for menstrual tampons. 801.430... menstrual tampons. (a) This section applies to scented or scented deodorized menstrual tampons as identified in § 884.5460 and unscented menstrual tampons as identified in § 884.5470 of this chapter. (b)...

  16. Prevalence of Migraine Among Medical Students in Zahedan Faculty of Medicine (Southeast of Iran

    Directory of Open Access Journals (Sweden)

    Mohammad R. Shahrakai

    2011-09-01

    Full Text Available  Introduction: Migraine is a refer pain which is common in adults and children. Migraine and its frequently limits the daily life activities. Since medical students are subjected to stresses regarding lots of tests and the implicit responsibility to the courses, the purpose of the present study carried out to evaluate the prevalence of migraine among medical students in Zahedan University. Methods: This cross-sectional, questionnaire-based study was performed on 210 (male 94 and female 116 medical students in Zahedan faculty of Medicine during an academic year (2005 to 2006. The questionnaire was specified on demographic data and headache questions based on International Headache Society (IHS. Students’ Migraine was confirmed by clinical interviews, general physical and neurological examinations then the data obtained were analyzed using v 11 of SPSS, Chi square. Afterward the percentage and the mean (±SD along with the statistical difference (P<0.05 of the T-tests were calculated. Results and Discussion: The present study showed that the rate of headache during recent academic years was 90.5% in males and 88.8 % in females. The prevalence of migraine was 7.14 % in both sex (migraine without aura 4.29% and migraine with aura 2.86%. The most common of migraine triggers was stress, (73% sleeplessness (52.5%, too much reading (39.25% and fasting (39.55%. In this sense the moderate light and severe incidence were 52.27%, 38.18% and 9.09%. The prevalence of migraine did not have any relations with gender but there was a relation between having migraine and number of studying years.

  17. Cognitive functioning in adolescents with migraine

    Directory of Open Access Journals (Sweden)

    Melissa Andréia Costa-Silva

    Full Text Available Although migraine is highly prevalent in children and teenagers, it often goes undetected in these patients, resulting in underdiagnosis and inadequate treatment. Several studies have investigated cognitive changes in adults with migraine. However, there are few studies focusing on children and adolescents. Objective : To investigate cognitive performance of adolescents with migraine. Methods : Twenty-eight adolescents diagnosed with migraine and twenty-six individuals without a history of headache were recruited for the study. All participants were evaluated using standardized neuropsychological tests. Results : Adolescents with migraine had worse performance on tests evaluating short- and long-term verbal memory, attention, executive function, and speed of processing information than controls. Conclusion : Cognitive dysfunction is common in adolescents with migraine. Since the cognitive deficits found in adolescents with migraine are similar to those reported in adults with migraine, cognitive impairment seems to persist throughout life.

  18. Genetics Home Reference: familial hemiplegic migraine

    Science.gov (United States)

    ... Plomp JJ, Frants RR, van den Maagdenberg AM, Ferrari MD. Genetic models of migraine. Arch Neurol. 2007 ... van den Maagdenberg AM, Haan J, Terwindt GM, Ferrari MD. Migraine: gene mutations and functional consequences. Curr ...

  19. Cyclic Vomiting Syndrome and Migraine in Children

    Directory of Open Access Journals (Sweden)

    Yi-Pei Lin

    2011-06-01

    Conclusion: Results of the study show that younger onset age and headache during CVS attacks may have increased risk of migraine development. Large-scale prospective studies are warranted to further clarify the relationship between CVS and migraine.

  20. Anxiety and Depression Symptomatology in Migraine: Retrospective ...

    African Journals Online (AJOL)

    Anxiety and Depression Symptomatology in Migraine: Retrospective Review of 257 ... Nigerian Journal of Psychiatry ... Objectives: To determine the prevalence of depressive and anxiety symptoms/disorders among patients with migraine ...

  1. Impact of Migraine on School Performance

    Science.gov (United States)

    ... Karceski, MD The impact of migraine on school performance Daniel Kantor, MD e168 WHAT QUESTION DID THE ... overlooked problem: how migraine headache affects the school performance of children. 1 It is bad enough to ...

  2. Incidences of menstrual cycle abnormalities in adolescence, and matches between the age at menarche and the development of menstrual cycle abnormalities.

    Science.gov (United States)

    Art, Mercedes Juliana; Doerfler, Daniela

    2010-08-01

    In this study the clinical data of all girls who visited the ambulance for paediatric and adolescent gynaecology at the university clinic for gynaecology and obstetrics in Vienna between 2001 and 2008 because of menstrual cycle abnormalities were used (n = 255). Most frequently, the girls suffered from dysmenorrhoea (29%), tempoanomaly (24%) and metrorrhagia (19%). For 57%, it was possible to find an underlying cause, mainly (24%) a hormonal one. The therapy was in 54% of all cases hormonal. In a second step, the study analyses matches between the age at menarche and the development of menstrual cycle abnormalities. Girls with primary amenorrhoea were excluded (n = 219). The study shows that every age of menarche has its special kind of menstrual cycle abnormality. Only if the menarche had set in at the age of 16, two kinds were named with equal frequency.

  3. A genotype-phenotype analysis of the 8q22.1 variant in migraine with aura

    DEFF Research Database (Denmark)

    Esserlind, A-L; Kirchmann, M; Hauge, A W

    2012-01-01

    and migraine. The aim of this study is to evaluate the association of clinical characteristics in migraine with aura (MA) with the newly discovered minor allele A of rs1835740 at 8q22.1. Methods: Participants were recruited from the Danish Headache Center and from specialist practices during the periods 1999...

  4. Migraine Headache and Labor Market Outcomes

    OpenAIRE

    REES, DANIEL I.; Sabia, Joseph J.

    2012-01-01

    While migraine headache can be physically debilitating, no study has attempted to estimate its effects on labor market outcomes. Using data drawn from the National Longitudinal Study of Adolescent Health, we estimate the effect of migraine headache on labor force participation, hours worked, and wages. We find that migraine headache is associated with a decrease in wages. However, there is little evidence that migraine headache leads to reductions in labor force participation or hours worked....

  5. Sporadic hemiplegic migraine with permanent neurological deficits.

    Science.gov (United States)

    Schwedt, Todd J; Zhou, Jiying; Dodick, David W

    2014-01-01

    By definition, the neurologic impairments of hemiplegic migraine are reversible. However, a few cases of permanent neurologic deficits associated with hemiplegic migraine have been reported. Herein, we present the case of a patient with permanent impairments because of hemiplegic migraine despite normalization of associated brain magnetic resonance imaging abnormalities. Cases like these suggest the need to consider aggressive prophylactic therapy for patients with recurrent hemiplegic migraine attacks.

  6. Evidence for a vascular factor in migraine

    DEFF Research Database (Denmark)

    Asghar, Mohammad S; Hansen, Adam E; Amin, Faisal Mohammad

    2011-01-01

    It has been suggested that migraine is caused by neural dysfunction without involvement of vasodilatation. Because dismissal of vascular mechanisms seemed premature, we examined diameter of extra- and intracranial vessels in migraine without aura patients.......It has been suggested that migraine is caused by neural dysfunction without involvement of vasodilatation. Because dismissal of vascular mechanisms seemed premature, we examined diameter of extra- and intracranial vessels in migraine without aura patients....

  7. MIGRAINE IN IRANIAN CHILDREN; WHICH CRITERIA ARE THE BEST DIAGNOSTIC CRITERIA?

    Directory of Open Access Journals (Sweden)

    A. Chitsaz

    2008-11-01

    Full Text Available ObjectiveThe aim of this study was to identify the best criteria for diagnosis of migraine in our pediatric population.Materials and MethodsA total of 85 children aged below 15 years who had been referred to the Neurology Clinic of Al-Zahra Hospital with headache as their chief complaint, were enrolled. Validated questionnaires were completed by them. The patients were evaluated using five sets of diagnostic criteria including the Vahlquist, the Prensky, the International Headache Society (IHS, the IHS-Revised (IHS-R, and the Maytal criteria; the sensitivity of each set of criteria was assessed.ResultsOf the 85 children, clinically diagnosed as having migraine, 61 (72%, 73 (86%, 75 (88%, 76 (89.5%, and 76 (89.5% met the criteria of IHS, Vahlquist, Prensky, IHS-R, and Maytal, respectively. Both the IHS-R and Maytal criteria had the highest, while the IHS criteria had the lowest sensitivity. Fifty-four children (63.5% were positive for all five sets of criteria. The application of IHS criteria for diagnosing pediatric migraine led to a smaller percentage of children with migraine being identified.ConclusionAssessment of the sensitivity of the five sets of criteria for the diagnosis of migraine revealed the inadequacies and limitations of the IHS criteria in the diagnosis of pediatric migraine.Key words:Migraine, Child, Diagnosis, Headache

  8. Transient nonverbal learning disorder in a child suffering from Familial Hemiplegic Migraine.

    Science.gov (United States)

    Podestà, Barbara; Briatore, Eleonora; Boghi, Andrea; Marenco, Daniela; Calzolari, Stefano

    2011-10-01

    To study the link between nonverbal learning disorder and right cerebral hemisphere dysfunction due to migraine attack in a case of Familial Hemiplegic Migraine. Familial Hemiplegic Migraine can cause neuropsychological deficits besides the motor ones. The nonverbal learning disorder is thought to be caused by a right hemisphere dysfunction. We describe a child with Familial Hemiplegic Migraine type 2 who showed a transient neuropsychological impairment featuring a nonverbal learning disorder during and after a Hemiplegic migraine attack. Clinical and neuropsychological data showed a nonverbal learning disorder. A mutation in the ATP1A2 gene on chromosome 1q23 was found. Symptoms of nonverbal learning disorder outlasted the left hemiparesis. Two months later he showed a full recovery. Neurophysiological and neuroradiological evaluations were congruent with clinical course and with right hemisphere involvement. The link between nonverbal learning disorder and right cerebral hemisphere dysfunction due to migraine attack is confirmed. Familial Hemiplegic Migraine can cause transient complex neuropsychological syndromes that can be overlooked if not appropriately investigated.

  9. A Case-Control Study of Migraine and Tension-Type Headache’s Risk Factors Among Shiraz Schoolchildren

    Directory of Open Access Journals (Sweden)

    S.M.T. Ayatollahi

    2005-01-01

    Full Text Available Studies of headache risk factors are numerous but their results are based on clinics and hospitals. Few data have been reported in children. No data are available regarding migraine and tension-type headache risk factors among Iranian children. Therefore we determined the sociodemographic risk factors of migraine and tension-type headaches and their correlations in schoolchildren.This study was a matched case-control method using the prevalence study data. The subjects were the patients with migraine and tension-type headache diagnosis (38 schoolchildren with migraine and 122 with tension- type headache. Each case was matched by school, sex and age, for migraine cases three controls and for tension-type headache cases two controls who had never been diagnosed as migraine or tension-type headache were chosen. Cases and controls for migraine and tension-type headache were compared separately for family history of headache , atopic diseases, sleep disorders and socioeconomic class. Conditional logistic regression was used for data analysis. Odds ratio for migraine in schoolchildren who had positive family history of headache was 8.4 (95% CI, 2.8 to 25.4 and for tension-type headache was 2.9 (95% CI, 1.7 to 4.9. The odds ratios for migraine and tension-type headache in students who had abnormal sleeping pattern were 5.6 (95% CI, 1.3 to 20.8 and 4.4 (95% CI, 2.2 to 8.4 times higher than those with normal sleeping pattern. OR of migraine and tension-type headache for atopic diseases were estimated as 15.4, 2.05, respectively. Migraine and tension- type headache were not significantly associated with other factors.It is concluded that family history of headache and sleep disorders had most significant effects on occurrence of migraine and tension-type headache in school children.

  10. Relationship between migraine and epilepsy in pediatric age.

    Science.gov (United States)

    Piccinelli, Paolo; Borgatti, Renato; Nicoli, Francesca; Calcagno, Patrizia; Bassi, Maria Teresa; Quadrelli, Marta; Rossi, Giorgio; Lanzi, Giovanni; Balottin, Umberto

    2006-03-01

    Many studies have supported the hypothesis of alteration of cortical hyperexcitability as a possible pathological mechanism underlying the onset of migraine and epileptic attacks. Different biochemical pathways involving cellular structures may increase or decrease the excitability of neuronal membranes. The aim of this study was to identify a possible link between migraine and epilepsy from a clinical and neurophysiologic point of view. One-hundred thirty-seven children and adolescents consecutively diagnosed for tension-type headache and idiopathic migraine with and without aura were studied. Anamnestic, clinical, and instrumental data were collected by a neurological examination, a specific questionnaire, and awake electroencephalogram (EEG) registrations. EEG features of nonheadache and nonseizures control group were compared. Fourteen cases (10.2%) had a positive history for seizures with fever, isolated seizures, or epilepsy. Distribution differed according to headache diagnosis; migraine with aura (MWA) was largely prevalent. Specific electroencephalographic abnormalities were present in 11.7% of the sample, with a significant different distribution across the groups of children with headache and the control group: specific interictal abnormalities were found in 10 of 23 (43.5%) children with MWA. Two factors, seizures and specific interictal electroencephalographic abnormalities, showed a different distribution in patients with MWA compared to other classes of headache and control group (P < or = .01). The present study supports the hypothesis of a possible clinical continuum between some types of MWA and epileptic syndromes as entities due to altered neuronal excitability with similar genetic substrates.

  11. Body composition and menstrual status in adults with a history of anorexia nervosa-at what fat percentage is the menstrual cycle restored?

    Science.gov (United States)

    Winkler, Laura Al-Dakhiel; Frølich, Jacob Stampe; Schulpen, Maya; Støving, René Klinkby

    2017-04-01

    To study the association between body composition measures and menstrual status in a large sample of adult patients with a history of anorexia nervosa and to calculate the predicted probability of resumption of menstrual function. Furthermore, to establish whether fat percentage is superior to body mass index in predicting the resumption of menses. One hundred and thirteen adult women with a history of anorexia nervosa underwent a dual energy X-ray absorptiometry (DXA) scan and completed questionnaires regarding medication prescription and menstrual function. Fifty percent of patients were expected to resume their menstrual function at a body mass index of 19 kg m(-2) or a fat percentage of 23%. Twenty-five percent of patients were expected to resume their menstrual function at body mass index 14 kg m(-2) or fat percentage 11%. Fat percentage and body mass index were equally capable of predicting the resumption of menses. Fat percentage and body mass index were positive predictors of the resumption of menses, however, body composition measured by dual energy X-ray absorptiometry was not superior to body mass index in predicting menstrual recovery, which is of great clinical relevance as body mass index is easier and cheaper to obtain. Body composition measures only account for one of numerous factors involved in the resumption of menses. Regression models based on our data had a R(2) value of 0.14, indicating that only 14% of the variation in menstrual recovery could be explained by the variables included. © 2016 Wiley Periodicals, Inc.(Int J Eat Disord 2017; 50:370-377). © 2016 Wiley Periodicals, Inc.

  12. Lack of association between urotensin-II (UTS2 gene polymorphisms (Thr21Met and Ser89Asn and migraine

    Directory of Open Access Journals (Sweden)

    Betül Ozan

    2017-07-01

    Full Text Available Migraine is a common neurovascular brain disorder with heterogeneous clinical presentation, including recurrent headache attacks. The pathophysiology of migraine is complex, and a number of genomic regions have been associated with the development of migraine. In this study, we analyzed the allele and genotype frequencies of the urotensin-II gene (UTS2 polymorphisms, Thr21Met and Ser89Asn, among Turkish patients with migraine. A total of 146 patients with migraine (14 with aura [MA group] and 132 without aura [MO group] were genotyped for Thr21Met and Ser89Asn polymorphisms and compared with 154 age- and sex-matched healthy controls. The UTS2 gene polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP. No significant differences were observed in allele and genotype frequencies for Thr21Met and Ser89Asn polymorphisms between the patients with migraine and control group. Similarly, we did not observe significant differences in allele and genotype frequencies between MA and MO and control group. Moreover, the haplotype analysis showed no association between UTS2 gene haplotypes (MN, MS, TN, and TS and migraine. In summary, Thr21Met and Ser89Asn polymorphisms of the UTS2 gene are not risk factors for migraine in our sample of Turkish migraine patients.

  13. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis.

    Science.gov (United States)

    Tarighat Esfanjani, Ali; Mahdavi, Reza; Ebrahimi Mameghani, Mehrangiz; Talebi, Mahnaz; Nikniaz, Zeinab; Safaiyan, Abdolrasool

    2012-12-01

    Given the conflicting results about the positive effects of magnesium and L-carnitine and as there is no report concerning concurrent supplementation of magnesium and L-carnitine on migraine prophylaxis, the effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation on migraine indicators were assessed. In this clinical trial, 133 migrainous patients were randomly assigned into three intervention groups: magnesium oxide (500 mg/day), L-carnitine (500 mg/day), and Mg-L-carnitine (500 mg/day magnesium and 500 mg/day L-carnitine), and a control group. After 12 weeks of supplementation, the checklist of migraine indicators including migraine attacks/month, migraine days/month, and headache severity was completed, and serum concentrations of magnesium and L-carnitine were measured by atomic absorption spectrophotometry and enzymatic UV test, respectively. The results showed a significant reduction in all migraine indicators in all studied groups (p supplemented and control groups (p = 0.008). By separating the effects of magnesium supplementation from other confounding factors such as routine treatments using the repeated measures and nested model, it was clarified that magnesium supplementation had a significant effect on all migraine indicators. Oral supplementation with magnesium oxide and L-carnitine and concurrent supplementation of Mg-L-carnitine besides routine treatments could be effective in migraine prophylaxis; however, larger trials are needed to confirm these preliminary findings.

  14. The Effect of Fennelin,Vitagnus and Mefenamic Acid in the Treatment of Menstrual Bleeding

    Directory of Open Access Journals (Sweden)

    F. Shobeiri

    2014-10-01

    Full Text Available Introduction & Objective: Most women in the course of their lives will experience menstrual bleeding. Some have bleeding almost all the time. Different approaches have been proposed and drugs with fewer side effects are preferred. The aim of this study was to compare the ef-fects of herbal medicines (fennelin & vitagnus and mefenamic acid in the treatment of severity of menstrual bleeding. Materials & Methods: This double blind clinical trial was carried out in one hundred and five students with severe menstrual bleeding at Hamadan University of medical sciences in 2010. The students were randomly grouped in four groups and herbal medicines of fennelin & vitagnus, mefenamic acid and placebo. The severity of menstrual bleeding was detected by the Higham table during one cycle before and two cycles after the intervention. The data analyzed by SPSS/16 and P<0.05 was considered significant. Results: Demographic characteristics of the students were similar in the four groups. There was not a significant difference in the mean of severity of menstrual bleeding during the one cycle before intervention between the four groups, but the difference was significant dur-ing the two cycles after the intervention. Mefenamic acid reduces menstrual bleeding com-pared with vitagnus & fennelin and showed no statistically significant difference. Conclusion: All three drugs; mefenamic acid, fennelin and vitagnus have been effective in reducing menstrual bleeding. The two herbal medicines (vitagnus and fennelin can be used as effective and safe drugs to reduce menstrual bleeding. (Sci J Hamadan Univ Med Sci 2014; 21(3:171-176

  15. 偏头痛采用尼美舒利分散片联合盐酸氟桂利嗪治疗的临床分析%Migraine Clinical Use of Nimesulide Dispersible Joint hydrochloride Flunar-izine Treatment

    Institute of Scientific and Technical Information of China (English)

    杨正运

    2016-01-01

    目的:探讨偏头痛采用尼美舒利分散片联合盐酸氟桂利嗪治疗的临床疗效。方法方便选取该院2014年2月—2016年2月收治的116例偏头痛患者作为研究对象,采取对照研究,按照随机数字对照法分为58例对照组和58例观察组。对照组采用尼美舒利分散片治疗,观察组采用尼美舒利分散片联合盐酸氟桂利嗪治疗;观察对比两组患者治疗前后的头痛病症严重程度、发作次数、持续时长、伴随症状变化情况、临床疗效以及偏头痛对生活影响情况评分。结果治疗后,观察组临床疗效总有效率为79.31%,对照组为49.55%,观察组显著高于对照组(P<0.05);两组治疗后证候评分均比治疗前有显著改善(P<0.05),观察组治疗后的头痛病症严重程度评分为(1.54±0.74)、发作次数评分为(1.01±0.85)、持续时长评分为(1.25±0.85)及伴随症状相关的证候评分为(0.85±0.36),对照组治疗后痛病症严重程度评分为(4.47±1.30)、发作次数评分为(2.79±1.54)、持续时长评分为(2.03±0.96)及伴随症状相关的证候评分为(0.85±0.36),观察组各项证候评分显著低于对照组(P<0.05),差异有统计学意义。结论在偏头痛的临床治疗中结合尼美舒利分散片和盐酸氟桂利嗪治疗能够显著提神给患者的临床治疗效果,同时明显延缓偏头痛的症状,能够降低患者治疗后的病症复发情况,同时改善治疗预后。%Objective To investigate the migraine using nimesulide dispersible tablets clinical efficacy combined with hy-drochloric acid flunarizine treatment. Methods Convenient selection 11 cases in our hospital from February 2014 to Febru-ary 2016 were treated of migraine patients as research subjects to take control study, according to the random number divid-ed into control 58 cases in the control group and 58 cases in the observation group. In the control group using nimesulide tablet

  16. Menstrual Irregularities and Related Plasma Hormone Levels in Multiple Sclerosis Patients Treated with Beta Interferone

    Directory of Open Access Journals (Sweden)

    Ehya Garshasbi

    2010-02-01

    Full Text Available Multiple sclerosis is a chronic inflammatory disease of central nervous system.Women are more susceptible to this disease. One of the obvious clinical complaints in women with multiple sclerosis specially treated with Beta Interferones is menstrual cycle irregularity. The aim of this study was to determine the prevalence of menstrual irregularities and probable changes in blood levels of related hormones (FSH, LH, PRL, TSH, T4, T3 in 58 females with definite MS treated with beta interferones versus 58 healthy women. In comparison to the control group, the patients had higher prevalence of irregular menstruation (P=0.001, oligomenorrhea (p=0.03, abnormal amount of menstrual blood flow (P=0.001, abnormal duration of menstrual flow (P=0.01 and missed period (P=0.04. Mean LH level in patients group was higher than control group (P=0.04.Hyperprolactinemia (>25.5ng/ml was more prevalent in patients group .There were not a significant difference in plasma levels of FSH and thyroid hormones between two groups. There were some relations between the type of Beta interferones and the subtype of menstrual irregularities in the patients. In conclusion, the results of this study emphasized the high rate of menstrual problem and changes of related plasma hormone levels in MS patients.

  17. CRP at early follicular phase of menstrual cycle can cause misinterpretation for cardiovascular risk assessment.

    Science.gov (United States)

    Gursoy, Asli Yarci; Caglar, Gamze Sinem; Kiseli, Mine; Pabuccu, Emre; Candar, Tuba; Demirtas, Selda

    2015-12-01

    C-reactive protein (CRP) is a well-known marker of inflammation and infection in clinical practice. This study is designed to evaluate CRP levels in different phases of menstrual cycle, which might end up with misleading conclusions especially when used for cardiovascular risk assessment. Twenty-seven women were eligible for the cross-sectional study. Venous blood samples from each participant were collected twice during the menstrual cycle. The first sampling was held at 2nd to 5th days of the menstrual cycle for FSH, estradiol, CRP, and sedimentation, and the second was done at 21st to 24th days of the menstrual cycle for measurement of progesterone, CRP, and sedimentation values. CRP values were significantly higher in the early follicular phase compared to luteal phase (1.8 mg/L [0.3-7.67] vs. 0.7 mg/L [0.1-8.3], p menstrual cycle, sedimentation rate was similar (12.1 ± 6.7 vs. 12.3 ± 7.7; p = 0.717, respectively). CRP levels in early follicular phase of the menstrual cycle (menstruation) are significantly higher than CRP levels in luteal phase of the same cycle. In reproductive age women, detection of CRP for cardiovascular risk assessment during menstruation might not be appropriate.

  18. Examination of Migraine Management in Emergency Departments

    Directory of Open Access Journals (Sweden)

    Satnam S Nijjar

    2011-01-01

    Full Text Available BACKGROUND: Despite advances in treatment, patients with migraine have been underdiagnosed and undertreated, specifically in emergency departments. In addition, great variability exists with respect to the diagnosis, management and treatment of migraine patients in emergency departments. In particular, migraine-specific treatments, including serotonin receptor agonists, appear to be rarely used.

  19. The impact of migraine on health status

    NARCIS (Netherlands)

    Essink-Bot, M L; van Royen, L; Krabbe, P; Bonsel, G J; Rutten, F F

    1995-01-01

    PROBLEMS: What is the effect of migraine on health status, defined as the patient's physical, psychological, and social functioning? And, suppose that the health status of migraine sufferers appears to be impaired, to what extent is this a consequence of migraine-associated comorbidity rather than o

  20. Migraine symptomatology and major depressive disorder

    NARCIS (Netherlands)

    Ligthart, Lannie; Penninx, Brenda; Nyholt, Dale R.; Distel, Marijn A.; de Geus, Eco J. C.; Willemsen, Gonneke; Smit, Johannes H.; Boomsma, Dorret I.

    2010-01-01

    Introduction and objective: Migraine and major depressive disorder (MDD) frequently co-occur, but it is unclear whether depression is associated with a specific subtype of migraine. The objective of this study was to investigate whether migraine is qualitatively different in MDD patients (N = 1816)

  1. Clinical study of traditional Chinese medicines based on the regimen of psychosomatic mutual aid treatment in treatment of menstrual disorders women with diminished ovarian reserve%中医心身同治方案对卵巢储备功能下降妇女月经失调的临床疗效

    Institute of Scientific and Technical Information of China (English)

    陈玲; 王小云

    2014-01-01

    目的:观察中医心身同治方案对卵巢储备功能下降妇女月经失调的临床疗效。方法采取随机平行对照临床研究,将50例患者随机分为中医心身同治治疗组25例(中药+情志治疗),对照组25例,采用上市中成药逍遥丸+六味地黄丸治疗。治疗前后观察月经周期、经期、经量状况并对其进行评分量化。同时治疗前后均采用抑郁自评量表( SDS)、焦虑自评量表( SAS)对患者情绪情况进行量化比较。结果治疗后2组SDS评分、SAS均有改善,与治疗前比较差异有统计学意义( P<0.01)。治疗组在改善月经失调积分方面优于对照组,2组差异有统计学意义( P<0.01)。结论中医心身同治方案可以有效改善卵巢储备功能下降妇女月经失调状况,值得推广应用。%Objective To evaluate the clinical efficacy of traditional Chinese medicines based on the regimen of psychosomatic mutual aid treatment in treatment of menstrual disorders women with diminished ovarian reserve . Methods Fifty patients were enrolled and randomized into two groups,namely the experiment group ( using Chinese medicines plus Chinese psychosomatic mutual aid treatment) and the control group( using Xiao yao wan plus Liu wei di huang wan intervention ) . The menstrual cycle, menstrual period and the volume status were evaluated. The self-rating depression scale( SDS) and self-rating anxiety scale( SAS) were used to evaluate patients with emotional situation. Results SDS and SAS scores improved greatly in both groups compared with before treatment(P<0.01). The score of menstrual disorders in the treatment group was higher than that in the control group(P<0.01). Conclusion Chinese medicines based on the regimen of psychosomatic mutual aid treatment can effectively improve the menstrual disorders in women with diminished ovarian reserve,which may be widely applied.

  2. Association of Concussion With Abnormal Menstrual Patterns in Adolescent and Young Women.

    Science.gov (United States)

    Snook, Meredith L; Henry, Luke C; Sanfilippo, Joseph S; Zeleznik, Anthony J; Kontos, Anthony P

    2017-09-01

    Brain injury may interrupt menstrual patterns by altering hypothalamic-pituitary-ovarian axis function. Investigators have yet to evaluate the association of concussion with menstrual patterns in young women. To compare abnormal menstrual patterns in adolescent and young women after a sport-related concussion with those after sport-related orthopedic injuries to areas other than the head (nonhead). This prospective cohort study of adolescent and young women with a sport-related concussion (n = 68) or a nonhead sport-related orthopedic injury (n = 61) followed up participants for 120 days after injury. Patients aged 12 to 21 years who presented within 30 days after a sport-related injury to a concussion or sports medicine clinic at a single academic center were eligible. Menstrual patterns were assessed using a weekly text message link to an online survey inquiring about bleeding episodes each week. The first patient was enrolled on October 14, 2014, and follow-up was completed on January 24, 2016. Inclusion criteria required participants to be at least 2 years postmenarche, to report regular menses in the previous year, and to report no use of hormonal contraception. Sport-related concussion or nonhead sport-related orthopedic injury. Abnormal menstrual patterns were defined by an intermenstrual interval of less than 21 days (short) or more than 35 days (long) or a bleeding duration of less than 3 days or more than 7 days. A total of 1784 survey responses were completed of the 1888 text messages received by patients, yielding 487 menstrual patterns in 128 patients (mean [SD] age, 16.2 [2.0] years). Of the 68 patients who had a concussion, 16 (23.5%) experienced 2 or more abnormal menstrual patterns during the study period compared with 3 of 60 patients (5%) who had an orthopedic injury. Despite similar gynecologic age, body mass index, and type of sports participation between groups, the risk of 2 or more abnormal menstrual bleeding patterns after injury

  3. 正天丸治疗瘀血阻络型偏头痛临床疗效观察%Observation of Clinical Curative Effect of Zhengtian Pill on Treatment of Migraine of Blood Stasis Blocking Channel Type

    Institute of Scientific and Technical Information of China (English)

    梁天山; 吴艳华; 徐念

    2015-01-01

    目的:探讨正天丸治疗瘀血阻络型偏头痛的临床疗效.方法:回顾性分析74例瘀血阻络型偏头痛患者临床资料,根据治疗方法的不同将患者分为观察组(n=41)和对照组(n=33),对照组给予西比灵治疗,观察组则给予正天丸治疗,治疗 8周后对比观察两组临床疗效和治疗前后疼痛视觉模拟评分(VAS)和中医症状积分.结果:观察组总有效率为95.1%,高于对照组的81.8%;两组治疗后VAS评分和中医症状积分均显著低于治疗前;观察组治疗后VAS评分和中医症状积均显著低于对照组治疗后,以上差异有统计学意义(P<0.05).结论:正天丸治疗瘀血阻络型偏头痛临床疗效显著,能有效改善患者中医症状,值得推广.%Objective: To explore the clinical curative effect of Zhengtian pill on migraine of blood stasis blocking channel type. Methods: The clinical materials of 74 cases of migraine of blood stasis blocking channel type were retrospectively analyzed. According to different treatment they received, the patients were divided into observation group (n=41) and the control group (n=33). The control group was given sibeline and the observation group was given Zhengtian pill. Eight weeks after treatment, the clinical curative effect, VAS score and TCM symptom score of the two groups were compared and observed. Results: The total effective rate of the observation group was 95.12% which was higher than that of the control group (P<0.05); after treatment, the VAS score and TCM symptom score of the two groups were significantly lower than that before treatment (P<0.05); after treatment, the VAS score and TCM symptom score of the observation group were significantly lower than that of the control group (P<0.05). The above differences were statistically significant (P<0.05). Conclusion: Zhengtian pill has significant curative effect on migraine of blood stasis blocking channel type. It can effectively improve the TCM symptoms of patients and is

  4. 高压氧治疗基底型偏头痛的临床研究%Clinical research on treating basilar migraine with hyperbaric oxygen

    Institute of Scientific and Technical Information of China (English)

    谷松; 过伟峰

    2014-01-01

    Objective:To observe the curative effect and discuss the mechanism of hyperbaric oxygen on treating basilar migraine. Methods: 65 patients with basilar migraine were randomly divided into the treatment group (n=33) and the control group (n=32) by random number table. Patients in the treatment group were treated by sealed pressure cabin, 0.2 MPa(2.0ATA)for 65min, and mask absorbing pure oxygen for 30min×2, absorbing air for 5min and depressurization for 25min, once daily. Patients in the control group were given orally 10mg flunarizine hydrochloride before sleeping. The curative effects were compared for 10 days, a course of treatment. Results:I Before treatment, there was no significant difference in VAS, VRS and non-painful duration between the two groups (P>0.05); After treatment, VAS and VRS reduced obviously in the two groups (P0.05);After treatment, Vs, Vm and Vd increased in both, and it was clearer in the treatment group (P0.05),治疗后两组 VAS、VRS 均较治疗前明显降低(P0.05);治疗后两组BA的Vs、Vm、Vd均有增加,并且治疗组(P<0.01)改善的程度比对照组(P<0.05)明显,治疗组 PI 明显下降;两组治疗后比较,差异具有明显统计学意义(P<0.01)。结论:两组治疗方法均能够显著改善基底型偏头痛患者发作时头痛程度及发作频度,改善患者基底动脉的血流速度及搏动指数,且高压氧治疗优于药物治疗。高压氧治疗基底型偏头痛有效,其机理之一可能为高压氧能够抑制炎性介质及血小板释放,增加基底动脉供血。

  5. Depression in chronic migraine: severity and clinical features Depressão em migrânea crônica: aspectos clínicos e gravidade

    Directory of Open Access Journals (Sweden)

    Juliane Prieto Peres Mercante

    2005-06-01

    Full Text Available INTRODUCTION: Chronic migraine (CM is a common medical condition affecting 2.4% of the general population. Depression is one of the most frequent comorbid disorders in CM. METHOD: Seventy patients diagnosed with chronic migraine were studied. All patients evaluated filled out the Beck Depression Inventory (BDI. Depression severity was divided into none or minimal depression, mild, moderate, and severe. RESULTS: BDI ranged from 4 to 55, mean 21 ± 10.7. Moderate or severe depression, were present in 58.7% of the patients . Some degree of depression appeared in 85.8% of patients. The BDI scores correlated with pain intensity (p = 0.02. Severe depression was more frequent in patients with comorbid fibromyalgia and in patients reporting fatigue. CONCLUSION: The BDI is an easy tool to access depression in CM patients. Suicide risk assessment is needed in CM patients. Patients with fibromyalgia and fatigue are at even higher risk for severe depression.INTRODUÇÃO: A migrânea crônica (MC é uma doença comum, que afeta 2,4% da população geral. A depressão é uma das comorbidades mais frequentes em enxaqueca. MÉTODO: Setenta pacientes diagnosticados com migrânea crônica foram estudados. Todos os pacientes preencheram o Inventário de Depressão Beck.(BDI. A gravidade da depressão foi dividida em nenhuma ou leve, mínima, moderada, e grave. RESULTADOS: O BDI variou de 4 a 55, média 21 ± 10,7. A depressão moderada ou grave esteve presente em 58,7% dos pacientes. Algum grau de depressão foi observado em 85,8% dos pacientes. Os escores de depressão correlacionaram-se com a intensidade da dor. A depressão grave foi mais freqüente em paciente com comorbidade com fibromialgia e fadiga. CONCLUSÃO: O BDI é um instrumento de fácil avaliação da depressão em MC. A identificação do risco de suicídio é necessária nestes pacientes. Fibromialgia e fadiga são fatores de risco para depressão grave.

  6. Migraine patients should be cautiously followed for risk factors leading to cardiovascular disease

    Directory of Open Access Journals (Sweden)

    Ivan Rocha Ferreira da Silva

    2013-02-01

    Full Text Available Migraine and ischemic strokes are two of the most prevalent diseases worldwide. Besides having a coincident symptomatology, for long researchers have been searching for a possible causal relation between these diseases. Current evidence based on data suggest that patients with aura migraine could have a doubled risk of developing an ischemic stroke, when compared to the rest of the population. At the same time, migraine sufferers apparently have higher incidences of risk factors for cardiovascular events. The aim of this review was not only to dissect some of the more compelling evidence based on data regarding this association, but also to discuss the possible clinical and therapeutic implications.

  7. No Such Thing as Menstrual Memory Fog

    Science.gov (United States)

    ... fullstory_167035.html No Such Thing as Menstrual Memory Fog Changes in hormones don't seem to ... negative impact of hormonal changes on [thinking and memory]," said the study's lead author, Brigitte Leeners. She's ...

  8. Menstrual cycle disorders in female volleyball players.

    Science.gov (United States)

    Wodarska, M; Witkoś, J; Drosdzol-Cop, A; Dąbrowska, J; Dąbrowska-Galas, M; Hartman, M; Plinta, R; Skrzypulec-Plinta, V

    2013-07-01

    The aim of this study was to examine the relation between increased physical activity and menstrual disorders in adolescent female volleyball players. The study was conducted on 210 Polish female volleyball players, aged 13-17 years, the authorship questionnaire was used. The results of the study showed that irregular menstruation occurred in 19% of girls, spotting between menstrual periods in 27% and heavy menstruation was reported in 33% of girls. Out of all volleyball female players participating in the study, 94 girls (45%) declared absence of menstrual periods after regular cycles. Statistical analysis showed that the more training hours per week, the bigger probability of the occurrence of irregular menstruation. It was concluded that the number of hours of volleyball training per week affects regularity of menstrual cycles in female volleyball players. The absence of menstruation might be caused by the duration of training per week or years of training.

  9. Dipyridamole may induce migraine in patients with migraine without aura

    DEFF Research Database (Denmark)

    Kruuse, C; Lassen, L H; Iversen, Helle Klingenberg

    2006-01-01

    Dipyridamole inhibits phosphodiesterase 5 (PDE5) and adenosine re-uptake. The most prominent side-effect is headache. We examined the migraine-generating effects of dipyridamole as well as the cerebral blood velocity response in a single-blind study, including 10 patients with migraine without aura...... and 10 healthy subjects. Dipyridamole 0.142 mg/kg per min was administered intravenously. Headache intensity was scored on a verbal rating scale along with pain characteristics and accompanying symptoms. Blood velocity in the middle cerebral artery (V(mca)), blood pressure and heart rate were recorded...... of dipyridamole on the cGMP signalling pathway as well as a possible bidirectional effect of adenosine on migraine induction....

  10. Menstrual cycling and breast cancer: an evolutionary perspective.

    Science.gov (United States)

    Strassmann, B I

    1999-03-01

    This article attempts to bridge the disciplinary gap between evolutionary biology and clinical studies of women's health. The resulting dialogue is predicted to have useful implications for research aimed at the prevention of women's reproductive cancers. The specific focus is on the relationship between breast cancer and exposure to ovarian hormones during normal menstrual cycling. The clinician's view of normal cycling is radically different from that uncovered by evolutionary studies of noncontracepting populations. This point is illustrated by data on the Dogon of Mali, a traditional West African population with a mean of 8.6 +/- 0.3 live births per woman. The Dogon data include hormonal profiles (urinary estrone-3-glucuronide and pregnanediol-3-glucuronide) of 93 women (sampled twice weekly for 10 weeks) and a census of women's visits to menstrual huts (n = 736 days). Dogon women menstruated regularly only if they were sterile. Otherwise, women aged 20-34 years had a median of only two menses each over the 2-year study period. The median number of menses per lifetime was approximately 100, about a third as many as experienced by an American woman who had three live births. These results contribute to a growing body of evidence that women's bodies were designed by natural selection to spend most of the time in lactational amenorrhea and add support to the view that contraceptives can be made safer if they forego the hormonal swings associated with menstruation. This conclusion is further reinforced by evidence that menstrual bleeding serves no adaptive purpose.

  11. Lateral pterygoid muscle volume and migraine in patients with temporomandibular disorders

    Science.gov (United States)

    Lopes, Sérgio Lúcio Pereira de Castro; Costa, André Luiz Ferreira; Gamba, Thiago de Oliveira; Cruz, Adriana Dibo; Min, Li Li

    2015-01-01

    Purpose Lateral pterygoid muscle (LPM) plays an important role in jaw movement and has been implicated in Temporomandibular disorders (TMDs). Migraine has been described as a common symptom in patients with TMDs and may be related to muscle hyperactivity. This study aimed to compare LPM volume in individuals with and without migraine, using segmentation of the LPM in magnetic resonance (MR) imaging of the TMJ. Materials and Methods Twenty patients with migraine and 20 volunteers without migraine underwent a clinical examination of the TMJ, according to the Research Diagnostic Criteria for TMDs. MR imaging was performed and the LPM was segmented using the ITK-SNAP 1.4.1 software, which calculates the volume of each segmented structure in voxels per cubic millimeter. The chi-squared test and the Fisher's exact test were used to relate the TMD variables obtained from the MR images and clinical examinations to the presence of migraine. Logistic binary regression was used to determine the importance of each factor for predicting the presence of a migraine headache. Results Patients with TMDs and migraine tended to have hypertrophy of the LPM (58.7%). In addition, abnormal mandibular movements (61.2%) and disc displacement (70.0%) were found to be the most common signs in patients with TMDs and migraine. Conclusion In patients with TMDs and simultaneous migraine, the LPM tends to be hypertrophic. LPM segmentation on MR imaging may be an alternative method to study this muscle in such patients because the hypertrophic LPM is not always palpable. PMID:25793177

  12. A Clinical Observation on Treating migraine by the Combination of scalp Acupuncture and Craniosacral Therapy%头针配合颅骶疗法治疗偏头痛的疗效观察

    Institute of Scientific and Technical Information of China (English)

    吴靖国; 李君; 黄泳; 曲姗姗

    2011-01-01

    目的:观察头针配合颅骶疗法治疗偏头痛的临床疗效.方法:62例慢性偏头痛患者随机分为对照组和治疗组,对照组患者接受单纯头针治疗,治疗组患者合并颅骶疗法,每周2次,治疗4周为一观察周期.治疗结束1个月后,观察临床疗效,并进行疼痛积分及各亚项分数评定.结果:治疗组和对照组比较,疗效没有显著性差异(P>0.05).两组治疗后疼痛积分总分比较没有显著性差异(P>0.05).各组头痛发作次数、疼痛程度、持续时间、伴随症状等亚项评分,与治疗前比较,均有显著降低(P>0.01~0.05).其中,治疗组治疗后疼痛持续时间亚项评分,与对照组治疗后比较,有显著性降低(P>0.05).结论:头针配合颅骶疗法,治疗偏头痛疗效肯定,在减少疼痛持续时间方面效果较好.%Objective-.To observe the clinical efficacy of treating migraine by the combination of scalp acupuncture and Cranio-sacral Therapy. Methods: Sixty - two cases of migraine were divided into 2 groups. Patients in control group received the treatment of scalp acupuncture,while patients in treatment group combined the Craniosacral Therapy. The treatment were arranged 2 times a week and continued for 4 weeks. One month after the treatment, the clinical efficacy and the general and sub - factor scores of Pain scale were assessed. Results: The clinical efficacies of the two groups had not any different (P > 0. 05). After the treatment, the general score and the sub - factor scores of Pain scale decreased obviously compared with those of before treatment respectively in two groups (P >0. 01). While the comparison between two groups after treatment showed, the continued painful time of treatment group was shortened than that of control group. Conclusion: Scalp acupuncture combined with Craniosacral Therapy has a good effect on treating migraine, manifested as shortening the painful time especially.

  13. Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.

    Science.gov (United States)

    Ho, T W; Fan, X; Rodgers, A; Lines, C R; Winner, P; Shapiro, R E

    2009-07-01

    This study examined the effect of age on placebo response rates in rizatriptan trials in adults. Data from eight rizatriptan adult trials involving patients treating moderate/severe migraine attacks with rizatriptan 5 mg (N = 1819), rizatriptan 10 mg (N = 2046) or placebo (N = 1322) were pooled for post hoc analysis. Logistic r